2025/04/01 更新

写真a

ウエノ シュウイチ
上野 修一
Ueno Shu-Ichi
所属
大学院医学系研究科 医学専攻 教授
職名
教授
連絡先
メールアドレス
プロフィール
精神科医です。精神神経疾患の分子生物学的解析に興味があります。よろしくお願いします。
外部リンク

学位

  • 医学博士 ( 愛媛大学 )

研究キーワード

  • 精神障害の薬理遺伝学

  • 包括脳ネットワーク

  • 定量的RT-PCR

  • CAG伸張病

  • TMEMI

  • VEGF

  • hDW

  • PCNT2遺伝子

  • 統合失調症

  • うつ病

  • DNAチップ

  • 気分障害

  • molecular biology of mental disorder

  • 遺伝子多型解析

  • 脳・神経

  • 家系解析

  • 常染色体劣性遺伝

  • SNP多型

  • ドーパミントランスポーター

  • 遺伝子発現

  • 末梢血白血球

  • 有棘赤血球舞踏病

  • ハプロタイプ解析

  • 逆転写酵素-PCR

  • 転写因子

  • 歯状核赤核淡蒼球ルイ体萎縮症

  • 遺伝子転写

  • マイクロアレイ

  • ラット

  • 選択的神経細胞死

  • 遺伝子発現解析

  • 常染色体劣性神経変性疾患

  • 遺伝子関連解析

  • pharnacogenomics of mental disorder

  • 精神障害の分子生物学

研究分野

  • ライフサイエンス / 精神神経科学

  • ライフサイエンス / 神経科学一般

学歴

  • 愛媛大学   医学研究科   機能系

    - 1990年

      詳細を見る

    国名: 日本国

    researchmap

  • 愛媛大学

    - 1990年

      詳細を見る

  • 徳島大学   医学部   医学科

    - 1985年

      詳細を見る

    国名: 日本国

    researchmap

  • 徳島大学

    - 1985年

      詳細を見る

経歴

  • 愛媛大学   医学(系)研究科(研究院)   教授

    2011年 - 2015年

      詳細を見る

  • - 愛媛大学大学院 医学系研究科 教授

    2008年

      詳細を見る

  • - 徳島大学医学部 教授

    2006年

      詳細を見る

  • - Assicuate Professor,The University of Tokushima

    2002年

      詳細を見る

  • - 徳島大学医学部 助教授

    2002年

      詳細を見る

  • School of Medicine

      詳細を見る

▼全件表示

所属学協会

▼全件表示

委員歴

  • 日本神経精神薬理学会   評議員  

    2013年 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本老年精神医学会   評議員  

    2013年 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本臨床精神薬理学会   理事  

    2012年 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本精神科診断学会   理事  

    2008年 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本生物学的精神医学会   評議員  

    2003年   

      詳細を見る

    団体区分:学協会

    日本生物学的精神医学会

    researchmap

  • Japanese Society for Neurochemistry   councilor  

    2000年   

      詳細を見る

    団体区分:学協会

    Japanese Society for Neurochemistry

    researchmap

  • 日本神経化学会   評議員  

    2000年   

      詳細を見る

    団体区分:学協会

    日本神経化学会

    researchmap

  • 日本精神神経学会   代議員  

      詳細を見る

    団体区分:学協会

    researchmap

▼全件表示

取得資格

  • 医師免許

論文

  • Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model Mice. 国際誌

    Hiroaki Mori, Yuta Yoshino, Mariko Okano, Yu Funahashi, Hiroshi Kumon, Shinichiro Ochi, Jun-Ichi Iga, Shu-Ichi Ueno

    Neuropsychopharmacology reports   45 ( 1 )   e12515   2025年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: Recent studies have implicated autophagy in both weight regulation and depression. This study aimed to investigate the relationship between stress-induced weight loss and autophagy-related gene expression in a mouse model of depression. METHOD: Male C57BL/6 mice were subjected to a chronic immobilization stress (CIS) protocol for 14 days to induce depressive-like behavior. Body weight was measured before and after the CIS, and depressive-like behavior was assessed using the tail suspension test (TST). The expression levels of autophagy-related genes (Atg5, Atg7, Atg12, Becn1, Mmp9, Fkbp5, and Map1lc3b) in the hippocampus and midbrain were evaluated using reverse transcription-quantitative PCR (RT-qPCR). Serum cortisol levels were also measured. RESULTS: The CIS resulted in significant weight loss and increased immobility time in the TST, indicating depressive-like behavior. Serum cortisol levels were not different between CIS-depression model and control mice. In the hippocampus, the expression levels of Fkbp5, Mmp9, and Map1lc3b were significantly higher in CIS-depression model mice than in control mice. In the midbrain, the expression levels of Fkbp5 and Mmp9 were significantly higher in CIS-depression model mice than in control mice. Increased autophagy-related gene expressions in CIS-depression model mice were consistent with the previous studies in the postmortem brains of patients with depression. A significant negative correlation was also found between Fkbp5 mRNA expression in the hippocampus and the weight change ratio before and after the CIS. CONCLUSION: The findings suggest that enhanced autophagy may be related to the pathology of depression and that Fkbp5, an autophagy regulator, mediates stress-induced weight loss.

    DOI: 10.1002/npr2.12515

    PubMed

    researchmap

  • The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment. 国際誌

    Shinichiro Ochi, Takashi Tsuboi, Naomi Hasegawa, Hikaru Hori, Kayo Ichihashi, Yayoi Imamura, Tsuyoshi Okada, Fumitoshi Kodaka, Yoshitaka Saito, Jun-Ichi Iga, Toshiaki Onitsuka, Kiyokazu Atake, Shu-Ichi Ueno, Ryota Hashimoto, Norio Yasui-Furukori

    Neuropsychopharmacology reports   2024年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: Constipation is one of the most common adverse effects in schizophrenia treatment, and it can sometimes cause severe gastrointestinal disease. However, the results of association studies between constipation and psychotropic medications in patients with schizophrenia are inconsistent. Therefore, we investigated the characteristics of psychotropic and laxative prescriptions at discharge in patients with schizophrenia to clarify the association between psychotropics and constipation. METHODS: We analyzed the data of 139 patients with schizophrenia with or without laxative prescriptions at discharge from eight institutions in 2020. RESULTS: Sixty-two patients were prescribed laxatives at discharge. The prescription of benzodiazepines in the laxative use group (66.1%) was significantly higher than that in the non-laxative use group (39.0%) (p = 1.4 × 10-3), and the mean number of benzodiazepines in the laxative use group (1.2 ± 1.1/day) was significantly higher than that in the non-laxative use group (0.7 ± 0.9/day) (p = 2.6 × 10-3). Multivariate logistic regression analyses revealed that benzodiazepine prescriptions were significantly associated with laxative usage (odds ratio, 3.059; 95% confidence interval, 1.523-6.144; p = 2.0 × 10-3). CONCLUSION: Benzodiazepines may be associated with constipation in patients with schizophrenia. Therefore, clinicians should be cautious when prescribing benzodiazepines for the treatment of schizophrenia.

    DOI: 10.1002/npr2.12499

    PubMed

    researchmap

  • Behavioral and psychological symptoms and brain volumes in community-dwelling older persons from the Nakayama Study. 国際誌

    Ayumi Tachibana, Jun-Ichi Iga, Tomoki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, Shinichiro Ochi, Kentaro Kawabe, Fumie Horiuchi, Taku Yoshida, Hideaki Shimizu, Takaaki Mori, Yasuko Tatewaki, Yasuyuki Taki, Toshiharu Ninomiya, Shu-Ichi Ueno

    Scientific reports   14 ( 1 )   26097 - 26097   2024年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The frequency of behavioral and psychological symptoms of dementia (BPSD) is high, and it is a challenge to elucidate its neural substrates underlying their development. In recent years, many findings have been reported on the relationship between BPSD and brain volume in dementia patients. However, the results are not fully conclusive. Furthermore, there have been few population-based studies. Therefore, the relationship between BPSD and brain volume was investigated as an exploratory study. Of the 927 older persons who participated in the fifth Nakayama study, 90 were included in this analysis, consisting of 52 patients with mild cognitive impairment and 38 patients with dementia, with head MRI and the Neuropsychiatric Inventory (NPI) data. Multiple regression analysis was used to examine the association between the total score of each BPSD score on the NPI and brain volume estimated by FreeSurfer. On multivariate adjustment, even after false discovery rate correction, insular cortical volumes decreased significantly as total scores for apathy/indifference increased (p value = 0.002, q-value = 0.01). Similarly, total brain volume decreased significantly as total scores for appetite and eating disturbance increased (p value = 0.03), and parietal, temporal, and hippocampal cortical volumes also decreased significantly as total scores for appetite and eating disturbance increased (all p and q values < 0.05). This study's results suggest that apathy is negatively correlated with insular cortical volume, and that appetite and eating disturbance are also correlated with brain regions, including parietal, temporal, and hippocampal volume in a community-dwelling older population.

    DOI: 10.1038/s41598-024-77477-5

    PubMed

    researchmap

  • うつはmicroRNA-20a-5pと関与しアルツハイマー病発症リスクを増加させるかもしれない

    岡野 真梨子, 吉野 祐太, 舟橋 裕, 近藤 航平, 森 大晃, 久門 啓志, 伊賀 淳一, 上野 修一

    Dementia Japan   38 ( 4 )   671 - 671   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • Blood RNA transcripts show changes in inflammation and lipid metabolism in Alzheimer's disease and mitochondrial function in mild cognitive impairment. 国際誌

    Jun-Ichi Iga, Yuta Yoshino, Tomoki Ozaki, Ayumi Tachibana, Hiroshi Kumon, Yu Funahashi, Hiroaki Mori, Mariko Ueno, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Masakatsu Yamashita, Shu-Ichi Ueno

    Journal of Alzheimer's disease reports   8 ( 1 )   1690 - 1703   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Abnormal immunity in the periphery has been reported in the pathogenesis of Alzheimer's disease (AD). OBJECTIVE: In this study, blood transcriptome analyses of patients with AD, those with mild cognitive impairment (MCI) due to AD, and heathy controls were performed to elucidate immune-related pathophysiology. METHODS: The sample included 63 participants from a complete enumeration study of elderly people in Nakayama town (the Nakayama Study), who were over 65 years of age, diagnosed as (1) healthy controls (N = 21, mean age: 83.8 years), (2) having MCI due to AD (N = 20, mean age: 82.6 years), or (3) having AD (N = 21, mean age: 84.2 years). Every participant underwent blood tests, magnetic resonance imaging, and questionnaires about lifestyle and cognitive function. With transcriptome analysis, differential gene expressions in the blood of the three groups were evaluated by gene ontology, pathway enrichment, and ingenuity pathway analyses, and quantitative real-time PCR was performed. RESULTS: Neutrophil extracellular trap signaling was increased, and lipid metabolism (FXR/RXR activation, triacylglycerol degradation) was decreased in AD, whereas MCI showed protective responses via decreased neutrophil extracellular trap signaling and mitochondrial functions such as upregulation of the sirtuin pathway and downregulation of oxidative stress. CONCLUSIONS: Based on these findings and consistent with other published studies, immune cells appear to have important roles in the pathogenesis of AD, and the transcriptome in blood may be useful as a biomarker for diagnosis via monitoring immunity in MCI and AD.

    DOI: 10.1177/25424823241307878

    PubMed

    researchmap

  • Effects of gestational haloperidol exposure on mRNA expressions related to glutamate and GABA receptors in offspring. 国際誌

    Hiroshi Kumon, Yuta Yoshino, Yu Funahashi, Shinichiro Ochi, Jun-Ichi Iga, Shu-Ichi Ueno

    IBRO neuroscience reports   15   281 - 286   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Antipsychotic treatment is vital for patients with schizophrenia even in the perinatal period, but the impact at the molecular biological level on offspring is unclear. The aim of the present study was to investigate the effects of intraperitoneal haloperidol injection to pregnant mice on glutamate and GABA receptors in the brain of offspring mice. Eight-week-old pregnant mice were treated with either intraperitoneal haloperidol or normal saline injection, and their offspring were defined as F1 mice. In addition, eight-week-old male mice were used as acute mice that were intraperitoneally injected with haloperidol or normal saline for 20 days. mRNA expression levels were measured by RT-qPCR. Western blotting was performed of the frontal lobes of F1 mice. In the hippocampi of F1 mice, Grik3 (p = 0.023) and Gabra3 (p = 0.004) mRNA expression levels were significantly higher in the haloperidol group than in the control group, whereas Gria2 (p < 0.001) and Grin2a (p < 0.001) mRNA expression levels were significantly lower in the haloperidol group than in the control group. Gria2 (p = 0.015), and Grik3 (p = 0.037), and Grin2a (p = 0.012) mRNA expression levels were significantly lower in the haloperidol group than in the control group in the frontal lobes of F1 mice. In the hippocampi of acute mice, Grik3 (p = 0.049) and Gabra3 (p = 0.007) mRNA expression levels were significantly decreased in the haloperidol group. Fetal exposure to haloperidol can affect glutamate and GABA receptors through mRNA expression changes in the brain of offspring.

    DOI: 10.1016/j.ibneur.2023.09.012

    PubMed

    researchmap

  • Analysis of factors related to cognitive impairment in a community‐based, complete enumeration survey in Japan: the Nakayama study 国際誌

    Taku Yoshida, Takaaki Mori, Hideaki Shimizu, Ayumi Tachibana, Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Yuki Ozaki, Kentaro Kawabe, Fumie Horiuchi, Kenjiro Komori, Jun-ichi Iga, Shu‐ichi Ueno

    Psychogeriatrics   23 ( 5 )   876 - 884   2023年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    BACKGROUND: The number of patients with cognitive disorders is rapidly increasing in the world, becoming not only a medical problem, but also a social problem. There have been many reports that various factors are associated with cognitive dysfunction, but the factors have not yet been fully identified. This was a community-based complete enumeration study which aimed to identify risk and protective factors for dementia. METHODS: The first phase included all residents aged 65 years or older in a town in Japan. They completed many examinations, such as living conditions questionnaires, physical examination, Mini-Mental State Examination, and brain magnetic resonance imaging. The participants with suspected cognitive impairment underwent additional examinations for detailed evaluation in the second phase. Statistical analysis was performed to identify risk and protective factors for dementia after all participants were diagnosed. RESULTS: There were 927 participants in the baseline evaluation; 611 (65.9%) were healthy, 165 (17.8%) had mild cognitive impairment (MCI), and 151 (16.3%) had dementia. The age-standardised prevalence of dementia was 9.5%. Statistical analyses for amnestic MCI and Alzheimer's disease showed that risk factors for cognitive decline were diabetes mellitus, low activities of daily living, and living alone, and that protective factors were history of exercise and drinking habit. CONCLUSION: The present findings suggest that several lifestyle-related diseases and factors are associated with cognitive decline. These results support similar findings from previous studies and will be helpful for preventing dementia in the future.

    DOI: 10.1111/psyg.13012

    PubMed

    researchmap

  • クロザピンが処方可能な施設体制と治療抵抗性の検討が統合失調症の抗精神病薬単剤治療に関連する

    越智 紳一郎, 小高 文聰, 長谷川 尚美, 古郡 規雄, 伊賀 淳一, 柏木 宏子, 小松 浩, 田形 弘実, 坪井 貴嗣, 沼田 周助, 飯田 仁志, 五十嵐 俊, 大井 一高, 高江洲 義和, 福本 健太郎, 村岡 寛之, 三浦 健一郎, 松本 純弥, 上野 修一, 渡邊 衡一郎, 稲田 健, 橋本 亮太

    精神神経学雑誌   ( 2023特別号 )   S694 - S694   2023年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease. 国際誌

    Hiroaki Mori, Yuta Yoshino, Jun-Ichi Iga, Shinichiro Ochi, Yu Funahashi, Kiyohiro Yamazaki, Hiroshi Kumon, Yuki Ozaki, Shu-Ichi Ueno

    Journal of Alzheimer's disease : JAD   2023年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: We explored the gene expression levels in the brain of 3xTg-AD model mice to elucidate the molecular pathological changes from the early to end stages of Alzheimer's disease (AD). OBJECTIVE: We re-analyzed our previously published microarray data obtained from the hippocampus of 3xTg-AD model mice at 12 and 52 weeks of age. METHODS: Functional annotation and network analyses of the up- and downregulated differentially expressed genes (DEGs) in mice aged 12 to 52 weeks were performed. Validation tests for gamma-aminobutyric acid (GABA)-related genes were also performed by quantitative polymerase chain reaction (qPCR). RESULTS: In total, 644 DEGs were upregulated and 624 DEGs were downregulated in the hippocampus of both the 12- and 52-week-old 3xTg-AD mice. In the functional analysis of the upregulated DEGs, 330 gene ontology biological process terms, including immune response, were found, and they interacted with each other in the network analysis. In the functional analysis of the downregulated DEGs, 90 biological process terms, including several terms related to membrane potential and synapse function, were found, and they also interacted with each other in the network analysis. In the qPCR validation test, significant downregulation was seen for Gabrg3 at the ages of 12 (p = 0.02) and 36 (p = 0.005) weeks, Gabbr1 at the age of 52 weeks (p = 0.001), and Gabrr2 at the age of 36 weeks (p = 0.02). CONCLUSION: Changes in immune response and GABAergic neurotransmission may occur in the brain of 3xTg mice from the early to end stages of AD.

    DOI: 10.3233/JAD-230078

    PubMed

    researchmap

  • Gestational Exposure to Haloperidol Changes Cdkn1a and Apaf1 mRNA Expressions in Mouse Hippocampus. 国際誌

    Hiroshi Kumon, Yuta Yoshino, Tomoki Ozaki, Yu Funahashi, Hiroaki Mori, Mariko Ueno, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Jun-Ichi Iga, Shu-Ichi Ueno

    Brain research bulletin   199   110662 - 110662   2023年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The onset of schizophrenia is associated with both genetic and environmental risks during brain development. Environmental factors during pregnancy can represent risk factors for schizophrenia, and we have previously reported that several microRNA and mRNA expression changes in fetal brains exposed to haloperidol during pregnancy may be related to the onset of this disease. This study aimed to replicate that research and focused on apoptotic-related gene expression changes. METHODS: Haloperidol (1mg/kg) or aripiprazole (1mg/kg) was injected into pregnant mice. Using RNA sequencing for the hippocampus of each offspring born from pregnant mice exposed to haloperidol, we analyzed genes identified as changed in our previous report and validated two apoptosis-related genes (Cdkn1a and Apaf1) using quantitative polymerase chain reaction (qPCR) methods. Furthermore, we attempted to elucidate the direct effects of haloperidol and aripiprazole on those mRNA expressions in in vitro experiments. RESULTS: RNA sequencing successfully replicated 16 up-regulated and 5 down-regulated genes in this study. Of those, up-regulations of Cdkn1a and Apaf1 mRNA expression were successfully validated by direct quantification. Moreover, haloperidol and aripiprazole dose-dependent upregulation of both mRNA expressions were confirmed in a Neuro2a cell line. CONCLUSIONS: In the hippocampus of offspring, intraperitoneal injection of haloperidol to pregnant mice induced up-regulation of apoptotic genes that representing the phenotypic change without apoptosis. These findings will be useful for understanding the molecular biological mechanisms underlying the effects of antipsychotics on the fetal brain.

    DOI: 10.1016/j.brainresbull.2023.110662

    PubMed

    researchmap

  • Lewy小体型認知症に先行した抑うつ症状により診断に苦慮した1例

    片田 未来, 井上 彩織, 森 大晃, 高石 裕介, 山崎 聖広, 越智 紳一郎, 河邉 憲太郎, 上野 修一

    精神神経学雑誌   125 ( 4 )   323 - 323   2023年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders 査読

    Hirotaka Yamagata, Ryouichi Tsunedomi, Toshiharu Kamishikiryo, Ayumi Kobayashi, Tomoe Seki, Masaaki Kobayashi, Kosuke Hagiwara, Norihiro Yamada, Chong Chen, Shusaku Uchida, Hiroyuki Ogihara, Yoshihiko Hamamoto, Go Okada, Manabu Fuchikami, Jun-ichi Iga, Shusuke Numata, Makoto Kinoshita, Takahiro A. Kato, Ryota Hashimoto, Hiroaki Nagano, Shuichi Ueno, Yasumasa Okamoto, Tetsuro Ohmori, Shin Nakagawa

    Heliyon   9 ( 1 )   e13059 - e13059   2023年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.heliyon.2023.e13059

    researchmap

  • Effects of social media on body dissatisfaction in junior high school girls in Japan. 国際誌

    Rie Hosokawa, Kentaro Kawabe, Kiwamu Nakachi, Junya Soga, Fumie Horiuchi, Shu-Ichi Ueno

    Eating behaviors   48   101685 - 101685   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIMS: Body dissatisfaction (BD) is a serious problem related to the incidence of eating disorders. Social media (SM) use is known to be associated with BD. With a view to preventing the incidence of eating disorders, this study aimed to investigate the association between SM and BD, particularly, the role of SM in the encouragement of thinness and its relationship with adolescent girls' BD. METHODS: Junior high school girls aged 12-15 in Japan completed the Body Shape Questionnaire (BSQ), Eating Attitudes Test-26, Bulimic Investigatory Test Edinburgh, Depression Self-Rating Scale for Children, and SM usage. Participants were classified into two groups based on their BSQ cut-off score. RESULTS: Overall, 161 students were recruited (44 participants with BD; 117 without BD). The BD group used SM more than the non-BD group (χ2 (1) = 4.61, p = .032). The frequency of following SM accounts related to thinness was significantly higher in the BD group than in the non-BD group (χ2 (1) = 7.76, p = .005). The association between BD and following SM accounts focused on thinness was the most important (adjusted OR = 3.82; 95 % CI: 1.05-13.89). CONCLUSIONS: The risks of SM use increasing BD in adolescent girls should be considered to prevent mental disorders, including eating disorders.

    DOI: 10.1016/j.eatbeh.2022.101685

    PubMed

    researchmap

  • School teachers' awareness of internet addiction in elementary school students: a regional survey in Japan. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu-Ichi Ueno

    Frontiers in psychiatry   14   1187387 - 1187387   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In recent years, concerns about internet addiction (IA) among children have been increasing. This study focused on the awareness of IA in elementary school teachers. A web-based anonymous survey was conducted in November 2021. The participants completed an original questionnaire about their awareness of IA. The participants were divided into three groups based on their positions in the classroom: class teachers, support teachers, and administrative teachers. Out of 283 participants, over 70% had not approached students with IA and had little practical knowledge about the disorder. Support and administrative teachers had more opportunities to interact with students with IA than class teachers (p < 0.001 in both cases). Support teachers had more opportunities to ask their colleagues about IA than class teachers (p < 0.01); similarly, administrative teachers also had more opportunities to discuss IA with colleagues than class teachers (p = 0.04). Preventive interventions are recommended for people who communicate with children with IA. Students with IA might cause anxiety among teachers; therefore, preventive education strategies should be implemented with the cooperation of psychiatrists, psychologists, and public health nurses.

    DOI: 10.3389/fpsyt.2023.1187387

    PubMed

    researchmap

  • MiR-15b-5p Expression in the Peripheral Blood: A Potential Diagnostic Biomarker of Autism Spectrum Disorder

    Rie Hosokawa, Yuta Yoshino, Yu Funahashi, Fumie Horiuchi, Jun-ichi Iga, Shu-ichi Ueno

    Brain Sciences   2022年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.3390/brainsci13010027

    researchmap

  • Blood <i>MAPT</i> expression and methylation status in Alzheimer's disease

    Hiroaki Mori, Yuta Yoshino, Mariko Ueno, Yu Funahashi, Hiroshi Kumon, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Jun‐ichi Iga, Shu‐ichi Ueno

    Psychiatry and Clinical Neurosciences Reports   1 ( 4 )   2022年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1002/pcn5.65

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pcn5.65

  • Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer's disease (from the Nakayama Study). 国際誌

    Tomoki Ozaki, Yuta Yoshino, Ayumi Tachibana, Hideaki Shimizu, Takaaki Mori, Tomohiko Nakayama, Kazuaki Mawatari, Shusuke Numata, Jun-Ichi Iga, Akira Takahashi, Tetsuro Ohmori, Shu-Ichi Ueno

    Scientific reports   12 ( 1 )   15205 - 15205   2022年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Alzheimer's disease (AD) is a progressive disease, and the number of AD patients is increasing every year as the population ages. One of the pathophysiological mechanisms of AD is thought to be the effect of metabolomic abnormalities. There have been several studies of metabolomic abnormalities of AD, and new biomarkers are being investigated. Metabolomic studies have been attracting attention, and the aim of this study was to identify metabolomic biomarkers associated with AD and mild cognitive impairment (MCI). Of the 927 participants in the Nakayama Study conducted in Iyo City, Ehime Prefecture, 106 were selected for this study as Control (n = 40), MCI (n = 26), and AD (n = 40) groups, matched by age and sex. Metabolomic comparisons were made across the three groups. Then, correlations between metabolites and clinical symptoms were examined. The blood mRNA levels of the ornithine metabolic enzymes were also measured. Of the plasma metabolites, significant differences were found in ornithine, uracil, and lysine. Ornithine was significantly decreased in the AD group compared to the Control and MCI groups (Control vs. AD: 97.2 vs. 77.4; P = 0.01, MCI vs. AD: 92.5 vs. 77.4; P = 0.02). Uracil and lysine were also significantly decreased in the AD group compared to the Control group (uracil, Control vs. AD: 272 vs. 235; P = 0.04, lysine, Control vs. AD: 208 vs. 176; P = 0.03). In the total sample, the MMSE score was significantly correlated with lysine, ornithine, thymine, and uracil. The Barthel index score was significantly correlated with lysine. The instrumental activities of daily living (IADL) score were significantly correlated with lysine, betaine, creatine, and thymine. In the ornithine metabolism pathway, the spermine synthase mRNA level was significantly decreased in AD. Ornithine was decreased, and mRNA expressions related to its metabolism were changed in the AD group compared to the Control and MCI groups, suggesting an association between abnormal ornithine metabolism and AD. Increased betaine and decreased methionine may also have the potential to serve as markers of higher IADL in elderly persons. Plasma metabolites may be useful for predicting the progression of AD.

    DOI: 10.1038/s41598-022-19670-y

    PubMed

    researchmap

  • Takotsubo cardiomyopathy associated with pneumatosis cystoides intestinalis and postprandial hypoglycemia of anorexia nervosa

    Shinichiro Ochi, Noboru Sano, Jun‐ichi Iga, Shu‐ichi Ueno

    Psychiatry and Clinical Neurosciences Reports   1 ( 3 )   2022年9月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1002/pcn5.33

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pcn5.33

  • 【一般身体疾患による精神症状とその薬物療法】感染性疾患に伴う精神障害に対する薬物療法の適応と注意すべき点

    越智 紳一郎, 上野 修一

    臨床精神薬理   25 ( 8 )   885 - 894   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    感染症による精神疾患においては、感染症が直接引き起こす器質性精神障害と、既知の精神障害が感染症によって影響される場合とがある。前者の代表例として神経梅毒が挙げられる。一方、新型コロナウイルス感染症(COVID-19)では、双方が引き起こされる可能性がある。また、抗菌薬など身体治療による精神症状の発現や向精神薬との薬物相互作用にも気をつけなければならない。この稿では、これら感染症による精神障害の捉え方、そこで注意することに触れた後に、最後に、薬物以外で心に留めなければいけないことについても概説する。(著者抄録)

    researchmap

  • Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. 国際誌

    Yu Funahashi, Yuta Yoshino, Jun-Ichi Iga, Shu-Ichi Ueno

    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry   1 - 11   2022年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVES: Recently, the expression changes of microRNAs (miRNAs) in the serum exosomes (EXO) of schizophrenia (SCZ) have been reported. The aim of this study was to investigate the global expression changes of miRNA derived from the plasma EXO of patients with treatment-resistant schizophrenia (TRS) and the effects of clozapine on miRNA expression. METHODS: Global miRNA expression changes in plasma EXO between TRS and controls were studied using microarray analysis. Then, miRNA expressions among TRS, non-TRS, and controls were confirmed with quantitative qPCR experiments. We also studied changes in EXO miRNA expression with in-vitro SH-SY5Y cells. RESULTS: A microarray for miRNA expression analysis (nine controls vs. nine patients with TRS) revealed 13 up- and 18 downregulated miRNAs that were relevant to neuronal and brain development based on gene ontology analysis. Of those, upregulated miR-675-3p expression was successfully validated in the same cohort by qPCR experiments. Conversely, miR-675-3p expression levels were significantly decreased in the non-TRS cohort (50 controls vs. 50 patients without TRS without clozapine treatment). CONCLUSIONS: We identified global miRNA changes in plasma EXO derived from patients with SCZ that were relevant to neuronal functions, among which, hsa-miR-675-3p expression was upregulated by clozapine treatment.

    DOI: 10.1080/15622975.2022.2104924

    PubMed

    researchmap

  • Impact of gestational haloperidol exposure on miR-137-3p and Nr3c1 mRNA expression in the hippocampus of offspring mice. 国際誌

    Yuta Yoshino, Hiroshi Kumon, Tetsuya Shimokawa, Hajime Yano, Shinichiro Ochi, Yu Funahashi, Jun-Ichi Iga, Seiji Matsuda, Junya Tanaka, Shu-Ichi Ueno

    The international journal of neuropsychopharmacology   2022年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Schizophrenia is a mental disorder caused by both environmental and genetic factors. Prenatal exposure to antipsychotics, an environmental factor for the fetal brain, induces apoptotic neurodegeneration and cognitive impairment of offspring similar to schizophrenia. The aim was to investigate molecular biological changes in the fetal hippocampus exposed to haloperidol (HAL) by RNA expression as a model of the disorder. METHODS: HAL (1 mg/kg/day) was administered to pregnant mice. Upregulated and downregulated gene expressions in the hippocampus of offspring were studied with RNA-seq and validated with the qPCR method, and miRNA regulating mRNA expressional changes was predicted by in silico analysis. An in vitro experiment was used to identify the miRNA using a dual-luciferase assay. RESULTS: There were significant gene expressional changes (1,370 upregulated and 1,260 down regulated genes) in the HAL group compared to the control group on RNA-seq analysis (p < 0.05 and q < 0.05). Of them, the increase of Nr3c1 mRNA expression was successfully validated, and in silico analysis predicted that microRNA-137-3p (miR-137-3p) possibly regulates that gene's expression. The expression of miR-137-3p in the hippocampus of offspring was significantly decreased in the first generation, but it increased in the second generation. In vitro experiments with Neuro2a cells showed that miR-137-3p inversely regulated Nr3c1 mRNA expression, which was upregulated in the HAL group. CONCLUSIONS: These findings will be keys for understanding the impact of the molecular biological effects of antipsychotics on the fetal brain.

    DOI: 10.1093/ijnp/pyac044

    PubMed

    researchmap

  • Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study. 国際誌

    Hideaki Shimizu, Takaaki Mori, Taku Yoshida, Ayumi Tachibana, Tomoki Ozaki, Yuta Yoshino, Shinichiro Ochi, Naomi Sonobe, Teruhisa Matsumoto, Kenjiro Komori, Jun-Ichi Iga, Toshiharu Ninomiya, Shu-Ichi Ueno, Manabu Ikeda

    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society   2022年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The number of dementia patients is increasing worldwide, especially in Japan, which has the world's highest ageing population. The increase in the number of older people with dementia is a medical and socioeconomic problem that needs to be prevented, but the actual situation is still not fully understood. METHODS: Four cross-sectional studies on dementia were conducted in 1997, 2004, 2012, and 2016 for complete enumeration of all residents aged 65 years and older. We examined the secular trends in the prevalence of all-cause dementia, Alzheimer's disease (AD), vascular dementia (VaD), and other/unclassified dementia. RESULTS: The age-standardised prevalence of all-cause dementia significantly increased (4.5% in 1997, 5.7% in 2004, 5.3% in 2012, 9.5% in 2016; P for trend <0.05). Similar trends were observed for AD (1.7%, 3.0%, 2.5% and 4.9%, respectively; P for trend <0.05) and other/unclassified dementia (0.8%, 1.0%, 1.0% and 2.2%, respectively; P for trend <0.05), whereas no significant change in VaD was seen (2.1%, 1.8%, 1.8%, 2.4%, respectively; P for trend = 0.77). The crude prevalence of all-cause dementia and AD increased from 1997 to 2016 among participants aged 75-79 years and ≥85 years (all P for trend <0.05). Similar trends were observed for other/unclassified dementia among participants aged ≥80 years (all P for trend <0.05), but not in VaD. CONCLUSIONS: The prevalence of dementia has increased beyond the ageing of the population, suggesting that factors in addition to ageing are involved in the increase in the number of older people with dementia. To control the increase in the number of older people with dementia, elucidation of secular trends in the incidence, mortality, and prognosis of dementia as well as the factors that promote and protect against dementia, and development of preventive strategies are necessary.

    DOI: 10.1111/psyg.12865

    PubMed

    researchmap

  • Functional AGXT2 SNP rs37369 Variant Is a Risk Factor for Diabetes Mellitus: Baseline Data From the Aidai Cohort Study in Japan 国際誌

    Hiroshi Kumon, Yoshihiro Miyake, Yuta Yoshino, Jun-ichi Iga, Keiko Tanaka, Hidenori Senba, Eizen Kimura, Takashi Higaki, Bunzo Matsuura, Ryuichi Kawamoto, Shu-ichi Ueno

    Canadian Journal of Diabetes   46 ( 8 )   829 - 834   2022年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVES: The relationship between alanine-glyoxylate aminotransferase 2 (AGXT2) single-nucleotide polymorphisms (SNPs) and diabetes mellitus (DM) has not been investigated. Therefore, we performed a case-control study to examine this relationship. METHODS: The study subjects included 2,390 Japanese men and women aged 34 to 88 years. In total, 190 cases were defined as having a fasting plasma glucose level ≥126 mg/dL, having a glycated hemoglobin ≥6.5% or currently using diabetic medication. The 2,200 remaining participants served as control subjects. RESULTS: Compared with study subjects with the CC genotype of AGXT2 SNP rs37369, those with the TT, but not CT, genotype had a significantly increased risk of DM: the adjusted odds ratio (OR) for the TT genotype was 1.83 (95% confidence interval [CI], 1.04 to 3.47). AGXT2 SNPs rs37370 and rs180749 were not significantly associated with the risk of DM. The CTA haplotype of rs37370, rs37369 and rs180749 was significantly positively associated with the risk of DM (crude OR, 1.25; 95% CI, 1.01 to 1.56), whereas the CCA haplotype was significantly inversely related to DM (crude OR, 0.53; 95% CI, 0.27 to 0.95). The multiplicative interaction between AGXT2 SNP rs37369 and smoking status with regard to the risk of DM was not significant (p=0.32 for interaction). CONCLUSIONS: This is the first study to show significant associations between AGXT2 SNP rs37369, the CTA haplotype, and the CCA haplotype and DM. No interaction with regard to the risk of DM was observed between rs37369 and smoking.

    DOI: 10.1016/j.jcjd.2022.06.004

    PubMed

    researchmap

  • Influence of an Esports Program on Problematic Gaming in Children with Autistic Spectrum Disorder: A Pilot Study. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu-Ichi Ueno

    Behavioral sciences (Basel, Switzerland)   12 ( 6 )   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Esports (electronic sports) programs are a variant of competitive gaming and have expanded worldwide in recent years. The prevalence of problematic gaming and gaming disorders (GD) is predicted to increase in adolescents. Children with autism spectrum disorder (ASD) have a high rate of digital gaming use, and their characteristics, such as social communication deficits and restricted interests, might contribute to problematic gaming. In this study, we aimed to examine whether participation in an Esports program would lead to problematic gaming or GD in children with ASD. The Internet Gaming Disorder Test (IGD-20) scores, Kid-KINDL scores, and gaming time at home were assessed in eight children with ASD before beginning the Esports program and at the three-month follow-up timepoint. The program was held once a week at the welfare service center, where the participants played a set game for 60 min. The results indicated there was no significant worsening in any of the scores after the program. Our program provided the participation time and frequency of Esports, type of game, and motivation of the participants are adequately considered. Even though this pilot study is limited by the small sample size, we concluded that the risk of these activities leading to problematic gaming might be low.

    DOI: 10.3390/bs12060172

    PubMed

    researchmap

  • Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease. 国際誌

    Mariko Ueno, Yuta Yoshino, Hiroaki Mori, Yu Funahashi, Hiroshi Kumon, Shinichiro Ochi, Tomoki Ozaki, Ayumi Tachibana, Taku Yoshida, Hideaki Shimizu, Takaaki Mori, Jun-Ichi Iga, Shu-Ichi Ueno

    Journal of Alzheimer's disease : JAD   87 ( 2 )   863 - 871   2022年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Late-onset Alzheimer's disease (LOAD) is a complex disease in which neuroinflammation plays an important pathophysiological role, and exposure to neurotoxic substrates such as aldehydes may contribute. Blood mRNA expression levels of neuroinflammation-related genes appear to be potential biological markers of LOAD. A relationship between ALDH2 and LOAD has been suggested. OBJECTIVE: Our objective was to examine blood ALDH2 expression in Japanese LOAD patients, conduct a genetic association study, and add new studies to an extended meta-analysis of the Asian population. METHODS: A blood expression study (45 AD subjects, 54 controls) in which total RNA was isolated from whole peripheral blood samples and ALDH2 expression measured was conducted. In addition, a genetic association study (271 AD subjects, 492 controls) using genomic DNA from whole peripheral blood samples was conducted. Finally, a meta-analysis examined the relationship between ALDH2*2 frequency and the risk of LOAD. RESULTS: ALDH2 mRNA expression was significantly higher in LOAD than in controls, and also higher in men with LOAD than in women with LOAD (p = 0.043). The genotypes in the two classified groups and the allele frequency were significantly different between AD and control subjects. The meta-analysis showed a significant difference in the ALDH2*2 allele, with an increased AD risk (OR = 1.38; 95% CI = 1.02-1.85; p = 0.0348, I2 = 81.1%). CONCLUSION: There was a significant increase in blood ALDH2 expression, and a genetic association with ALDH2*2 in LOAD. ALDH2 may have significant roles in the pathogenesis of LOAD in the Asian population.

    DOI: 10.3233/JAD-215627

    PubMed

    researchmap

  • アリピプラゾールの持効性注射剤が効果的であった高齢者双極性障害の1症例

    上野 真梨子, 大町 北斗, 河邉 憲太郎, 曽我 純也, 長岡 大文, 尾崎 優樹, 吉野 祐太, 越智 紳一郎, 森 崇明, 伊賀 淳一, 上野 修一

    精神神経学雑誌   124 ( 4付録 )   S - 395   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • アルツハイマー型認知症を併発した双極I型障害の緊張病症候群に対し電気痙攣療法が奏効した一例

    森 大晃, 河邉 憲太郎, 片田 未来, 高石 裕介, 井上 彩織, 山崎 聖広, 越智 紳一郎, 伊賀 淳一, 上野 修一

    精神神経学雑誌   124 ( 4付録 )   S - 646   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • アルツハイマー型認知症を併発した双極I型障害の緊張病症候群に対し電気痙攣療法が奏効した一例

    森 大晃, 河邉 憲太郎, 片田 未来, 高石 裕介, 井上 彩織, 山崎 聖広, 越智 紳一郎, 伊賀 淳一, 上野 修一

    精神神経学雑誌   124 ( 4付録 )   S - 646   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Prevalence of Comorbid Dementia in Late-life Depression and Bipolar Disorder: A Retrospective Inpatient Study. 国際誌

    Shinichiro Ochi, Takaaki Mori, Jun-Ichi Iga, Shu-Ichi Ueno

    Journal of Alzheimer's disease reports   6 ( 1 )   589 - 598   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: Dementia in patients with late-life mood disorders is clinically important. Objective: We aimed to investigate the prevalence of dementia in patients with late-life major depressive disorder (MDD) or bipolar disorder (BD) and to clarify the clinical characteristics associated with the diagnosis of dementia. Methods: The prevalence of dementia at hospital discharge and the clinical characteristics at hospitalization who are diagnosed with MDD or BD over 65 years of age, from the medical records of 684 patients who had been admitted from 2015 to 2020 were investigated. Results: A total of 66 patients with MDD (n = 50) and BD (n = 16) were analyzed. The prevalence of dementia was significantly higher in MDD than in BD (24.0% versus 0%; p = 0.026). The mean age at onset of MDD was significantly older in the MDD with dementia group than in the MDD without (76.9±6.3 years versus 62.2±14.0 years; p < 0.001). The rate of first depressive episode at this admission was significantly higher in the MDD with dementia group (91.7% versus 30.3%; p < 0.001). The diagnosis of dementia was significantly associated with lower scores for "insomnia early" (p = 0.019) and higher scores for "insight" (p = 0.049) on the 17-item Hamilton Depression Rating (HAMD-17) subscales and lower scores for "recall" (p = 0.003) on the MMSE subscales. Conclusion: The older age of first onset of depression, "insomnia early", "insight" and "recall" may be useful indicators for a diagnosis of dementia in late-life depression.

    DOI: 10.3233/ADR-220052

    PubMed

    researchmap

  • 5-HT1A Partial Agonist Tandospirone for Behavioral and Psychological Symptoms in Oldest-old Patients with Dementia at a Special Elderly Nursing Home. 国際誌

    Shinichiro Ochi, Takaaki Mori, Jun-Ichi Iga, Shu-Ichi Ueno

    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology   19 ( 3 )   514 - 520   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Objective: To investigate the efficacy of tandospirone, an azapirone anxiolytic similar to buspirone that is used in Japan, for behavioral and psychological symptoms of dementia (BPSD), especially in oldest-old patients. Methods: This was an open-label observational study involving residents with BPSD in a special elderly nursing home between August 2013 and August 2018. The severity of dementia was assessed using the Clinical Dementia Rating (CDR) scale; as the main outcomes, the severity of BPSD was assessed using the Clinical Global Impressions-Severity scale (CGI-S) and Neuropsychiatric Inventory-12 (NPI-12) at baseline and 4 weeks after the maintenance dose of tandospirone was reached. The administration of tandospirone started at 30 mg, divided into three doses per day. Two weeks later, if the efficacy was sufficient based on the clinical nursing record, that dose was continued; if the efficacy was insufficient, the daily dose was increased from 40 mg/day to a maximum dose of 60 mg/day. Results: Thirty-three participants (25 females [76%], mean age 87.1 ± 5.4 years) completed the study. Twenty-three participants (70%) were oldest-old (18 females [78%], mean age 89.9 ± 3.4 years). The mean CDR score was 2.9 ± 0.3 in all participants. Tandospirone treatment showed few or no obvious adverse effects and significantly improved CGI-S scores, as well as total scores and many subscale scores on the NPI-12, in both the sample at large and the oldest-old participants. Conclusion: This study demonstrated the efficacy and safety of tandospirone for BPSD in oldest-old participants.

    DOI: 10.9758/cpn.2021.19.3.514

    PubMed

    researchmap

  • Optimized protocol for the extraction of RNA and DNA from frozen whole blood sample stored in a single EDTA tube. 国際誌

    Hirotaka Yamagata, Ayumi Kobayashi, Ryouichi Tsunedomi, Tomoe Seki, Masaaki Kobayashi, Kosuke Hagiwara, Chong Chen, Shusaku Uchida, Go Okada, Manabu Fuchikami, Toshiharu Kamishikiryo, Jun-Ichi Iga, Shusuke Numata, Makoto Kinoshita, Takahiro A Kato, Ryota Hashimoto, Hiroaki Nagano, Yasumasa Okamoto, Shuichi Ueno, Tetsuro Ohmori, Shin Nakagawa

    Scientific reports   11 ( 1 )   17075 - 17075   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cryopreservation of whole blood is useful for DNA collection, and clinical and basic research. Blood samples in ethylenediaminetetraacetic acid disodium salt (EDTA) tubes stored at - 80 °C are suitable for DNA extraction, but not for high-quality RNA extraction. Herein, a new methodology for high-quality RNA extraction from human blood samples is described. Quickly thawing frozen whole blood on aluminum blocks at room temperature could minimize RNA degradation, and improve RNA yield and quality compared with thawing the samples in a 37 °C water bath. Furthermore, the use of the NucleoSpin RNA kit increased RNA yield by fivefold compared with the PAXgene Blood RNA Kit. Thawing blood samples on aluminum blocks significantly increased the DNA yield by ~ 20% compared with thawing in a 37 °C water bath or on ice. Moreover, by thawing on aluminum blocks and using the NucleoSpin RNA and QIAamp DNA Blood kits, the extraction of RNA and DNA of sufficient quality and quantity was achieved from frozen EDTA whole blood samples that were stored for up to 8.5 years. Thus, extracting RNA from frozen whole blood in EDTA tubes after long-term storage is feasible. These findings may help advance gene expression analysis, as well as biomarker research for various diseases.

    DOI: 10.1038/s41598-021-96567-2

    PubMed

    researchmap

  • Expression of overadaptation in children through drawing a man as a projective measure: A community sample study. 国際誌

    Fumie Horiuchi, Ayumi Yoshino-Ozaki, Hideyuki Hattori, Rie Hosokawa, Kiwamu Nakachi, Ruriko Ito, Tomoe Miyama, Yumina Tachibana, Saori Inoue, Kentaro Kawabe, Shuichi Ueno

    Pediatrics international : official journal of the Japan Pediatric Society   2021年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Overadaptation, the behavior of individuals who follow the expectations of others as perfectly as possible, is often observed and related to maladjustment, school refusal, and physical symptoms; however, no method has been proposed yet to assess the overadaptive tendency. This study evaluated the efficacy of the draw-a-man test as a projective measure of overadaptation in community children. METHODS: Eighty children (36 boys, 44 girls) aged 6-8 years were assessed for their ability to draw a man using the Goodenough Draw-A-Man Test (DAM test). Class teachers were asked to assess whether the child was overadapting. The total and subscale DAM scores and pass rates were compared between children with a teacher-assessed tendency for overadaptation and control children, separately for girls and boys. RESULTS: The mean total DAM score was significantly higher for girls versus boys for both the overadapting children and controls. For boys, no significant differences on the total and subscale DAM scores were noted between the overadapting boys and controls. Conversely, for girls, total and three subscale DAM scores (Mouth/Nose/Ears, Hairs, Fingers) were significantly higher in the overadapting girls versus controls. Moreover, for girls, the DAM pass rates on five items (ratio of head; ears present; position and shape of nose; depiction of hair, not to see the scalp; details of fingers) were higher in the overadapting girls versus controls. CONCLUSIONS: The DAM test could extract the overadaptive tendencies of girls aged 6-8 years.

    DOI: 10.1111/ped.14919

    PubMed

    researchmap

  • 家庭問題から抑うつ状態となり入院が必要であった父子家庭の思春期女性症例

    榎木 萌, 三好 幸代, 細川 里瑛, 上野 真梨子, 渡部 椋, 尾崎 智樹, 西川 洋, 河邉 憲太郎, 清水 秀明, 伊賀 淳一, 上野 修一

    日本うつ病学会総会・日本認知療法・認知行動療法学会プログラム・抄録集   18回・21回   403 - 403   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本うつ病学会・日本認知療法・認知行動療法学会  

    researchmap

  • 疼痛を主訴とした高齢者うつ病にセルトラリンとアリピプラゾールによる補助療法が有効であった1例

    松本 優, 三好 幸代, 河邉 憲太郎, 清水 秀明, 西川 洋, 舟橋 裕, 根岸 彩花, 森 大晃, 伊賀 淳一, 上野 修一

    日本うつ病学会総会・日本認知療法・認知行動療法学会プログラム・抄録集   18回・21回   376 - 376   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本うつ病学会・日本認知療法・認知行動療法学会  

    researchmap

  • Behavioral Affect in Children with Autism Spectrum Disorder during School Closures Due to the COVID-19 Pandemic in Japan: A Case-Controlled Study. 国際誌

    Rie Hosokawa, Kentaro Kawabe, Kiwamu Nakachi, Ayumi Yoshino, Fumie Horiuchi, Shu-Ichi Ueno

    Developmental neuropsychology   1 - 10   2021年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Children with autism spectrum disorder (ASD) could experience more stress due to the changes consequent to school closures because of the coronavirus disease 2019 (COVID-19) pandemic. This study investigated differences in behavioral affect between children with ASD and typically developing children (TD). We conducted an online survey with mothers. The data of 84 children with ASD and 361 TD children aged 6 to 18 years were analyzed. Children with ASD were more frustrated due to the changes in their schedule and engaged more in restricted and repetitive behavior. Children with ASD had different types of behavioral affect compared to TD.

    DOI: 10.1080/87565641.2021.1939350

    PubMed

    researchmap

  • Positional cloning and comprehensive mutation analysis identified a novel KDM2B mutation in a Japanese family with minor malformations, intellectual disability, and schizophrenia. 国際誌

    Saeko Yokotsuka-Ishida, Masayuki Nakamura, Yoko Tomiyasu, Mio Nagai, Yuko Kato, Akiyuki Tomiyasu, Hiromi Umehara, Takehiro Hayashi, Natsuki Sasaki, Shu-Ichi Ueno, Akira Sano

    Journal of human genetics   66 ( 6 )   597 - 606   2021年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The importance of epigenetic control in the development of the central nervous system has recently been attracting attention. Methylation patterns of lysine 4 and lysine 36 in histone H3 (H3K4 and H3K36) in the central nervous system are highly conserved among species. Numerous complications of body malformations and neuropsychiatric disorders are due to abnormal histone H3 methylation modifiers. In this study, we analyzed a Japanese family with a dominant inheritance of symptoms including Marfan syndrome-like minor physical anomalies (MPAs), intellectual disability, and schizophrenia (SCZ). We performed positional cloning for this family using a single nucleotide polymorphism (SNP) array and whole-exome sequencing, which revealed a missense coding strand mutation (rs1555289644, NM_032590.4: c.2173G>A, p.A725T) in exon 15 on the plant homeodomain of the KDM2B gene as a possible cause of the disease in the family. The exome sequencing revealed that within the coding region, only a point mutation in KDM2B was present in the region with the highest logarithm of odds score of 2.41 resulting from whole genome linkage analysis. Haplotype analysis revealed co-segregation with four affected family members (IV-9, III-4, IV-5, and IV-8). Lymphoblastoid cell lines from the proband with this mutation showed approximately halved KDM2B expression in comparison with healthy controls. KDM2B acts as an H3K4 and H3K36 histone demethylase. Our findings suggest that haploinsufficiency of KDM2B in the process of development, like other H3K4 and H3K36 methylation modifiers, may have caused MPAs, intellectual disability, and SCZ in this Japanese family.

    DOI: 10.1038/s10038-020-00889-4

    PubMed

    researchmap

  • Mental health and sleep habits/problems in children aged 3-4 years: a population study. 国際誌

    Fumie Horiuchi, Kentaro Kawabe, Yasunori Oka, Kiwamu Nakachi, Rie Hosokawa, Shu-Ichi Ueno

    BioPsychoSocial medicine   15 ( 1 )   10 - 10   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Sleep is essential for mental health at all ages, but few studies have investigated the importance of sleep for mental health in early childhood. Therefore, this study examined the association between mental health and sleep habits/problems in children aged 3-4 years. METHODS: Children aged 3 to 4 years who were living in the community (n = 415; 211/204 boys/girls) were recruited for this study. Their mental health was assessed using the Strengths and Difficulties Questionnaire (SDQ), and their sleep habits/problems were evaluated using the Child and Adolescent Sleep Checklist. RESULTS: Based on the total difficulties score of the SDQ, the children were divided into two groups: a poor mental health group (n = 76) and a control group (n = 339). In terms of sleep habits, which included total sleep time, bedtime, wake time, and nap conditions, there were no differences between the two groups. Regarding sleep-related problems, however, anxiety before going to sleep (p = 0.026), circadian rhythm abnormalities (p = 0.014), and sleepiness during classes outside of naptimes (p = 0.031) were significantly higher in the poor mental health group than in the control group. Multiple regression analysis showed that poor mental health status was significantly associated with sleepiness and snoring (p = 0.017 and p = 0.018, respectively). CONCLUSIONS: The mental health status of 3-4-year-old children was associated with sleep-related problems, namely sleepiness and snoring. Healthcare providers should pay attention to children's irregular sleep-wake patterns; moreover, interventions for appropriate sleep hygiene will reduce the psychological burden on both children and their families.

    DOI: 10.1186/s13030-021-00213-2

    PubMed

    researchmap

  • Association between Internet Addiction and Application Usage among Junior High School Students: A Field Survey. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Rie Hosokawa, Kiwamu Nakachi, Shu-Ichi Ueno

    International journal of environmental research and public health   18 ( 9 )   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The purpose of this study was to elucidate the relationship between the severity of Internet addiction and various media-related applications. The participants were junior high school students between 12 and 15 years old. A total of 529 students (283 males, 246 females) were included. The participants answered Young's Internet Addiction Test (IAT) and a structural questionnaire about their access to electronic devices and applications. An Internet addiction prevalence of 4.3% (95% CI: 2.8-6.5%) was reported in this study, with an additional 26.3% (95% CI: 22.6-30.2%) of participants possibly addicted. The accessibility of gaming devices was significantly higher in male students than in female students. The use of applications for SNSs was significantly higher in female students than in male students. Twitter accessibility was a factor that contributed to Internet addiction in both genders. The prevalence of severe Internet addiction among school students in Japan was 4.3%, and Twitter was the most important factor associated with this addiction. Media literacy must be increased in adolescents and their friends, teachers, and families.

    DOI: 10.3390/ijerph18094844

    PubMed

    researchmap

  • Identification of aberrant innate and adaptive immunity based on changes in global gene expression in the blood of adults with autism spectrum disorder. 国際誌

    Fumie Horiuchi, Yuta Yoshino, Hiroshi Kumon, Rie Hosokawa, Kiwamu Nakachi, Kentaro Kawabe, Jun-Ichi Iga, Shu-Ichi Ueno

    Journal of neuroinflammation   18 ( 1 )   102 - 102   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Autism spectrum disorder (ASD) is characterized as a neurodevelopmental disorder, and one of the main hypotheses regarding its cause is genetic factors. A previous meta-analysis of seven microarray studies and one RNA sequencing (RNA-seq) study using the blood of children with ASD identified dysregulation of gene expressions relevant to the immune system. In this study, we explored changes in global gene expression as the phenotype of ASD in the blood of adults with ASD. METHODS: We recruited an RNA-seq cohort (ASD vs. control; n = 6 each) and a replication cohort (ASD vs. control; n = 19 each) and conducted RNA-seq to explore changes in global gene expression. We then subjected the significantly up- and downregulated genes to gene ontology (GO) and core analyses. Weighted gene correlation network analysis (WGCNA) was performed with all 11,617 genes detected in RNA-seq to identify the ASD-specific gene network. RESULTS: In total, 117 significantly up- and 83 significantly downregulated genes were detected in the ASD compared with the control group, respectively (p < 0.05 and q < 0.05). GO analysis revealed that the aberrant innate and adaptive immunity were more obvious in the 117 upregulated than in the 83 downregulated genes. WGCNA with core analysis revealed that one module including many immune-related genes was associated with the natural killer cell signaling pathway. In the results for the replication cohort, significant changes with same trend found in RNA-seq data were confirmed for MAFB (p = 0.046), RPSAP58 (p = 0.030), and G2MK (p = 0.004). LIMITATIONS: The sample size was relatively small in both the RNA-seq and replication cohorts. This study examined the mRNA expression level, so the interaction between mRNA and protein remains unclear. The expression changes between children and adults with ASD were not compared because only adults with ASD were targeted. CONCLUSIONS: The dysregulated gene expressions confirmed in the blood of adults with ASD were relevant to the dysfunction of innate and adaptive immunity. These findings may aid in understanding the pathogenesis of ASD.

    DOI: 10.1186/s12974-021-02154-7

    PubMed

    researchmap

  • Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method. 国際誌

    Yuta Yoshino, Hiroshi Kumon, Takaaki Mori, Taku Yoshida, Ayumi Tachibana, Hideaki Shimizu, Jun-Ichi Iga, Shu-Ichi Ueno

    BMC genomics   22 ( 1 )   287 - 287   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Alanine:glyoxylate aminotransferase 2 (AGXT2; EC 2.6.1.44) is the only enzyme that degrades the R-form of 3-aminoisobutyrate, an intermediate metabolite of thymine. AGXT2, as well as diaminoarginine dimethylaminohydrolase 1 (DDAH1; EC 3.5.3.18), works as an enzyme that degrades asymmetric dimethylarginine (ADMA), which competitively inhibits the nitric oxide synthase family. Thus, these two enzyme activities may change vascular vulnerability for a lifetime via the nitric oxide (NO) system. We investigated the association between vascular conditions and diseases such as hypertension and diabetes mellitus and polymorphisms of these two genes in 750 older Japanese subjects (mean age ± standard deviation, 77.0 ± 7.6 years) recruited using the complete enumeration survey method in the Nakayama study. Demographic and biochemical data, such as blood pressure (BP) and casual blood sugar (CBS), were obtained. Four functional single nucleotide polymorphisms (SNPs; rs37370, rs37369, rs180749, and rs16899974) of AGXT2 and one functional insertion/deletion polymorphism in the promotor region with four SNPs (rs307894, rs669173, rs997251, and rs13373844) of DDAH1 were investigated. Plasma ADMA was also analyzed in 163 subjects. RESULTS: The results of multiple regression analysis showed that a loss of the functional haplotype of AGXT2, CAAA, was significantly positively correlated with BP (systolic BP, p = 0.034; diastolic BP, p = 0.025) and CBS (p = 0.021). No correlation was observed between DDAH1 and either BP or CBS. ADMA concentrations were significantly elevated in subjects with two CAAA haplotypes compared with subjects without the CAAA haplotype (p = 0.033). CONCLUSIONS: Missense variants of AGXT2, but not DDAH1, may be related to vulnerability to vascular diseases such as hypertension and DM via the NO system.

    DOI: 10.1186/s12864-021-07612-3

    PubMed

    researchmap

  • Neural precursor cells are decreased in the hippocampus of the delayed carbon monoxide encephalopathy rat model. 国際誌

    Shinichiro Ochi, Keisuke Sekiya, Naoki Abe, Yu Funahashi, Hiroshi Kumon, Yuta Yoshino, Tasuku Nishihara, Shuken Boku, Jun-Ichi Iga, Shu-Ichi Ueno

    Scientific reports   11 ( 1 )   6244 - 6244   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The pathophysiology of delayed carbon monoxide (CO) encephalopathy remains unclear. In this study, the effects of CO exposure on the dentate gyrus (DG) were investigated in a Wistar rat model by histochemical and molecular methods. Model rats showed significant cognitive impairment in the passive-avoidance test beginning 7 days after CO exposure. Immunohistochemistry showed that compared to the control, the cell number of SRY (sex-determining region Y)-box 2 (SOX2)+/brain lipid binding protein (BLBP)+/glial fibrillary acidic protein (GFAP)+ cells in the DG was significantly less, but the number of SOX2+/GFAP- cells was not, reflecting a decreased number of type 1 and type 2a neural precursor cells. Compared to the control, the numbers of CD11b+ cells and neuron glial antigen 2+ cells were significantly less, but the number of SOX2-/GFAP+ cells was not. Flow cytometry showed that the percent of live microglial cells isolated from the hippocampus in this CO rat model was significantly lower than in controls. Furthermore, mRNA expression of fibroblast growth factor 2 and glial cell-derived neurotrophic factor, which are neurogenic factors, was significantly decreased in that area. We conclude that, in this rat model, there is an association between delayed cognitive impairment with dysregulated adult hippocampal neurogenesis and glial changes in delayed CO encephalopathy.

    DOI: 10.1038/s41598-021-85860-9

    PubMed

    researchmap

  • Parent-Adolescent Agreement on Adolescents’ Emotional and Behavioral Problems Assessed by the Strengths and Difficulties Questionnaire

    Kentaro Kawabe, Fumie Horiuchi, Hiroyuki Uno, Kiwamu Nakachi, Rie Hosokawa, Yasunori Oka, Shu-Ichi Ueno

    Global Pediatric Health   8   2333794X2110012 - 2333794X2110012   2021年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:SAGE Publications  

    Objective. The perception of emotion and behavior is different between adolescents and their parents. Parent-adolescent agreement on emotional and behavioral problems has not been well researched. The aim of this study was to explore and compare how well the information from themselves matches with the judgments by their parents in terms of emotional and behavioral problems. Methods. The cross-sectional study was conducted using the self-report and parent-report Strengths and Difficulties Questionnaire (SDQ). A total of 1254 Japanese school adolescents aged 12 to 18 and their parents were assessed almost the same time. The results were analyzed using the paired t-test and 2-way analysis of variance for the discrepancies of parent-adolescent agreements in each age and gender groups. Results. Adolescents obtained higher total difficulty and all subscales scores of SDQ than their parents. The effect of grade on the self/parent discrepancy scores were significantly observed on the conduct problems ( P &lt; .001), hyperactivity ( P = .009), and prosocial behavior ( P &lt; .001). The effect of gender was shown significantly on the emotional problems ( P &lt; .001), conduct problems ( P &lt; .001), and peer problems ( P = .002). Conclusion. Adolescents reported more problems than their parents did. For comprehensive evaluation of adolescents’ mental health, it is necessary to draw information from both the adolescents themselves and their parents, and pay attention to the gap between adolescents and their parents’ perception.

    DOI: 10.1177/2333794x211001245

    researchmap

    その他リンク: http://journals.sagepub.com/doi/full-xml/10.1177/2333794X211001245

  • Differences in Psychological and Behavioral Changes between Children following School Closure due to COVID-19. 国際誌

    Kiwamu Nakachi, Kentaro Kawabe, Rie Hosokawa, Ayumi Yoshino, Fumie Horiuchi, Shu-Ichi Ueno

    Psychiatry journal   2021   5567732 - 5567732   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    School closure due to coronavirus disease 2019 (COVID-19) pushed children across ages and nationalities into a state of mental health crisis. In Japan, children between the ages of 6 and 18 were ordered to stay at home and observe social distancing for several months. This study is aimed at investigating the effects of quarantine due to COVID-19 on children belonging to different developmental stages in life. Data were collected from mothers of typically developing children aged between 6 and 18 years. The differences in psychological and behavioral changes following school closure during the COVID-19 pandemic were explored. A total of 535 children, including 145 students in lower grades of elementary school (6-9 years), 124 students in higher grades of elementary school (9-12 years), 132 students in junior high school (12-15 years), and 134 students in high school (15-18 years), were recruited. Children in lower grades of elementary school (lower grades group) gained significantly lower understanding about COVID-19 and the necessity of COVID-19 restrictions than children in the other groups. Moreover, they had more psychological problems: they easily cried and complained, were unable to keep calm, and were dependent on parents and family members. Changes in sleep patterns were more prevalent in junior and senior high school students. We concluded that mental health care should be provided based on the growth period of each child not only during school closure but also after school reopening.

    DOI: 10.1155/2021/5567732

    PubMed

    researchmap

  • Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases. 国際誌

    Hiroaki Mori, Yu Funahashi, Yuta Yoshino, Hiroshi Kumon, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Ayumi Tachibana, Taku Yoshida, Hideaki Shimizu, Takaaki Mori, Jun-Ichi Iga, Shu-Ichi Ueno

    Journal of Alzheimer's disease : JAD   82 ( 4 )   1737 - 1744   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Cyclin-dependent kinase inhibitor 2A (CDKN2A) is an important gene in cellular senescence and aging. OBJECTIVE: This study assessed the utility of blood CDKN2A mRNA expression levels and methylation status as a potential biomarker for aging and the pathogenesis of Alzheimer's disease (AD). METHODS: The correlation between CDKN2A mRNA expression levels and age was examined in 45 healthy subjects, after which mRNA expression levels were compared among 46 AD patients, 20 mild cognitive impairment due to AD patients, 21 Parkinson's disease patients, 21 dementia with Lewy bodies patients, and 55 older healthy controls. The methylation rates of the second exon of the CDKN2A gene, known to influence its expression levels, was also examined. RESULTS: A significant correlation between CDKN2A mRNA expression levels and age was found (Spearman's rank correlation coefficient: r = 0.407, p = 0.005). CDKN2A mRNA expression levels in blood were significantly decreased in AD patients, although those of healthy controls were significantly increased with age. Further, only in AD patients were CDKN2A mRNA expression levels significantly and positively correlated with methylation rates. CONCLUSION: Although further research with a larger sample size is needed to elucidate the relationships between CDKN2A gene expression in blood and the development of other neurodegenerative diseases, CDKN2A mRNA expression in blood may be a biomarker for differentiating AD from normal aging and other neurodegenerative diseases.

    DOI: 10.3233/JAD-210483

    PubMed

    researchmap

  • PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression. 国際誌

    Hiroshi Kumon, Yuta Yoshino, Yu Funahashi, Hiroaki Mori, Mariko Ueno, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Takaaki Mori, Jun-Ichi Iga, Masahiro Nagai, Masahiro Nomoto, Shu-Ichi Ueno

    Journal of Alzheimer's disease : JAD   79 ( 3 )   1055 - 1062   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Phosphatidylinositol-binding clathrin assembly protein (PICALM) is a validated genetic risk factor for late-onset Alzheimer's disease (AD) and is associated with other neurodegenerative diseases. However, PICALM expression in the blood of neurodegenerative diseases remains elusive. OBJECTIVE: This study aimed to assess the usefulness of PICALM expression levels in the blood of patients with AD, Parkinson's disease (PD), dementia with Lewy bodies (DLB), and geriatric major depressive disorder (MDD) as a diagnostic biomarker. METHODS: In total, 45, 20, 21, and 19 patients with AD, PD, DLB, and geriatric MDD, respectively, and 54 healthy controls (HCs) were enrolled in the study. Expression data from Gene Expression Omnibus database (GSE97760), (GSE133347) and (GSE98793), (GSE48350), and (GSE144459) were used to validate the ability of biomarkers in the blood of patients with AD, PD, geriatric MDD, and a postmortem human AD brain and animal model of AD (3xTg-AD mouse), respectively. RESULTS: PICALM mRNA expression in human blood was significantly increased in patients with AD compared with that in HCs. PICALM mRNA expression and age were negatively correlated only in patients with AD. PICALM mRNA expression in human blood was significantly lower in patients with PD than in HCs. No changes in PICALM mRNA expression were found in patients with DLB and geriatric MDD. CONCLUSION: PICALM mRNA expression in blood was higher in patients with AD, but lower in patients with PD, which suggests that PICALM mRNA expression in human blood may be a useful biomarker for differentiating neurodegenerative diseases and geriatric MDD.

    DOI: 10.3233/JAD-201046

    PubMed

    researchmap

  • Parent-Adolescent Agreement on Adolescents' Emotional and Behavioral Problems Assessed by the Strengths and Difficulties Questionnaire. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Hiroyuki Uno, Kiwamu Nakachi, Rie Hosokawa, Yasunori Oka, Shu-Ichi Ueno

    Global pediatric health   8   2333794X211001245   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Objective. The perception of emotion and behavior is different between adolescents and their parents. Parent-adolescent agreement on emotional and behavioral problems has not been well researched. The aim of this study was to explore and compare how well the information from themselves matches with the judgments by their parents in terms of emotional and behavioral problems. Methods. The cross-sectional study was conducted using the self-report and parent-report Strengths and Difficulties Questionnaire (SDQ). A total of 1254 Japanese school adolescents aged 12 to 18 and their parents were assessed almost the same time. The results were analyzed using the paired t-test and 2-way analysis of variance for the discrepancies of parent-adolescent agreements in each age and gender groups. Results. Adolescents obtained higher total difficulty and all subscales scores of SDQ than their parents. The effect of grade on the self/parent discrepancy scores were significantly observed on the conduct problems (P < .001), hyperactivity (P = .009), and prosocial behavior (P < .001). The effect of gender was shown significantly on the emotional problems (P < .001), conduct problems (P < .001), and peer problems (P = .002). Conclusion. Adolescents reported more problems than their parents did. For comprehensive evaluation of adolescents' mental health, it is necessary to draw information from both the adolescents themselves and their parents, and pay attention to the gap between adolescents and their parents' perception.

    DOI: 10.1177/2333794X211001245

    PubMed

    researchmap

  • The Association between Autistic Traits and Sleep Habits/Problems in Toddlers. 国際誌

    Fumie Horiuchi, Kentaro Kawabe, Yasunori Oka, Kiwamu Nakachi, Rie Hosokawa, Shu-Ichi Ueno

    Developmental neuropsychology   1 - 11   2020年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Sleep disturbances are the comorbid conditions most frequently associated with autism spectrum disorder (ASD). Sleep problems might precede and worsen the behavioral outcomes of ASD. This study examined the association between sleep habits/problems and autistic traits in toddlers. Eighteen-month-old toddlers (N= 426; boys/girls, 204/222) were assessed for autistic traits using the Japanese version of the Modified Checklist for Autism in Toddlers and sleep habits/problems using the Child and Adolescent Sleep Checklist during health checkups. There were no significant differences in sleep habits, including total sleep time, wake time, bedtime, and naps, between autistic toddlers (n= 26) and non-autistic toddlers (n= 400). However, toddlers with autistic traits more commonly exhibited bedtime resistance, abnormality in circadian rhythm, and sleepiness outside of naptime than toddlers without autistic traits. Moreover, autistic traits were significantly associated with daytime sleepiness. Autistic traits are associated with sleep problems in toddlers. In particular, daytime sleepiness might be avisible symptom that enables the earlier detection of ASD in children.

    DOI: 10.1080/87565641.2020.1865357

    PubMed

    researchmap

  • Excessive and Problematic Internet Use During the Coronavirus Disease 2019 School Closure: Comparison Between Japanese Youth With and Without Autism Spectrum Disorder

    Kentaro Kawabe, Rie Hosokawa, Kiwamu Nakachi, Ayumi Yoshino, Fumie Horiuchi, Shu-ichi Ueno

    Frontiers in Public Health   8   2020年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    Internet use in the youth has increased manifold during the coronavirus disease 2019 (COVID-19) pandemic. Individuals with autism spectrum disorder (ASD) generally have a higher risk of problematic internet use. The aim of this study is to investigate the differences in internet and related digital media use between children with ASD and their typically developing counterparts during the COVID-19 pandemic. In this online survey in Japan conducted from April 30 to May 8, 2020, we analyzed digital media time of 84 children with ASD and 361 age- and gender-matched controls before and after school closure. Digital media use duration was significantly longer in the ASD group than in the control group before the pandemic. The increase of media use time was more prominent in the control group than in the ASD group. We observed excessive Internet use among children with ASD and without ASD, especially during the COVID-19 pandemic. It is necessary to establish strategies to prevent excessive internet use in not only children and adolescents with ASD but also without ASD in the post-pandemic world.

    DOI: 10.3389/fpubh.2020.609347

    researchmap

  • 老年期の高血圧と認知機能との関連についての後方視的検討 大規模認知症コホート研究 中山町調査より

    立花 亜由美, 森 崇明, 尾崎 智樹, 吉田 卓, 吉野 祐太, 河邉 憲太郎, 越智 紳一郎, 清水 秀明, 堀内 史枝, 小森 憲治郎, 伊賀 淳一, 上野 修一

    老年精神医学雑誌   31 ( 増刊II )   184 - 184   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • Making a brochure about coronavirus disease (COVID-19) for children with autism spectrum disorder and their family members. 国際誌

    Kentaro Kawabe, Rie Hosokawa, Kiwamu Nakachi, Ayumi Yoshino, Fumie Horiuchi, Shu-Ichi Ueno

    Psychiatry and clinical neurosciences   74 ( 9 )   498 - 499   2020年9月

     詳細を見る

    記述言語:英語  

    DOI: 10.1111/pcn.13090

    PubMed

    researchmap

  • 初老期の精神病性うつ病の背景にレビー小体病の存在が疑われた一例

    森 大晃, 細川 里瑛, 清水 秀明, 高山 由華子, 舟橋 裕, 久門 啓志, 尾崎 優樹, 河邉 憲太郎, 山内 宏治, 上野 修一

    精神神経学雑誌   ( 2020特別号 )   S296 - S296   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 統合失調症薬物療法の様々な課題にどう対応するか 統合失調症の緊張病

    伊賀 淳一, 越智 紳一郎, 上野 修一

    精神神経学雑誌   ( 2020特別号 )   S496 - S496   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 統合失調症薬物療法の様々な課題にどう対応するか 統合失調症の緊張病

    伊賀 淳一, 越智 紳一郎, 上野 修一

    精神神経学雑誌   ( 2020特別号 )   S496 - S496   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Identifying Blood Transcriptome Biomarkers of Alzheimer's Disease Using Transgenic Mice. 国際誌

    Shinichiro Ochi, Jun-Ichi Iga, Yu Funahashi, Yuta Yoshino, Kiyohiro Yamazaki, Hiroshi Kumon, Hiroaki Mori, Yuki Ozaki, Takaaki Mori, Shu-Ichi Ueno

    Molecular neurobiology   57 ( 12 )   4941 - 4951   2020年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The testing of pathological biomarkers of Alzheimer's disease (AD), such as amyloid beta and tau, is time-consuming, expensive, and invasive. Here, we used 3xTg-AD mice to identify and validate putative novel blood transcriptome biomarkers of AD that can potentially be identified in the blood of patients. mRNA was extracted from the blood and hippocampus of 3xTg-AD and control mice at different ages and used for microarray analysis. Network and functional analyses revealed that the differentially expressed genes between AD and control mice modulated the immune and neuroinflammation systems. Five novel gene transcripts (Cdkn2a, Apobec3, Magi2, Parp3, and Cass4) showed significant increases with age, and their expression in the blood was collated with that in the hippocampus only in AD mice. We further assessed previously identified candidate biomarker genes. The expression of Trem1 and Trem2 in both the blood and brain was significantly increased with age. Decreased Tomm40 and increased Pink1 mRNA levels were observed in the mouse blood. The changes in the expression of Snca and Apoe mRNA in the mouse blood and brain were similar to those found in human AD blood. Our results demonstrated that the immune and neuroinflammatory system is involved in the pathophysiologies of aging and AD and that the blood transcriptome might be useful as a biomarker of AD.

    DOI: 10.1007/s12035-020-02058-2

    PubMed

    researchmap

  • Prevalence of Internet addiction in Japan: Comparison of two cross-sectional surveys. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Kiwamu Nakachi, Rie Hosokawa, Shu-Ichi Ueno

    Pediatrics international : official journal of the Japan Pediatric Society   62 ( 8 )   970 - 975   2020年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Internet addiction is a serious problem, and the incidence has increased significantly in recent years. In two cross-sectional studies over a 4-year period, we investigated Internet addiction in adolescents and evaluated the resulting changes in their lives. METHODS: Junior high-school students (aged 12 to 15 years) were assessed in 2014 (survey I) and in 2018 (survey II). They filled out Young's Internet Addiction Test (IAT), the Japanese version of the General Health Questionnaire, and a questionnaire on sleep habits and usage of electric devices. RESULTS: In total, 1,382 students were recruited for the two surveys. The mean IAT score was significantly higher in survey II (36.0 ± 15.2) than in survey I (32.4 ± 13.6) (P < 0.001). The increase in total IAT score indicates that the rate of Internet addiction was significantly higher in 2018 than in 2014. For each subscale of the General Health Questionnaire, social dysfunction scores were significantly lower in survey II than in survey I (P = 0.022). During the weekend, mean total sleep time was 504.8 ± 110.1 min, and the time awake was 08:02 h in survey II; the total sleep time and time awake were significantly longer and later, respectively, in survey II than in survey I (P < 0.001, P = 0.004, respectively). Smartphone use was also significantly higher in survey II than in survey I (P < 0.001). CONCLUSIONS: The prevalence of Internet addiction differed over the 4 years of this study.

    DOI: 10.1111/ped.14250

    PubMed

    researchmap

  • DRD2遺伝子のDNAメチル化率によるレビー小体型認知症とパーキンソン病の鑑別(DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's disease)

    伊賀 淳一, 尾崎 優樹, 吉野 祐太, 山崎 聖広, 越智 紳一郎, 永井 将弘, 野元 正弘, 上野 修一

    日本神経精神薬理学会年会・日本生物学的精神医学会年会・日本精神薬学会総会・学術集会合同年会プログラム・抄録集   50回・42回・4回   187 - 187   2020年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経精神薬理学会・日本生物学的精神医学会・日本精神薬学会  

    researchmap

  • 統合失調症と気分障害における末梢血CTLA4 mRNA発現の変化

    舟橋 裕, 宮本 圭介, 吉野 祐太, 河邊 憲太郎, 山崎 聖広, 尾崎 優樹, 森 蓉子, 越智 紳一郎, 伊賀 淳一, 上野 修一

    日本神経精神薬理学会年会・日本生物学的精神医学会年会・日本精神薬学会総会・学術集会合同年会プログラム・抄録集   50回・42回・4回   191 - 191   2020年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経精神薬理学会・日本生物学的精神医学会・日本精神薬学会  

    researchmap

  • Sleep Habits and Electronic Media Usage in Japanese Children: A Prospective Comparative Analysis of Preschoolers. 国際誌

    Fumie Horiuchi, Yasunori Oka, Kentaro Kawabe, Shu-Ichi Ueno

    International journal of environmental research and public health   17 ( 14 )   2020年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Children are increasingly exposed to electronic media, which can potentially influence their sleep habits. However, few studies have investigated the effects of children's life patterns on sleep habits and electronic media usage. This study investigated the differences in sleep habits and electronic media usage between 18- and 42-month-old children attending nursery schools, kindergartens, or staying at home, and respectively enrolled 183 (boys, n = 93; girls, n = 90) and 215 (boys, n = 104; girls, n = 111) 18- and 42-month-old children who underwent health check-ups. We found that 18-month-old children attending nursery school had significantly earlier wake times on weekdays and shorter sleep durations on weekends than children who stayed at home despite no differences in electronic media usage. There were no differences in sleep duration among 42-month-old children attending nursery schools, kindergartens, or staying at home; however, kindergarteners demonstrated a higher use of portable and home video games. Different life patterns affect electronic media usage in preschool children, especially those attending kindergarten. Particular attention should be paid to the higher usage of electronic media devices by kindergarteners, although they had the same sleep duration, as did other preschool children.

    DOI: 10.3390/ijerph17145189

    PubMed

    researchmap

  • 愛媛大学医学部附属病院子どものこころセンター開設後2年間における初診患者の受診動向

    橘 侑南, 河邉 憲太郎, 城賀本 敏宏, 相原 香織, 福田 光成, 見山 朋恵, 越智 麻里奈, 伊藤 瑠里子, 芳野 歩美, 服鳥 秀幸, 南立 芙美子, 堀内 史枝, 上野 修一

    精神医学   62 ( 7 )   1055 - 1060   2020年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    <文献概要>愛媛大学医学部附属病院は2015年4月に子どものこころセンターを開設した。本調査では,開設後2年間の初診患者の動向を明らかにすることを目的に,後方視的に調査を行った。初診患者は1〜15歳の292例(男性192例,女性100例)であった。約9割が紹介受診であり,最も多い紹介元は院外の小児科(49.7%)であった。ICD-10に基づいて行った診断では,F8が最も多く(43.6%),F4,F9と続いた。2017年3月現在の転帰は,治療継続中が150例(51.4%)で,その3/4が発達障害圏の患者であった。センター化したことで,初診患者数が増加し,低年齢化した。また,小児科からの紹介が増加し,発達障害圏を中心に患者が集約されていた。しかし,地域と当センターの連携の不十分さなどの課題も明らかとなり,今後のセンターのあり方について模索中である。

    researchmap

  • 愛媛大学医学部附属病院子どものこころセンター開設後2年間における初診患者の受診動向

    橘 侑南, 河邉 憲太郎, 城賀本 敏宏, 相原 香織, 福田 光成, 見山 朋恵, 越智 麻里奈, 伊藤 瑠里子, 芳野 歩美, 服鳥 秀幸, 南立 芙美子, 堀内 史枝, 上野 修一

    精神医学   62 ( 7 )   1055 - 1060   2020年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    <文献概要>愛媛大学医学部附属病院は2015年4月に子どものこころセンターを開設した。本調査では,開設後2年間の初診患者の動向を明らかにすることを目的に,後方視的に調査を行った。初診患者は1〜15歳の292例(男性192例,女性100例)であった。約9割が紹介受診であり,最も多い紹介元は院外の小児科(49.7%)であった。ICD-10に基づいて行った診断では,F8が最も多く(43.6%),F4,F9と続いた。2017年3月現在の転帰は,治療継続中が150例(51.4%)で,その3/4が発達障害圏の患者であった。センター化したことで,初診患者数が増加し,低年齢化した。また,小児科からの紹介が増加し,発達障害圏を中心に患者が集約されていた。しかし,地域と当センターの連携の不十分さなどの課題も明らかとなり,今後のセンターのあり方について模索中である。

    researchmap

  • Prevalence of possible idiopathic normal pressure hydrocephalus in older inpatients with schizophrenia: a replication study. 査読 国際誌

    Yuta Yoshino, Taku Yoshida, Hideo Morino, Masayuki Nakamura, Masao Abe, Hokuto Omachi, Saori Inoue, Yukiyo Miyoshi, Yumina Tachibana, Noriko Yamauchi, Naoya Takeda, Mutsuhiko Mizobuchi, Yuki Ozaki, Shinichiro Ochi, Junichi Iga, Shu-Ichi Ueno

    BMC psychiatry   20 ( 1 )   273 - 273   2020年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: We recently reported that older patients with schizophrenia (SZ) show possible idiopathic normal pressure hydrocephalus (iNPH) more frequently than the general population. In this study, we estimated the prevalence of iNPH in a larger number of older SZ patients and explored useful examination values for diagnosis in the SZ population. METHODS: We enrolled older inpatients with SZ (n = 39, mean age = 68.6 ± 7.7 years) from several psychiatric hospitals in Ehime, Japan and acquired brain imaging data using computed tomography. We evaluated three iNPH symptoms (dementia, gait disturbance, and urinary incontinence). In addition, we combined these data with our previous data to elucidate the relationship between iNPH and characteristics of SZ symptoms. RESULTS: In total, five (12.8%) patients were diagnosed with possible iNPH. Evans' index for patients with iNPH was significantly higher than for those without iNPH (p = 0.002). The number of disproportionately enlarged subarachnoid space hydrocephalus (DESH) findings was significantly higher in patients with iNPH than in those without iNPH (p <  0.001). Using combined data, Drug-Induced Extra-pyramidal Symptoms Scale (DIEPSS) subscales of gait and bradykinesia showed an increasing trend in the SZ with iNPH group. CONCLUSIONS: We reconfirmed that older inpatients with SZ experienced possible iNPH more frequently than the general population. We should pay attention to the DIEPSS subscales of gait and bradykinesia and DESH findings in addition to the three main symptoms of iNPH and Evans' index so as to not miss SZ patients with iNPH.

    DOI: 10.1186/s12888-020-02690-1

    PubMed

    researchmap

  • CTLA4 mRNA expression in blood is lower in schizophrenia, but not in affective disorders. 査読 国際誌

    Keisuke Miyamoto, Yu Funahashi, Yuta Yoshino, Kentaro Kawabe, Kiyohiro Yamazaki, Yuki Ozaki, Yoko Mori, Shinichiro Ochi, Jun-Ichi Iga, Shu-Ichi Ueno

    Asian journal of psychiatry   52   102112 - 102112   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    CTL-associated antigen 4 (CTLA4) and its downstream signals compose an important mechanism that suppresses immune activity. Recent studies have shown that immune abnormalities are associated with the pathogenesis of schizophrenia (SCZ), but little research has been performed on the relevance of CTLA4 and SCZ. In the present study, we investigated the relationship between CTLA4 mRNA expression and SCZ. We examined the expression of CTLA4 mRNA in blood from patients with SCZ, bipolar disorder (BD), and major depressive disorder (MDD). We compared 50 SCZ subjects, 46 BD subjects, and 63 MDD subjects with age- and sex-matched healthy controls (HCs). Quantitative real-time PCR was performed to examine CTLA4 mRNA expression in peripheral blood using TaqMan probes. Levels of CTLA4 mRNA expression were significantly lower in patients with SCZ compared with HCs (p < 0.001), whereas no differences were found between affective disorder (BD and MDD) patients and HCs. We analyzed the correlation between CTLA4 mRNA expression and clinical parameters, but no significant correlation was found. The expression of CTLA4 mRNA was lower specifically in SCZ, suggesting that abnormal CTLA4 expression may be particularly related to the pathogenesis of SCZ. CTLA4 may be a useful diagnostic marker and a potential therapeutic target of SCZ.

    DOI: 10.1016/j.ajp.2020.102112

    PubMed

    researchmap

  • DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's disease. 査読 国際誌

    Yuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, Shinichiro Ochi, Jun-Ichi Iga, Masahiro Nagai, Masahiro Nomoto, Shu-Ichi Ueno

    Acta neurologica Scandinavica   141 ( 2 )   177 - 182   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: The aim was to clarify whether DRD2 methylation changes in leukocytes of dementia with Lewy bodies (DLB) or Parkinson's disease (PD) patients are seen and can be used to discriminate between them. METHODS: Methylation rates were examined in 23 DLB subjects and 23 age- and sex-matched healthy controls and 37 PD patients and 37 age- and sex-matched healthy controls. RESULTS: Significant DRD2 DNA methylation changes were found in leukocytes of DLB and PD patients compared with healthy subjects. Discriminant analysis between DLB and PD using seven CpG sites demonstrated sensitivity and specificity of 83.8% and 90.9%, respectively. None of the CpG sites were associated with sex, age, age of onset, disease duration, and any of the neuropsychological tests in DLB and PD patients. CONCLUSION: This is the first report showing that DRD2 DNA methylation rates in leukocytes were increased in DLB patients and decreased in PD patients. These results may be an important step in understanding epigenetic mechanisms underlying DLB and PD pathogenesis and providing a novel biomarker for discriminating between them.

    DOI: 10.1111/ane.13186

    PubMed

    researchmap

  • Hypoglycemia with atypical antipsychotics, but not with typical antipsychotics: A case report 査読

    Ochi Shinichiro, Abe Masao, Shimizu Hideaki, Iga Jun-ichi, Ueno Shu-ichi

    Clinical Neuropsychopharmacology and Therapeutics   11 ( 0 )   5 - 8   2020年

     詳細を見る

    記述言語:英語   出版者・発行元:日本臨床精神神経薬理学会  

    <p>Atypical antipsychotics cause hypoglycemia as a rare metabolic adverse effect in patients without diabetes. However, its mechanism is not sufficiently clarified. In the present case, a patient with schizophrenia presented with hypoglycemia induced by risperidone and olanzapine after becoming generally debilitated, but not by haloperidol. A complex interaction of serotonergic and adrenergic pathways with atypical antipsychotics may play a role in hypoglycemia. When prescribing atypical antipsychotics for patients, clinicians should be careful not only about the amount and character of the antipsychotics, but also the general status of the patients.</p>

    DOI: 10.5234/cnpt.11.5

    researchmap

  • ABCA7 Gene Expression and Genetic Association Study in Schizophrenia. 査読 国際誌

    Kiyohiro Yamazaki, Yuta Yoshino, Kentaro Kawabe, Tomomasa Ibuki, Shinichiro Ochi, Yoko Mori, Yuki Ozaki, Shusuke Numata, Jun-Ichi Iga, Tetsuro Ohmori, Shu-Ichi Ueno

    Neuropsychiatric disease and treatment   16   441 - 446   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Introduction: Although ATP-binding cassette sub-family A member 7 gene (ABCA7) is known to be associated with Alzheimer's disease, the relationship between ABCA7 and schizophrenia has been unknown. Methods: Schizophrenia patients (n = 50; 24 males, 62.1 ± 0.50 years old) and age- and sex-matched healthy controls (n = 50) were recruited for the mRNA analysis. Additionally, a case-control study for the rs3764650 genotypes was performed with 1308 samples (control subjects; n = 527, schizophrenia patients; n = 781). All participants were Japanese, unrelated to each other, and living in the same area. Results: The distributions of the rs3764650 genotypes in schizophrenia patients were not different from that of controls. However, the ABCA7 mRNA expression levels in schizophrenia patients were significantly higher than those in controls by a logistic regression analysis. Additionally, the ABCA7 mRNA expression levels in schizophrenia patients were correlated with the rs3764650 genotypes in a dose-dependent manner. Discussion: The ABCA7 mRNA expression levels in peripheral blood with the rs3764650 genotypes may be related to pathological mechanisms in schizophrenia and may be a biological marker for schizophrenia.

    DOI: 10.2147/NDT.S238471

    PubMed

    researchmap

  • School refusal and bullying in children with autism spectrum disorder. 査読 国際誌

    Marina Ochi, Kentaro Kawabe, Shinichiro Ochi, Tomoe Miyama, Fumie Horiuchi, Shu-Ichi Ueno

    Child and adolescent psychiatry and mental health   14   17 - 17   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: Few studies have explored school refusal in children with autism spectrum disorder (ASD), despite being considered a serious problem. One of the leading causes of school refusal is bullying, which is defined by the feelings of students who are bullied or not, and psychological suffering caused by a psychological or physical attack. This study investigated the characteristics of school refusal in children with ASD. Methods: A total of 94 outpatients with school refusal and ASD and 143 outpatients with school refusal without ASD aged 6-18 years were included. Chi squared tests and Mann-Whitney tests were used to compare the characteristics of school refusal in children with and without ASD. Univariate and multivariate logistic regression analyses were performed to analyze the reasons for school refusal in children with ASD by sex. Results: School refusal significantly occurred earlier in children with ASD than in those without. In addition, "bullying" was significantly associated with school refusal in both boys and girls with ASD. Conclusions: These findings suggest that school refusal should be monitored early in children with ASD. The importance of recognizing bullying among children with ASD should be highlighted as an opportunity for early intervention.

    DOI: 10.1186/s13034-020-00325-7

    PubMed

    researchmap

  • Clinical Assessment for Attention Test in adult with Attention-Deficit/Hyperactivity Disorder for Evaluation of symptoms and medication effects

    Kawabe Kentaro, Horiuchi Fumie, Nakachi Kiwamu, Hosokawa Rie, Ueno Shu-ichi

    Clinical Neuropsychopharmacology and Therapeutics   11 ( 0 )   35 - 42   2020年

     詳細を見る

    記述言語:英語   出版者・発行元:日本臨床精神神経薬理学会  

    <p><b>Purpose: </b>Although attention-deficit/hyperactivity disorder (ADHD) has historically been thought to be predominantly a childhood disorder, many cases of ADHD persist into adulthood. Therefore, it is necessary to assess the symptoms and efficacy of medication using objective assessment tools in adults with ADHD. The aim of this study was to assess usefulness of the Clinical Assessment for Attention Test (CAT) comprising Span, Cancellation and Detection Test, Symbol Digit Modalities Test, memory updating test, paced auditory serial addition test, position Stroop test, and continuous performance test (CPT) for adults with ADHD.</p><p><b>Methods: </b>ADHD outpatients without intellectual disorders (IQ ≥ 80) with age range of 20-39 years were recruited (15 males and 10 females; mean age 27.7 ± 5.5). The participants did not receive any psychopharmacological treatment and were assessed with CAT at baseline.</p><p><b>Results: </b>The patients showed significantly decreased attention scores in Cancellation and Detection Test (Visual Cancellation Task and Auditory Detection Task) and CPT, although this decrease was not correlated to age or intelligence quotient. The effect of psychopharmacological treatment was assessed in two participants using CAT.</p><p><b>Discussion: </b>Cancellation and Detection Test and CPT are useful tools to support the diagnosis of adults with ADHD as well as evaluation of the efficacy of psychopharmacological treatment.</p>

    DOI: 10.5234/cnpt.11.35

    researchmap

  • Excessive and Problematic Internet Use During the Coronavirus Disease 2019 School Closure: Comparison Between Japanese Youth With and Without Autism Spectrum Disorder. 国際誌

    Kentaro Kawabe, Rie Hosokawa, Kiwamu Nakachi, Ayumi Yoshino, Fumie Horiuchi, Shu-Ichi Ueno

    Frontiers in public health   8   609347 - 609347   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Internet use in the youth has increased manifold during the coronavirus disease 2019 (COVID-19) pandemic. Individuals with autism spectrum disorder (ASD) generally have a higher risk of problematic internet use. The aim of this study is to investigate the differences in internet and related digital media use between children with ASD and their typically developing counterparts during the COVID-19 pandemic. In this online survey in Japan conducted from April 30 to May 8, 2020, we analyzed digital media time of 84 children with ASD and 361 age- and gender-matched controls before and after school closure. Digital media use duration was significantly longer in the ASD group than in the control group before the pandemic. The increase of media use time was more prominent in the control group than in the ASD group. We observed excessive Internet use among children with ASD and without ASD, especially during the COVID-19 pandemic. It is necessary to establish strategies to prevent excessive internet use in not only children and adolescents with ASD but also without ASD in the post-pandemic world.

    DOI: 10.3389/fpubh.2020.609347

    PubMed

    researchmap

  • Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Shu-Ichi Ueno

    Psychiatry and clinical neurosciences   73 ( 12 )   762 - 763   2019年12月

     詳細を見る

    記述言語:英語  

    DOI: 10.1111/pcn.12935

    PubMed

    researchmap

  • Efficacy of Asenapine in Schizophrenia Resistant to Clozapine Combined with Electroconvulsive Therapy: A Case Report. 査読 国際誌

    Shinichiro Ochi, Saori Inoue, Yuta Yoshino, Hideaki Shimizu, Jun-Ichi Iga, Shu-Ichi Ueno

    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology   17 ( 4 )   559 - 563   2019年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Schizophrenic patients resistant to antipsychotics are diagnosed as having treatment-refractory schizophrenia, and they are treated with clozapine. However, clozapine is sometimes combined with electroconvulsive therapy (ECT) if clozapine monotherapy fails. In this report, a severe treatment-refractory schizophrenic patient who did not respond to clozapine even with ECT, but who recovered with asenapine monotherapy, is presented. Asenapine, considered a serotonin spectrum dopamine modulator, is a new atypical antipsychotic with unique pharmacological features that is used not only for schizophrenia, but also for bipolar disorder. The unique features of asenapine may be effective for some treatment-refractory schizophrenic patients.

    DOI: 10.9758/cpn.2019.17.4.559

    PubMed

    researchmap

  • Association between Sleep Habits and Problems and Internet Addiction in Adolescents. 国際誌

    Kentaro Kawabe, Fumie Horiuchi, Yasunori Oka, Shu-Ichi Ueno

    Psychiatry investigation   16 ( 8 )   581 - 587   2019年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: This study examined the association between sleep habits and problems and Internet addiction in adolescents. METHODS: Junior high school students from a local town in Japan (n=853; male/female, 425/428) were the subjects of this study, and were assessed for severity of Internet addiction and sleep habits and problems using the self-reported version of the Young's Internet Addiction Test (IAT) and Child and Adolescent Sleep Checklist (CASC). RESULTS: The wake time on weekdays was not significantly different among the three groups; addicted, possibly-addicted, and non-addicted. In the addicted group, the total night sleep time was significantly shorter, and the bedtime was significantly delayed on both weekdays and weekends compared with those in the possibly-addicted and non-addicted groups. The wake time of the addicted group was significantly later than that of the other groups. The total scores of sleep problems measured by the CASC were significantly higher in the addicted and possibly-addicted groups than in the non-addicted group. CONCLUSION: Internet addiction is strongly associated with sleep habits and problems in adolescents. These findings suggest that internet addiction should be considered while examining adolescent lifestyle.

    DOI: 10.30773/pi.2019.03.21.2

    PubMed

    researchmap

  • Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia. 査読 国際誌

    Yu Funahashi, Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Yoko Mori, Takaaki Mori, Shinichiro Ochi, Jun-Ichi Iga, Shu-Ichi Ueno

    Psychiatry research   278   135 - 140   2019年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The gene for dopamine receptor D2 (DRD2) is associated with schizophrenia (SCZ). Epigenetic changes may be related to SCZ pathology. The -141C Ins/Del polymorphism in DRD2 (rs1799732) is functional and associated with SCZ. Fifty SCZ patients and 50 control subjects were newly recruited and analyzed in addition to 50 previously reported SCZ samples and 50 previously reported control samples. Genomic DNA from peripheral leukocytes was analyzed. We replicated analysis of DNA methylation rates at seven CpG sites (CpG 1-1 to 1-7) and also analyzed five additional sites (CpG 2-1 to 2-5) in the upstream region of DRD2. We also performed genotyping of -141C IIns/Del and analyzed the effects of -141C Ins/Del on methylation of DRD2. Methylation rates were significantly lower in SCZ patients compared to control subjects, respectively. In control subjects, the methylation rates were significantly lower in individuals with the Ins/Ins genotype than in Del allele carriers. We replicated hypomethylation of the DRD2 promoter region in SCZ patients compared to age-matched control subjects. The -141C Ins/Del polymorphism affected the methylation rates in regions of DRD2. Hypomethylation and the -141C Ins/Del polymorphism of DRD2 may be biomarkers for SCZ.

    DOI: 10.1016/j.psychres.2019.06.001

    PubMed

    researchmap

  • 【インターネット依存の現状と課題】青少年におけるインターネット依存の現状と関連する心理・社会的問題

    河邉 憲太郎, 堀内 史枝, 上野 修一

    精神神経学雑誌   121 ( 7 )   540 - 548   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    インターネットはいまや日常的に必要不可欠なツールとなっており,接続できるデバイスもパーソナルコンピューターのみならず,スマートフォンやタブレット,テレビや携帯型ゲームなどさまざまである.その一方で,インターネット使用の制御が困難となり,生活上の問題をきたすインターネット依存が社会的問題になっている.2018年6月に世界保健機関(WHO)から公表されたICD-11においては,ゲーム障害が収載された.国際的にもインターネット依存およびゲーム障害に関して報告が蓄積されつつある.本稿では,これまでの報告を踏まえ,精神医療におけるインターネット依存の現状について整理する.(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2019&ichushi_jid=J00755&link_issn=&doc_id=20190731180002&doc_link_id=vol%3D121%26year%3D2019%26mag%3D0%26number%3D7%26start%3D540&url=https%3A%2F%2Fjournal.jspn.or.jp%2FDisp%3Fstyle%3Dabst%26vol%3D121%26year%3D2019%26mag%3D0%26number%3D7%26start%3D540&type=%90%B8%90_%90_%8Co%8Aw%8EG%8E%8F&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00022_2.gif

  • Dose-Dependent Efficacy of Tandospirone for an Oldest-Old Patient With Behavioral and Psychological Symptoms of Dementia. 査読

    Ochi S, Mori T, Iga JI, Ueno SI

    Journal of clinical psychopharmacology   2019年1月

  • Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia. 査読 国際誌

    Nakata S, Yoshino Y, Okita M, Kawabe K, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Iga JI, Ueno SI

    Psychiatry research   272   334 - 339   2018年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.psychres.2018.12.135

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0003-4409-3096

  • 【ITの進化と精神科医療のこれから-情報端末活用の実際も含めて】インターネット依存の現状と関連する心理・社会的問題

    河邉 憲太郎, 堀内 史枝, 上野 修一

    日本精神科病院協会雑誌   37 ( 10 )   1042 - 1047   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神科病院協会  

    researchmap

  • Ghrelin cascade changes in the peripheral blood of Japanese patients with Alzheimer's disease. 査読

    Yoshino Y, Funahashi Y, Nakata S, Ozaki Y, Yamazaki K, Yoshida T, Mori T, Mori Y, Ochi S, Iga JI, Ueno SI

    Journal of psychiatric research   2018年10月

  • Neurocognitive assessment of children with neurodevelopmental disorders: Preliminary findings. 査読 国際誌

    Kawabe K, Horiuchi F, Kondo S, Matsumoto M, Seo K, Oka Y, Ueno SI

    Pediatrics international : official journal of the Japan Pediatric Society   60 ( 9 )   820 - 827   2018年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/ped.13662

    PubMed

    researchmap

  • 自閉スペクトラム症児における発達指数と知能指数の関連性の検討

    河邉 憲太郎, 近藤 静香, 伊藤 瑠里子, 松本 美希, 堀内 史枝, 上野 修一

    臨床精神医学   47 ( 8 )   929 - 935   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)アークメディア  

    新版K式発達検査2001(KSPD)を用いた発達指数(DQ)がWISC-IVを用いたIQの代替となり得るかについて検討した。自閉スペクトラム症(ASD)の対象者は、2016年7月から2017年3月に愛媛大学医学部附属病院子どものこころセンターを受診した5から10歳の患者のうち、DSM-5の診断基準によりASDと診断され、WISC-IVにより測定されたFSIQが70以上の9名(男児8名、女児1名、平均月齢99.7ヵ月)とした(ASD群)。また、通常学級または一般の幼稚園に通う児童6名(男児3名、女児3名、平均月齢86.2ヵ月)を定型発達群とした。ASD群において、WISC-IVの言語理解とKSPD全領域DQおよび言語・社会DQとそれぞれ0.859、0.872の相関が確認されたが、定型発達児においては、同指標の相関係数は0.162であった。KSPDとWISC-IVから算出されるDQ・IQの関連性は認められるが、DQ・IQの代替や縦断的に評価には慎重を期す必要があることが示唆された。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2018&ichushi_jid=J01552&link_issn=&doc_id=20180913090012&doc_link_id=%2Fao1clphd%2F2018%2F004708%2F012%2F0929-0935%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fao1clphd%2F2018%2F004708%2F012%2F0929-0935%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Frontotemporal lobar degeneration due to P301L tau mutation showing apathy and severe frontal atrophy but lacking other behavioral changes: A case report and literature review. 査読 国際誌

    Miki T, Yokota O, Takenoshita S, Mori Y, Yamazaki K, Ozaki Y, Ueno SI, Haraguchi T, Ishizu H, Kuroda S, Terada S, Yamada N

    Neuropathology : official journal of the Japanese Society of Neuropathology   38 ( 3 )   268 - 280   2018年6月

     詳細を見る

  • TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease. 査読 国際誌

    Sao T, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI

    Journal of Alzheimer's disease : JAD   64 ( 4 )   1275 - 1284   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3233/jad-180418

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0003-4409-3096

  • 愛媛大学病院精神科外来における成人期発達障害に対する診療パスの予備的研究

    河邉 憲太郎, 越智 麻里奈, 松本 美希, 近藤 静香, 伊藤 瑠里子, 芳野 歩美, 妹尾 香苗, 堀内 史枝, 上野 修一

    精神医学   60 ( 5 )   545 - 557   2018年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    <文献概要>本研究は愛媛大学病院精神科外来において,成人期発達障害における発達障害の特徴を,診療パスの内容により検討することを目的とした。対象は2013〜16年に当院を初診し,発達障害の精査を希望した18歳以上の患者104名(男性57,女性47)である。診療パスは生育歴の聴取や主訴の問診票と,AQ-J,ASRS,CAARS,BDI-II,SFS,SRSなどの質問紙とWAIS-IIIで構成されている。対象者のうちASD29例,ADHD18例,精神疾患に該当しない18例の3群を比較した。結果,ASD群はADHD群と比較して有意に男性,精神症状の主訴が多く,SFSが低値,WAIS-IIIのVIQが高値であった。ADHD群は不注意の主訴,既婚者の割合,ASRSが有意に高かった。診療パスは精神症状や社会機能の把握に一定の有用性があった。本研究は予備的研究であり,診療パスにはさらなる検討が必要である。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2018&ichushi_jid=J00749&link_issn=&doc_id=20180524210016&doc_link_id=10.11477%2Fmf.1405205600&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1405205600&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

  • 愛媛大学附属病院子どものこころセンター開設後2年間における初診患者の受診動向 査読

    橘 侑南, 河邉 憲太郎, 見山 朋恵, 城賀本 敏宏, 日野 香織, 福田 光成, 越智 麻里奈, 伊藤 瑠里子, 芳野 歩美, 服鳥 秀幸, 南立 芙美子, 堀内 史枝, 上野 修一

    精神神経学雑誌   120 ( 4 )   339 - 339   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer's disease 査読 国際誌

    Tomoko Sao, Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Yoko Mori, Shinichiro Ochi, Taku Yoshida, Takaaki Mori, Jun-ichi Iga, Shu-ichi Ueno

    Psychiatry and Clinical Neurosciences   72 ( 3 )   160 - 167   2018年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley-Blackwell  

    DOI: 10.1111/pcn.12618

    PubMed

    researchmap

  • Pick's disease with neuronal four-repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum 査読

    Chikako Ikeda, Osamu Yokota, Tomoko Miki, Shintaro Takenoshita, Hideki Ishizu, Yoko Mori, Kiyohiro Yamazaki, Yuki Ozaki, Shu-Ichi Ueno, Takeshi Ishihara, Masato Hasegawa, Seishi Terada, Norihito Yamada

    Neuropathology   37 ( 6 )   544 - 559   2017年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Blackwell Publishing  

    It is very rare that cases of Pick's disease, a representative three-repeat (3R) tauopathy, also have significant four-repeat (4R) tau accumulation. Here, we report a Pick's disease case that clinically showed behavioral variant frontotemporal dementia without motor disturbance during the course, and pathologically had 3R tau-positive Pick bodies as well as numerous 4R tau-positive neuronal cytoplasmic inclusions (NCIs). Abundant 3R tau-positive 4R tau-negative spherical or horseshoe-shaped Pick bodies were found in the frontotemporal cortex, limbic region, striatum and pontine nucleus. On the other hand, many 4R tau-positive, 3R tau-negative, Gallyas-negative dot-, rod- or intertwined skein-like NCIs were found mainly in the subthalamic nucleus, pontine nucleus, inferior olivary nucleus and cerebellar dentate nucleus. Tufted astrocytes, astrocytic plaques, argyrophilic grains or globular glial inclusions were absent. Double-labeling immunofluorescence demonstrated that 3R tau was hardly accumulated in 4R tau-positive inclusions. On tau immunoblotting, while 60 and 64 kDa bands were demonstrated in the frontal cortex, 60, 64 and 68 kDa bands, as well as the 33 kDa tau fragments that are reported to be characteristic of progressive supranuclear palsy brains, were found in the basal ganglia and cerebellum. No mutation was identified in the tau gene. The present case suggests that, although probably rare, some Pick's disease cases have non-negligible 4R tau pathology in the subcortical nuclei, and that such 4R tau pathology can affect the evaluation of the distribution of AT8-positive tau pathology in Pick's disease cases.

    DOI: 10.1111/neup.12394

    Scopus

    researchmap

  • Suvorexant for the Treatment of Insomnia in Adolescents 査読

    Kentaro Kawabe, Fumie Horiuchi, Marina Ochi, Kayoko Nishimoto, Shu-ichi Ueno, Yasunori Oka

    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY   27 ( 9 )   792 - 795   2017年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MARY ANN LIEBERT, INC  

    Objectives: Suvorexant is the first dual orexin receptor antagonist for treating insomnia. This study aimed to evaluate the tolerability, efficacy, and safety of suvorexant on insomnia in adolescents. Methods: Thirty patients (8 male and 22 female; mean standard deviation age: 15.72.4 years; range: 10-20) with insomnia were administered suvorexant. Clinical background, persistence rate, the Clinical Global Impression (CGI), and the Athens Insomnia Scale (AIS) were compared between patients who continued and discontinued suvorexant treatment. Results: Seventeen patients (56.7%) successfully continued taking suvorexant. Among the 13 patients who did not continue treatment, 5 patients were lost to follow-up. Of the remaining eight who did not continue treatment, four decided to discontinue of their own accord, two decided to discontinue due to lack of effectiveness, and two decided to discontinue due to adverse reaction, namely abnormal dreams. Among patients who completed the study, CGI significantly decreased from 3.6 +/- 0.8 to 3.1 +/- 0.9 (p=0.014). The score of sleep quality in AIS was significantly higher among the patients who discontinued suvorexant than those who continued suvorexant (p=0.02). Conclusion: Our results indicate that suvorexant could be considered a treatment option for adolescents.

    DOI: 10.1089/cap.2016.0206

    Web of Science

    PubMed

    researchmap

  • DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease 査読

    Yuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, Tomoko Sao, Yoko Mori, Shinichiro Ochi, Taku Yoshida, Takaaki Mori, Jun-ichi Iga, Shu-ichi Ueno

    JOURNAL OF PSYCHIATRIC RESEARCH   92   74 - 80   2017年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Objectives: Recent genome-wide association studies revealed that Triggering receptor expressed on myeloid cells 2 (TREM2) was associated with Alzheimer's disease (AD) and other neurodegenerative diseases. We previously reported that TREM2 mRNA is highly expressed in leukocytes of AD patients compared to those in healthy controls. However, the mechanism of TREM2 expression change is still not known. In this study, we examined the involvement of the DNA methylation status of TREM2 in its high gene expression.
    Materials and methods: Fifty AD subjects and age- and sex-matched control subjects were recruited (25 males, 25 females; 79.9 +/- 5.27 and 79.4 +/- 3.92 years old, respectively). TREM2 mRNA expression and the percentage of DNA methylation at four CpG sites in intron 1 of TREM2 were studied using their peripheral leukocytes.
    Results: We confirmed that TREM2 mRNA expression in leukocytes was significantly higher in AD patients than in controls (p = 0.007). The percentage methylation at three CpG sites in TREM2 intron 1 was significantly lower in AD subjects than in control: CpG1, 9.4 +/- 3.2 vs 11.9 +/- 4.0 (p = 0.001); CpG2, 15.4 +/- 4.9 vs 19.1 +/- 4.8 (p = 0.001); CpG3, 20.8 +/- 5.5 vs 25.5 +/- 5.4 (p &lt; 0.001); and the average percentage methylation of all CpG sites: 13.5 +/- 3.7 vs 16.1 +/- 3.8 (p = 0.002), respectively. In addition, there were significant negative correlations between TREM2 mRNA expression and the percentage DNA methylation of each of CpG sites (CpG1, r = -0.416, p &lt; 0.001; CpG2, r = -0.510, p &lt; 0.001; CpG3, r = -0.504, p &lt; 0.001; CpG4, r = -0.356, p &lt; 0.001).
    Conclusions: Lower DNA methylation at TREM2 intron 1 caused higher TREM2 mRNA expression in the leukocytes of AD subjects versus controls and may be a biomarker for AD. (C) 2017 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jpsychires.2017.04.003

    Web of Science

    researchmap

  • 精神医学のフロンティア 青少年におけるインターネット依存の有病率と精神的健康状態との関連

    河邉 憲太郎, 堀内 史枝, 越智 麻里奈, 岡 靖哲, 上野 修一

    精神神経学雑誌   119 ( 9 )   613 - 620   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    【目的】インターネットは急速に普及し,生活に必要不可欠なものとなりつつある一方,インターネット使用の制御が困難となるインターネット依存が社会的問題になっている.本研究では,中学生におけるインターネット依存の有病率を調査し,インターネット依存と精神的問題の関連および要因の特定を目的とした.【方法】12〜15歳の中学生874名を対象に,インターネット依存度テスト(IAT),日本語版精神健康調査質問紙短縮版30項目(GHQ)に加え,電子機器の使用状況に関する質問紙を行った.【結果】中学生853名(回収率97.6%,男子425名,女子428名)から回答を得た.IATの平均総得点は32.4±13.6(男子31.4±13.2,女子33.3±13.9)であった.IATの重症度分類では,addictedが2.0%(男子2.1%,女子1.9%),possibly-addictedが21.7%(男子19.8%,女子23.6%)であった.IATの得点に影響する因子は,学年(P=0.001)とGHQ総得点(P&lt;0.001)が有意であった.GHQの平均総得点は,addictedが12.9±7.4,possibly-addictedが8.8±6.0,non-addictedが4.3±4.6であり,依存傾向があるaddictedおよびpossibly-addictedはnon-addictedより有意に得点が高く,問題を抱えた生徒の割合が多かった.また,スマートフォンを自由に使用できることがインターネット依存と関連があった.【考察】インターネット依存の有病率は,possibly-addictedを含め中学生の23.7%にみられ,精神的問題との関連が考えられた.インターネットの適切な利用に関して,保護者,教育機関,医療機関がそれぞれ注意する必要がある.(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J00755&link_issn=&doc_id=20171010080001&doc_link_id=vol%3D119%26year%3D2017%26mag%3D0%26number%3D9%26start%3D613&url=https%3A%2F%2Fjournal.jspn.or.jp%2FDisp%3Fstyle%3Dabst%26vol%3D119%26year%3D2017%26mag%3D0%26number%3D9%26start%3D613&type=%90%B8%90_%90_%8Co%8Aw%8EG%8E%8F&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00022_2.gif

  • Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment 査読

    Yuta Yoshino, Takaaki Mori, Taku Yoshida, Yasutaka Toyota, Hideaki Shimizu, Jun-ichi Iga, Shusaku Nishitani, Shu-ichi Ueno

    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE   15 ( 3 )   243 - 247   2017年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN COLL NEUROPSYCHOPHARMACOLOGY  

    Objective: Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo spatial dysfunction is a well known symptom of DLB. Non verbal Raven's Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil.
    Methods: Twenty one DLB patients (mean age, 78.7 +/- 4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil.
    Results: There were significant improvements of RCPM in the total scores between one year donepezil treatment (p=0.013), in both Set A score (p=0.002) and Set AB score (p=0.015), but trend in the Set B score (p=0.083).
    Conclusion: Donepezil is useful for improving visuo spatial impairment in DLB, but not for problem solving impairment.

    DOI: 10.9758/cpn.2017.15.3.243

    Web of Science

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0003-4409-3096

  • Endothelial nitric oxide synthase in rat brain is downregulated by sub-chronic antidepressant treatment 査読

    Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Shunsuke Nakata, Jun-ichi Iga, Shu-ichi Ueno

    PSYCHOPHARMACOLOGY   234 ( 11 )   1663 - 1669   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Background
    Nitric oxide (NO) is a neurotransmitter that may be related to major depressive disorder (MDD) because the selective neuronal NO synthase (NOS) inhibitor, 7-nitroindazole, induces a dose-dependent antidepressant-like effect. NO modulates major neurotransmitters involved in the neurobiology of MDD, such as norepinephrine, serotonin, dopamine, and glutamate. In this study, we investigated the effects of antidepressants as NO modulators in acute and sub-chronic treatments.
    Methods
    Rats were injected with the SSRI paroxetine (PAR, 10 mg/kg), the SNRI milnacipran (MIL, 30 mg/kg), or the NaSSA mirtazapine (MIR, 10 mg/kg) for acute (1 h) or sub-chronic (3 weeks) treatment prior to analysis of nine brain regions (frontal cortex, temporal cortex, striatum, thalamus, hippocampus, midbrain, pons, cerebellum, and olfactory bulb). The mRNA expression levels of three NOS subtypes (neuronal: nNOS, inducible: iNOS, and endothelial: eNOS) were analyzed using real-time PCR with Taqman probes.
    Results
    Acute MIR treatment significantly increased nNOS mRNA expression in the hippocampus, midbrain, cerebellum and olfactory bulb, and iNOS mRNA expression in the frontal cortex and midbrain. Acute PAR and MIR treatments significantly increased eNOS mRNA expression in most brain regions. Conversely, sub-chronic treatment with all types of antidepressants resulted in significant decreases of eNOS mRNA expression in most brain regions.
    Conclusions
    Sub-chronic treatment with the three types of antidepressants consistently decreased eNOS mRNA expression levels in the rat brain. These effects may be associated with the involvement of the NO system in the mechanism of action of antidepressants.

    DOI: 10.1007/s00213-017-4567-z

    Web of Science

    PubMed

    researchmap

  • 大学病院子どものこころセンターを受診した中学生におけるインターネット依存状態の検討

    河邉 憲太郎, 見山 朋恵, 日野 香織, 越智 麻里奈, 堀内 史枝, 上野 修一

    精神神経学雑誌   119 ( 6 )   435 - 435   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects 査読

    Yuta Yoshino, Yuki Ozaki, Kiyohiro Yamazaki, Tomoko Sao, Yoko Mori, Shinichiro Ochi, Jun-ichi Iga, Shu-ichi Ueno

    FRONTIERS IN NEUROSCIENCE   11   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:FRONTIERS MEDIA SA  

    A hypothesis for schizophrenia (SCZ) called the microglia hypothesis has been suggested. In SCZ, expression of triggering receptor expressed on myeloid cell 2 (TREM2) mRNA is higher in leukocytes than in healthy individuals. Here, the methylation rates of four CpG sites in TREM2 intron 1 that may bind important transcription factors and the correlation between the methylation rate and mRNA expression were determined. We compared the methylation rates in SCZ patients and age-matched controls (n = 50 each). SCZ patients had significantly lower methylation rates of CpG 2 (17.0 +/- 6.7 vs. 20.2 +/- 5.0; p = 0.02) and CpG 3 (23.8 +/- 8.2 vs. 28.1 +/- 6.2; p = 0.01). The average methylation rate (15.3 +/- 5.2 vs. 17.6 +/- 3.9; p = 0.009) was also lower. A significant negative correlation was found between TREM2 mRNA expression and the methylation rate of CpG 2 (r = -0.252, p = 0.012). SCZ susceptibility markers may include low methylation at TREM2 intron 1 and increased TREM2 mRNA levels. Our pilot study requires validation with higher numbers of participants and with other myeloid cell types.

    DOI: 10.3389/fnins.2017.00275

    Web of Science

    researchmap

  • 統合失調症との鑑別に苦慮した青年期女性自閉スペクトラム症の1例

    越智 麻里奈, 河邉 憲太郎, 見山 芳隆, 近藤 静香, 松本 美希, 妹尾 香苗, 堀内 史枝, 上野 修一

    精神科   30 ( 5 )   455 - 460   2017年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    症例は18歳女性で、17歳頃から幻聴が絶えず出現し、被害念慮が増悪したため、アリピプラゾールによる薬物療法を開始したが、症状に改善を認めず、入院となった。絵画欲求不満テストでは、場面状況理解は悪く、場面に関係なく自責的な反応を多く認め、柔軟な対応が困難であることが分かった。会話はオウム返しが多く、周囲の話題についていけないといった社会的コミュニケーションの障害を認め、飲み物の温度に関するこだわり、感覚刺激に対する過敏さといった限局的反復的な行動パターンを認め、DSM-5による自閉症スペクトラム症(ASD)の診断基準を満たした。現在までの行動観察と心理検査結果を総合し、ASDに精神病症状が併存する状態であると診断した。本人に対しては、苦手なところをどう補っていくのかを具体的に伝えるなどした。

    researchmap

  • 自閉スペクトラム症におけるバウム・テストに関する検討 気分障害に着目して

    松本 美希, 近藤 静香, 妹尾 香苗, 河邉 憲太郎, 越智 麻里奈, 小森 憲治郎, 堀内 史枝, 上野 修一

    最新精神医学   22 ( 3 )   275 - 281   2017年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)世論時報社  

    バウム・テストは臨床場面において一般的に用いられる投影法だが、自閉スペクトラム症(Autism Spectrum Disorders:ASD)児にバウム・テストを用いた先行研究は多くない。本研究はASD児に併存する抑うつ状態を検出できる指標を明らかにすることを目的に、抑うつ状態ありと児童精神科医が判断したASD児を対象として、バウム・テストとバールソン児童用抑うつ性尺度(Birleson Depression Self-Rating Scale for Children:DSRS-C)を実施し、臨床症状を反映しえるか検討した。その結果、DSRS-Cの総点はASD児の抑うつ状態の有無によって有意差を認めず、バウム・テストの気分の落ち込みを示す指標は、抑うつ状態を伴うASD群で出現数が有意に多かった。バウム・テストの気分の落ち込みを示す指標の出現が、ASD児の抑うつ状態の検出に有用である可能性が示された。(著者抄録)

    researchmap

  • Elevated mRNA expression of CASPR3 in patients with schizophrenia 査読

    Mitsuo Okita, Yuta Yoshino, Jun-ichi Iga, Shu-ichi Ueno

    NORDIC JOURNAL OF PSYCHIATRY   71 ( 4 )   312 - 314   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS LTD  

    Background: Recently, it was reported that antipsychotic treatment reverted Contactin Associated Protein-Like 3 (CASPR3, same as CNTNAP3) mRNA expressions in leukocytes of schizophrenia (SCZ) subjects to the same levels as healthy controls. CASPR3 was expressed in various regions of the mice brain (cortex, frontal lobes, corpus callosum, hippocampus, etc.). Thus, this study evaluated CASPR3 mRNA expression in SCZ subjects to find a new clue of schizophrenia pathogenesis.Methods: One hundred SCZ subjects and 100 age-matched controls were compared. Levels of CASPR3 mRNA in leukocytes were analysed with a quantitative real-time PCR method using TaqMan probes.Results: CASPR3 mRNA expression was significantly higher in leukocytes of SCZ subjects than controls. However, there were no significant correlations between expression level and any clinical parameters in 50 SCZ subjects.Conclusion: Considering that CASPR3 is involved in building the brain neural network and autophagy in circulating leukocytes, abnormal CASPR3 expression in SCZ subjects may be associated with the pathogenesis of SCZ.

    DOI: 10.1080/08039488.2017.1291720

    Web of Science

    researchmap

  • 研究と報告 標準注意検査法を用いた成人期ADHDの注意機能評価

    近藤 静香, 河邉 憲太郎, 松本 美希, 妹尾 香苗, 越智 麻里奈, 堀内 史枝, 上野 修一

    精神医学   59 ( 5 )   483 - 490   2017年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    注意欠如・多動症(ADHD)は生涯にわたる障害であるが,成人期におけるADHDの診断は小児期より困難をきわめる。本研究では,標準注意検査法(CAT)を用いて,成人期ADHDの注意機能の特徴を明らかにすることを目的に調査を行った。当院外来を受診した18歳以上の知的障害を伴わないADHD患者を対象とし,認知機能検査としてWAIS-IIIを,注意機能検査としてCATを実施した。CAT各検査結果とWAIS-III全検査IQとの関連について検討し,標準化データと比較検討した。CATの各課題のうち,知的機能の影響を受けず注意障害を認めたものは,Visual Cancellation Task, Auditory Detection Task, PASATであった。成人期ADHDでは視覚的・聴覚的な選択性注意,ワーキングメモリーが特徴的に障害されることが示唆された。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J00749&link_issn=&doc_id=20170608060018&doc_link_id=10.11477%2Fmf.1405205390&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1405205390&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

  • Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and I-123-IMP SPECT imaging results 査読

    Taku Yoshida, Takaaki Mori, Hideaki Shimizu, Yuta Yoshino, Naomi Sonobe, Teruhisa Matsumoto, Keiichi Kikuchi, Masao Miyagawa, Junichi Iga, Teruhito Mochizuki, Shu-ichi Ueno

    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY   32 ( 4 )   407 - 413   2017年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    ObjectiveImpairment of visual perception frequently occurs in Alzheimer's disease (AD) and can cause severe constraints in daily activities. The nonverbal Raven's Colored Progressive Matrices (RCPM) test consists of sets A, AB, and B and is easily performed in a short time to evaluate both visual perception and reasoning ability. The purpose of this study was to evaluate the neural basis of visual perception and reasoning ability in patients with AD using RCPM and single-photon emission computed tomography (SPECT).
    MethodsFifty patients who fulfilled the National Institute on Aging/Alzheimer's Association criteria for probable AD dementia were examined with RCPM and SPECT. All SPECTs were performed using N-isopropyl-p-[I-123]-iodoamphetamine. A multiple regression model was used to perform multivariate analyses of the relationships between regional cerebral blood flow (rCBF) and RCPM scores.
    ResultsThere was a significant positive correlation between RCPM total score and rCBF in the inferior parietal lobes bilaterally, the right inferior temporal gyrus, and the right middle frontal gyrus. Set A was positively correlated with rCBF in the right temporal and right parietal lobes. Set AB was positively correlated with rCBF in the right temporal, right parietal, and right frontal lobes. Set B was positively correlated with rCBF in the right parietal and right frontal lobes.
    ConclusionOur findings suggest that deteriorations of specific brain regions are associated with dysfunction of visual perception and reasoning ability in AD. RCPM is another informative assessment scale of cognition for use in patients with AD. Copyright (c) 2016 John Wiley & Sons, Ltd.

    DOI: 10.1002/gps.4481

    Web of Science

    Scopus

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0003-4409-3096

  • DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies 査読

    Yu Funahashi, Yuta Yoshino, Kiyohiro Yamazaki, Yoko Mori, Takaaki Mori, Yuki Ozaki, Tomoko Sao, Shinichiro Ochi, Jun-ichi Iga, Shu-ichi Ueno

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   71 ( 1 )   28 - 35   2017年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    AimIt is difficult to diagnose dementia with Lewy bodies (DLB) because it exhibits clinical and neuropathological overlap with both Alzheimer's disease and Parkinson's disease. The -synuclein protein is a major component of Lewy bodies, and accumulation of -synuclein aggregates causes synaptic dysfunction in DLB. Epigenetic changes at the synuclein alpha (SNCA) gene may be involved in DLB pathogenesis.
    MethodsWe examined DNA methylation rates at 10 CpG sites located in intron 1 of SNCA and SNCA mRNA expression in peripheral leukocytes to compare DLB patients (n=20; nine men, 11 women; age=78.87.7years) with healthy controls (n=20; eight men, 12 women; age=77.0 6.9years).
    ResultsThe methylation rate at CpG 4 (P=0.002) and the overall mean methylation rate at these sites (P&lt; 0.001) were significantly lower in DLB patients than in healthy controls after Bonferroni correction. Although SNCA126, a partial form of SNCA mRNA expression, was significantly increased in DLB (P=0.017), there was no significant difference in total SNCA mRNA expression between DLB patients and healthy controls (P=0.165). No correlation was observed between SCNA mRNA expression levels and blood DNA methylation rates in either DLB or healthy controls.
    ConclusionOur findings indicated that lower methylation rates may be a biomarker for DLB.

    DOI: 10.1111/pcn.12462

    Web of Science

    researchmap

  • INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects 査読

    Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Tomoko Sao, Taku Yoshida, Takaaki Mori, Yoko Mori, Shinichiro Ochi, Jun-Ichi Iga, Shu-Ichi Ueno

    JOURNAL OF ALZHEIMERS DISEASE   58 ( 3 )   687 - 694   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:IOS PRESS  

    Microglial dysfunction and inflammation have recently been shown to be related to the development of Alzheimer's disease (AD). Inositol polyphosphate-5-phosphatase (INPP5D) functions broadly as a negative regulator of immune signaling, and its locus was associated with development of AD in a large-scale genome-wide association study. Thus, we examined INPP5D mRNA expression and methylation rates of the CpG sites in the upstream region of INPP5D exon 1 in peripheral leukocytes in 50 AD and age- and sex-matched control subjects. INPP5D mRNA expression in AD subjects was significantly higher than that in control subjects (1.16 +/- 0.39 versus 1.0 +/- 0.23, p = 0.049) and was correlated with the Mini-Mental State Examination score (p = 0.002, r = 0.426) and the total score of the Alzheimer's Disease Assessment Scale (p &lt; 0.001, r = -0.697). Methylation rates in the upstream region of INPP5D exon 1 were not significantly different between AD and control subjects (average rate: 3.5 +/- 3.0 versus 2.8 +/- 1.3, p = 0.551). Our results suggested that INPP5D mRNA expression was elevated in the early stage and decreased with cognitive decline in AD. INPP5D mRNA expression in leukocytes may be a useful biomarker for the early stage of AD.

    DOI: 10.3233/JAD-161211

    Web of Science

    PubMed

    researchmap

  • TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects 査読

    Ayano Mise, Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Tomoko Sao, Taku Yoshida, Takaaki Mori, Yoko Mori, Shinichiro Ochi, Jun-ichi Iga, Shu-ichi Ueno

    JOURNAL OF ALZHEIMERS DISEASE   60 ( 3 )   1107 - 1117   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:IOS PRESS  

    Background: TOMM40 is located on chromosome 19, is in linkage disequilibrium with apolipoprotein E (APOE), and is reported in several genome-wide association studies to be associated with Alzheimer's disease (AD).
    Objective: Assess APOE and TOM40 and mitochondrial genes as blood biomarkers for AD.
    Methods: We examined TOMM40, PTEN-induced putative kinase 1 (PINK1), Parkin RBR E3 ubiquitin protein ligase (PARK2), and APOE mRNA expression in relation to the methylation rates of CpG sites in the upstream region of TOMM40exon 1 in peripheral leukocytes and TOMM40523 polyT genotypes in 60 AD and age-and sex-matched control subjects.
    Results: TOMM40 mRNA expression was significantly lower in AD subjects (0.87 +/- 0.18 versus 1.0 +/- 0.23, p = 0.005), and PINK1 mRNA expression was higher in AD subjects (1.5 +/- 0.61 versus 1.0 +/- 0.52, p &lt; 0.001). TOMM40 mRNA expression was significantly correlated with the Mini-Mental State Examination total score (r = 0.290, p = 0.027). There was no expressional change in peripheral APOE mRNA in either AD or control subjects (p = 0.32). Methylation rates in the upstream region of TOMM40exon 1 were not different between AD and control subjects (average rate: 1.37 +/- 0.99 versus 1.39 +/- 1.20, p = 0.885), and TOMM40523 polyT genotypes were also not different between AD and control subjects (p = 0.67).
    Conclusion: TOMM40 mRNA expression was lower in AD subjects and was correlated with cognitive decline. Significant changes in both TOMM40 and PINK1 mRNA may be related to mitochondrial dysfunction.

    DOI: 10.3233/JAD-170361

    Web of Science

    PubMed

    researchmap

  • Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease 査読

    Kiyohiro Yamazaki, Yuta Yoshino, Takaaki Mori, Taku Yoshida, Yuki Ozaki, Tomoko Sao, Yoko Mori, Shinichiro Ochi, Jun-ichi Iga, Shu-ichi Ueno

    JOURNAL OF ALZHEIMERS DISEASE   57 ( 1 )   171 - 181   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:IOS PRESS  

    Background/Objective: The aim of this study was to examine the blood gene expression and methylation of ATP-binding cassette sub-family A member 7 gene (ABCA7) as a biological marker of AD.
    Methods: AD subjects (n = 50; 11 males, 77.7 +/- 6.05 years old) and age-and sex-matched healthy controls (n = 50) were recruited. A single nucleotide polymorphism in ABCA7 (rs3764650), methylation rates of CpG sites in the ABCA7 promoter region, and ABCA7 mRNA expression levels in peripheral blood were examined.
    Results: The distribution of the rs3764650 polymorphism in AD subjects was not different from that of controls. Although the methylation rates of AD subjects were not significantly different from those of controls, the ABCA7 mRNA expression level in AD subjects was significantly higher than that in controls. Additionally, the ABCA7 mRNA expression level in AD subjects was significantly correlated with Mini-Mental State Examination recall, the Alzheimer's Disease Assessment Scale total score, and the Clinical Dementia Rating score. We also found a significant correlation between the ABCA7 mRNA expression level and duration of illness.
    Conclusion: The ABCA7 mRNA expression level in peripheral blood may be a marker for early stages of AD and disease progression regardless of rs3764650 and the methylation rate of its promoter.

    DOI: 10.3233/JAD-161195

    Web of Science

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0003-4409-3096

  • De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity. 査読 国際誌

    Nishi A, Numata S, Tajima A, Zhu X, Ito K, Saito A, Kato Y, Kinoshita M, Shimodera S, Ono S, Ochi S, Imamura A, Kurotaki N, Ueno SI, Iwata N, Fukui K, Imoto I, Kamiya A, Ohmori T

    Scientific Reports   7 ( 1 )   2887 - 2887   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/s41598-017-02792-z

    PubMed

    researchmap

  • DNA Methylation Changes in Intron 1 of <i>Triggering Receptor Expressed on Myeloid Cell 2</i> in Japanese Schizophrenia Subjects. 査読

    Yoshino Y, Ozaki Y, Yamazaki K, Sao T, Mori Y, Ochi S, Iga JI, Ueno SI

    Frontiers in neuroscience   11   275   2017年

  • Developmental quotient to estimate intelligence in autism spectrum disorder 査読

    Kentaro Kawabe, Shizuka Kondo, Miki Matsumoto, Kanae Seo, Marina Ochi, Yasunori Oka, Fumie Horiuchi, Shu-ichi Ueno

    PEDIATRICS INTERNATIONAL   58 ( 10 )   963 - 966   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    BackgroundAutism spectrum disorders (ASD) are characterized by persistent deficits in social communication and social interaction across contexts, and are associated with restricted patterns of behavior. The developmental quotient (DQ) is based on the developmental age and chronological age of children. This study investigated the utility of the DQ to estimate cognitive ability in young children with ASD.
    MethodsThe DQ and intelligence quotient (IQ) were assessed using the Kyoto Scale of Psychological Development 2001 (KSPD) and Wechsler Intelligence Scale for Children-III (WISC-III), respectively. The correlation between the DQ and IQ was then analyzed among children with ASD.
    ResultsWe enrolled 18 children with ASD (16 boys, two girls; age, 63.6 9.4 months; age range, 45-83 months). Overall, Cognitive-Adaptive and Language-Social DQ scores were significantly correlated with IQ score in the full scale, verbal, and performance domains. Full-scale IQ and overall DQ had a linear correlation (y = -22.747 + 1.177x, R-2 = 0.677, R = 0.823).
    ConclusionsThe DQ scores obtained using the KSPD were a reasonable estimate of cognitive ability in children with ASD. The KSPD may be a useful alternative to the WISC-III for young children with ASD and could facilitate earlier assessment.

    DOI: 10.1111/ped.12969

    Web of Science

    PubMed

    researchmap

  • 中学生におけるインターネット依存と睡眠習慣との関連

    河邉 憲太郎, 堀内 史枝, 越智 麻里奈, 近藤 静香, 松本 美希, 伊藤 瑠里子, 上野 修一, 岡 靖哲

    不眠研究   2016   41 - 45   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)三原医学社  

    2014年11月に、愛媛県伊予郡松前町内の公立中学校3校に在籍する生徒874名を対象に、地域の中学生においてインターネットの利用・依存が睡眠習慣に与える影響について調査し検討した。最終的な有効回答は853名(男子425名、女子428名、平均13.6±0.9歳)であった。IATスコアによる重症度分類では依存状態が2.0%、依存傾向が21.7%であった。重症が高い即ち依存傾向が強いほど、睡眠の問題が有意に多く、平日の睡眠時間・就寝時刻、休日の起床・就寝時刻に群間差を認め、インターネット依存と睡眠習慣・睡眠衛生への関与が示唆された。

    researchmap

  • Internet addiction: Prevalence and relation with mental states in adolescents 査読

    Kentaro Kawabe, Fumie Horiuchi, Marina Ochi, Yasunori Oka, Shu-ichi Ueno

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   70 ( 9 )   405 - 412   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    AimInternet addiction disrupts the daily lives of adolescents. We investigated the prevalence of Internet addiction in junior high school students, elucidated the relation between Internet addiction and mental states, and determined the factors associated with Internet addiction in adolescents.
    MethodsJunior high school students (aged 12-15 years) were assessed using Young's Internet Addiction Test (IAT), the Japanese version of the General Health Questionnaire (GHQ), and a questionnaire on access to electronic devices.
    ResultsBased on total IAT scores, 2.0% (male, 2.1%; female, 1.9%) and 21.7% (male, 19.8%; female, 23.6%) of the total 853 participants (response rate, 97.6%) were classified as addicted and possibly addicted, respectively. Total GHQ scores were significantly higher in the addicted (12.9 7.4) and possibly addicted groups (8.8 +/- 6.0) than in the non-addicted group (4.3 +/- 4.6; P &lt; 0.001, both groups). A comparison of the percentage of students in the pathological range of GHQ scores revealed significantly higher scores in the possibly addicted group than in the non-addicted group. Further, accessibility to smartphones was significantly associated with Internet addiction.
    ConclusionStudents in the addicted and possibly addicted groups were considered problematic' Internet users. Use of smartphones warrants special attention, being among the top factors contributing to Internet addiction.

    DOI: 10.1111/pcn.12402

    Web of Science

    PubMed

    researchmap

  • Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects. 査読

    Yoshino Y, Mori T, Yoshida T, Yamazaki K, Ozaki Y, Sao T, Funahashi Y, Iga JI, Ueno SI, Jou, Alzheimer's, disease : JAD

    2016年8月

     詳細を見る

    Yoshino Y, Mori T, Yoshida T, Yamazaki K, Ozaki Y, Sao T, Funahashi Y, Iga JI, Ueno SI, Journal of Alzheimer&#039;s disease : JAD, 2016, 2016

    DOI: 10.3233/JAD-160430

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0003-4409-3096

  • Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects. 査読

    Yoshino Y, Kawabe K, Mori T, Mori Y, Yamazaki K, Numata S, Nakata S, Yoshida T, Iga JI, Ohmori T, Ueno SI

    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry   1 - 8   2016年7月

  • 児童青年期の不眠におけるオレキシン受容体拮抗薬の使用経験

    堀内 史枝, 河邉 憲太郎, 西本 佳世子, 越智 麻里奈, 上野 修一, 岡 靖哲

    日本睡眠学会定期学術集会プログラム・抄録集   41回   283 - 283   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本睡眠学会  

    researchmap

  • Suicidal ideation in adolescents and their caregivers: a cross sectional survey in Japan 査読

    Kentaro Kawabe, Fumie Horiuchi, Marina Ochi, Yasunori Oka, Shu-ichi Ueno

    BMC PSYCHIATRY   16   231   2016年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Backgrounds: Suicide is a leading cause of death in adolescence. Effective strategies are required to prevent suicide. We aimed to assess the prevalence of suicidal ideation in early teens and the relationship between family mental health and suicidal ideation of their child.
    Methods: A population-based survey in a rural town included 185 junior high school students and their caregivers. Suicidal ideation and mental states were assessed with General Health Questionnaire (GHQ) and Profile of Mood States (POMS) form.
    Results: Nineteen (10.3 %) students experienced suicidal ideation in the preceding weeks and had more mental health problems than students without suicidal ideation. Caregivers of students with suicidal ideation demonstrated significantly higher suicidal depression scores in GHQ. Multivariate logistic regression analysis revealed that suicidal depression of caregivers was the most important factor for suicidal ideation of students.
    Conclusions: Suicidal ideation of children is associated with suicidal depression of their caregivers. For the prevention of suicide in adolescents, not only their own mental status but also that of caregivers should be taken into consideration.

    DOI: 10.1186/s12888-016-0934-2

    Web of Science

    PubMed

    researchmap

  • Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease. 査読

    Yamazaki K, Yoshino Y, Mori T, Okita M, Yoshida T, Mori Y, Ozaki Y, Sao T, Iga JI, Ueno SI

    Dementia and geriatric cognitive disorders   41 ( 5-6 )   334 - 347   2016年7月

  • 【発達障害治療のトピックス】 睡眠障害と発達障害 どのように診立てていくべきか

    堀内 史枝, 岡 靖哲, 河邉 憲太郎, 上野 修一

    精神神経学雑誌   118 ( 6 )   410 - 416   2016年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    神経発達障害,主に注意欠如・多動症(ADHD)や自閉スペクトラム症(ASD)に関連する睡眠障害には,生来性の睡眠の量や質の低下,睡眠覚醒リズムの構築異常,発達障害に並存する睡眠障害,発達障害の二次障害としての睡眠障害,二次障害の一症状としての睡眠障害,さらに発達障害の薬物治療に伴う睡眠障害があり多因子である.小児ADHDとの関連が深い睡眠障害としては,閉塞性睡眠時無呼吸症候群(OSAS)やレストレスレッグス症候群(RLS)が挙げられる.小児のOSASは低身長や認知機能・行動の問題,ADHD様症状や夜尿の遷延などの症状がみられる.アデノイド・扁桃腺肥大によるものが多く,外科的処置が第一選択となる場合が多い.ADHDとRLSでは共通して鉄欠乏やドパミン系の異常の関与が指摘され,合併頻度は予想以上に高い.RLSでは一般的に睡眠薬は無効であり,的確な診断が重要となる.小児ASDと関連の深い睡眠障害としては,不眠障害,睡眠時随伴症および概日リズム睡眠-覚醒障害などが挙げられる.発達障害児の不眠やリズム障害に対しては睡眠衛生指導や行動療法的介入が一般的であるが,薬物治療も必要となる場合がある.実臨床では眠気が目立ち,低覚醒状態ではないかと思われる発達障害児に遭遇する.発達障害児は過覚醒状態・低覚醒状態・混合状態であるとの説が存在し,今後発達障害と覚醒度との関連は注目すべきポイントである.ADHD治療薬である中枢神経刺激薬は不眠の原因ともなりうるが,逆にADHD症状の改善に伴い睡眠が改善するとの報告もある.一方,非中枢神経刺激薬は不眠を改善する場合があり,併存する睡眠の問題を考慮して診療する必要があるが,さらなる検討を要する.以上のように,睡眠障害が発達障害の症状を増幅している場合があり,睡眠障害の治療により発達障害の症状が軽減しうる可能性がある.睡眠障害をも念頭において,発達障害の日常診療を行う必要がある.(著者抄録)

    researchmap

  • Risk of idiopathic normal pressure hydrocephalus in older inpatients with schizophrenia. 査読

    Yoshino Y, Yoshida T, Mori T, Hirota S, Iga J, Ueno S

    International psychogeriatrics / IPA   28 ( 5 )   863 - 868   2016年5月

  • Association between high serum carcinoembryonic antigen and clinical state of male anorexia nervosa: A case report 査読

    Shinichiro Ochi, Hideaki Shimizu, Shu-ichi Ueno

    INTERNATIONAL JOURNAL OF EATING DISORDERS   49 ( 4 )   428 - 431   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Anorexia nervosa (AN) is a complex psychiatric disorder, which is not yet fully understood. Several studies reported that AN was associated with disruption of cytokine network. Carcinoembryonic antigen (CEA) is a glycoprotein related to its network, used as a tumor marker of adenocarcinoma, and suggested to stimulate monocytes and macrophages to release proinflammatory cytokines. Here, we report a 41-year-old male suffering from AN who was suspected of having a malignant tumor due to markedly elevated serum CEA levels. However, on further examinations, he was discovered to have no malignant tumors, and, interestingly, his CEA levels actually decreased as his clinical state of AN improved. Furthermore, it was found that his CEA levels were elevated proportionally to his clinical state of AN and that his body mass index was significantly correlated with serum CEA levels. Therefore, it is suggested that inflammatory responses may be associated with the clinical state of AN. (c) 2016 Wiley Periodicals, Inc. (Int J Eat Disord 2016; 49:428-431).

    DOI: 10.1002/eat.22474

    Web of Science

    PubMed

    researchmap

  • Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder. 査読

    Yoshino Y, Kawabe K, Yamazaki K, Watanabe S, Numata S, Mori Y, Yoshida T, Iga J, Ohmori T, Ueno SI

    Journal of neural transmission (Vienna, Austria : 1996)   123 ( 6 )   637 - 641   2016年4月

  • Pharmacogenomic study of clozapine-induced agranulocytosis/granulocytopenia in a Japanese population. 査読 国際誌

    Saito T, Ikeda M, Mushiroda T, Ozeki T, Kondo K, Shimasaki A, Kawase K, Hashimoto S, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Takeda M, Kamatani Y, Numata S, Ohmori T, Ueno S, Makinodan M, Nishihata Y, Kubota M, Kimura T, Kanahara N, Hashimoto N, Fujita K, Nemoto K, Fukao T, Suwa T, Noda T, Yada Y, Takaki M, Kida N, Otsuru T, Murakami M, Takahashi A, Kubo M, Hashimoto R, Iwata N

    Biol Psychiatry   80 ( 8 )   636 - 642   2016年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.biopsych.2015.12.006

    PubMed

    researchmap

  • [The Diagnosis and Treatment of Sleep and Neurodevelopmental Disorders].

    Fumie Horiuchi, Yasunori Oka, Kentaro Kawabe, Shu-Ichi Ueno

    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica   118 ( 6 )   410 - 416   2016年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are commonly associated with sleep disturbances. The etiology of sleep disorders is multifactorial, such as congenital vulnerability of the quality and quantity of sleep, congenital abnormality of the sleep-wake pattern, comorbid sleep problems with developmental disorders, and sleep disturbances associated with pharmacological treat- ment. Obstructive sleep apnea disorder (OSAS) and restless legs syndrome (RLS) are closely associated with ADHD. OSAS in children not only presents with symptoms of sleep distur- bances, but also with associated symptoms such as growth failure, neurocognitive and behav- ioral symptoms, ADHD-like symptoms, and enuresis. The first-line treatment is adenotonsillec- tomy. ADHD and RLS show high rates of comorbidity with common etiologies like iron defi- ciency and the alternation of dopamine transporter expression. Hypnotics are not effective for RLS, and a precise diagnosis is vital to treat RLS associated with ADHD. ASD is also associated with a high frequency of sleep disorders, especially insomnia, para- somnia, and sleep-wake disorders. The first strategy against sleep disturbances is behavioral intervention ; however, pharmacological treatment is sometimes needed. In clinical practice, excessive daytime sleepiness was reported in children with ADHD or ASD, which might lead to a deficit in alertness. Alertness deficits associated with neurodevel- opmental disorders remain uncertain, and so they should be assessed. The effect of stimulants on sleep in patients with ADHD differed among individuals, which might be the cause of insomnia and also treatment for ADHD and sleep hygiene. Non-stimu- lants are often effective for insomnia. Neurodevelopmental and sleep disorders are complex and bidirectional. Sleep disturbances should be taken into consideration in daily clinical practice.

    PubMed

    researchmap

  • A Case of Nasu-Hakola Disease without Fractures or Consanguinity Diagnosed Using Exome Sequencing and Treated with Sodium Valproate. 査読

    Yamazaki K, Yoshino Y, Mori Y, Ochi S, Yoshida T, Ishimaru T, Ueno S

    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology   13 ( 3 )   324 - 326   2015年12月

  • Relationship between regional cerebral blood flow and neuropsychiatric symptoms in dementia with Lewy bodies 査読

    Taku Yoshida, Takaaki Mori, Kiyohiro Yamazaki, Naomi Sonobe, Hideaki Shimizu, Teruhisa Matsumoto, Keiichi Kikuchi, Masao Miyagawa, Teruhito Mochizuki, Shu-ichi Ueno

    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY   30 ( 10 )   1068 - 1075   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Objective: This aim of this study was to examine the mechanisms underlying the neuropsychiatric symptoms in dementia with Lewy bodies by investigating regional cerebral blood flow.
    Methods: Participants were 27 patients who fulfilled the diagnostic criteria for probable dementia with Lewy bodies. All subjects underwent single-photon emission computed tomography scans using technetium-99m hexamethylpropyleneamine oxime. Neuropsychiatric symptoms were evaluated by neuropsychiatric inventory. Multiple regression analyses using neuropsychiatric inventory and voxel-based analyses of covariance of the regional cerebral blood flow images between subjects with or without each neuropsychiatric symptom were performed. Additionally, similar voxel-based analyses of covariance between subjects with each neuropsychiatric symptom and normal subjects were performed.
    Results: There were no significant correlations in any psychiatric symptoms in multiple regression analyses. All subjects had hallucination but none had euphoria. We analyzed eight neuropsychiatric symptom scores with the exception of hallucination and euphoria using voxel-based analyses of covariance. Significant differences of regional cerebral blood flow were shown in groups with agitation, disinhibition, and irritability. Subjects with agitation showed hypoperfusion in the parietal lobule, the precuneus, and the angular gyrus, and hyperperfusion in the fusiform gyrus, the lingual gyrus, and the thalamus. Subjects with disinhibition showed hypoperfusion in the left frontal gyrus. Subjects with irritability showed hyperperfusion in the right frontal gyrus. There were no significant differences in regional cerebral blood flow between subjects with any neuropsychiatric symptoms and normal subjects.
    Conclusion: This study reveals that dysfunction of specific brain regions is associated with various neuropsychiatric symptoms in dementia with Lewy bodies. Copyright (C) 2015 John Wiley & Sons, Ltd.

    DOI: 10.1002/gps.4263

    Web of Science

    PubMed

    researchmap

  • Metabolic status and resistin in chronic schizophrenia over a 2-year period with continuous atypical antipsychotics. 査読 国際誌

    Kawabe K, Ochi S, Yoshino Y, Mori Y, Onuma H, Osawa H, Hosoda Y, Ueno S

    Therapeutic advances in psychopharmacology   5 ( 5 )   271 - 277   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1177/2045125315596697

    PubMed

    researchmap

  • ワークブックを活用した中学生の睡眠改善の試み

    堀内 史枝, 河邉 憲太郎, 岡 靖哲, 上野 修一

    不眠研究   2015   45 - 50   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)三原医学社  

    2014年度に愛媛県久万高原町の全中学生を対象に、夏季休暇時期に生活習慣についてのワークブックを作成し、その取り組みおよび介入効果について検討した。夏季休暇開始1週間前に学校担任からワークブックを配布してもらい、配布日の夜から記入を開始し、夏季休暇終了後1週間目までの記入を依頼した。全中学生204名のうち、171名(中学1年生49名、中学2年生60名、中学3年生62名)からワークブックを回収することができた。ワークブックへの記入を実施した後のアンケート(有効回答137名)では、「頑張って取り組めた」15.3%、「まずまず取り組めた」42.3%、「あまり取り組めなかった」19.0%、との回答であった。睡眠改善の課題についての自覚的達成感について尋ねたところ、「達成できた」「やや達成できた」と、規則正しい生活の確立で72%、光環境の調整で52%、メディア環境の調整で53%が回答した。中学生自身が記入するワークブックは、睡眠改善などに有効なことが示唆された。

    researchmap

  • Antidepressant action via the nitric oxide system: A pilot study in an acute depressive model induced by arginin 査読

    Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Shunsuke Nakata, Masao Abe, Yoko Mori, Shu-ichi Ueno

    NEUROSCIENCE LETTERS   599   69 - 74   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    Nitric oxide (NO) may be a neurotransmitter related to major depressive disorder (MDD) because the selective neuronal NO synthase (NOS) inhibitor, 7-nitroindazole, induces dose-dependent antidepressant-like effects. However, its role in MDD is not yet known. The purpose of our study was to determine if antidepressants improve depression via the NO pathway using an acute depressive rat model induced by L-arginine (AR). Three types of antidepressants were examined, fluoxetine (FLX, 10 mg/kg), milnacipran (MIL, 30 mg/kg), and mirtazapine (MIR, 10 mg/kg), in a depressive model that used AR (750 mg/kg) pretreatment. mRNA expression levels of three NOS subtypes were analyzed by real-time PCR, as well as serum NO levels. Significant increases in iNOS mRNA expression levels were found in brain regions after AR treatment, although the eNOS gene tended to decrease with AR injection. After antidepressant treatment, there were no mRNA expression changes in either nNOS or iNOS. However, eNOS mRNA expression significantly increased with FLX (cerebellum, P = 0.011; hippocampus, P = 0.011; midbrain, P = 0.011; pons, P = 0.013; striatum, P = 0.011; and thalamus, P &lt; 0.001). There was a statistically significant increase in serum NO levels with MIL treatment (P = 0.011). We conclude that changes in eNOS mRNA levels in the brain with FLX treatment, and amount of serum NO with MIL treatment may be related to antidepressant effects of both agents, but further experiments are needed to confirm involvement of the NO system in MDD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2015.05.043

    Web of Science

    PubMed

    researchmap

  • No abnormal hexanucleotide repeat expansion of C9ORF72 in Japanese schizophrenia patients 査読

    Yuta Yoshino, Yoko Mori, Shinichiro Ochi, Shusuke Numata, Takashi Ishimaru, Kiyohiro Yamazaki, Tetsuro Ohmori, Shu-ichi Ueno

    JOURNAL OF NEURAL TRANSMISSION   122 ( 5 )   731 - 732   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER WIEN  

    Abnormal hexanucleotide repeat expansion of C9ORF72 is known to cause neurodegenerative disorders such as frontotemporal dementia. Additionally, patients with psychotic symptoms are more likely to have abnormal hexanucleotide repeat expansion than are patients without them. We investigated the hexanucleotide repeat sizes of C9ORF72 in 466 Japanese schizophrenia patients. We found no abnormal hexanucleotide repeat expansion. In conclusion, C9ORF72 may not be responsible for schizophrenia susceptibility in the Japanese population.

    DOI: 10.1007/s00702-014-1295-y

    Web of Science

    PubMed

    researchmap

  • 不登校の背景要因としての自閉スペクトラム症 臨床的特徴に関する検討 A retrospective chart review

    永井 麻里奈, 河邉 憲太郎, 近藤 静香, 竹之内 美希, 妹尾 香苗, 堀内 史枝, 上野 修一

    精神神経学雑誌   117 ( 5 )   382 - 383   2015年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 発達障害者の勤務実態と職場における就労支援対策 愛媛県下における大規模事業所の取り組み調査から

    河邉 憲太郎, 堀内 史枝, 牧 徳彦, 森 秀人, 園田 順二, 上野 修一

    愛媛医学   34 ( 1 )   25 - 30   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:愛媛医学会  

    【目的】昨今、発達障害者に対する就労支援の関心も高まりつつある。発達障害者の現場での就労状況について実態を把握することを目的に、事業所スタッフを対象とした実態調査を行った。【対象と方法】2013年8〜12月の期間、愛媛県内の専属産業医を選任している事業所8ヶ所に勤務する産業医及び人事労務管理担当者を対象に対面での聞き取り調査を行った。【結果】対象事業所は5ヶ所で、発達障害者の雇用をしている事業所は1ヶ所、過去に雇用経験がある事業所は2ヶ所であった。これら3ヶ所の事業所で雇用されている、もしくはされていた発達障害者は、メンタルヘルス不調で休職後に広汎性発達障害と診断された。【考察】メンタルヘルス不調をおこした発達障害者に対し、不調の根底にあるであろう障害特性への対応を早期に行うことが望ましい。当事者と会社が障害特性を把握し、その特性を考慮した環境調整が必要であることを両者が理解する必要がある。発達障害者の雇用増加に備え、適切な対応が期待される。(著者抄録)

    researchmap

  • 統合失調症と自閉症スペクトラム障害の鑑別診断に苦慮した1症例

    永井 麻里奈, 見山 芳隆, 竹之内 美希, 近藤 静香, 妹尾 香苗, 河邉 憲太郎, 堀内 史枝, 上野 修一

    愛媛医学   34 ( 1 )   70 - 70   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:愛媛医学会  

    researchmap

  • TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia. 査読

    Mori Y, Yoshino Y, Ochi S, Yamazaki K, Kawabe K, Abe M, Kitano T, Ozaki Y, Yoshida T, Numata S, Mori T, Iga J, Kuroda N, Ohmori T, Ueno S

    PloS one   10 ( 9 )   e0136835   2015年

  • 発達支援を要する児童への強さと困難さ質問票(SDQ)を用いた検討

    河邉 憲太郎, 堀内 史枝, 岡 靖哲, 上野 修一

    臨床精神医学   43 ( 12 )   1811 - 1819   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)アークメディア  

    2010年4月1日から2012年3月31日迄にA児童発達支援センターに通所した児童のうち、毎日(週5)通所しており、難聴児・肢体不自由児を除く91名(男児75名、女児16名)を対象に、児童の養育者および児童指導員双方からみた児童の精神健康状態の認識の違いを明らかにするために、強さと困難さ質問票(Strengths and Difficulties Questionnaire:SDQ)を用いた調査を行った。地域の児童と比較して児童発達支援センターに通所する児童は男女ともSDQにおける殆どの下位尺度(情緒面、多動・不注意、仲間関係、向社会性)で困難さが存在し、支援の必要性が高いと考えられた。男児のSDQ「総スコア」および下位尺度の「多動・不注意」において、児童指導員は養育者よりも支援の必要性を有意に高いと認識していることが分かった。女児に関しては養育者と児童指導員の比較で有意差を認めなかった。SDQは児童の困難さを数値化し表すことができ、養育者と教師が共通理解を得るために役立つことが示唆された。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2014&ichushi_jid=J01552&link_issn=&doc_id=20141209140015&doc_link_id=%2Fao1clphd%2F2014%2F004312%2F016%2F1811-1819%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fao1clphd%2F2014%2F004312%2F016%2F1811-1819%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • mirtazapine急性投与によるラット脳でのニコチン性アセチルコリン受容体遺伝子発現変化について

    越智 紳一郎, 吉野 祐太, 北野 知地, 大塚 由理, 森 蓉子, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   24回・44回   200 - 200   2014年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease 査読

    Michitaka Aono, Jun-ichi Iga, Shu-ichi Ueno, Masahito Agawa, Toshio Tsuda, Tetsuro Ohmori

    JOURNAL OF CLINICAL NEUROSCIENCE   21 ( 9 )   1595 - 1598   2014年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    The physical benefits of subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD) patients are well documented, but the mental benefits are uncertain, particularly in Japanese patients. This study evaluated the clinical and neuropsychological characteristics before and after STN-DBS surgery in Japanese PD patients. PD patients (n = 13, age 67.0 +/- 7.8 years) were evaluated pre-surgery (baseline) and at 1 and 6 months post-surgery by two trained psychiatrists. The motor symptoms were assessed by the Unified Parkinson's Disease Rating Scale (UPDRS) motor score. The neuropsychological and psychiatric tests performed were the Mini-Mental State Examination, the Wisconsin Card Sorting Test (WCST), the Verbal Fluency Test (VET), the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale (HAM-A). The UPDRS motor score (p &lt; 0.001) and HAM-A score (p = 0.004) showed significant improvement at 1 month post-surgery, but a significant decline was observed in the WCST total error (p = 0.005) and the semantic VFT score (p &lt; 0.001). The phonetic VFT also showed a substantial decline (p = 0.015) at 1 month post-surgery. At 6 months post-surgery, the improvement in the UPDRS motor score was maintained, and the scores on the neuropsychological and psychiatric tests had returned to baseline. Although bilateral STN-DBS did not appear to have long-term effects on neuropsychological and psychiatric outcomes, the microlesion effects associated with STN-DBS appear to increase the risk of transient cognitive and psychiatric complications. These complications should be monitored by careful observation of neurological and psychiatric symptoms. (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jocn.2013.12.020

    Web of Science

    PubMed

    researchmap

  • Combined Clozapine and Electroconvulsive Therapy in a Japanese Schizophrenia Patient: A Case Report 査読

    Yuta Yoshino, Yuki Ozaki, Koichiro Kawasoe, Shinichiro Ochi, Takanori Niiya, Naomi Sonobe, Teruhisa Matsumoto, Shu-ichi Ueno

    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE   12 ( 2 )   160 - 162   2014年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN COLL NEUROPSYCHOPHARMACOLOGY  

    Clozapine is well known for successful use in schizophrenic patients treatment resistant to other antipsychotics. However, even with clozapine, 25% of schizophrenic patients are not in remission. Recently, as adjunctive treatment with clozapine, electroconvulsive therapy has been reported to be an effective and safe adjunctive treatment. We report a Japanese schizophrenic woman who was not in remission with clozapine alone but with both clozapine and electroconvulsive therapy.

    DOI: 10.9758/cpn.2014.12.2.160

    Web of Science

    PubMed

    researchmap

  • Missense variants of the alanine:glyoxylate aminotransferase 2 gene are not associated with Japanese schizophrenia patients 査読

    Yuta Yoshino, Masao Abe, Shusuke Numata, Shinichiro Ochi, Yoko Mori, Takashi Ishimaru, Makoto Kinoshita, Hidehiro Umehara, Kiyohiro Yamazaki, Takaaki Mori, Tetsuro Ohmori, Shu-ichi Ueno

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY   53   137 - 141   2014年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Alanine:glyoxylate aminotransferase 2 (AGXT2) is the only enzyme that degrades D-3-aminoisobutyrate (D-AIB), which is an intermediate product of thymine, and 30-40% of Japanese lack AGXT2 activity genetically and excrete high amounts of D-AIB in their urine. Recently, AGXT2 is reported to metabolize asymmetric dimethyl arginine (ADMA), a competitive inhibitor of nitric oxide (NO) synthase. Since AGXT2 is expressed in the central nervous system, the loss of AGXT2 activity will be related to the vulnerability for neuropsychiatric disorders related to the NO system. In this study, we recruited 85 Japanese subjects to discover loss variants of the AGXT2 gene with the amount of D-AIB excretion in their urine. From the statistical relevance between them, we found three missense polymorphisms (rs37370, rs37369, and rs180749) independently related to AGXT2 activity (P &lt; 0.0001). Then, we performed a case-control association analysis of its missense polymorphisms with 1136 schizophrenia and 1908 control subjects because the NO system may be involved in the vulnerability of schizophrenia processes. We could not find any associations of three functional SNPs with schizophrenia pathogenesis in the analyses of either genotypic or allelic models. We concluded that the AGXT2 gene is not associated with schizophrenia in Japanese subjects. (C) 2014 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.pnpbp.2014.04.002

    Web of Science

    PubMed

    researchmap

  • 研究と報告 地域における中学生への自殺予防対策の取り組み 愛媛県久万高原町メンタルヘルス実態調査

    河邉 憲太郎, 堀内 史枝, 妹尾 香苗, 近藤 静香, 竹之内 美希, 上野 修一

    精神医学   56 ( 7 )   575 - 584   2014年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    自殺に関する意識の高い愛媛県久万高原町において,若年者の自殺予防対策の一環として,中学生のメンタルヘルスの実態を明らかにすることを目的に,日本語版Profile of Mood States-Brief Formと日本版精神健康調査質問票を用いて調査を行った。町内全生徒220名から回答を得た。全体の傾向として,中学2,3年で精神的不調の訴えが多かったが,女子で特にその傾向が強かった。抑うつ感情は中学2,3年の女子が男子に比し有意に高く,自殺しようと考えたことがあると回答した生徒は男子9名,女子12名で計21名(9.5%)であった。自殺予防の観点から,特に中学2,3年女子に一定の配慮が必要であると思われた。今後,縦断的な自殺対策活動と支援体制の確立が必要である。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2014&ichushi_jid=J00749&link_issn=&doc_id=20140808060003&doc_link_id=10.11477%2Fmf.1405102754&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1405102754&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

  • Age- and sex-related emotional and behavioral problems in children with autism spectrum disorders: Comparison with control children 査読

    Fumie Horiuchi, Yasunori Oka, Hiroyuki Uno, Kentaro Kawabe, Fumi Okada, Isao Saito, Takeshi Tanigawa, Shu-ichi Ueno

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   68 ( 7 )   542 - 550   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim: Children with autism spectrum disorders (ASD) often present with emotional and behavioral problems, which could change the clinical course, especially during childhood, and affect future quality of life. The aim of this study was to clarify the age- and sex-related differences of these problems in ASD.
    Methods: The study subjects were 173 patients with ASD (age: 4-16 years) and 173 age-and sex-matched community children (control group). The parent version of the Strengths and Difficulties Questionnaire was used for comparison of the emotional and behavioral problems between the two groups.
    Results: The Strengths and Difficulties Questionnaire scores were significantly higher in children with ASD than controls at all ages. The score of total difficulties was significantly higher in girls with ASD than in boys, while the score in male controls was significantly higher than in female controls. Age-related differences in emotional and behavioral problems were observed both in children with ASD and controls, but the characteristics were different: in children with ASD, emotional symptoms and peer problems in both sexes and conduct problems in girls increased significantly with age, while none of the problems in the controls changed with age except for a decrease in the score of hyperactivity/inattention developmentally in both sexes. Prosocial behaviors of children with ASD and controls showed small changes with age.
    Conclusion: Emotional and behavioral problems are common in children with ASD and showed age-and sex-related differences. Our study emphasizes the importance of recognizing those differences among children with ASD for early intervention.

    DOI: 10.1111/pcn.12164

    Web of Science

    PubMed

    researchmap

  • 標準注意検査法がatomoxetine薬物治療による不注意症状の改善を反映しえた成人期注意欠如・多動性障害の1例

    河邉 憲太郎, 堀内 史枝, 妹尾 香苗, 近藤 静香, 竹之内 美希, 小森 憲治郎, 上野 修一

    臨床精神薬理   17 ( 7 )   1013 - 1023   2014年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    成人期の注意欠如・多動性障害(Attention-Deficit/Hyperactivity Disorder:ADHD)の治療においては、効果判定は主観的な臨床評価によっており、客観的な評価方法は確立されていない。今回我々は、atomoxetineを用いた成人期ADHD患者の診断・治療効果判定に、客観的臨床評価手法として標準注意検査法(Clinical Assessment for Attention:CAT)を使用し、臨床経過をよく反映した1例を経験したので報告する。症例は40歳女性、中学時代から学校への忘れ物が多く、集中力がないことを自覚し始めた。21歳時にうつ病と診断されていたが、40歳時に発達障害を疑われ当院に紹介された。改めて病歴聴取を行い、学童期以降のADHD症状を確認し、CATの結果も参考にしながら、ADHDとの診断に至った。Atomoxetineを40mg/日から内服開始し、80mg/日に増量したところ、日常生活およびCATでの評価における不注意症状の改善を認めた。成人期ADHDでは、不注意が生活の障害となることが多いが、CATは、ADHDの不注意症状を反映する可能性があると思われた。(著者抄録)

    researchmap

  • 愛媛大学医学部附属病院児童青年期精神科診療の現状とその変遷

    永井 麻里奈, 河邉 憲太郎, 近藤 静香, 竹之内 美希, 妹尾 香苗, 堀内 史枝, 上野 修一

    最新精神医学   19 ( 4 )   339 - 346   2014年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)世論時報社  

    【目的】本研究は愛媛大学医学部附属病院精神科の児童青年期精神科部門における外来診療の10年間の変遷を明らかにすることを目的に調査を行った。【方法】2002年と2012年の1年間の18歳以下の初診患者を対象に、性別、初診時年齢、受診経路、主訴・主症状、診断、転帰について診療録に基づいて後方視的に比較検討を行った。【結果】2002年と比較し2012年では18歳以下の初診患者の増加、患者の低年齢化、紹介率の増加、発達障害と診断される患者の増加を認めた。主訴として最も多かった不登校に関して、契機と発達障害の有無について追加調査したところ、発達障害を伴う不登校は伴わない不登校と比べ男性に多く、低年齢の傾向があった。【考察】精神科医療を必要とする児童青年期患者の増加に伴い、より専門的な診療体制を整えることが必要である。また、発達障害に関する精査や発達障害を伴う不登校の増加から、医療・教育・福祉、さらには就労も視野に入れた連携と強化が必要と考えられた。(著者抄録)

    researchmap

  • The nicotinic cholinergic system is affected in rats with delayed carbon monoxide encephalopathy 査読

    Shinichiro Ochi, Masao Abe, Cheng Li, Yoko Mori, Takashi Ishimaru, Yuta Yoshino, Kiyohiro Yamazaki, Takaaki Mori, Ryuji Fukuhara, Satoshi Tanimukai, Seiji Matsuda, Kenichi Yoshida, Shu-ichi Ueno

    NEUROSCIENCE LETTERS   569   33 - 37   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    Delayed carbon monoxide (CO) encephalopathy may occur following recovery from acute CO poisoning. However, the mechanism of delayed neuronal injury remains unknown. The nicotinic acetylcholine receptors (nAChRs) have been suggested to play a role in cognitive status in neurodegenerative diseases, including Alzheimer's disease. Therefore, in the current study, we investigated the effect of delayed neuronal CO poisoning on gene expression of nAChRs in the hippocampus of Wistar rats. Behavioral effects (measured by the passive-avoidance test) and histological analyses (hematoxylin-eosin-stained hippocampal cell counts and cell death observations) were also investigated, 21 days after CO exposure for I h (1000 ppm for 40 min + 3000 ppm for 20 min). Our findings show cognitive impairment and hippocampal cell death, suggesting our rat model is suitable for studying delayed CO encephalopathy. Expression of nAChR (Chrna3, Chrna4, Chnra7, and Chrnb2) mRNA was assessed using quantitative real-time polymerase chain reaction. Hippocampal Chrna3 expression was significantly decreased, and cerebellar Chrna7 expression significantly increased, in the delayed CO encephalopathy rat model. Thus, the nicotinic cholinergic system may be affected in delayed CO encephalopathy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neu1et.2014.03.054

    Web of Science

    PubMed

    researchmap

  • A Case of Acute Pancreatitis Associated with Risperidone Treatment 査読

    Kentaro Kawabe, Shu-ichi Ueno

    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE   12 ( 1 )   67 - 68   2014年4月

     詳細を見る

    記述言語:英語   出版者・発行元:KOREAN COLL NEUROPSYCHOPHARMACOLOGY  

    Acute pancreatitis with antipsychotic treatment is rare but sometimes causes a fatal adverse effect. Most cases of acute pancreatitis due to atypical antipsychotic agents are reported to occur within six months of starting antipsychotic administration. Acute pancreatitis caused by risperidone is rare. The patient had a high fever, stomachache and vomiting. The results of the abdominal computed tomograhpy scan were negative. The results of the abdominal ultrasonography were positive for gallstones in gallbladder and distention of the common bile duct. She had been fasting and received antibiotic intravenous injections. Amylase and lipase titers were high. After risperidone discontinuation, both the levels of the amylase and the lipase were gradually decreased. Three months later, the patient still maintains a good clinical balance. Although atypical antipsychotic-induced pancreatitis has been reported in conjunction with hyperglycemia, the pathophysiologic mechanism of these adverse events remains unclear. This case got pancreatitis 6 month after risperidone treatment. Using the antipsychotic agents, it is necessary to monitor pancreas function.

    DOI: 10.9758/cpn.2014.12.1.67

    Web of Science

    PubMed

    researchmap

  • Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease. 査読

    Mori T, Shimada H, Shinotoh H, Hirano S, Eguchi Y, Yamada M, Fukuhara R, Tanimukai S, Zhang MR, Kuwabara S, Ueno S, Suhara T

    Journal of neurology, neurosurgery, and psychiatry   85 ( 4 )   449 - 455   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1136/jnnp-2013-306110

    Web of Science

    PubMed

    researchmap

  • Distribution of D-3-aminoisobutyrate-pyruvate aminotransferase in the rat brain 査読

    Masao Abe, Shinichiro Ochi, Yoko Mori, Kiyohiro Yamazaki, Takashi Ishimaru, Yuta Yoshino, Ryuji Fukuhara, Satoshi Tanimukai, Seiji Matsuda, Shu-ichi Ueno

    BMC NEUROSCIENCE   15   53   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: D-3-aminoisobutyrate, an intermediary product of thymine, is converted to 2-methyl-3-oxopropanoate using pyruvate as an amino acceptor by D-3-aminoisobutyrate-pyruvate aminotransferase (D-AIB AT; EC 2.6.1.40). A large amount of D-AIB AT is distributed in the kidney and liver; however, small amounts are found in the brain. Recently, D-AIB AT was reported to metabolize asymmetric dimethylarginine (ADMA) in vivo and was suggested to be an important enzyme for nitric oxide metabolism because ADMA is a competitive inhibitor for nitric oxide synthase. In this study, we examined the distribution of D-AIB AT in the rat brain further to understand its role. We measured D-AIB AT mRNA and protein expression using quantitative RT-PCR and Western blotting, and monitored its distribution using immunohistochemical staining.
    Results: D-AIB AT was distributed throughout the brain, with high expression in the cortex and hippocampus. Immunohistochemical staining revealed that D-AIB AT was highly expressed in the retrosplenial cortex and in hippocampal neurons.
    Conclusion: Our results suggest that D-AIB AT is distributed in the examined-just the regions and may play an important role there.

    DOI: 10.1186/1471-2202-15-53

    Web of Science

    PubMed

    researchmap

  • 就学後に視知覚認知障害が明らかとなった発達障害の一例

    北村 伊津美, 堀内 史枝, 福原 竜治, 石川 智久, 上野 修一, 池田 学

    高次脳機能研究   34 ( 1 )   70 - 71   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能障害学会  

    researchmap

  • Effects of adenotonsillectomy on neurocognitive function in pediatric obstructive sleep apnea syndrome. 査読 国際誌

    Horiuchi F, Oka Y, Komori K, Tokui Y, Matsumoto T, Kawabe K, Ueno S

    Case reports in psychiatry   2014   520215 - 520215   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1155/2014/520215

    PubMed

    researchmap

  • 直交半直線交差グラフとナノ回路

    上野 修一

    電子情報通信学会 基礎・境界ソサイエティ Fundamentals Review   8 ( 1 )   30 - 36   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:The Institute of Electronics, Information and Communication Engineers  

    Carbon Nano-Tube などを構成要素とするナノ回路は,製造が比較的容易であることなどから,有望なアーキテクチャとして活発に研究されている.しかしながら,その微細さからナノ回路には欠陥が不可避であり,ナノ回路の耐欠陥設計は大変重要な課題である.本稿では,ナノ回路の耐欠陥設計に関する二つの基本的な問題を取り上げ,付随するグラフ理論を紹介する.

    DOI: 10.1587/essfr.8.30

    researchmap

  • 意味性認知症の臨床像から.

    小森憲治郎, 谷向知, 数井裕光, 上野修一

    基礎心理学研究   33   55 - 63   2014年

     詳細を見る

  • The melatonin receptor agonist ramelteon effectively treats insomnia and behavioral symptoms in autistic disorder. 査読 国際誌

    Kawabe K, Horiuchi F, Oka Y, Ueno S

    Case reports in psychiatry   2014   561071 - 561071   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1155/2014/561071

    PubMed

    researchmap

  • FK506 attenuates thymic output in patients with myasthenia gravis 査読

    Takao Mitsui, Yukiko Kuroda, Shu-ichi Ueno, Naoko Matsui, Ryuji Kaji

    ARCHIVES OF MEDICAL SCIENCE   9 ( 6 )   1090 - 1096   2013年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TERMEDIA PUBLISHING HOUSE LTD  

    Introduction: Myasthenia gravis (MG) is an antibody-mediated, T-cell-dependent autoimmune disease. The symptoms are caused by high-affinity IgG against the muscle acetylcholine receptor (AChR) at the neuromuscular junction. The production of these antibodies in B-cells depends on AChR-specific CD4(+) T-cells and the thymus gland seems to play a significant role in the pathogenesis of MG. Altered thymic T-cell export seems to be associated with a pathological mechanism in myasthenia gravis. Tacrolimus (FK506) has recently been used to treat MG.
    Material and methods: We examined the effects of tacrolimus on thymic T-cell export in patients with MG. Sixteen patients with nonthymomatous and/or thymectomized MG were treated with oral administrations of tacrolimus. To assess the effect of tacrolimus on the thymic output, we assayed the levels of T-cell receptor excision circle (TREC), a molecular marker of thymus emigrants.
    Results: T-cell receptor excision circle was not significantly different from those in age-matched controls before tacrolimus therapy, but they were partially decreased 4 months after tacrolimus therapy. T-cell receptor excision circle levels were significantly decreased in the thymomatous group (p &lt; 0.05), but not in the nonthymomatous group. Tacrolimus treatment significantly attenuated TREC levels in cultured CD4(-)CD8(+) cells (p &lt; 0.05), but total cell counts were not significantly changed.
    Conclusions: These results indicate that TREC levels may become a marker of the curative effect of tacrolimus therapy for thymomatous MG, and that tacrolimus suppresses not only activating T-lymphocytes, but also naive T-cells.

    DOI: 10.5114/aoms.2013.39797

    Web of Science

    PubMed

    researchmap

  • Blonanserin, a Novel Antipsychotic, Is Suitable for Treating Schizophrenia Associated With Hyperprolactinemia: A Case Series 査読

    Kentaro Kawabe, Fumie Horiuchi, Shu-ichi Ueno

    CLINICAL NEUROPHARMACOLOGY   36 ( 6 )   239 - 241   2013年11月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: Recently, atypical antipsychotic agents have primarily been used in pharmacological treatment of schizophrenia because of the fewer associated adverse effects. Blonanserin is a novel atypical antipsychotic recently introduced to treat patients with schizophrenia in Japan and South Korea. In this study, we examined the efficacy of switching antipsychotic medications to blonanserin monotherapy in patients with chronic schizophrenia with associated hyperprolactinemia.
    Methods: Ten schizophrenic patients (5 males and 5 females) with hyperprolactinemia were recruited. Clinical data before (baseline) and 12 weeks after (end point) switching to blonanserin monotherapy were assessed using the Brief Psychiatric Rating Scale score, Drug-Induced Extrapyramidal Symptoms Scale, and serum prolactin levels.
    Results: The mean (SD) blonanserin dosage was 14.8 (3.8) mg/d. After switching to blonanserin, there were significant improvements in the Brief Psychiatric Rating Scale in the patients from both sexes. Moreover, serum prolactin levels in the female patients significantly decreased to within reference range. There were no additional adverse effects observed with the blonanserin treatment.
    Conclusions: Switching to blonanserin can reverse medication-induced prolactin elevations found in female patients-and blonanserin is a suitable antipsychotic for schizophrenic patients.

    DOI: 10.1097/WNF.0000000000000006

    Web of Science

    PubMed

    researchmap

  • 多彩な精神症状を呈し、遺伝子診断によりAPP遺伝子変異を認めた若年性Alzheimer病の1例 査読

    石丸 喬士, 越智 紳一郎, 松本 光央, 吉田 卓, 安部 賢郎, 豊田 泰孝, 福原 竜治, 谷向 知, 上野 修一

    精神神経学雑誌   115 ( 10 )   1042 - 1050   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    症例は60歳男性で、本人は特に困ることはないと述べており、家族は認知症の精査と体が動くようにして欲しいと望んでいた。50歳頃から近時記憶障害が出現し、近医受診されるが異常は指摘されなかった。56歳頃から失見当識が出現し、59歳時には幻視や着衣失行、散歩中警察に保護された。つじつまの合わない言動や易怒性から精神科病院に入院し、診断および治療目的で転院となった。遺伝子検査においてアミロイド前駆体タンパク遺伝子変異(APPV7171)を認め、若年発症のAlzheimer病と診断した。診断後、抗精神病薬を減量中止し、過鎮静や錐体外路兆候が消失した。donepezilを10mgまで増量し、意欲、活動性が改善した。家族歴が明らかでなく、多彩な精神神経症状を認める若年発症の認知症の診断には、遺伝子検査を行うことで、有益な結果がもたらされる可能性が示唆された。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2013&ichushi_jid=J00755&link_issn=&doc_id=20131101090002&doc_link_id=40019838319&url=http%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F40019838319&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 発症後10年を経過した進行性非流暢性失語の発話特徴とその変化

    北村 伊津美, 福原 竜治, 谷向 知, 石川 智久, 吉田 卓, 上野 修一, 池田 学

    言語聴覚研究   10 ( 3 )   230 - 230   2013年9月

  • 地域における認知症患者の高齢介護者の実態について

    園部 直美, 松本 光央, 清水 秀明, 豊田 泰孝, 森 崇明, 品川 俊一郎, 足立 浩祥, 石川 智久, 福原 竜治, 谷向 知, 池田 学, 上野 修一

    老年精神医学雑誌   24 ( 増刊II )   227 - 227   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • Fluvoxamineからduloxetineへの置換が有効であった線維筋痛症の1例

    越智 紳一郎, 河邉 憲太郎, 福原 竜治, 谷向 知, 上野 修一

    精神神経学雑誌   115 ( 6 )   678 - 678   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • うつ症状再燃後、診断・治療が変更となった血管性認知症の1例

    山崎 聖広, 新谷 孝典, 松本 光央, 宮崎 大輔, 吉田 卓, 福原 竜治, 谷向 知, 上野 修一

    精神神経学雑誌   115 ( 6 )   685 - 686   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 発症後10年を経過した進行性非流暢性失語の一例

    北村 伊津美, 谷向 知, 福原 竜治, 上野 修一

    老年精神医学雑誌   24 ( 増刊II )   185 - 185   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. 査読

    Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H

    Cell stem cell   12 ( 4 )   487 - 496   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stem.2013.01.009

    Web of Science

    PubMed

    researchmap

  • [A case report of early-onset Alzheimer's disease with multiple psychotic symptoms, finally diagnosed as APPV717I mutation by genetic testing]. 査読

    Ishimaru T, Ochi S, Matsumoto T, Yoshida T, Abe M, Toyota Y, Fukuhara R, Tanimukai S, Ueno S

    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica   115 ( 10 )   1042 - 1050   2013年

     詳細を見る

  • Extremely Severe Hyperprolactinemia in a Woman With Renal Failure Receiving Risperidone 査読

    Yoshino Yuta, Ando Yaoki, Ochi Shinichiro, Ueno Shuichi

    Clinical Neuropsychopharmacology and Therapeutics   4 ( 0 )   20 - 22   2013年

     詳細を見る

    記述言語:英語   出版者・発行元:日本臨床精神神経薬理学会  

    We present the case of an epileptic patient who experienced risperidone-induced hyperprolactinemia with chronic renal failure under hemodialysis. Her prolactin level was 1058 ng/ml, which was unexpectedly high. Because prolactin is mainly excreted in the urine, clinicians should pay more attention to chronic renal failure as one of the risk factors of hyperprolactinemia when prescribing risperidone.

    DOI: 10.5234/cnpt.4.20

    researchmap

  • Nocturnal Eating/Drinking Syndrome With Restless Legs Syndrome Caused by Neuroleptics Improved by Yi-Gan San Add-on Treatment: A Case Report 査読

    Kentaro Kawabe, Shu-ichi Ueno, Yoshiki Hosoda, Jun Horiguchi

    CLINICAL NEUROPHARMACOLOGY   35 ( 6 )   290 - 291   2012年11月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Nocturnal eating/drinking syndrome is characterized by awakening in the middle of the night, getting out of bed, and consuming large quantities of food quickly and uncontrollably. We report a middle-aged male patient with schizophrenia who had nocturnal eating/drinking syndrome with restless legs syndrome whose condition improved with the administration of the herbal medicine Yi-Gan San (Yokukan-San in Japanese).

    DOI: 10.1097/WNF.0b013e3182746a5b

    Web of Science

    PubMed

    researchmap

  • Heteroplasmic m.1624C&gt;T mutation of the mitochondrial tRNA<sup>Val</sup> gene in a proband and his mother with repeated consciousness disturbances 査読

    Yoko Sangatsuda, Masayuki Nakamura, Akiyuki Tomiyasu, Akiko Deguchi, Yasutaka Toyota, Yu Ichi Goto, Ichizo Nishino, Shu Ichi Ueno, Akira Sano

    Mitochondrion   12 ( 6 )   617 - 622   2012年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Homoplasmic m.1624C>T mutation of the mitochondrial tRNAVal gene was previously demonstrated to cause fatal neonatal Leigh syndrome. Here, we report the clinical phenotypes of a Japanese male and his mother with heteroplasmic m.1624C>T mutation. The 36-year-old male presented with repeated episodes of consciousness disturbance since the age of 25, cognitive decline, and personality change. Cerebrospinal fluid levels of lactate and pyruvate were elevated. His mother showed similar symptoms and course. The mutation m.1624C>T was identified heteroplasmically in the proband's muscle and leukocytes and in the mother's leukocytes. The heteroplasmy load decreased with age. © 2012 Elsevier B.V. and Mitochondria Research Society.

    DOI: 10.1016/j.mito.2012.10.002

    Scopus

    PubMed

    researchmap

  • Clinical correlates associated with cognitive dysfunction in people with schizophrenia 査読

    Tsunehiko Tanaka, Masahito Tomotake, Yoshinori Ueoka, Yasuhiro Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno, Tetsuro Ohmori

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   66 ( 6 )   491 - 498   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aims The purpose of the present study was to investigate the correlation between cognitive function and clinical variables in people with schizophrenia. Methods The subjects were 61 stabilized outpatients with schizophrenia (DSM-IV). Their mean age was 40.1 (SD?=?12.2) years. All subjects gave written informed consent to participate in the research. Cognitive function was evaluated using the Brief Assessment of Cognition in Schizophrenia. Clinical symptoms were assessed using the Positive and Negative Syndrome Scale, the Calgary Depression Scale for Schizophrenia, and the Drug-Induced Extrapyramidal Symptoms Scale. Results The Positive and Negative Syndrome Scale Negative syndrome score was significantly correlated with verbal memory score (r?=?-0.37, P?&lt;?0.01), working memory score (r?=?0.38, P?&lt;?0.01), attention and speed of information processing score (r?=?-0.51, P?&lt;?0.01), verbal fluency score (r?=?-0.39, P?&lt;?0.01), and composite score (r?=?-0.54, P?&lt;?0.01). In addition, the Drug-Induced Extrapyramidal Symptoms Scale score was significantly correlated with attention and speed of information processing (r?=?-0.45, P?&lt;?0.01), and composite score (r?=?-0.41, P?&lt;?0. 01). Dose of antipsychotics and anti-Parkinson drugs was not significantly correlated with the Brief Assessment of Cognition in Schizophrenia scores. Conclusions These results indicate that cognitive dysfunction of people with schizophrenia might be associated with negative and drug-induced extrapyramidal symptoms, suggesting that their minimization would be important for improving cognitive dysfunction.

    DOI: 10.1111/j.1440-1819.2012.02390.x

    Web of Science

    PubMed

    researchmap

  • sertraline 3週間投与によるラット脳での遺伝子発現変化について 脳由来神経栄養因子およびヒストン脱アセチル化酵素6に注目して

    越智 紳一郎, 安部 賢郎, 森 蓉子, 石丸 喬士, 吉野 祐太, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   22回・42回   195 - 195   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 児童青年期の睡眠の問題 学齢による眠気と睡眠時間との関連

    堀内 史枝, 岡 靖哲, 淡野 桜子, 高田 律美, 川崎 由理, 櫻井 進, 斉藤 功, 谷川 武, 上野 修一

    不眠研究   2012   101 - 106   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:メディカルフロントインターナショナル(有)  

    愛媛県東温市の幼稚園5園、小学校7校、中学校2校、高等学校1校に通う児の保護者に質問紙調査を行った。3676名から有効回答が得られた。授業中に眠くなることが週2回以上ある児の割合は、幼稚園児で1%、小学生8%、中学生21%、高校生32%であり、学齢が高いほど高率であった。授業中に居眠りしてしまうことが週2回以上ある割合は、幼稚園児1%、小学生1%、中学生6%、高校生14%であった。睡眠時間は幼稚園児が平均9時間57分、小学生が8時間28分、中学生7時間5分、高校生6時間24分であった。睡眠時間が平均より1時間以上短い群と1時間以上長い群および平均±1時間群の3群に分け、「授業中の眠気・居眠り」を群間比較したところ、小・中・高校生では睡眠時間が短いほど「授業中の眠気」が強い傾向にあったが、幼稚園児ではこの傾向は認められなかった。「授業中の居眠り」は、小・中学生では睡眠時間が短い群で有意に高頻度であったが、幼稚園児と高校生では有意な群間差は認められなかった。

    researchmap

  • 愛媛県の精神科医における広汎性発達障害の診療に関するアンケート調査

    河邉 憲太郎, 堀内 史枝, 岡田 芙美, 小森 憲治郎, 上野 修一

    精神科   21 ( 2 )   254 - 260   2012年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    愛媛県内には児童・青年期精神科専門の病棟や情緒障害児短期治療施設は存在せず、児童青年期精神医療に関する相談機関の配備にも遅れが目立つ。このような状況下で精神科医が広汎性発達障害(PDD)の診療や支援を行うにあたり、苦慮していることは想像に難くない。そこで今回、今後の支援体制を構築していく上で、まず医療機関におけるPDDの診療状況を把握することが必要と考え、県内の医療機関に従事する精神科医153名にアンケートを行った。82名から回答が得られ、次のようなことが明らかになった。1)2010年1年間に一人の医師が診療した児童青年期PDD患者数は、「10人以上」と答えた医師が7.5%、「1〜9人」が21.2%、「診療しなかった」が71.3%であった。2)2010年1年間に一人の医師が診療した成人期PDD患者数は、「10人以上」が17.5%、「1〜9人」が56.3%、「診療しなかった」が26.3%であった。3)児童青年期PDDの診療で苦慮すること(複数回答)は、「社会資源の不足」51.9%、「確定診断の困難さ」48.1%、「他機関との連携」44.4%、「親の理解」37%、「社会認識」37%などであった。4)成人期PDDの診療で苦慮することは、「確定診断の困難さ」58.7%、「発達歴の聴取」56.5%、「社会資源の不足」50%、「併存症状の存在」47.8%、「社会認識」41.3%などであった。

    researchmap

  • 私のカルテから Quetiapineへの切り替え後に社会機能の改善がみられた慢性期統合失調症の2例 精神障害者社会生活評価尺度(Life Assessment Scale for the Mentally Ill;LASMI)を用いて

    河邉 憲太郎, 栗林 達也, 福原 竜治, 細田 能希, 上野 修一

    精神医学   54 ( 8 )   847 - 852   2012年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    症例1:63歳女、症例2:65歳男。2症例は、表出は少ないものの、幻覚や妄想など陽性症状の存在が疑われ、感情の平板化、活動性減退、情動的ひきこもりなどの陰性症状も強かった。コミュニケーション障害があり、感情の不安定および問題行動などから病棟での他患者との共同生活が難しく、結果として長期隔離を余儀なくされた。抗精神病薬の投与が行われたが、結果に乏しかった。Quetiapineへの置換により理学療法や作業療法などが受けられるまで陰性症状が改善した。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2012&ichushi_jid=J00749&link_issn=&doc_id=20120814150010&doc_link_id=10.11477%2Fmf.1405102249&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1405102249&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

  • Functional genetic variation at the NRGN gene and schizophrenia: Evidence from a gene-based case-control study and gene expression analysis 査読

    Kazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, Motoyuki Fukumoto, Hidenaga Yamamori, Satomi Umeda-Yano, Takeya Okada, Kouzin Kamino, Takashi Morihara, Masao Iwase, Hiroaki Kazui, Shusuke Numata, Masashi Ikeda, Tohru Ohnuma, Nakao Iwata, Shu-ichi Ueno, Norio Ozaki, Tetsuro Ohmori, Heii Arai, Masatoshi Takeda

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   159B ( 4 )   405 - 413   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Genome-wide association and follow-up studies have reported an association between schizophrenia and rs12807809 of the NRGN gene on chromosome 11q24.2. We investigated the association of five linkage disequilibrium-tagging SNPs and haplotypes that cover the NRGN gene with schizophrenia in a Japanese sample of 2,019 schizophrenia patients and 2,574 controls to determine whether rs12807809 is the most strongly associated variant for schizophrenia in the vicinity of the NRGN gene. We found that the rs12807809rs12278912 haplotype of the NRGN gene was associated with schizophrenia (global P?=?0.0042). The frequencies of the TG and TA haplotypes of rs12807809rs12278912 in patients were higher (OR?=?1.14, P?=?0.0019) and lower (OR?=?0.85, P?=?0.0053), respectively, than in the controls. We did not detect any evidence of association of schizophrenia with any SNPs; however, two nominal associations of rs12278912 (OR?=?1.10, P?=?0.057) and rs2075713 (OR?=?1.10, P?=?0.057) were observed. Furthermore, we detected an association between the rs12807809rs12278912 haplotype and NRGN expression in immortalized lymphoblasts derived from 45 HapMap JPT subjects (z?=?2.69, P?=?0.007) and confirmed the association in immortalized lymphoblasts derived from 42 patients with schizophrenia and 44 healthy controls (z?=?3.09, P?=?0.002). The expression of the high-risk TG haplotype was significantly lower than the protective TA haplotype. The expression was lower in patients with schizophrenia than in controls; however, this difference was not statistically significant. This study provides further evidence of the association of the NRGN gene with schizophrenia, and our results suggest that there is a link between the TG haplotype of rs12807809rs12278912, decreased expression of NRGN and risk of developing schizophrenia. (C) 2012 Wiley Periodicals, Inc.

    DOI: 10.1002/ajmg.b.32043

    Web of Science

    PubMed

    researchmap

  • Molecular imaging of dementia 査読

    Takaaki Mori, Jun Maeda, Hitoshi Shimada, Makoto Higuchi, Hitoshi Shinotoh, Shu-ichi Ueno, Tetsuya Suhara

    PSYCHOGERIATRICS   12 ( 2 )   106 - 114   2012年6月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Diagnosis and treatment strategies for dementia are based on the sensitive and specific detection of the incipient neuropathological characteristics, combined with emerging treatments that counteract molecular processes in its pathogenesis. Positron emission tomography (PET) is used for diverse clinical and basic studies on dementia with a wide range of radiotracers. Approaches to visualize amyloid deposition in human brains non-invasively with PET depend on imaging agents reacting with amyloid fibrils. The most widely used tracer is [11C]-6-OH-BTA-1, also known as Pittsburgh Compound-B, which has a high affinity to amyloid beta peptide (A beta) aggregates. Some 18F-labeled amyloid ligands with a longer radioactive half-life have also been developed for broader clinical applications. In addition, there have been demonstrated advantages of tracers with high specific radioactivity in the sensitive detection of amyloid, which have indicated the significance of A beta-N3-pyroglutamate as a new diagnostic and therapeutic target. Furthermore, beneficial outcomes of A beta and tau immunization in humans and mouse models have highlighted crucial roles of immunocompetent glia in the protection of neurons against amyloid toxicities. The utility of PET with a radioligand for translocator protein as a biomarker for tau-triggered toxicity, and as a complement to amyloid and tau imaging for diagnostic assessment of tauopathies with and without A beta pathologies, has also been demonstrated. Meanwhile, brain cholinergic function can be estimated by measuring acetylcholinesterase activity in the brain with PET and radiolabeled acetylcholine analogues. It has been reported that patients with early Parkinson's disease exhibit a reduction in acetylcholinesterase activity in the cerebral cortex, and this decline is more profound in patients with Parkinson's disease with dementia and dementia with Lewy bodies than in patients with Parkinson's disease without dementia. The Alzheimer's Disease Neuroimaging Initiative was a multicentre research project conducted over 6 years that studied changes in cognition, brain structure, and biomarkers in healthy elderly controls and subjects with mild cognitive impairment and Alzheimer's disease. An international workgroup of the National Institute on Aging-Alzheimer's Association has suggested that Alzheimer's disease would be optimally treated before significant cognitive impairment, defined as a presymptomatic or preclinical stage. Therefore, PET will be of technical importance for both clinical and basic research aimed at prodromal pathologies of Alzheimer's disease.

    DOI: 10.1111/j.1479-8301.2012.00409.x

    Web of Science

    PubMed

    researchmap

  • Phenotypical difference of Amyloid Precursor Protein (APP) V717L mutation in Japanese family 査読

    Masao Abe, Naomi Sonobe, Ryuji Fukuhara, Yoko Mori, Shinichiro Ochi, Teruhisa Matsumoto, Takaaki Mori, Satoshi Tanimukai, Shu-ichi Ueno

    BMC NEUROLOGY   12   38   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: Alzheimer's disease (AD) is the most common form of dementia. Mutations in genes such as those encoding amyloid precursor protein (APP), presenilin 1 and presenilin 2, are responsible for early-onset familial AD.
    Case presentation: In this study, we report a 275341 G &gt; C (Val717Leu) mutation in the APP gene in a Japanese family with early onset AD by genetic screening. This mutation has previously been detected in European families. In the Japanese family we screened, the age at onset of AD was 47.1 +/- 3.1 years old (n = 9; range, 42-52). The symptoms in the affected members included psychiatric vulnerability and focal signs such as pyramidal signs, epileptic seizures, and myoclonic discharges. An MR imaging study showed relatively mild atrophic changes in the bilateral hippocampus and cerebral cortices in all affected members compared with their clinical presentations.
    Conclusion: We conclude that the clinical features of Alzheimer's disease can be different even when caused by the same mutation in the APP gene. Further clinical and genetic studies are required to clarify the relationship between phenotypes and genotypes.

    DOI: 10.1186/1471-2377-12-38

    Web of Science

    PubMed

    researchmap

  • 精神疾患に伴う不眠に対するramelteonの臨床効果

    河邉 憲太郎, 堀内 史枝, 岡 靖哲, 細田 能希, 上野 修一

    最新精神医学   17 ( 3 )   271 - 276   2012年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)世論時報社  

    2010年に本邦で上市されたramelteonは、メラトニン受容体MT1、MT2に選択的なアゴニストであり、入眠作用や生体リズム位相変位作用を有する。現在の睡眠薬の主流はベンゾジアゼピン系睡眠薬や非ベンゾジアゼピン系睡眠薬であるが、精神疾患が基盤にある睡眠障害に対しては、抗うつ剤や抗精神病薬も治療に使用されている。このような精神疾患を伴う不眠に対し、ramelteonを使用し、30症例(男性19例、女性11例)の治療を行った。平均年齢は56.2±19.0歳(16〜89歳)であり、症例の内訳は統合失調症14例、認知症圏6例、気分障害圏4例、神経症性障害圏3例、発達障害圏3例であった。Ramelteon継続症例は22例(73.3%)であり、切り替え前後で有意に併用睡眠薬が減少した。精神疾患を伴う不眠に対するramelteonの使用は、既存の睡眠薬を減薬することができ、忍容性が高いことが示唆された。今後、精神疾患を伴う不眠へのramelteonの有効性に関して、臨床知見の蓄積が必要である。(著者抄録)

    researchmap

  • 多彩な精神症状を呈し、遺伝子検査により診断が確定した若年性Alzheimer型認知症の1例

    石丸 喬士, 松本 光央, 越智 紳一郎, 安部 賢郎, 吉田 卓, 豊田 泰孝, 福原 竜治, 谷向 知, 上野 修一

    精神神経学雑誌   ( 2012特別 )   S - 551   2012年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 入院によりルーチン化が短期間に形成されたのものの、自宅への移行が困難であった意味性認知症の一例

    宮崎 大輔, 松本 光央, 園部 直美, 佐野 昇, 越智 紳一郎, 松尾 浩司, 小森 憲治郎, 福原 竜治, 谷向 知, 上野 修一

    精神神経学雑誌   114 ( 4 )   469 - 469   2012年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 外来精神科チーム医療における患者情報の共有ツール『私のお薬連絡帳』の評価

    岡井 彰男, 井門 敬子, 末丸 克矢, 松本 千代子, 竹本 ひとみ, 堀内 史枝, 福原 竜治, 園部 漢太郎, 新谷 孝典, 越智 紳一郎, 谷向 知, 上野 修一, 荒木 博陽

    医療薬学   37 ( 12 )   675 - 680   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医療薬学会  

    外来精神科チーム医療における患者情報の共有ツール「私のお薬連絡帳」について検討した。お薬連絡帳により収集した患者情報を基に、薬剤師が処方変更提案を行った患者は50例中29例で、総件数は47件であった。内容は、ふらつき10件、服用忘れが多いタイミングの処方9件、起床困難7件、便秘7件、薬剤性錐体外路症状6件、性機能障害5件、中途覚醒3件であった。薬剤師からの処方変更提案に対する医師の受諾率は74.5%(35件)であった。処方変更後の患者の症状は、ふらつき8件、服用忘れが多いタイミングの処方7件、起床困難5件、便秘7件、薬剤性錐体外路症状2件、性機能障害4件、中途覚醒2件で改善を認めた。お薬連絡帳を介して患者情報の提供を受けた8例の医師にアンケートを行い、すべての医師がお薬連絡帳は有用であったと答えた。また、お薬連絡帳を使用して問題発生なしとすべての医師が答えた。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2011&ichushi_jid=J03520&link_issn=&doc_id=20111214470002&doc_link_id=%2Fdb5pharm%2F2011%2F003712%2F002%2F0675-0680%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdb5pharm%2F2011%2F003712%2F002%2F0675-0680%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 頭部外傷例における語の意味記憶障害 健忘失語か語義失語か?

    小森 憲治郎, 北村 伊津美, 福原 竜治, 石川 智久, 豊田 泰孝, 谷向 知, 上野 修一

    神経心理学   27 ( 4 )   334 - 334   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • 初診から8年を経過して意味性認知症と診断された一例

    坂根 真弓, 小森 憲治郎, 北村 伊津美, 園部 直美, 豊田 泰孝, 松本 光央, 福原 竜治, 谷向 知, 上野 修一

    神経心理学   27 ( 4 )   348 - 348   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • A case study: Neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation 査読

    Shinichiro Ochi, Koichiro Kawasoe, Masao Abe, Ryuji Fukuhara, Kantaro Sonobe, Kentaro Kawabe, Shu-ichi Ueno

    General Hospital Psychiatry   33 ( 6 )   640 - e2   2011年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We present a schizophrenic patient who experienced neuroleptic malignant syndrome with risperidone treatment due to variants of the CYP2D6 gene with reduced function. Clinicians need to be aware of this potential complication. © 2011 Elsevier Inc.

    DOI: 10.1016/j.genhosppsych.2011.03.003

    Scopus

    PubMed

    researchmap

  • Remapping and mutation analysis of benign adult familial myoclonic epilepsy in a Japanese pedigree 査読

    Satsuki Mori, Masayuki Nakamura, Takeshi Yasuda, Shu Ichi Ueno, Sunao Kaneko, Akira Sano

    Journal of Human Genetics   56 ( 10 )   742 - 747   2011年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Benign adult familial myoclonic epilepsy (BAFME), alternatively named familial adult myoclonic epilepsy 1/familial cortical myoclonic tremor with epilepsy 1 (FAME1/FCMTE1), is a hereditary epileptic syndrome characterized by autosomal dominant inheritance, adult-onset tremulous hand movement, myoclonus, infrequent epileptic seizure and non-progressive course without cerebellar ataxia and dementia. We previously reported evidence for linkage of BAFME to the region between D8S1784 and D8S1694 on chromosome 8q. Subsequently, other research groups reported mapping of the same clinical syndrome to different chromosomal loci, 2p and 5p, in Italian (FAME2/FCMTE2) and French (FAME3/FCMTE3) families, respectively. In this study, we performed a genome-wide linkage analysis using 10K single-nucleotide polymorphism arrays and additional microsatellite markers to reconfirm the BAFME-linked region. The BAFME-linked region was mapped to 7.16 Mb spanned by rs1898287 and rs2891799 on chromosomes 8q23.3-8q24.13 with a maximum two-point logarithm of odds score of 6.0 for the marker rs1021897. Sequence analysis and copy-number variant analysis of all 38 genes localized in the candidate region were performed, but no pathogenic mutation was identified. We conclude that the etiology of BAFME remains to be solved, and further genetic studies, which may require analysis in non-coding regions of a gene, introns or intergenic spacer regions, are necessary to reveal its unknown mutations. © 2011 The Japan Society of Human Genetics All rights reserved.

    DOI: 10.1038/jhg.2011.93

    Scopus

    PubMed

    researchmap

  • 双極性感情障害躁病エピソードにaripiprazoleの併用が著効した2症例

    石丸 喬士, 松本 光央, 越智 紳一郎, 豊田 泰孝, 福原 竜治, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   21回・41回   201 - 201   2011年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • The effects of FK506 on refractory inflammatory myopathies 査読

    Takao Mrrsui, Yukiko Kuroda, Shu-ichi Ueno, Ryuji Kaji

    ACTA NEUROLOGICA BELGICA   111 ( 3 )   188 - 194   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACTA MEDICA BELGICA  

    We performed an observational clinical study, the effects of tacrolimus (FK506) on the thymic output in patients with refractory inflammatory myopathies. Sixteen patients with polymyositis (PM) and 15 with dermatomyositis (DM) were treated orally with tacrolimus. Serum CK levels significantly decreased 2 to 4 months after tacrolimus therapy (p &lt; 0.01), and MRC (Medical Research Council) scores were significantly improved 2 months after tacrolimus therapy (p &lt; 0.01). T-cell receptor excision circle (TREC) content, a proxy for thymic export was not significantly different from that in age-matched controls, except for an increase in the TREC content within CD8+ single positive cells in patients with DM. TREC contents within double-positive cells and CD4(+) single-positive cells were significantly decreased 4 M after tacrolimus therapy (p &lt; 0.05) in PM/DM patients. Tacrolimus treatment significantly attenuated TREC content within cultured CD4(+)CD8(-) cells from PM/DM patients (p &lt; 0.05), but total cell counts were not significantly changed. These results indicate that tacrolimus therapy suppresses not only activated T-lymphocytes, but also some naive T-cell subsets in both PM and DM.

    Web of Science

    PubMed

    researchmap

  • 初診から8年を経過して意味性認知症と診断された一例

    坂根 真弓, 小森 憲治郎, 北村 伊津美, 園部 直美, 豊田 泰孝, 松本 光央, 福原 竜治, 谷向 知, 上野 修一

    日本神経心理学会総会プログラム・予稿集   35回   128 - 128   2011年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • 頭部外傷例における語の意味記憶障害 健忘失語か語義失語か?

    小森 憲治郎, 北村 伊津美, 福原 竜治, 石川 智久, 豊田 泰孝, 谷向 知, 上野 修一

    日本神経心理学会総会プログラム・予稿集   35回   87 - 87   2011年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • Novel pathogenic mutations and copy number variations in the VPS13A Gene in patients with chorea-acanthocytosis 査読

    Akiyuki Tomiyasu, Masayuki Nakamura, Mio Ichiba, Shuichi Ueno, Shinji Saiki, Mizuki Morimoto, Jan Kobal, Yasufumi Kageyama, Toshio Inui, Koichi Wakabayashi, Tatsuo Yamada, Yuji Kanemori, Hans H. Jung, Haruhiko Tanaka, Satoshi Orimo, Zaid Afawi, Ilan Blatt, Jan Aasly, Hiroshi Ujike, Dusica Babovic-Vuksanovic, Keith A. Josephs, Rie Tohge, Guilherme Riccioppo Rodrigues, Nicolas Dupré, Hidetaka Yamada, Fusako Yokochi, Katya Kotschet, Takanobu Takei, Monika Rudzińska, Andrzej Szczudlik, Silvana Penco, Masaki Fujiwara, Kana Tojo, Akira Sano

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics   156 ( 5 )   620 - 631   2011年7月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neurodegenerative disorder caused by loss of function mutations in the vacuolar protein sorting 13 homolog A (VPS13A) gene that encodes chorein. It is characterized by adult-onset chorea, peripheral acanthocytes, and neuropsychiatric symptoms. In the present study, we performed a comprehensive mutation screen, including sequencing and copy number variation (CNV) analysis, of the VPS13A gene in ChAc patients. All 73 exons and flanking regions of VPS13A were sequenced in 35 patients diagnosed with ChAc. To detect CNVs, we also performed real-time quantitative PCR and long-range PCR analyses for the VPS13A gene on patients in whom only a single heterozygous mutation was detected. We identified 36 pathogenic mutations, 20 of which were previously unreported, including two novel CNVs. In addition, we investigated the expression of chorein in 16 patients by Western blotting of erythrocyte ghosts. This demonstrated the complete absence of chorein in patients with pathogenic mutations. This comprehensive screen provides an accurate and useful method for the molecular diagnosis of ChAc. © 2011 Wiley-Liss, Inc.

    DOI: 10.1002/ajmg.b.31206

    Scopus

    PubMed

    researchmap

  • No association between the PCM1 gene and schizophrenia: A multi-center case-control study and a meta-analysis 査読

    Ryota Hashimoto, Kazutaka Ohi, Yuka Yasuda, Motoyuki Fukumoto, Hidenaga Yamamori, Kouzin Kamino, Takashi Morihara, Masao Iwase, Hiroaki Kazui, Shusuke Numata, Masashi Ikeda, Shu-ichi Ueno, Tetsuro Ohmori, Nakao Iwata, Norio Ozaki, Masatoshi Takeda

    SCHIZOPHRENIA RESEARCH   129 ( 1 )   80 - 84   2011年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Alterations in centrosomal function have been suggested in the pathology of schizophrenia. The molecule pericentriolar material 1 (PCM1) is involved in maintaining centrosome integrity and in the regulation of the microtubule cytoskeleton. PCM1 forms a complex at the centrosome with the disrupted-in-schizophrenia 1 (DISCI) protein, which is a major susceptibility factor for schizophrenia. The association between genetic variants in the PCM1 gene and schizophrenia has been reported by several case-control studies, linkage studies and a meta-analysis. The aims of this study are to replicate the association between four single-nucleotide polymorphisms (SNPs) in the PCM1 gene and schizophrenia in a Japanese population (1496 cases and 1845 controls) and to perform a meta-analysis of the combined sample groups (3289 cases and 3567 controls). We failed to find a significant association between SNPs or haplotypes of the PCM1 gene and schizophrenia in the Japanese population (P&gt;0.28). The meta-analysis did not reveal an association between the four examined SNPs and schizophrenia. Our data did not support genetic variants in the PCM1 gene as a susceptibility locus for schizophrenia. (C) 2011 Elsevier BM. All rights reserved.

    DOI: 10.1016/j.schres.2011.03.024

    Web of Science

    PubMed

    researchmap

  • Risk of progression from mild memory impairment to clinically diagnosable Alzheimer&apos;s disease in a Japanese community (from the Nakayama Study) 査読

    Naomi Sonobe, Ryuji Hata, Tomohisa Ishikawa, Kantaro Sonobe, Teruhisa Matsumoto, Yasutaka Toyota, Takaaki Mori, Ryuji Fukuhara, Kenjiro Komori, Shu-ichi Ueno, Satoshi Tanimukai, Manabu Ikeda

    INTERNATIONAL PSYCHOGERIATRICS   23 ( 5 )   772 - 779   2011年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CAMBRIDGE UNIV PRESS  

    Background: Memory impairment has been proposed as the most common early sign of Alzheimer&apos;s disease (AD). The aims of this work were to evaluate the risk of progression from mild memory impairment / no dementia (MMI/ND) to clinically diagnosable AD in a community-based prospective cohort and to establish the risk factors for progression from MMI/ND to AD in the elderly.
    Methods: Elderly subjects aged over 65 years were selected from the participants in the first Nakayama study. MMI/ND was defined as memory deficit on objective memory assessment, without dementia, impairment of general cognitive function, or disability in activities of daily living. A total of 104 MMI/ND subjects selected from 1242 community-dwellers were followed longitudinally for five years.
    Results: During the five-year follow-up, 11 (10.6%) subjects were diagnosed with AD, five (4.8%) with vascular dementia (VaD), and six (5.8%) with dementia of other etiology. Logistic regression analysis revealed that diabetes mellitus (DM) and a family history of dementia (within third-degree relatives) were positively associated with progression to AD, while no factor was significantly associated with progression to VaD or all types of dementia.
    Conclusions: DM and a family history of dementia were significant risk factors for progression from MMI/ND to clinically diagnosable AD in the elderly in a Japanese community.

    DOI: 10.1017/S104161021000222X

    Web of Science

    PubMed

    researchmap

  • 【統合失調症様症状をきたす脳神経疾患】橋本脳症・甲状腺機能異常

    新谷 孝典, 福原 竜治, 上野 修一

    Schizophrenia Frontier   12 ( 1 )   21 - 25   2011年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルレビュー社  

    甲状腺機能異常によって精神障害が起こることは稀ではなく、臨床上必ず検討しておくべき症状性精神障害の代表である。一般に甲状腺機能異常によって起こる精神障害は、意識障害や気分障害様の臨床症状を呈すが、橋本脳症は、甲状腺に対する自己免疫障害から起こる珍しい脳症であり、甲状腺機能異常は軽度であるにもかかわらず、痙攣、意識障害、精神病症状、認知機能障害などの精神症状および不随意運動や小脳失調などの神経症状をきたす。臨床的には、甲状腺に対する比較的高い自己免疫抗体価は示すものの、診断を確定するための典型的な所見を呈しないため、診断に難渋する事例が多く、注意が必要である。しかし、一方で、副腎皮質ステロイドや免疫抑制薬への反応は良好であるため、適切な診断と治療により、その予後を劇的に改善できることもわかっている。本稿では、橋本脳症の特徴について、精神症状に焦点を当て、自験例を交え概説したい。(著者抄録)

    researchmap

  • 高気圧酸素療法治療中に鏡現象を呈した間歇型一酸化炭素中毒後遺症の1例

    清水 秀明, 鉾石 和彦, 福原 竜治, 上野 修一

    最新精神医学   16 ( 3 )   349 - 353   2011年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)世論時報社  

    鏡現象とは、自己鏡像を自分ではなく、他者として誤認し、交流をもつ現象である。この現象は、アルツハイマー病(AD)に多いとされ、認知機能障害の進行に伴って出現し、さらに進行すると消失する。今回、間歇型一酸化炭素中毒後遺症にて高気圧酸素療法治療中に鏡現象が出現した初めての症例を報告する。本症例の鏡現象は、「自己鏡像に話しかける」ことが中心で、認知機能障害は重度であるなど、内容はADの報告例と一致していたが、本症例では、いったん出現した鏡現象が、認知機能の回復過程で消失し、出現パターンはADと異なっていた。本症例では、脳血流シンチグラフィーにおいて、両側前頭葉から側頭頭頂葉における血流低下を認めたが、鏡現象を大脳巣症状として捉えることは困難であった。今後は、鏡現象における神経基盤の解明のため、詳細な臨床観察や神経画像など包括的な研究が必要と思われる。(著者抄録)

    researchmap

  • 当院で高気圧酸素療法を行った間歇型一酸化炭素中毒17症例の検討

    瀬野 隆太, 園部 漢太郎, 清水 秀明, 越智 紳一郎, 園部 直美, 森 崇明, 福原 竜治, 小森 憲治郎, 谷向 知, 上野 修一

    精神神経学雑誌   113 ( 5 )   523 - 523   2011年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Mitochondrial DNA deletion mutations in patients with neuropsychiatric symptoms 査読

    Maiko Kato, Masayuki Nakamura, Mio Ichiba, Akiyuki Tomiyasu, Hirochika Shimo, Itsuro Higuchi, Shu ichi Ueno, Akira Sano

    Neuroscience Research   69 ( 4 )   331 - 336   2011年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    It has been suggested that mitochondrial dysfunction is important in the pathogenesis of psychiatric disorders such as depression, schizophrenia and dementia. We report herein three adult patients exhibiting such psychiatric symptoms as the core manifestation, accompanied by various degrees of myopathic symptoms. Pathological findings in biopsied skeletal muscle were compatible with mitochondrial myopathy in all cases. Maternal inheritance was not apparent in all three cases; however, two patients were born to consanguineous parents. Mutation analysis on the mitochondrial DNA (mtDNA) and seven nuclear genes, in which pathogenic mutations are known to cause mtDNA deletions, was performed. MtDNA deletion mutations were identified in skeletal muscles of all patients. Neither pathogenic mutations nor copy number variation was identified among the nuclear genes. Although further studies are needed, the molecular pathways inducing mitochondrial abnormalities may be implicated in a variety of psychiatric conditions. © 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society.

    DOI: 10.1016/j.neures.2010.12.013

    Scopus

    PubMed

    researchmap

  • Clinical profiles of late-onset semantic dementia, compared with early-onset semantic dementia and late-onset Alzheimer&apos;s disease 査読

    Hideaki Shimizu, Kenjiro Komori, Ryuji Fukuhara, Shunichiro Shinagawa, Yasutaka Toyota, Tetsuo Kashibayashi, Naomi Sonobe, Teruhisa Matsumoto, Takaaki Mori, Tomohisa Ishikawa, Kazuhiko Hokoishi, Satoshi Tanimukai, Shu-ichi Ueno, Manabu Ikeda

    PSYCHOGERIATRICS   11 ( 1 )   46 - 53   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Background:
    Semantic dementia (SD) has been recognized as a representative of dementia with presenile onset; however, recent epidemiological studies have shown that SD also occurs in the elderly. There have been few studies about the differences of clinical profiles between early-onset SD (EO-SD) and late-onset SD (LO-SD). Age-associated changes in the brain might cause some additional cognitive and behavioural profiles of LO-SD in contrast to the typical EO-SD cases. The aim of the present study was to clarify the characteristics of neuropsychological, and behavioural and psychological symptoms of dementia (BPSD) profiles of LO-SD patients observed in screening tests in comparison with EO-SD patients and late-onset Alzheimer&apos;s disease (LO-AD) patients as controls.
    Methods:
    Study participants were LO-SD (n = 10), EO-SD (n = 15) and LO-AD (n = 47). We examined the Mini-Mental State Examination (MMSE), the Raven&apos;s Coloured Progressive Matrices (RCPM), the Short-Memory Questionnaire (SMQ), the Neuropsychiatric Inventory (NPI) and the Stereotypy Rating Inventory (SRI).
    Results:
    Both SD groups scored significantly lower than the LO-AD patients in &apos;naming&apos; of the MMSE. In the &apos;construction&apos; score of the MMSE and the RCPM score, however, the LO-SD patients as well as the LO-AD patients were significantly lower than the EO-SD patients. In the SMQ score, &apos;euphoria&apos; and &apos;disinhibition&apos; scores of the NPI, the SRI total and subscale scores, both SD groups were significantly higher, whereas in the &apos;delusion&apos; score of the NPI, both SD groups were significantly lower than the LO-AD patients.
    Conclusions:
    Visuospatial and constructive skills of LO-SD patients might be mildly deteriorated compared with EO-SD patients, whereas other cognitive and behavioural profiles of LO-SD are similar to EO-SD. Age-associated changes in the brain should be considered when we diagnose SD in elderly patients.

    DOI: 10.1111/j.1479-8301.2010.00351.x

    Web of Science

    PubMed

    researchmap

  • Comprehensive analysis of the genes responsible for neuroacanthocytosis in mood disorder and schizophrenia 査読

    Hirochika Shimo, Masayuki Nakamura, Akiyuki Tomiyasu, Mio Ichiba, Shu Ichi Ueno, Akira Sano

    Neuroscience Research   69 ( 3 )   196 - 202   2011年3月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Neuroacanthocytosis syndromes are mainly comprised of two diseases: chorea-acanthocytosis (ChAc) and McLeod syndrome (MLS). There is a high incidence of psychiatric disorders such as mood disorder and schizophrenia among neuroacanthocytosis patients. We hypothesized that neuroacanthocytosis-related-genes might be associated with susceptibility to these psychiatric disorders. We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles. We also performed copy number variation (CNV) analysis in 72 mood disorder subjects and 86 schizophrenia subjects. We identified three non-synonymous, two synonymous and six intron variants in mood disorder subjects and a novel GAT triplet repeat polymorphism in VPS13A. By CNV analysis, we identified a heterozygous exon 60-61 deletion in VPS13A in one mood disorder subject. We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK. The presence of a pathogenic mutation or a potentially functional variant in mood disorder or schizophrenia subjects suggests that neuroacanthocytosis-related-genes might be involved in the pathogenesis of these psychiatric disorders. © 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society.

    DOI: 10.1016/j.neures.2010.12.001

    Scopus

    PubMed

    researchmap

  • Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions 査読

    Satoshi Yamamura, Masao Abe, Masanori Nakagawa, Shinichiro Ochi, Shu-ichi Ueno, Motohiro Okada

    NEUROPHARMACOLOGY   60 ( 4 )   550 - 560   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    The atypical antidepressant, mirtazapine enhances noradrenergic transmission, but its effects on serotonergic transmission remain to be clarified. The present study determined the effects of acute and chronic administration of mirtazapine on serotonergic transmissions in raphe nuclei and their innervation regions, frontal and entorhinal cortex, using multiple-probes microdialysis with real-time PCR and western blotting. Acute administration of mirtazapine did not affect extracellular serotonin level in raphe nuclei or cortex; however, chronic administration increased extracellular serotonin level in raphe nuclei without affecting that in cortex. Blockade of 5-HT1A receptor, but not that of the 5-HT2A/2C receptor, enhanced the effects of acute administration of mirtazapine on extracellular serotonin level in raphe nuclei. Chronic mirtazapine administration reduced the inhibitory function associated with somatodendritic 5-HT1A receptor in raphe nuclei, but enhanced postsynaptic 5-HT1A receptor in serotonergic innervated cortical regions. Chronic administration reduced the expression of mRNA and protein of serotonin transporter and 5-HT1A receptor in raphe nuclei, but not in the cortices. These results suggested that acute administration of mirtazapine probably activated serotonergic transmission, but its stimulatory action was abolished by activated inhibitory 5-HT1A receptor. Chronic administration of mirtazapine resulted in increased extracellular serotonin level via reduction of serotonin transporter with reduction of somatodendritic 5-HT1A autoreceptor function in raphe nuclei. These pharmacological actions of mirtazapine include its serotonergic profiles as noradrenergic and specific serotonergic antidepressant (NaSSA). (C) 2011 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.neuropharm.2010.12.025

    Web of Science

    PubMed

    researchmap

  • Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population 査読

    Masahito Nakataki, Jun-ichi Iga, Shusuke Numata, Eriko Yoshimoto, Kanami Kodera, Shin-ya Watanabe, Hongwei Song, Shu-ichi Ueno, Tetsuro Ohmori

    NEUROSCIENCE LETTERS   489 ( 2 )   126 - 130   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    The epithelial membrane protein 1 (EMP1) plays a role in neuronal differentiation and neurite outgrowth, which are involved in the pathogenesis of major depressive disorder (MDD). We sought to determine whether the EMP1 gene is implicated in MDD. We determined the mRNA expression levels of the EMP1 gene in peripheral-blood leukocytes of patients and control subjects (n = 27 each). Next, we performed case-control association analyses (MDD, n = 182: controls, n = 350) in the Japanese population. The level of expression of the EMP1 mRNA was significantly lower in medication-free patients compared with control subjects (P&lt;0.001). The association analysis revealed an absence of association between the polymorphisms studied and MDD, whereas a gender-specific association was observed between male controls and male patients for marker rs7315725 (permutation P = 0.039). Our results suggest that the EMP1 gene may be implicated in the pathophysiology of MDD in the Japanese population. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2010.12.001

    Web of Science

    PubMed

    researchmap

  • Quality of life and cognitive dysfunction in people with schizophrenia 査読

    Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno, Tetsuro Ohmori

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY   35 ( 1 )   53 - 59   2011年1月

     詳細を見る

    記述言語:英語   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    The main purpose of the present study was to examine the relationship between quality of life (QOL) and cognitive dysfunction in schizophrenia. Subjects were 61 stabilized outpatients. Quality of life and cognitive function were assessed using the Quality of Life Scale (QLS) and the Brief Assessment of Cognition in Schizophrenia (BACS), respectively. Clinical symptoms were evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Calgary Depression Scale for Schizophrenia (CDSS). The BACS composite score and the BACS Verbal memory score were positively correlated with the QLS total score and two subscales. The BACS Attention and speed of information processing score had positive correlation with the QLS total and all the subscales scores. The PANSS Positive and Negative syndrome scores also had significant correlations with the QLS total score and all of the subscales. In addition, the CDSS score was negatively correlated with the QLS total score and some of the subscales. Stepwise regression analysis showed that the BACS Attention and speed of information processing score was an independent predictor of the QLS total score but it was less associated with the QLS than the PANSS Negative syndrome score and the CDSS score. The results suggest that negative and depressive symptoms are important factors on patients' QOL and also support the view that cognitive performance provides a determinant of QOL in patients with schizophrenia. (C) 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.pnpbp.2010.08.018

    Web of Science

    PubMed

    researchmap

  • 入院を契機にアスペルガー障害と確定診断され治療が奏効した成人2症例

    河邉 憲太郎, 堀内 史枝, 長谷川 芙美, 畠中 しおり, 牧 徳彦, 谷向 知, 上野 修一

    精神科   17 ( 5 )   559 - 566   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    過去に統合失調症と診断され、精神運動興奮状態のため入院に至ったが、入院中の詳細な生育歴の聴取や入院中の行動観察、および薬物反応よりアスペルガー障害と診断を改め、支援および治療を再検討することにより軽快した2症例(25歳男性、24歳女性)について報告した。本2例は家庭内不適応で入院に至ったが、入院治療中の目的を明確にし、退院後の方向性を入院中に決めておくことや退院後の生活の基盤となる家族への疾患教育が必須であると示唆された。

    researchmap

  • Association Study Between the Pericentrin (PCNT) Gene and Schizophrenia 査読

    Shusuke Numata, Masahito Nakataki, Jun-ichi Iga, Toshihito Tanahashi, Yoshihiro Nakadoi, Kazutaka Ohi, Ryota Hashimoto, Masatoshi Takeda, Mitsuo Itakura, Shu-ichi Ueno, Tetsuro Ohmori

    NEUROMOLECULAR MEDICINE   12 ( 3 )   243 - 247   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:HUMANA PRESS INC  

    Disrupted-in-schizophrenia 1 (DISC1), a known genetic risk factor for schizophrenia (SZ) and major depressive disorder (MDD), interacts with several proteins and some of them are reported to be genetically associated with SZ. Pericentrin (PCNT) also interacts with DISC1 and recently single-nucleotide polymorphisms (SNPs) within the PCNT gene have been found to show significant associations with SZ and MDD. In this study, case-controlled association analysis was performed to determine if the PCNT gene is implicated in SZ. Nine SNPs were analyzed in 1,477 individuals (726 patients with SZ and 751 healthy controls). No significant difference was observed between the controls and the patients in allelic frequencies or genotypic distributions of eight SNPs. Although allelic distribution of rs11702684 was different between the two groups (P = 0.042), the difference did not reach statistical significance after permutation correction for multiple comparisons. In the haplotypic analysis, we could not find any significant association in our subjects, either. This gene may not play a major role independently in the etiology of SZ in the Japanese population.

    DOI: 10.1007/s12017-009-8106-x

    Web of Science

    PubMed

    researchmap

  • 繰り返す抗精神病薬に対する脆弱性からCYP2D6遺伝子多型を解析し、その結果に基づいた抗精神病薬の選択により改善した統合失調症の一例

    川添 康一郎, 福原 竜治, 越智 紳一郎, 安部 賢郎, 園部 漢太郎, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   20回・40回   147 - 147   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 著明な脳萎縮を呈した全身性エリテマトーデス(SLE)の1例

    園田 亜希, 福原 竜治, 上野 修一

    精神神経学雑誌   112 ( 8 )   820 - 820   2010年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • CBDによる非流暢性失語の検討

    北村 伊津美, 小森 憲治郎, 福原 竜治, 園部 直美, 石川 智久, 池田 学, 山下 光, 谷向 知, 上野 修一

    日本神経心理学会総会プログラム・予稿集   34回   123 - 123   2010年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • コルサコフ症候群との鑑別を要した家族性アルツハイマー型認知症の一例

    園部 直美, 福原 竜治, 森 崇明, 新谷 孝典, 越智 紳一郎, 園部 漢太郎, 谷向 知, 上野 修一, 池田 学

    老年精神医学雑誌   21 ( 増刊II )   98 - 98   2010年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • Aripiprazoleが奏効したトゥレット障害の2症例

    河邉 憲太郎, 堀内 史枝, 越智 紳一郎, 上野 修一

    臨床精神薬理   13 ( 6 )   1209 - 1214   2010年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    トゥレット障害の主な薬物療法は、haloperidolやpimozide、risperidoneなどの抗精神病薬が使用されるが、近年、トゥレット障害に対するaripiprazoleの使用についての報告が散見される。AripiprazoleはドーパミンD2受容体部分アゴニストであり、多くの抗精神病薬がドーパミンD2受容体アンタゴニストであることから、特殊な薬理学特性を持つ抗精神病薬と言える。Aripiprazoleは、また、強力な抗精神病作用を有し、錐体外路症状、代謝異常や過鎮静をきたしにくい安全性の高い抗精神病薬のため、統合失調症の第一選択薬として国内で認識され、広く使われている。今回、我々は、トゥレット障害と診断し、多彩なチック症状に対してaripiprazoleの使用により改善に至った2症例を経験したので報告する。1例目は14歳男性、risperidoneによる治療を開始したが、過鎮静と効果不十分のためaripiprazoleに置換して6mg/日から開始、24mg/日まで増量し、奏効した。2例目は12歳男性、広汎性発達障害が併存していた。Aripiprazole 3mg/日から開始し、12mg/日まで増量したところ、チック症状は改善した。2症例とも副作用は眠気のみであった。以上から、aripiprazoleは、継続投与が可能で忍容性が高く、効果が期待でき、トゥレット障害に用いることのできる薬物治療の選択肢の1つであると判断した。(著者抄録)

    researchmap

  • 【児童青年期双極性障害に対する薬物療法】 児童青年期双極性障害における睡眠障害

    堀内 史枝, 岡 靖哲, 河邉 憲太郎, 上野 修一

    臨床精神薬理   13 ( 5 )   933 - 940   2010年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    児童青年期双極性障害における睡眠障害は、躁病エピソード・うつ病エピソードいずれにも関連する臨床症状として重要な所見である。睡眠の質・量の低下や睡眠覚醒リズムの問題は、日中の活動性・認知面・学習面への影響が大きく、特に児童期において発達に及ぼす影響を考慮すると、早期発見・早期介入が必要である。児童青年期における睡眠障害の薬物療法については、十分なコンセンサスが得られておらず、心理学的介入や認知行動療法が主として用いられる。認知行動療法的アプローチをする上で、夜間の睡眠状態に加えて日中の活動性も把握できる睡眠日誌は有用である。(著者抄録)

    researchmap

  • アミロイド前駆体タンパク質変異を認めた若年性家族性アルツハイマー病の一例

    安部 賢郎, 園部 直美, 福原 竜治, 森 崇明, 新谷 孝典, 越智 紳一郎, 園部 漢太郎, 谷向 知, 上野 修一

    精神神経学雑誌   ( 2010特別 )   S - 195   2010年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 【児童期における精神疾患の非定型性 成人期の精神疾患と対比して】睡眠障害

    堀内 史枝, 岡 靖哲, 上野 修一

    精神医学   52 ( 5 )   477 - 483   2010年5月

  • GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study 査読

    Shin&apos;Ya Tayoshi, Masahito Nakataki, Satsuki Sumitani, Kyoko Taniguchi, Sumiko Shibuya-Tayoshi, Shusuke Numata, Jun-ichi Iga, Shu-ichi Ueno, Masafumi Harada, Tetsuro Ohmori

    SCHIZOPHRENIA RESEARCH   117 ( 1 )   83 - 91   2010年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Gamma-amino butyric acid (GABA) is thought to play a role in the pathophysiology of schizophrenia. High magnetic held proton magnetic resonance spectroscopy ((1)H-MRS) provides a reliable measurement of GABA in specific regions of the brain. This Study measured GABA concentration in the anterior cingulate cortex (ACC) and ill the left basal ganglia (ItBG) in 38 patients with chronic schizophrenia and 29 healthy control subjects.
    There was no significant difference in GABA concentration between the schizophrenia patients and the healthy controls in either the ACC (1.36 +/- 0.45 mmol/l in schizophrenia patients and 1.52 +/- 0.54 mmol/l in control Subjects) or the ItBG (1.13 +/- 0.26 mmol/l ill schizophrenia patients and 1.18 +/- 0.20 mmol/l in control Subjects). Among the right handed schizophrenia patients, the GABA concentration in the ItBG was significantly higher in patients talking typical antipsychotics (1.25 +/- 0.24 mmol/l) than in those taking atypical antipsychotics (1.03 +/- 0.24 mmol/l, p = 0.026). In the ACC, the GABA concentration was negatively correlated with the close of the antipsychotics (rs = -0.347, p = 0.035). In the ItBG, the GABA concentration was positively correlated with the dose of the anticholinergics (rs = 0.403, p = 0.015).
    To the best of four knowledge, this is the first Study to have directly measured GABA concentrations in schizophrenia patients using (1)H-MRS. Out, results suggest that there are no differences in GABA concentrations in the ACC or the ItBG of schizophrenia patients compared to healthy controls. Antipsychotic medication may cause changes in GABA concentration, and atypical and typical antipsychotics may have differing effects. It is possible that medication effects conceal inherent differences in GABA concentrations between schizophrenia patients and healthy controls. (C) 2009 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.schres.2009.11.011

    Web of Science

    PubMed

    researchmap

  • The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case-control study and meta-analysis 査読

    Kazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, Tetsuhiko Yoshida, Hidetoshi Takahashi, Naomi Iike, Masao Iwase, Kouzin Kamino, Ryouhei Ishii, Hiroaki Kazui, Motoyuki Fukumoto, Hironori Takamura, Hidenaga Yamamori, Michiyo Azechi, Koji Ikezawa, Hitoshi Tanimukai, Shinji Tagami, Takashi Morihara, Masayasu Okochi, Kazuo Yamada, Shusuke Numata, Masashi Ikeda, Toshihisa Tanaka, Takashi Kudo, Shu-ichi Ueno, Takeo Yoshikawa, Tetsuro Ohmori, Nakao Iwata, Norio Ozaki, Masatoshi Takeda

    SCHIZOPHRENIA RESEARCH   116 ( 2-3 )   126 - 132   2010年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    The chitinase 3-like 1 (CHI3L1) gene acts as a cellular survival factor in response to several environmental and psychosocial stresses. The expression level of CHI3L1 was increased in the hippocampus and prefrontal cortex regions of patients with schizophrenia. Genetic variants of the CHI3L1 gene have been significantly associated with schizophrenia in two distinct ethnic groups, the Chinese and Irish populations. The aims of this study are to confirm the association between the CHI3L1 gene and schizophrenia in a Japanese population using the largest sample size to date (1463 cases and 1795 controls) and perform a meta-analysis of the combined samples (3005 cases, 3825 controls and 601 trios). We found significant associations between single nucleotide polymorphism (SNP) 4/rs4950928 (p = 0.009), which is located in the promoter region of the CHI3L1 gene, and haplotypes including this SNP and schizophrenia (the most significant global p&lt;0.001). As the meta-analysis of the combined samples showed significant heterogeneity among studies of SNP3/rs10399805 (p = 0.026) and SNP4 (p&lt;0.001), we performed meta-analyses separately in the Japanese (2033 cases and 2365 controls) and Chinese populations (412 cases, 464 controls and 601 trios), the major groups analyzed in association studies of the CHI3L1 gene. The meta-analysis in Japanese populations showed stronger evidence for the association of schizophrenia with SNP4 (p = 0.003), while the meta-analysis in Chinese populations showed an association with a different variant (SNP3) (p = 0.003). We conclude that the genetic variants in the CHI3L1 gene have ethnic heterogeneity and confer a susceptibility to schizophrenia in Asian populations. (C) 2009 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.schres.2009.12.002

    Web of Science

    PubMed

    researchmap

  • Transition of Distinctive Symptoms of Semantic Dementia during Longitudinal Clinical Observation 査読

    Tetsuo Kashibayashi, Manabu Ikeda, Kenjiro Komori, Shunichiro Shinagawa, Hideaki Shimizu, Yasutaka Toyota, Takaaki Mori, Tomohisa Ishikawa, Ryuji Fukuhara, Shu-ichi Ueno, Satoshi Tanimukai

    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS   29 ( 3 )   224 - 232   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Background/Aims: The aim of this study is to examine the clinical symptoms in a number of semantic dementia (SD) patients and to reveal the longitudinal progression and clinical course of these distinctive symptoms of SD. Methods: 19 consecutive SD patients were examined. Symptoms were classified into 23 distinct categories: behavioral symptoms, language and cognitive symptoms and symptoms concerning the impairment of activities of daily living (ADL). We divided patients into two subgroups, left-and right-dominant SD, and compared the onset of each symptom. Results: Language impairments occurred as the initial symptom in 16 cases. At the first examination, all cases showed both anomia and impairment of word comprehension. By around 3 years after onset, almost all language impairments were observed. Approximately 3-5 years after onset, prosopagnosia and behavioral symptoms appeared. Around the period when the loss of the language faculty and apathy became remarkable, impairment of ADL appeared. Patients spent all day in bed at this stage. Moreover, prosopagnosia appeared significantly earlier in right-dominant SD. Conclusion: Our findings clarify the progression of distinctive symptoms of SD patients. It is necessary to create a treatment strategy for SD patients with such a disease-specific course of SD. Copyright (C) 2010 S. Karger AG, Basel

    DOI: 10.1159/000269972

    Web of Science

    PubMed

    researchmap

  • Semantic Dementia例の進行期における描画特徴について

    園部 直美, 小森 憲治郎, 松本 伊津美, 福原 竜治, 森 崇明, 石川 智久, 谷向 知, 池田 学, 上野 修一

    神経心理学   25 ( 4 )   313 - 313   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • Semantic Dementia例の進行期における描画特徴について

    園部 直美, 小森 憲治郎, 松本 伊津美, 福原 竜治, 森 崇明, 石川 智久, 谷向 知, 池田 学, 上野 修一

    日本神経心理学会総会プログラム・予稿集   33回   104 - 104   2009年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • 児童青年期睡眠チェックリスト(Child and Adolescent Sleep Checklist:CASC)による睡眠調査・問診システムの作成と評価

    岡 靖哲, 堀内 史枝, 谷川 武, 鈴木 周平, 近藤 富香, 櫻井 進, 斉藤 功, 谷向 知, 上野 修一, 井上 雄一

    睡眠医療   3 ( 3 )   404 - 408   2009年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ライフ・サイエンス  

    子どもの睡眠の問題を調査・スクリーニングする手法としては、問診票を用いた調査が最も簡便であるが、特に子どもの調査においては、年齢とともに睡眠の量的・質的変化がみられることに加え、睡眠環境の影響も受けることから、問診項目や設問の内容に工夫が必要である。われわれは幼児〜高校生までの幅広い年齢層に対応し、医療・教育・公衆衛生の分野で睡眠の問題をスクリーニングすることを目的として、「児童青年期睡眠チェックリスト(CASC)」を作成し、これを用いた睡眠調査・問診システムを構築した。CASCの特徴は、同一の設問セットで横断的なスクリーニングと、経時的追跡を行えることに加え、年齢に応じて保護者記入版、本人記入版を併用することで、より幅広く正確な情報を得ることができる点である。今後、各年代の標準化を行い、疫学調査や小児睡眠臨床において活用することで、小児の睡眠問題のマネジメントに貢献する有力なツールとなることが期待される。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2009&ichushi_jid=J04991&link_issn=&doc_id=20090812050014&doc_link_id=%2Fai5slepd%2F2009%2F000303%2F015%2F0404-0408%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fai5slepd%2F2009%2F000303%2F015%2F0404-0408%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population 査読

    Shusuke Numata, Jun Ichi Iga, Masahito Nakataki, Shin'ya Tayoshi, Kyoko Taniguchi, Satsuki Sumitani, Masahito Tomotake, Toshihito Tanahashi, Mitsuo Itakura, Yoko Kamegaya, Masahiko Tatsumi, Akira Sano, Takashi Asada, Hiroshi Kunugi, Shu Ichi Ueno, Tetsuro Ohmori

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics   150 ( 4 )   527 - 534   2009年6月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    The phosphodiesterase 4B (PDE4B) interacts with disrupted-inschizophrenia 1 (DISC1), which is a knowngenetic risk factor for schizophrenia, bipolar disorder and major depressive disorder (MDD). PDE4B is also important in the regulation of cAMP signaling, a second messenger implicated in learning, memory, and mood. In this study, we determined mRNA expression levels of the PDE4B gene in the peripheral blood leukocytes of patients with MDD and control subjects (n = 33, each). Next we performed two-stage case-controlled association analyses (first set; case = 174, controls = 348; second set; case = 481, controls = 812) in the Japanese population to determine if the PDE4B gene is implicated in MDD. In the leukocytes, a significantly higher expression of the PDE4B mRNA was observed in the drug-naïve MDD patients compared with control subjects (P<0.0001) and the expression of the MDD patients significantly decreased after antidepressant treatment (P = 0.030). In the association analysis, we observed significant allelic associations of four SNPs (the most significant, rs472952; P = 0.002) and a significant haplotypic association (permutation P = 0.019) between the PDE4B gene and MDD in the first-set samples. However, we could not confirm these significant associations in the following independent second-set of samples. Our results suggest that the PDE4B gene itself does not link to MDD but the elevated mRNA levels of PDE4B might be implicated in the pathophysiology of MDD. © 2008 Wiley-Liss, Inc.

    DOI: 10.1002/ajmg.b.30852

    Scopus

    PubMed

    researchmap

  • No association between Rho-associated coiled-coil forming protein serine/threonine kinase1 gene and schizophrenia in the Japanese population 査読

    Masahito Nakataki, Shusuke Numata, Jun-ichi Iga, Shin&apos;Ya Tayoshi, Sumiko Tayoshi-Shibuya, Hongwei Song, Toshihito Tanahashi, Mitsuo Itakura, Shu-ichi Ueno, Tetsuro Ohmori

    PSYCHIATRIC GENETICS   19 ( 3 )   162 - 162   2009年6月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    DOI: 10.1097/YPG.0b013e32832a5030

    Web of Science

    PubMed

    researchmap

  • 妄想の出現に伴い、統合失調症を疑われたアスペルガー症候群の1例

    河邉 憲太郎, 堀内 史枝, 福島 亜希, 福原 竜治, 蓮井 康弘, 谷向 知, 上野 修一

    精神神経学雑誌   111 ( 6 )   717 - 717   2009年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 愛媛大学医学部附属病院精神科神経科における児童青年期精神科診療の現状

    安部 賢郎, 堀内 史枝, 谷向 知, 上野 修一

    精神神経学雑誌   111 ( 6 )   716 - 716   2009年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese population 査読

    Shusuke Numata, Jun-ichi Iga, Masahito Nakataki, Shin&apos;Ya Tayoshi, Toshihito Tanahashi, Mitsuo Itakura, Shu-ichi Ueno, Tetsuro Ohmori

    JOURNAL OF PSYCHIATRY & NEUROSCIENCE   34 ( 3 )   195 - 198   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CMA-CANADIAN MEDICAL ASSOC  

    Background: Pericentrin (PCNT) interacts with disruption-in-schizophrenia 1 (DISC1), a known genetic risk factor for schizophrenia, bipolar disorder and major depressive disorder (MDD). We sought to determine whether the PCNT gene is implicated in MDD. Methods: We performed case-control association analyses in the Japanese population. We analyzed 9 single nucleotide polymorphisms (SNPs) in 173 patients with MDD and 348 healthy controls. Results: We found a significant allelic association between 3 SNPs (rs3788265, rs2073376 and rs2073380) of the PCNT gene and MDD (p = 0.006, 0.005 and 0.021, respectively). After correction for multiple testing, 2 SNPs (rs3788265 and rs2073376) retained significant allelic associations with MDD. In addition, we found a significant association between the 2 marker haplotypes (r3788265 and rs2073376) and MDD (permutation p = 0.011). Limitations: Our sample was small and comprised only Japanese participants. In addition, owing to the late onset of MDD, it is possible that the disorder will develop in at least some participants in our control group. Finally, we did not show how SNPs of the PCNT gene alter its function. Conclusion: Our results suggest that genetic variations in the PCNT gene may play a significant role in the etiology of MDD in the Japanese population.

    Web of Science

    PubMed

    researchmap

  • 亜急性に進行する認知機能障害をきたし橋本脳症と診断した1例

    新谷 孝典, 豊田 泰孝, 福原 竜治, 石川 智久, 谷向 知, 上野 修一

    精神神経学雑誌   ( 2009特別 )   S - 400   2009年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 広汎性発達障害児における睡眠と行動との関連

    堀内 史枝, 安部 賢郎, 河邉 憲太郎, 谷向 知, 上野 修一

    精神神経学雑誌   ( 2009特別 )   S - 269   2009年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population 査読

    Shusuke Numata, Shu ichi Ueno, Jun ichi Iga, Hongwei Song, Masahito Nakataki, Shin'Ya Tayoshi, Satsuki Sumitani, Masahito Tomotake, Mitsuo Itakura, Akira Sano, Tetsuro Ohmori

    Journal of Psychiatric Research   43 ( 1 )   7 - 12   2008年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    The phosphodiesterase 4B (PDE4B) gene is located at 1p31, a susceptibility region for schizophrenia (SZ). Moreover, PDE4B interacts with DISC1, which is a known genetic risk factor for SZ. Recently, it was reported that the PDE4B gene is associated with SZ in Caucasian and African American populations. In this study, case-controlled association analyses were performed in the Japanese population to determine if the PDE4B gene is implicated in SZ. Thirteen single nucleotide polymorphisms (SNPs) were analyzed in 444 schizophrenic patients and 452 control subjects. Three SNPs (rs2180335, rs910694 and rs472952) were significantly associated with SZ after applying multiple test correction (p = 0.039, 0.004 and 0.028). In addition, a significant association was found between specific haplotypes (rs2180335 and rs910694) and SZ (permutation p = 0.001). Our result suggests that variations at the PDE4B locus may play a significant role in the etiology of SZ in the Japanese population. © 2008 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jpsychires.2008.01.013

    Scopus

    PubMed

    researchmap

  • TGFBR2 gene expression and genetic association with schizophrenia 査読

    Shusuke Numata, Shu-ichi Ueno, Jun-ichi Iga, Ken Yamauchi, Song Hongwei, Ryota Hashimoto, Masatoshi Takeda, Hiroshi Kunugi, Mitsuo Itakurla, Tetsuro Ohmori

    JOURNAL OF PSYCHIATRIC RESEARCH   42 ( 6 )   425 - 432   2008年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    TGFBR2 gene is a tumor suppressor gene located at chromosome 3p22, and the locus is reported to be linked with schizophrenia susceptibility. According to the previous studies, a reduced incidence of cancer is observed in schizophrenic patients compared with the general population and tumor suppressor genes may be associated with schizophrenia. We measured the mRNA expression of TGFBR2 gene in the peripheral leukocytes from 19 medication-free schizophrenics and 25 medication-free major depressive patients compared with age- and sex-matched control subjects using a quantitative real-time PCR method. We also followed up the TGFBR2 mRNA expression levels from 13 schizophrenics after several weeks - antipsychotic treatments. The TGFBR2 mRNA levels of medication free schizophrenics were significantly higher than those of control subjects and decreased to almost the same level as controls after antipsychotic treatment. On the other hand, the TGFBR2 mRNA levels of medication-free major depressive patients were not significantly different from controls. In genetic studies, we failed to find any association between the TGFBR2 gene and schizophrenia with 10 SNPs of TGFBR2 gene in Japanese subjects (279 subjects each) and there was no significant difference with haplotype analysis, either. Our results suggest that the TGFBR2 gene itself does not link to schizophrenia but that the TGFBR2 mRNA levels in the peripheral leukocytes may be a potential state marker for schizophrenia. (c) 2007 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jpsychires.2007.04.002

    Web of Science

    PubMed

    researchmap

  • Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia 査読

    Hirofumi Aki, Masahito Tornotake, Yasuhiro Kaneda, Jun-Ichi Iga, Sawako Kinouchi, Surniko Shibuya-Tayoshi, Shin-Ya Tayoshi, Ikuyo Motoki, Kazuhiko Moriguchi, Satsuki Sumitani, Ken Yamauchi, Takahide Taniguchi, Yasuhito Ishimoto, Shu-Ichi Ueno, Tetsuro Ohmori

    PSYCHIATRY RESEARCH   158 ( 1 )   19 - 25   2008年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    The purpose of the present Study is to investigate the relationships among subjective and objective quality of life (QOL), and levels of life skills, and their clinical determinants in outpatients with schizophrenia by using schizophrenia disease-specific QOL measures.. Data collected from 64 Outpatients were analyzed. Subjective QOL was measured with the Schizophrenia Quality of Life Scale (SQLS) and objective QOL with the Quality of Lire Scale (QLS). Patients' family members completed the Life Skills Profile (LSP). Clinical symptoms were also assessed with several scales including the Brief Psychiatric Rating Scale (BPRS) and the Calgary Depression Scale for Schizophrenia (CDSS). Only the motivation/energy scale, but lot the Other scales of the SQLS, correlated with the QLS. The LSP rated by the family showed significant correlations with both the SQLS and the QLS. The CDSS score predicted each scale of the SQLS, and the BPRS negative symptoms score predicted the QLS. The LSP was predicted by the BPRS negative symptoms score and the CDSS score independently. These results indicate that the Patient's QOL could be predicted by the life: skills measured by a family member and Suggest that active treatment for depressive and negative symptoms might be recommended to improve the patient's QOL and life skills. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.psychres.2006.05.017

    Web of Science

    PubMed

    researchmap

  • A mouse model of chorea-acanthocytosis 査読

    M. Nakamura, Y. Katoh, K. Yutaka, Y. Kurano, M. Ichiba, M. Matsuda, M. Katoh, S. Ueno, A. Sano

    Neuroacanthocytosis Syndromes II   153 - 159   2008年

     詳細を見る

    掲載種別:論文集(書籍)内論文  

    © 2008 Springer-Verlag Berlin Heidelberg. All rights are reserved. We have recently generated a model mouse of chorea-acanthocytosis (ChAc), which carries a targeted deletion mutation in the mouse VPS13A gene corresponding to a human disease mutation. Although these model mice exhibited a normal life span, they begin to display a disease phenotype with red cell acanthocytosis and behavioral abnormalities in old age. Neuropathological examination reveals prominent apoptotic neuronal cells and astrogliosis in the striatum. These are thought to be very similar to the features of the disease course and neuropathology seen in ChAc patients. Thus, this model mouse may be useful for pathogenic studies related to ChAc. Here, we review the ChAc-model mouse and recent findings on the upregulation of gephyrin and its related proteins in ChAcmodel mouse striatum.

    DOI: 10.1007/978-3-540-71693-8_12

    Scopus

    researchmap

  • A new phenotype of chorea-acanthocytosis with dilated cardiomyopathy and myopathy [3] 査読

    Yasufumi Kageyama, Keiji Matsumoto, Keiji Ichikawa, Shu Ichi Ueno, Mio Ichiba, Masayuki Nakamura, Akira Sano

    Movement Disorders   22 ( 11 )   1669 - 1670   2007年8月

  • 8.女子学生における性周期と精神状態の変化についての検討(第30回日本心身医学会中国・四国地方会演題抄録)

    木内 佐和子, 上野 修一, 大森 哲郎

    心身医学   47 ( 12 )   1053 - 1053   2007年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本心身医学会  

    DOI: 10.15064/jjpm.47.12_1053_2

    researchmap

  • [Genetic aspects of depressive disorder]. 査読

    Ueno S, Iga J, Numata S, So K, Tayoshi N, Nakataki M, Yamauchi K, Omori T

    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica   109   859 - 863   2007年

     詳細を見る

    出版者・発行元:9  

    PubMed

    researchmap

  • Gene expression and association analysis of LIM (PDLIM5) in major depression 査読

    Jun ichi Iga, Shu ichi Ueno, Ken Yamauchi, Shusuke Numata, Ikuyo Motoki, Sumiko Tayoshi, Sawako Kinouchi, Koshi Ohta, Hongwei Song, Kyoko Morita, Kazuhito Rokutan, Hirotaka Tanabe, Akira Sano, Tetsuro Ohmori

    Neuroscience Letters   400 ( 3 )   203 - 207   2006年6月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    LIM (PDLIM5) is a small protein that interacts with protein kinase C-epsilon and the N-type calcium channel alpha-1B subunit and modulates neuronal calcium signaling. Recently, the LIM mRNA expression in postmortem brains and immortalized lymphoblastoid cells from mood disorder patients was reported to be changed and seems to be involved in its pathophysiology. We hypothesized that the expression of the LIM mRNA in the native peripheral leukocytes may be a good candidate for the biological marker for mood disorders. Twenty patients with major depression and age- and sex-matched control subjects were included in this expression study. The LIM mRNA levels in the peripheral leukocytes from drug-naive depressive patients were significantly lower than those from control subjects and increased significantly after 4-week paroxetine treatments, to almost the same level as controls'. Hamilton depressive scores (HAM-D) were improved about 50% after 4-week treatment but neither paroxetine concentrations nor the changes of HAM-D scores showed significant correlation with the change of the mRNA levels. Then, we genotyped three single nucleotide polymorphic markers of LIM gene, which were reported to be associated with bipolar disorder in patients with major depression and control subjects (n = 130, each), but there were no associations between these SNPs and major depression. Our investigation indicates that the lower expression levels of LIM mRNA in the peripheral leukocytes are associated with the depressive state and that its recovery after treatment may be an adaptive change induced by the antidepressant. © 2006 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2006.02.044

    Scopus

    PubMed

    researchmap

  • Reversible left ventricular dysfunction complicating eating disorder 査読

    S Shibuya-Tayoshi, T Taniguchi, C Moriya, T Matsushita, M Akaike, SI Ueno, T Ohmori

    GENERAL HOSPITAL PSYCHIATRY   28 ( 2 )   180 - 182   2006年3月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE INC  

    DOI: 10.1016/j.genhosppsych.2005.09.003

    Web of Science

    PubMed

    researchmap

  • CHAC(VPS13A)遺伝子異常による精神神経障害の多因子性に関する研究 査読

    室屋 真二, 市場 美緒, 加藤 ゆう子, 水野 恵三子, 倉野 裕, 中村 雅之, 上野 修一, 佐野 輝

    精神薬療研究年報   ( 38 )   122 - 125   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    有棘赤血球舞踏病(ChAc)発症者およびその家族について有棘赤血球舞踏病原因遺伝子CHAC(VPS13A)の変異を検索し,精神神経障害の多因子性を検討した.ChAc発症者40例を含む30家系68例を対象とした.未報告の疾患変異9種を同定した.発症者40例中,疾患変異をホモ接合性もしくは複合ヘテロ接合性に有すものは16例で,一つの疾患変異をヘテロ接合性に有すのみのものが8例あった.残りの16例の発症者は疾患変異を認めなかった.疾患変異を1箇所ヘテロ接合性に有すのみでありながらChAcの臨床症状を呈す症例が存在することから,ChAcの遺伝形式が浸透率の低い優性遺伝である可能性および発症に関与するその他の修飾因子の存在が推測された

    researchmap

  • [Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses]. 査読

    Sumitani S, Ueno S, Ishimoto Y, Taniguchi T, Tomotake M, Motoki I, Yamauchi K, Ohmori T

    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica   108 ( 12 )   1282 - 1292   2006年

     詳細を見る

  • Hemodynamic changes in the prefrontal cortex during mental works as measured by multi channel near-infrared spectroscopy (NIRS) 査読

    Satsuki Sumitani, Tsunehiko Tanaka, Shin'Ya Tayoshi, Koshi Ota, Naomi Kameoka, Mizuki Morimune, Sumiko Shibuya-Tayoshi, Sawako Kinouchi, Shu-Ichi Ueno, Tetsuro Ohmori

    Journal of Medical Investigation   52   302 - 303   2005年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)  

    To investigate the brain activation in the prefrontal cortex (PFC) during mental works, we examined blood oxygenation changes of healthy subjects by using multi channel near infrared spectropcopy (NIRS). It was directly confirmed that the PFC was activated during mental tasks in vivo and it was suggested that distribution of the activation in the PFC is different among healthy individuals.

    DOI: 10.2152/jmi.52.302

    Scopus

    PubMed

    researchmap

  • Assessment of human stress and depression by DNA microarray analysis 査読

    Tetsuro Ohmori, Kyoko Morita, Toshiro Saito, Masayuki Ohta, Shu-Ichi Ueno, Kazuhito Rokutan

    Journal of Medical Investigation   52   266 - 271   2005年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)  

    Precise assessment of stress is an imminent issue to deal with stress-related social, medical and psychological problems. Psychological stress is known to stimulate the neuroendocrine, sympathetic nervous, and immune systems. By analyzing mRNA expression levels in leukocytes, which express receptors for hormones, neurotransmitters, growth factors, cytokines, and other stress related signals, levels of stress may be adequately measured. In a series of studies, our group has developed a cDNA microarray specifically designed to measure the mRNA levels of stress-related genes in peripheral blood leukocytes. This microarray enabled us to sensitively detect the response to psychological stress. In addition, our preliminary study suggests that the array could differentiate patients with depression from sex- and age-matched control subjects.

    DOI: 10.2152/jmi.52.266

    Scopus

    PubMed

    researchmap

  • The effect of milnacipran (serotonin noradrenaline reuptake inhibitor) on memory in Korsakoff's syndrome after encephalitis 査読

    S Numata, HW Song, S Ueno, T Ohmori

    GENERAL HOSPITAL PSYCHIATRY   27 ( 3 )   224 - 226   2005年5月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE INC  

    DOI: 10.1016/j.genhosppsych.2005.02.003

    Web of Science

    PubMed

    researchmap

  • Chorea-acanthocytosis with the ehime-deletion mutation 査読

    Shu Ichi Ueno, Kazue Kamae, Yoriaki Yamashita, Yoshiko Maruki, Yuko Tomemori, Masayuki Nakamura, Manabu Ikeda, Hirotaka Tanabe, Akira Sano

    Neuroacanthocytosis Syndromes   39 - 43   2005年

     詳細を見る

    掲載種別:論文集(書籍)内論文  

    © 2004 Springer. All Rights Reserved. Chorea-acanthocytosis (ChAc) is a hereditary neurodegenerative disease showing Huntington disease-like neuropsychiatric symptoms and peripheral blood red cell acanthocytosis. Recently, we have identified the gene, CHAC, encoding a newly discovered protein, chorein, in which a deletion mutation was found in three Japanese ChAc families. Although four patients possessed the same mutation homozygously, their clinical characteristics varied, which means that multifactorial effects on the pathogenesis are present. Even some of the heterozygous carriers in the families showed a slight degree of acanthocytosis and psychiatric features including emotional lability or cognitive disturbance. We found heterozygous carriers of the deletion-mutation allele in the group of patients with mood disorder. The CHAC gene product, chorein, may function as an important protein in the brain not only for motor but also for mental function.

    DOI: 10.1007/1-4020-2898-9_5

    Scopus

    researchmap

  • 有棘赤血球舞踏病病因遺伝子CHACの疾患モデルマウスの表現型解析 査読

    留守 ゆう子, 市場 美緒, 楠本 朗, 森田 恵三子, 佐藤 大輔, 上野 修一, 勝木 元也, 佐野 輝

    精神薬療研究年報   ( 36 )   66 - 73   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    今回,日本人家系で見つかった有棘赤血球舞踏病(CHAC)の病因となる愛媛欠失変異を持ったモデルマウスを作成し,その表現型の解析を行った.モデルマウスでは,老齢化後に運動機能障害と末梢血有棘赤血球症を認め,浸透圧試験で赤血球の脆弱性が実証された.行動解析でCHACモデルマウスでは自発運動量が減少し,ソーシャルインタラクションは有意に減少した.病理学的所見では線条体でアポトーシスとグリオーシスが存在し,抗GAD抗体陽性神経細胞と線維,抗TH抗体陽性神経線維が減少した.黒質ではpars reticulataにグリオーシスが見られ,抗GAD抗体陽性神経細胞と線維,抗TH抗体陽性神経線維の抗サブスタンスP抗体陽性線維の減少をもたらした.これらの所見はヒトでの所見と合致し,作成したマウスはCHACの疾患モデルとして妥当であると考えられた

    researchmap

  • A case of motor neuron disease with progressive aphasia and dementia 査読

    Takayuki Hyodo, Manabu Ikeda, Shu-ichi Ueno, Kenjiro Komori, Kazuhiko Hokoishi, Ryuji Fukuhara, Hirotaka Tanabe

    Brain and Nerve   54 ( 8 )   713 - 718   2002年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    We report a 71-year-old woman showing rapidly progressive non-fluent aphasia and dementia accompanied by motor neuron disease (MND). There was no family history of dementia or motor neuron disease. There was 10 months history of dysarthria and dysphagia. On examination, she showed profound difficulty in articulation. Her comprehension was impaired in that she was unable to obey three-stage command. Her written language was also impaired with phonological spelling errors, syntactic errors, and perseveration. Neuroradiological investigations showed atrophic changes and hypoperfusion of left temporal and bilateral parietal region revealed by MRI and SPECT, respectively. Her subsequent decline was rapid. It might be likely that aphasia is much more common in dementia with bulbar MND than is currently recognized because bulbar palsy might mask the language disorder.

    Scopus

    PubMed

    researchmap

  • 運動ニューロン疾患を伴い進行性の失語を呈した痴呆の1例

    兵頭 隆幸, 池田 学, 上野 修一, 小森 憲治郎, 鉾石 和彦, 福原 竜治, 田邉 敬貴

    脳と神経   54 ( 8 )   713 - 718   2002年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    71歳女.構音障害,嚥下障害等,球麻痺症状で発症し,失語が前景に立った痴呆症状が出現し,急速に進行して失外套症候群に至った.痴呆や運動ニューロン疾患の家族歴はなかった.運動ニューロン疾患を伴う痴呆症や前頭側頭型痴呆とは異なり,人格変化等の前頭葉症状は目立たないこと,非流暢性失語が前景に出た痴呆症状がみられたこと,形態画像で左側頭葉と両側頭頂葉の障害がみられたことから,非典型的であった

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2002&ichushi_jid=J01231&link_issn=&doc_id=20020918160011&doc_link_id=10.11477%2Fmf.1406901991&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1406901991&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

  • The silencer activity of the novel human serotonin transporter linked polymorphic regions 査読

    Kazuo Sakai, Masayuki Nakamura, Shu Ichi Ueno, Akira Sano, Norio Sakai, Yasuhito Shirai, Naoaki Saito

    Neuroscience Letters   327 ( 1 )   13 - 16   2002年7月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Enhancer/silencer activity of each allelic variant of the human serotonin transporter linked polymorphic region (5-HTTLPR) including newly found ones was measured in several cell lines including raphe-nucleus-derived RN46A. 5-HTTLR variants ligated in pGL-3 promoter vector increased luciferase activity in COS-7 cells and PC12 cells, where no significant differences among the variants were observed. In RN46 cell lines, however, 5-HTTLPRs decreased luciferase activity to 80-30%, acting as silencers not as enhancers. Some allelic variants (15, 19, 20 and 22) showed even significantly stronger silencer activities than others in RN46A. We also examined relationship between allelic frequencies, the enhancer/silencer activities and incidents of mood disorder. The categorized genotypic or allelic frequencies was not significantly different between the mood disorder and the control. No significant difference was detected either when analyzed by silencer activities of each allelic variant. © 2002 Elsevier Science Ireland Ltd. All rights reserved.

    DOI: 10.1016/S0304-3940(02)00348-8

    Scopus

    PubMed

    researchmap

  • The Simian Virus 40 Large T Antigen Does Not Inhibit Translation of the 14‐kDa Myelin Basic Protein mRNA in Reticulocyte Lysates or in Transfected Cells 査読

    S. Ueno, L. Foster, G. T. Hifumi, G. I. Tennekoon, A. T. Campagnoni

    Journal of Neurochemistry   64 ( 2 )   928 - 931   1995年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Abstract: Viral T antigens are transcription factors that have been suspected of inhibiting expression of the myelin basic protein (MBP) mRNA at the translational level in vitro and in vivo. The effect of simian virus 40 (SV40) large T antigen (T‐ag) was examined on the translation of the 14‐kDa MBP mRNA in reticulocyte lysates and on MBP expression after transfection into cells that express SV40 T‐ag. SV40 T‐ag did not inhibit translation of 14‐kDa MBP cRNAs in cell‐free translations even at 30 µM (∼600 µg/ml) T‐ag. Permanent transfection of COS‐1 cells (which endogenously express SV40 T‐ag) with the 14‐kDa MBP cDNA resulted in the expression of the 14‐kDa MBP as determined by western blot analysis. Permanent transfection of N20.1 cells, an oligodendrocyte line immortalized with a temperature‐sensitive SV40 T‐ag, with the 14‐kDa MBP cDNA construct also resulted in the expression of the 14‐kDa MBP under conditions in which the cells expressed functional SV40 T‐ag. These results indicate that SV40 T‐ag does not prevent expression of the MBP gene at the translational level and that in those immortalized oligodendrocyte lines that express MBP mRNA, but not MBP protein, some factor other than the SV40 large T‐ag is responsible for the posttranscriptional regulation. Copyright © 1995, Wiley Blackwell. All rights reserved

    DOI: 10.1046/j.1471-4159.1995.64020928.x

    Scopus

    PubMed

    researchmap

  • DISTRIBUTION OF FREE METHYLARGININES IN RAT-TISSUES AND IN THE BOVINE BRAIN 査読

    S UENO, A SANO, K KOTANI, K KONDOH, Y KAKIMOTO

    JOURNAL OF NEUROCHEMISTRY   59 ( 6 )   2012 - 2016   1992年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:LIPPINCOTT-RAVEN PUBL  

    A sensitive and specific method for determining three forms of methylarginine, i.e., N(G)-monomethylarginine, N(G),N(G)-dimethylarginine, and N(G),N'G-dimethylarginine, in mammalian tissues was developed. After partial purification by ion-exchange chromatography, the methylarginines were derivatized to phenylthiocarbamyl compounds and quantitatively determined using HPLC with a reverse-phase C18 column. In rat organs, the highest concentrations of methylarginines were observed in the spleen. In rat brain, cerebellum and olfactory bulb contained large amounts of N(G)-monomethylarginine and N(G),N(G)-dimethylarginine. A detailed study of the distribution of methylarginines in the bovine brain was also made, and the concentration of N(G),N'G-dimethylarginine was almost the same in all regions. The cerebellar gray matter, hippocampus, and hypothalamus contained large amounts of methlarginines. The distribution of methylarginines seems to parallel the distribution of nitric oxide synthase, which is known to be inhibited by N(G)-monomethylarginine. This may indicate that methylarginines play some role in controlling nitric oxide synthase activity.

    Web of Science

    researchmap

  • ISOLATION AND IDENTIFICATION OF METHYLARGININES FROM BOVINE BRAIN 査読

    K KOTANI, S UENO, A SANO, Y KAKIMOTO

    JOURNAL OF NEUROCHEMISTRY   58 ( 3 )   1127 - 1129   1992年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:LIPPINCOTT-RAVEN PUBL  

    Methylarginines in free form were identified in bovine brain. Three compounds were isolated from the basic aliphatic amino acid fraction of bovine brain with several ion-exchange chromatographies. They showed the same R(f) values in paper and thin-layer chromatographies as those of authentic N(G)-monomethylarginine, N(G),N(G)-dimethylarginine, and N(G),N'(G)-dimethylarginine. The migration distance of the isolated compounds in high-voltage paper electrophoresis and the retention times in ion-exchange HPLC were also identical to those of the above authentic methylarginines. We concluded that these three compounds are the methyl derivatives of arginine described above. The amount of these three compounds isolated from 1,090 g of bovine brain was 0.3-mu-mol of N(G)-monomethylarginine, 0.1-mu-mol of N(G),N(G)-dimethylarginine, and 0.5-mu-mol of N(G),N'(G)-dimethylarginine. The occurrence of these free methylarginines may have an important role in regulating the signal transduction through the nitric oxide system.

    Web of Science

    researchmap

  • 糖尿病における起立性低血圧の成因に対する交感神経・副腎髄質ならびにカテコールアミン受容体の役割に関する研究

    上野 修一

    日本内分泌学会雑誌   64 ( 12 )   1293 - 1312   1988年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本内分泌学会  

    To clarify the role of the sympatho-adrenomedullary and renin-angiotensin-aldosterone systems, and catecholamine receptors, in the pathogenesis of orthostatic hypotension in diabetes mellitus (DM), urinary excretion of catecholamines, and plasma levels of norepinephrine (PNE), epinephrine (PE), renin activity (PRA), aldosterone (PAC), cyclic AMP (PcAMP) and cyclic GMP (PcGMP) were measured in 16 normal subjects (N) and 50 diabetic patients with or without orthostatic hypotension (DMOH (+), DMOH (-)). Changes in PNE, PE, PRA, PAC, PcAMP and PcGMP by standing, glucagon (G) adminsitration and cold pressor test were examined. Furthermore, the effect of metoclopramide on catecholamine levels and blood pressure was investigated before and after cold pressor test. The results were following;<BR>(1) Urinary free norepinephrine excretion was significantly lower in DMOH (+), while urinary total norepinephrine excretion was normal in the two DM groups. Urinary free and total epinephrine excretions were lower in DMOH (+) than in N and DMOH (-).<BR>(2) PNE and PE were elevated after standing in all groups tested, and more pronounced in some cases of DMOH (+). Although PRA and PAC were elevated normally after standing in all groups, a dissociation between the two parameters was seen in some cases of DM. PcAMP after standing was correlated with PE (r=0.829). Basal PcGMP was high in manycases of DMOH (+). However, no difference in the elevation of PcGMP after standing was noted between N and the two DM groups.<BR>(3) Systolic blood pressure (SBP) rose markedly in only DMOH (+) from 146 ± 27mmHg to 178 ± 34mmHg 5 minutes after G administration. The increment of PNE and PE 5 minutes after G administration were similar in all groups. In only DMOH (+), the increase in PcAMP 15 minutes after G test was proportional (r=0.498) to that of epinephrine.<BR>(4) Responses of SBP, PNE, PE and PAC to cold pressor test apparently improved after administration of metoclopramide (MC) in some patients with DM.<BR>These results suggest that not only organic disturbance of sympathetic nerves but also functional inhibition of norepinephrine release mediated by dopamine receptor, may play an important role in the pathogenesis of orthostatic hypotension in diabetes mellitus. It is considered that catecholamine secretion from the adrenal medulla in DMOH (+) is increased by hypotension induced by standing. Furthermore, the vascular response to catecholamines may be accelerated through the increment of the extrajunctional receptor in DMOH (+).<BR>In conclusion, for the purpose of finding any abnormality in blood pressure regulation in the early stages of diabetes mellitus, it is necessary to clarify the sympathetic and dopamine activities by orthostatic, glucagon loading and cold pressor tests. Therefore, it is suggested that sympathetic stimulants are useful for patients with sympathetic dysfunction; and antidopaminergic drugs for those diabetic patients with the hyperdopaminergic state.

    DOI: 10.1507/endocrine1927.64.12_1293

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/1990046456

▼全件表示

書籍等出版物

  • 精神医学

    上野 修一, 大蔵 雅夫, 谷岡 哲也

    中外医学社  2014年  ( ISBN:9784498076686

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 現代の看護におけるケアリングとしての技術力 : 実践のためのモデル

    Locsin Rozzano C, 谷岡 哲也, 上野 修一, 眞野 元四郎, 高橋 みどり, 安原 由子

    ふくろう出版  2013年  ( ISBN:9784861865718

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 現代の看護におけるケアリングとしての技術力 : 実践のためのモデル

    Locsin Rozzano C, 谷岡 哲也, 上野 修一, 眞野 元四郎, 高橋 みどり

    ふくろう出版  2009年  ( ISBN:9784861863905

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • NeuroNeuroacanthocytosis Syndromes II (R.H. Walker eds.), pp. 153-159, A Mouse Model of Chorea-Acanthocytosis

    Springer, Berlin, Germany  2008年 

     詳細を見る

  • 精神医学

    上野 修一, 大蔵 雅夫, 谷岡 哲也

    中外医学社  2007年  ( ISBN:9784498076112

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 精神科リハビリテーション

    谷岡 哲也, 眞野 元四郎, 山崎 正雄, 上野 修一

    中外医学社  2007年  ( ISBN:9784498076303

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Chorea-acabthocytosis with the Ehime-deletion mutation. Neuroacanthocytosis Syndromes (A. Danek eds.)

    Springer, Berlin, Germany  2004年 

     詳細を見る

  • Serotonin transporter gene in relation to psychiatric disorders. Recent Research Developments in Dynamical Genetics.

    Transworld Research Network  2004年 

     詳細を見る

  • B. 表現促進・3塩基反復配列異常伸長と多因子遺伝疾患 臨床精神医学講座 第11巻 精神疾患と遺伝 IV. 精神疾患周辺の遺伝研究 pp 415-424

    中山書店  2000年 

     詳細を見る

  • H. 染色体・遺伝子 臨床精神医学講座 第16巻 精神医学的診断法と検査法 III. 精神医学的診断のための検査 pp 325-340

    中山書店  1999年 

     詳細を見る

▼全件表示

MISC

  • 境界性パーソナリティ障害の症状改善にグアンファシンが有効であった2症例

    森大晃, 森大晃, 越智紳一郎, 橋田英俊, 伊賀淳一, 上野修一

    日本臨床精神神経薬理学会プログラム・抄録集   34th (CD-ROM)   2024年

     詳細を見る

  • クロザピンが処方可能な施設体制と治療抵抗性の検討が統合失調症の抗精神病薬単剤治療に関連する

    越智 紳一郎, 小高 文聰, 長谷川 尚美, 古郡 規雄, 伊賀 淳一, 柏木 宏子, 小松 浩, 田形 弘実, 坪井 貴嗣, 沼田 周助, 飯田 仁志, 五十嵐 俊, 大井 一高, 高江洲 義和, 福本 健太郎, 村岡 寛之, 三浦 健一郎, 松本 純弥, 上野 修一, 渡邊 衡一郎, 稲田 健, 橋本 亮太

    精神神経学雑誌   ( 2023特別号 )   S694 - S694   2023年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Escitalopramを使用したうつ病33例の臨床的検討-年齢層に注目したcase series-

    松本優, 松本優, 中村真之, 河邉憲太郎, 武田直也, 上野修一

    臨床精神薬理   26 ( 7 )   2023年

     詳細を見る

  • Lewy小体型認知症に先行した抑うつ症状により診断に苦慮した1例

    片田未来, 井上彩織, 森大晃, 高石裕介, 山崎聖広, 越智紳一郎, 河邉憲太郎, 上野修一

    精神神経学雑誌   125 ( 4 )   2023年

     詳細を見る

  • 身近な臨床疑問から研究を:睡眠・摂食・ネット依存

    堀内史枝, 堀内史枝, 河邉憲太郎, 細川里瑛, 仲地究, 上野修一

    愛媛医学   42 ( 2 )   2023年

     詳細を見る

  • バイオマーカーによるうつ病診断への期待

    伊賀 淳一, 吉野 祐太, 岡山 さくら, 野津 佑真, 熊ノ郷 頼之, 辻川 真緒, 上野 修一

    精神科臨床legato   7 ( 1 )   40 - 43   2021年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:メディカルレビュー社  

    CiNii Books

    researchmap

  • 発達障害診療の連携および推進を目的とした愛媛県内の小児科医・精神科医への意識調査

    河邉憲太郎, 堀内史枝, 細川里瑛, 仲地究, 上野修一

    愛媛医学   40 ( 3 )   2021年

     詳細を見る

  • 高齢者の薬物動態と治療反応性

    伊賀 淳一, 熊ノ郷 頼之, 辻川 真緒, 岡山 さくら, 野津 佑真, 上野 修一

    Depression strategy : うつ病治療の新たなストラテジー   10 ( 4 )   4 - 6   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:先端医学社  

    CiNii Books

    researchmap

  • 高用量のフルボキサミンにアリピプラゾールの増強療法を行ったことで速やかに寛解に至った重症強迫性障害の一例

    三好 幸代, 越智 紳一郎, 森 崇明, 安部 賢郎, 吉田 卓, 立花 亜由美, 久門 啓志, 曽我 純也, 長岡 大文, 坪内 浩一, 伊賀 淳一, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   29回・49回   133 - 133   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 超高齢化地域における認知症実態調査 認知機能障害に関係する因子の検討

    吉田 卓, 森 崇明, 立花 亜由美, 越智 紳一郎, 清水 秀明, 小森 憲治郎, 上野 修一

    Dementia Japan   33 ( 4 )   562 - 562   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 難治性疼痛に挑む〜心理的アプローチの可能性〜 慢性疼痛をきたす精神疾患及び慢性疼痛に対する認知行動療法について

    越智 紳一郎, 上野 修一

    日本関節病学会誌   38 ( 3 )   207 - 207   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本関節病学会  

    researchmap

  • 健康寿命延伸に寄与する体力医学(第13回) 高齢者が身体不活動に陥る精神・心理的背景とその対策 とくにうつ病に着目して

    越智 紳一郎, 上野 修一

    医学のあゆみ   270 ( 3 )   273 - 278   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:医歯薬出版(株)  

    健康寿命を伸ばすためには身体的活動を保つことが重要であり、そのためには身体的な視点に加え精神・心理的な視点を持たなければならない。高齢者では、加齢により、生物・心理・社会的にすべての能力が低下することから、自己肯定感を損ねがちで、それがさらに閉じこもりを引き起こすという悪循環を導く可能性もある。高齢者に起こる身体的活動が低下する精神疾患の代表であるうつ病は、うつ症状に加え、不定愁訴が多いこと、認知症と間違えられる認知機能低下がみられること、加えて自殺率が高いことから、早期に診断し適切な治療的介入を行わなければいけない病気である。高齢者のうつ病の治療においても、若年者と同様に安静・休養は大事であるが、早期に改善させることにより身体不活動をできるだけ予防すべきで、高齢とはいえ抗うつ薬は副作用に留意しつつも十分量・十分期間使わなければならない。施行できる機関は限られるが、電気痙攣療法も有効な治療法のひとつである。そして、精神療法においては、常に礼節を持って接し、若年者以上に自己肯定感を高めるようにしなければならない。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2019&ichushi_jid=J00060&link_issn=&doc_id=20190722030012&doc_link_id=%2Faa7ayuma%2F2019%2F027003%2F013%2F0273-0278%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faa7ayuma%2F2019%2F027003%2F013%2F0273-0278%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 超高齢化地域における認知症の実態調査 大規模認知症コホート研究 中山町調査

    立花 亜由美, 吉田 卓, 森 崇明, 尾崎 優樹, 山崎 聖広, 吉野 祐太, 森 蓉子, 河邉 憲太郎, 越智 紳一郎, 安部 賢郎, 清水 秀明, 堀内 史枝, 小森 憲治郎, 伊賀 淳一, 上野 修一

    老年精神医学雑誌   30 ( 増刊II )   200 - 200   2019年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • 超高齢化地域における認知症の実態調査 大規模認知症コホート研究 中山町調査

    立花 亜由美, 吉田 卓, 森 崇明, 尾崎 優樹, 山崎 聖広, 吉野 祐太, 森 蓉子, 河邉 憲太郎, 越智 紳一郎, 安部 賢郎, 清水 秀明, 堀内 史枝, 小森 憲治郎, 伊賀 淳一, 上野 修一

    老年精神医学雑誌   30 ( 増刊II )   200 - 200   2019年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • 超高齢化地域における認知症の実態調査 大規模認知症コホート研究 中山町調査

    立花 亜由美, 吉田 卓, 森 崇明, 尾崎 優樹, 山崎 聖広, 吉野 祐太, 森 蓉子, 河邉 憲太郎, 越智 紳一郎, 安部 賢郎, 清水 秀明, 堀内 史枝, 小森 憲治郎, 伊賀 淳一, 上野 修一

    日本老年医学会雑誌   56 ( Suppl. )   90 - 90   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本老年医学会  

    researchmap

  • 超高齢化地域における認知症の実態調査 大規模認知症コホート研究 中山町調査

    立花 亜由美, 吉田 卓, 森 崇明, 尾崎 優樹, 山崎 聖広, 吉野 祐太, 森 蓉子, 河邉 憲太郎, 越智 紳一郎, 安部 賢郎, 清水 秀明, 堀内 史枝, 小森 憲治郎, 伊賀 淳一, 上野 修一

    日本老年医学会雑誌   56 ( Suppl. )   90 - 90   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本老年医学会  

    researchmap

  • Alzheimer病での末梢血白血球MAPT遺伝子mRNA発現およびDNAメチル化率変化の解析

    森大晃, 吉野祐太, 舟橋裕, 山崎聖広, 尾崎優樹, 越智紳一郎, 吉田卓, 森崇明, 伊賀淳一, 上野修一

    日本生物学的精神医学会(Web)   41st   2019年

     詳細を見る

  • 施設入所中の認知症患者における周辺症状に対するtandospironeの有効性の検討 第2報

    越智 紳一郎, 参田 文, 丹 紀代, 伊賀 淳一, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   28回・48回   189 - 189   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 施設入所中の認知症患者における周辺症状に対するtandospironeの有効性の検討 第2報

    越智 紳一郎, 参田 文, 丹 紀代, 伊賀 淳一, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   28回・48回   189 - 189   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 【神経系のトランスポーター-Up to date】 トランスポーターと疾患 アルツハイマー病

    伊賀 淳一, 上野 修一

    Clinical Neuroscience   36 ( 6 )   720 - 723   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • 【神経系のトランスポーター-Up to date】 トランスポーターと疾患 アルツハイマー病

    伊賀 淳一, 上野 修一

    Clinical Neuroscience   36 ( 6 )   720 - 723   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • 脳梗塞が疑われたが孤発性クロイツフェルト・ヤコブ病と診断した1例

    橘 侑南, 吉野 祐太, 清水 秀明, 伊賀 淳一, 上野 修一

    精神神経学雑誌   ( 2018特別号 )   S522 - S522   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 脳梗塞が疑われたが孤発性クロイツフェルト・ヤコブ病と診断した1例

    橘 侑南, 吉野 祐太, 清水 秀明, 伊賀 淳一, 上野 修一

    精神神経学雑誌   ( 2018特別号 )   S522 - S522   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 9歳時に発症し、発達障害を合併する15歳摂食障害の1例

    三好 幸代, 吉田 卓, 清水 秀明, 大町 北斗, 橘 侑南, 山崎 聖広, 河邉 憲太郎, 堀内 史枝, 伊賀 淳一, 上野 修一

    精神神経学雑誌   120 ( 4 )   344 - 344   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 9歳時に発症し、発達障害を合併する15歳摂食障害の1例

    三好 幸代, 吉田 卓, 清水 秀明, 大町 北斗, 橘 侑南, 山崎 聖広, 河邉 憲太郎, 堀内 史枝, 伊賀 淳一, 上野 修一

    精神神経学雑誌   120 ( 4 )   344 - 344   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 腸管気腫性嚢胞症や重篤な低血糖を契機にたこつぼ型心筋症を発症した摂食障害の1例

    佐野 昇, 新谷 孝典, 森 蓉子, 越智 紳一郎, 松本 光央, 上野 修一

    精神神経学雑誌   120 ( 2 )   146 - 147   2018年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 長期間意欲の低下が遷延していたうつ病患者に単純行動活性化療法プログラムとフォローアップを続けることで改善を認めた1例

    越智 紳一郎, 妹尾 香苗, 境 泉洋, 上野 修一

    精神神経学雑誌   120 ( 2 )   146 - 146   2018年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 精神神経科学講座の研究紹介 最近の精神科薬物療法を中心に

    越智 紳一郎, 伊賀 淳一, 上野 修一

    愛媛医学   36 ( 4 )   201 - 205   2017年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:愛媛医学会  

    researchmap

  • ChEI未投薬のアルツハイマー病患者における血清BDNFとFDG-PETの関係

    森 崇明, 吉田 卓, 山崎 聖広, 吉野 祐太, 尾崎 優樹, 工藤 佳代, 清水 秀明, 伊賀 淳一, 上野 修一

    Dementia Japan   31 ( 4 )   606 - 606   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • ChEI未投薬のアルツハイマー病患者における血清BDNFとFDG-PETの関係

    森 崇明, 吉田 卓, 山崎 聖広, 吉野 祐太, 尾崎 優樹, 工藤 佳代, 清水 秀明, 伊賀 淳一, 上野 修一

    Dementia Japan   31 ( 4 )   606 - 606   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • アルツハイマー型認知症患者の末梢血白血球MBOAT4、GHSR mRNA発現変化

    吉野 祐太, 山崎 聖広, 尾崎 優樹, 越智 紳一郎, 伊賀 淳一, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   185 - 185   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • アルツハイマー型認知症患者の血液におけるABCA7遺伝子のDNAメチル化率およびmRNA発現量の解析

    山崎 聖広, 吉野 祐太, 尾崎 優樹, 佐尾 知子, 越智 紳一郎, 伊賀 淳一, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   186 - 186   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • 絞扼性神経損傷モデルを用いたニコチン系アセチルコリン受容体サブユニットのmRNA発現の検証

    越智 紳一郎, 西原 佑, 吉野 祐太, 山崎 聖広, 尾崎 優樹, 伊賀 淳一, 萬家 俊博, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   188 - 188   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • パーキンソン病患者におけるドパミンD2受容体遺伝子のDNAメチル化率の変化

    尾崎 優樹, 吉野 祐太, 山崎 聖広, 永井 将弘, 野元 正弘, 伊賀 淳一, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   191 - 191   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • レビー小体型認知症ではSNCA遺伝子DNAメチル化が変化する

    舟橋 裕, 吉野 祐太, 山崎 聖広, 森 蓉子, 森 崇明, 尾崎 優樹, 佐尾 知子, 越智 紳一郎, 伊賀 淳一, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   156 - 156   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • ラット脳を用いた抗うつ薬投与に対する急性期および亜慢性期の一酸化窒素合成酵素mRNA発現量の検索

    沖田 光雄, 吉野 祐太, 越智 紳一郎, 山崎 聖広, 中田 俊輔, 伊賀 淳一, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   164 - 164   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • 統合失調症におけるグレリンの、GHSR、MBOAT4のmRNA発現量からみた神経保護作用の増強

    中田 俊輔, 吉野 祐太, 三瀬 綾乃, 山崎 聖広, 尾崎 優樹, 越智 紳一郎, 伊賀 淳一, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   39回・47回   177 - 177   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • Lewy小体型認知症に先行した難治性の抑うつ症状に修正型電気けいれん療法が有効であった1例

    越智紳一郎, 清水秀明, 森崇明, 伊賀淳一, 上野修一

    精神神経学雑誌   119 ( 6 )   435 - 435   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    J-GLOBAL

    researchmap

  • 摂食障害の身体的治療中に宿便性潰瘍を発症した1例

    安部賢郎, 清水秀明, 佐尾知子, 森蓉子, 吉田卓, 河邉憲太郎, 伊賀淳一, 上野修一

    精神神経学雑誌   119 ( 6 )   436 - 436   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    J-GLOBAL

    researchmap

  • 多様な精神神経症状を呈したWilson病の一例

    佐尾 知子, 河邉 憲太郎, 吉田 卓, 安部 賢郎, 清水 秀明, 熊木 天児, 伊賀 淳一, 上野 修一

    精神神経学雑誌   ( 2017特別号 )   S486 - S486   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 多様な精神神経症状を呈したWilson病の一例

    佐尾知子, 河邉憲太郎, 吉田卓, 安部賢郎, 清水秀明, 熊木天児, 伊賀淳一, 上野修一

    日本精神神経学会総会プログラム・抄録集   113th ( 2017特別号 )   S486 - S486   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    J-GLOBAL

    researchmap

  • 精神科薬物療法pros and cons 非寛解うつ病に対して切り替えか、増強か 高齢者の非寛解うつ病で考えておきたいこと

    越智 紳一郎, 上野 修一

    臨床精神薬理   20 ( 5 )   585 - 588   2017年5月

  • 宗教的文化的背景により,治療に難渋した一症例

    越智紳一郎, 伊賀淳一, 上野修一

    こころと文化   16 ( 1 )   78‐79 - 79   2017年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:多文化間精神医学会  

    J-GLOBAL

    researchmap

  • 高齢の気分障害への薬物療法 抗認知症薬の抑うつ状態への効果

    山崎聖広, 伊賀淳一, 上野修一

    臨床精神薬理   19 ( 12 )   1707‐1715 - 1715   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    認知症には様々な精神症状がみられ、患者のADLの低下や介護者の負担の増大を引き起こす。中でも抑うつ状態は多くの疾患で高率にみられる。認知症に併存する抑うつ状態は治療が困難なことが多く、確立された治療法はない。近年、抗認知症薬として、コリンエステラーゼ阻害薬(donepezil、galantamine、rivastigmine)とNMDA受容体拮抗薬(memantine)の合計4剤が使用できるようになり、認知機能障害に対する効果のみならず、抑うつ状態を含めた精神症状にも効果があると報告されている。本稿では認知症に併存する抑うつ状態への抗認知症薬の効果を中心に報告する。(著者抄録)

    J-GLOBAL

    researchmap

  • 精神科外来での単純行動活性化療法の有効性の検討

    越智 紳一郎, 妹尾 香苗, 境 泉洋, 伊賀 淳一, 上野 修一

    日本認知・行動療法学会大会プログラム・抄録集   42回   472 - 473   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知・行動療法学会  

    researchmap

  • 認知機能低下に対する薬物療法 : アルツハイマー型認知症・レビー小体型認知症を中心に (特集 認知症の薬物療法 : 最新Update)

    清水 秀明, 森 崇明, 上野 修一

    臨床精神薬理   19 ( 9 )   1267 - 1275   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:星和書店  

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2016374386

  • アルツハイマー病におけるセロトニントランスポーター遺伝子の機能性多型、末梢血白血球でのDNAメチル化率およびmRNA量を用いた解析研究

    山崎 聖広, 吉野 祐太, 森 崇明, 沖田 光雄, 吉田 卓, 森 蓉子, 尾崎 優樹, 佐尾 知子, 伊賀 淳一, 上野 修一

    日本神経精神薬理学会年会プログラム・抄録集   46回   230 - 230   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経精神薬理学会  

    researchmap

  • 単科精神科病院における慢性期統合失調症の認知機能性能

    河邉 憲太郎, 松本 覚, 多田 敦博, 水口 健太郎, 三木 大輔, 堀川 和美, 兒島 文子, 上野 修一

    最新精神医学   21 ( 4 )   315 - 321   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:世論時報社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2016356351

  • うつ病に伴う身体症状と鑑別が困難であった抗GAD抗体陽性小脳失調症の一例

    工藤 佳代, 伊賀 淳一, 尾崎 優樹, 見山 芳隆, 安部 賢郎, 清水 秀明, 上野 修一

    精神神経学雑誌   ( 2016特別号 )   S328 - S328   2016年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 認知症と運転 (特集 認知症の生活をどう支えるか)

    松本 光央, 上野 修一

    精神科 = Psychiatry   27 ( 5 )   339 - 343   2015年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:科学評論社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2016057131

  • 統合失調症患者におけるNasu-Hakola病関連遺伝子の相関解析及び末梢血白血球の発現解析研究

    森 蓉子, 吉野 祐太, 越智 紳一郎, 山崎 聖弘, 安部 賢郎, 尾崎 優樹, 北野 知地, 沼田 周助, 伊賀 淳一, 大森 哲郎, 上野 修一

    日本生物学的精神医学会・日本神経精神薬理学会合同年会プログラム・抄録集   37回・45回   202 - 202   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会・日本神経精神薬理学会  

    researchmap

  • 【日本におけるParkinson病治療の歴史と将来展望】ヒト脳内ドパミンの分布とParkinson病によるドパミン減少の発見 査読

    柿本 泰男, 上野 修一, 佐野 輝

    神経治療学   32 ( 1 )   9 - 14   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • The mRNA expressions of the nicotinic acetylcholine receptor genes in rat brains after a 21-day sertraline treatment

    S. Ochi, M. Abe, T. Kitano, Y. Otsuka, Y. Mori, T. Ishimaru, Y. Yoshino, S-I Ueno

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   17   57 - 57   2014年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:CAMBRIDGE UNIV PRESS  

    Web of Science

    researchmap

  • アルツハイマー病の臨床 (特集 アルツハイマー病の診断と治療の最先端(後編))

    森 崇明, 上野 修一, 須原 哲也

    PET journal   ( 26 )   28 - 30   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:寺田国際事務所先端医療技術研究所  

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2014296197

  • 大学病院精神科外来を受診した成人期広汎性発達障害の後方視的検討 児童青年期症例との比較を通して

    河邉憲太郎, 堀内史枝, 長谷川芙美, 安部賢郎, 小森憲治郎, 上野修一

    精神医学   54 ( 5 )   517 - 522   2012年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    DOI: 10.11477/mf.1405102179

    CiNii Books

    J-GLOBAL

    researchmap

  • Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis (Vol 156B, pg 620, 2011)

    A. Tomiyasu, M. Nakamura, M. Ichiba, S. Ueno, S. Saiki, M. Morimoto, J. Kobal, Y. Kageyama, T. Inui, K. Wakabayashi, T. Yamada, Y. Kanemori, H. Jung, H. Tanaka, S. Orimo, Z. Afawi, I. Blatt, J. Aasly, H. Ujike, D. Babovic-Vuksanovic, K. A. Josephs, R. Tohge, G. R. Rodrigues, N. Dupre, H. Yamada, F. Yokochi, K. Kotschet, T. Takei, M. Rudzinska, A. Szczudlik, S. Penco, M. Fujiwara, K. Tojo, A. Sano

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   159B ( 3 )   360 - 360   2012年4月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1002/ajmg.b.32039

    Web of Science

    researchmap

  • 【脳の機能と統合失調症-新たな診断と治療への展望-II】 抗精神病薬の薬理遺伝

    越智 紳一郎, 安部 賢郎, 森 蓉子, 上野 修一

    精神科治療学   26 ( 12 )   1493 - 1500   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    薬物の標的臓器での作用は、薬物の体内での血液循環を介した系である薬物動態(pharmacokinetics:PK)、薬物が標的臓器に取り込まれ、その効果を発揮する応答性である薬物感受性(pharmacodynamics:PD)の2つの要素によって決定される。本稿では抗精神病薬のPKについて概説する。PKに関する最も重要な反応の1つはチトクロムP-450(cytochrome P-450:CYP)による酸化反応である。全CYPの中でも最も研究が進んでいるCYP2D6活性は、超代謝型、高代謝型、中間代謝型、低代謝型と分けられるが、それらは70種類以上の遺伝子多型によって決定される。日本人の約30〜50%は中間代謝型(intermediate metabolizers:IMs)のCYP2D6*10を持つ、抗精神病薬では、risperidoneやaripiprazoleなど、CYP2D6を主要な代謝経路として持つ薬物が多く、この遺伝子多型と薬物投与量や副作用との関連が報告されている。抗精神病薬の使用にあたっては、CY-P2D6に限らずその他の代謝酵素活性の個人差、薬物による酵素誘導や阻害など薬物相互作用にまで留意していく必要があると思われる。(著者抄録)

    researchmap

  • Support provided to dementia patients by caregivers and the community

    Takaaki Mori, Shu-Ichi Ueno

    Japan Medical Association Journal   54 ( 5 )   301 - 304   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等  

    Japan is currently experiencing an unprecedented aging of society and decline in the birth rate. According to the White Paper published by the Ministry of Health, Labour and Welfare, the number of dementia patients in Japan is estimated to reach 2.5 million by 2015, and so community understanding and response to dementia are expected to become increasingly important. Depending on the cause, the symptoms of, drug therapies for, and responses to dementia differ, and so first of all it is necessary to know diagnostic information that leads to treatment policies. With regard to the epidemiology of dementia, we present a study conducted in Nakayama Town in Ehime Prefecture. Furthermore, it is possible to divide the symptoms of dementia into core symptoms and peripheral symptoms such as behavioral and psychological symptoms of dementia. With core symptoms, it is important that the characteristics of the symptoms and prognosis be sufficiently explained using images and tests of cognitive function. With peripheral symptoms, the burden of care on caregivers is even greater than that with core symptoms. Here we present a brief overview of delirium, hallucinations, delusions, agitation/aggression, apathy/indifference, roaming, stereotypy, and eating abnormalities. In future, it is envisaged that the involvement of not only health professionals but also members of the community as a whole in dementia care will be extremely important.

    Scopus

    researchmap

  • 認知症治療病棟への入院の原因となったBPSDの検討

    坂根 真弓, 樫林 哲雄, 酒井 ミサヲ, 小森 憲治郎, 塩田 一雄, 谷向 知, 上野 修一

    老年精神医学雑誌   22 ( 増刊III )   187 - 187   2011年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • 発症初期からの臨床症状を観察し得た石灰沈着を伴うび漫性神経原線維変化病(DNTC)の1例

    山本 蓉子, 森 崇明, 樫林 哲雄, 清水 秀明, 鉾石 和彦, 福原 竜治, 谷向 知, 上野 修一

    精神神経学雑誌   113 ( 5 )   520 - 520   2011年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 認知症に対応する(No.9)認知症に対する周囲の人々の対応--コミュニティでの対応を含めて

    森 崇明, 上野 修一

    日本医師会雑誌   139 ( 10 )   2149 - 2151   2011年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本医師会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2011112487

  • 周産期の抑うつに影響を与える心理特性に関する検討

    菊地 久美子, 友竹 正人, 伊賀 淳一, 上野 修一, 苛原 稔, 大森 哲郎

    臨床精神医学   39 ( 11 )   1459 - 1468   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)アークメディア  

    妊娠20週前後の妊婦113名を対象に、個人の背景や性格傾向、被養育体験・ストレス時の対処行動について調査し、周産期の抑うつの影響を与える心理特性について検討した。その結果、出産後3〜4ヵ月の間に全体の23.0%が抑うつ傾向を呈し、その半数以上は妊娠期も抑うつ傾向にあったことが示された。今回の研究では、この時期に測定しても個人内では差は少ないと思われる性格・被養育体験・ストレス対処行動と、周産期の抑うつとの関連をみた結果、産後に初めて抑うつ傾向を認めた群よりも、妊娠期から認めた群と周産期非抑うつ群との間に、多くの項目でスコアの隔たりのある傾向が認められた。

    researchmap

  • CO中毒による意識障害に対し、NST介入にて良好な経過を得た3例

    鳥巣 真幹, 上田 晃久, 三宅 映己, 古川 慎哉, 松浦 文三, 恩地 森一, 豊田 泰孝, 越智 紳一郎, 園田 亜希, 上野 修一, 山下 加奈, 清家 祐子, 岡本 真紀, 隅田 有紀子, 太宰 有里香, 岩崎 志緒美, 永井 祥子, 利光 久美子

    日本病態栄養学会誌   13 ( 5 )   193 - 193   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病態栄養学会  

    researchmap

  • mirtazapine 亜急性投与でのラット脳におけるBDNFとTrkBのmRNA発現量の変化についての検討

    安部賢郎, 越智紳一郎, 山村哲史, 牧戸操, 牧戸操, 岡田元宏, 上野修一

    日本生物学的精神医学会誌   21 ( Supplement )   107   2010年10月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 服薬アドヒアランス向上のための医療チーム 患者間で情報共有を図るツール(『私のお薬連絡帳』)の作成とその有用性についての検討

    越智 紳一郎, 岡井 彰男, 福原 竜治, 樫林 哲雄, 谷向 知, 上野 修一

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   20回・40回   150 - 150   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 意味性認知症の連続例からみた臨床症状の推移(Transition of Distinctive Symptoms of Semantic Dementia during Longitudinal Clinical Observation)

    樫林 哲雄, 池田 学, 小森 憲次郎, 品川 俊一郎, 清水 秀明, 豊田 泰孝, 森 崇明, 石川 智久, 福原 竜治, 上野 修一, 谷向 知

    神経化学   49 ( 2-3 )   581 - 581   2010年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • 前頭側頭葉変性症(FTLD)の問題行動に対するルーチン化療法の試み

    坂根 真弓, 樫林 哲雄, 小森 憲治郎, 大竹 なほ代, 園田 亜希, 福原 竜治, 塩田 一雄, 上野 修一, 谷向 知

    老年精神医学雑誌   21 ( 増刊II )   93 - 93   2010年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • 老年期意味性認知症の臨床像に関する検討 初老期発症および老年期アルツハイマー病例と比較して

    清水 秀明, 小森 憲治郎, 福原 竜治, 品川 俊一郎, 豊田 泰孝, 樫林 哲雄, 園部 直美, 松本 光央, 森 崇明, 石川 智久, 鉾石 和彦, 谷向 知, 上野 修一, 池田 学

    老年精神医学雑誌   21 ( 増刊II )   90 - 90   2010年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • CHI3L1遺伝子プロモーター領域多型と統合失調症のリスク及び性格傾向の関連

    大井一高, 橋本亮太, 安田由華, 吉田哲彦, 高橋秀俊, 井池直美, 岩瀬真生, 紙野晃人, 石井良平, 数井裕光, 福本素由己, 疇地道代, 池澤浩二, 谷向仁, 田上真次, 森原剛史, 大河内正康, 沼田周助, 池田匡志, 上野修一, 田中稔久, 工藤喬, 大森哲郎, 岩田仲生, 尾崎紀夫, 武田雅俊

    精神薬療研究年報   ( 42 )   17 - 18   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    J-GLOBAL

    researchmap

  • Blonanserinへの切り替えにより心不全徴候を伴う頻脈が改善した統合失調症の1例

    河邉憲太郎, 松岡崇人, 細田能希, 上野修一

    精神医学   52 ( 3 )   285 - 288   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    DOI: 10.11477/mf.1405101591

    CiNii Books

    J-GLOBAL

    researchmap

  • Transition of distinctive symptoms of semantic dementia during longitudinal clinical observation

    Tetsuo Kashibayashi, Manabu Ikeda, Kenjiro Komori, Shunichiro Shinagawa, Hideaki Shimizu, Yasutaka Toyota, Takaaki Mori, Tomohisa Ishikawa, Ryuji Fukuhara, Shu-ichi Ueno, Satoshi Tanimukai

    NEUROSCIENCE RESEARCH   68   E191 - E191   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.2419

    Web of Science

    researchmap

  • ビタミンB12の経静脈的投与により、精神症状、意識障害および認知機能障害が著明に改善した2例

    樫林 哲雄, 石川 智久, 小森 憲治郎, 福原 竜治, 清水 秀明, 豊田 泰孝, 森 崇明, 上野 修一, 谷向 知

    老年精神医学雑誌   20 ( 11 )   1287 - 1295   2009年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    ビタミンB12(Vit.B12)欠乏症では神経症状などの身体症状のほか、意識障害に加え抑うつなどの多彩な精神症状を呈する。胃全摘後10年以上経過してから抑うつ、不眠、自発性低下などの精神症状が出現し、その後に著しい意識障害、認知機能障害が出現した2例を報告する。2症例とも明らかな器質的な病変は認めず、小球性低色素性貧血を呈したが、精査の結果Vit.B12欠乏症と診断し、経静脈的にVit.B12の投与を行い、精神症状は短期間で改善した。しかし、認知機能障害が残存するため、その後もVit.B12補充療法を継続したところ、1例は10ヵ月、もう1例は1年で認知機能障害の改善を認めた。Vit.B12欠乏症に伴う認知機能障害は早期に治療を開始することが重要であるが、ルーチン検査では大球性貧血を呈さない場合があり、認知症の評価を含む慎重な診察が大切である。また、本病態で器質因を認めない場合、残存する認知機能障害に対し長期間補充を行うことで症状が改善する可能性が示唆された。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2009&ichushi_jid=J02464&link_issn=&doc_id=20091211100011&doc_link_id=%2Faj2rsizd%2F2009%2F002011%2F012%2F1287-1295%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faj2rsizd%2F2009%2F002011%2F012%2F1287-1295%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population

    Shusuke Numata, Jun Ichi Iga, Masahito Nakataki, Shin'ya Tayoshi, Kyoko Taniguchi, Satsuki Sumitani, Masahito Tomotake, Toshihito Tanahashi, Mitsuo Itakura, Yoko Kamegaya, Masahiko Tatsumi, Akira Sano, Takashi Asada, Hiroshi Kunugi, Shu Ichi Ueno, Tetsuro Ohmori

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics   150 ( 4 )   527 - 534   2009年6月

     詳細を見る

    The phosphodiesterase 4B (PDE4B) interacts with disrupted-inschizophrenia 1 (DISC1), which is a knowngenetic risk factor for schizophrenia, bipolar disorder and major depressive disorder (MDD). PDE4B is also important in the regulation of cAMP signaling, a second messenger implicated in learning, memory, and mood. In this study, we determined mRNA expression levels of the PDE4B gene in the peripheral blood leukocytes of patients with MDD and control subjects (n = 33, each). Next we performed two-stage case-controlled association analyses (first set; case = 174, controls = 348; second set; case = 481, controls = 812) in the Japanese population to determine if the PDE4B gene is implicated in MDD. In the leukocytes, a significantly higher expression of the PDE4B mRNA was observed in the drug-naïve MDD patients compared with control subjects (P<0.0001) and the expression of the MDD patients significantly decreased after antidepressant treatment (P = 0.030). In the association analysis, we observed significant allelic associations of four SNPs (the most significant, rs472952; P = 0.002) and a significant haplotypic association (permutation P = 0.019) between the PDE4B gene and MDD in the first-set samples. However, we could not confirm these significant associations in the following independent second-set of samples. Our results suggest that the PDE4B gene itself does not link to MDD but the elevated mRNA levels of PDE4B might be implicated in the pathophysiology of MDD. © 2008 Wiley-Liss, Inc.

    DOI: 10.1002/ajmg.b.30852

    Scopus

    PubMed

    researchmap

  • 当科におけるSemantic Dementiaの連続例からみた臨床症状の推移

    樫林 哲雄, 品川 俊一郎, 石川 智久, 清水 秀明, 森 崇明, 福原 竜治, 上野 修一, 池田 学, 谷向 知

    老年精神医学雑誌   20 ( 増刊II )   139 - 139   2009年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ワールドプランニング  

    researchmap

  • 愛媛県における若年性認知症の実態調査

    樫林 哲雄, 石川 智久, 清水 秀明, 豊田 泰孝, 森 崇明, 福原 竜治, 上野 修一, 谷向 知

    精神神経学雑誌   ( 2009特別 )   S - 397   2009年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • Association study of the G72 gene with schizophrenia in a Japanese population: A multicenter study

    Kazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, Tetsuhiko Yoshida, Hidetoshi Takahashi, Naomi Iike, Motoyuki Fukumoto, Hironori Takamura, Masao Iwase, Kouzin Kamino, Ryouhei Ishii, Hiroaki Kazui, Ryuji Sekiyama, Yuri Kitamura, Michiyo Azechi, Koji Ikezawa, Ryu Kurimoto, Eiichiro Kamagata, Hitoshi Tanimukai, Shinji Tagami, Takashi Morihara, Masayuki Ogasawara, Masayasu Okochi, Hiromasa Tokunaga, Shusuke Numata, Masashi Ikeda, Tohru Ohnuma, Shu-ichi Ueno, Tomoko Fukunaga, Toshihisa Tanaka, Takashi Kudo, Heii Arai, Tetsuro Ohmori, Nakao Iwata, Norio Ozaki, Masatoshi Takeda

    SCHIZOPHRENIA RESEARCH   109 ( 1-3 )   80 - 85   2009年4月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    G72 is one of the most widely tested genes for association with schizophrenia. As G72 activates the D-amino acid oxidase (DAO), G72 is termed D-amino acid oxidase activator (DAOA). The aim of this study is to investigate the association between G72 and schizophrenia in a Japanese population, using the largest sample size to date (1774 patients with schizophrenia and 2092 healthy controls). We examined eight single nucleotide polymorphisms (SNPs), which had been associated with schizophrenia in previous studies. We found nominal evidence for association of alleles, M22/rs778293, M23/rs3918342 and M24/rs1421292, and the genotype of M22/rs778293 with schizophrenia, although there was no association of allele or genotype in the other five SNPs. We also found nominal haplotypic association, including M15/rs2391191 and M19/rs778294 with schizophrenia. However, these associations were no longer positive after correction for multiple testing. We conclude that G72 might not play a major role in the risk for schizophrenia in the Japanese population. (C) 2009 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.schres.2009.01.019

    Web of Science

    researchmap

  • Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (H-1-MRS)

    Shin&apos;Ya Tayoshi, Satsuki Sumitani, Kyoko Taniguchi, Sumiko Shibuya-Tayoshi, Shusuke Numata, Jun-ichi Iga, Masahito Nakataki, Shu-ichi Ueno, Masafumi Harada, Tetsuro Ohmori

    SCHIZOPHRENIA RESEARCH   108 ( 1-3 )   69 - 77   2009年3月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    A change in the glutamatergic system is thought to play an important role in the pathophysiology of schizophrenia. The aim of this study was to investigate the changes in metabolites, including glutamate (Glu), in the anterior cingulate cortex (ACC) and the left basal ganglia (ItBG) of patients with chronic schizophrenia using proton magnetic resonance spectroscopy (H-1-MRS). In addition, since gender differences in this illness were known, we examined the effects of gender on these metabolites.
    The H-1-MRS was performed on the ACC and ItBG of 30 patients with schizophrenia and 25 healthy individuals who acted as the control group. The levels of Glu, glutamine (Gln), creatine plus phosphocreatine (Cre), myo-inositol (ml), N-acetylaspartate (NAA), and choline-containing compounds (Cho) were measured.
    Two-way analysis of variance revealed that the illness significantly affected the levels of Glu and ml in the ACC; both metabolites were lower in the patients with schizophrenia as compared to the control subjects. The results also revealed that gender significantly affected the level of Gln in the ACC and the levels of Cre and NAA in the ItBG; the level of Gln in the ACC were higher in male subjects versus female subjects, whereas Cre and NAA levels in the ItBG were lower in male subjects as compared to female subjects.
    These results confirmed a change in the glutamatergic system and suggested an involvement of ml in the pathophysiology of schizophrenia. (C) 2008 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.schres.2008.11.014

    Web of Science

    researchmap

  • 大うつ病の末梢白血球におけるPDE4B遺伝子の発現と関連研究

    沼田 周助, 中瀧 理仁, 伊賀 淳一, 田吉 伸哉, 谷口 京子, 住谷 さつき, 友竹 正人, 板倉 光夫, 亀ヶ谷 洋子, 巽 雅彦, 佐野 輝, 朝田 隆, 功刀 浩, 上野 修一, 大森 哲郎

    精神薬療研究年報   ( 41 )   29 - 30   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    researchmap

  • Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine

    Toshiyuki Yasui, Masayo Yamada, Hirokazu Uemura, Shu-ichi Ueno, Shusuke Numata, Tetsuro Ohmori, Naoko Tsuchiya, Masamichi Noguchi, Mitsutoshi Yuzurihara, Yoshio Kase, Minoru Irahara

    MATURITAS   62 ( 2 )   146 - 152   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    Objective: The aim of the present study was to compare the effects on serum cytokine concentrations of paroxetine, a selective serotonin re-uptake inhibitor, and kamishoyosan, a Japanese traditional medicine, in midlife women with psychological symptoms.
    Methods: Seventy-six women with psychological symptoms such as anxiety and mild depression as menopausal symptoms were enrolled in this study. Thirty-eight women received oral administration of 10 mg paroxetine every day, and 38 women received oral administration of kamshoyosan every day for 6 months. Overall climacteric symptoms were assessed using Greene&apos;s climacteric scale. Serum levels of cytokines were measured using a multiplexed human cytokine assay.
    Results: Greene&apos;s total scores in both women treated with paroxetine and in women treated with kamishoyosan decreased significantly. Percentage decreases in Greene&apos;s total, psychological and vasomotor scores during the 6-month period in the paroxetine group were significantly greater than those in the kamishoyosan group. Serum IL-6 concentration in women treated with paroxetine decreased significantly. Serum concentrations of IL-8, IL-10, macrophage inflammatory protein (MIP)-1 beta and monocyte chemoattractant protein-1 in women treated with paroxetine decreased significantly. On the other hand, serum IL-6 concentration in women treated with kamishoyosan decreased significantly, but other serum concentrations did not change significantly.
    Conclusion: Decrease in IL-6 concentration may be involved in the mechanism of the actions of both paroxetine and kamishoyosan in women with psychological symptoms, and IL-6 may therefore be useful as a marker of treatment. The action of paroxetine may also be associated with decreases in IL-8, IL-10, MIP-1 beta. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.maturitas.2008.12.007

    Web of Science

    researchmap

  • Promater variant in the Chitinase 3-like 1 gene is associated with risk for schizophrenia and personality trait

    Kazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, Hidetoshi Takahashi, Naomi Iike, Masao Iwase, Kouzin Kamino, Hiroaki Kazui, Hironori Takamura, Motoyuki Fukumoto, Hidenaga Yamamori, Kazuo Yamada, Shusuke Numata, Masashi Ikeda, Takashi Kudo, Shu-ichi Ueno, Takeo Yoshikawa, Tetsuro Ohmori, Nakao Iwata, Norio Ozaki, Masatoshi Takeda

    NEUROSCIENCE RESEARCH   65   S122 - S122   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.578

    Web of Science

    researchmap

  • Common coding variant in the TCF7L2 gene and study of the association with type 2 diabetes in Japanese subjects

    Kiyoshi Kunika, Toshihito Tanahashi, Shusuke Numata, Shu-ichi Ueno, Tetsuro Ohmori, Naoto Nakamura, Kazue Tsugawa, Katsuyuki Miyawaki, Maki Moritani, Hiroshi Inoue, Mitsuo Itakura

    JOURNAL OF HUMAN GENETICS   53 ( 11-12 )   972 - 982   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:NATURE PUBLISHING GROUP  

    Genetic variants of the transcription factor 7-like 2 (TCF7L2) gene affect the risk of type 2 diabetes in populations with multiple ethnic groups. However, a comprehensive survey of this gene has not been done for a Japanese population. Thus, we conducted this gene-based association study, in which the common genetic variants were analyzed. Using 24 Japanese type 2 diabetic subjects, we first screened a 9.5 kb region, which included the entire coding sequence, to assess potential functional variants of TCF7L2. Sequencing revealed a common coding variant (Pro477Thr) in exon 14 of TCF7L2 that was not enrolled in the public SNP database. Nineteen SNPs and the microsatellite DG10S478 were genotyped across the gene in 2,877 unrelated Japanese subjects. This independent screen identified the previously reported rs7903146 with a strongest association (allele P = 0.0001, odds ratio = 1.59 [95% confidence interval 1.25-2.01]), but there was no significant association between Pro477Thr and type 2 diabetes (allele P = 0.64). Expression of the Pro477Thr variant did not alter TCF7L2 expression in 30 lymphoblast cells. Although a genotypic effect of Pro477Thr on expression of TCF7L2 was not apparent, Pro477Thr was identified as a common variant of TCF7L2 in 2,877 Japanese subjects. Further functional studies are required to determine the possible effect of this coding variant on type 2 diabetes.

    DOI: 10.1007/s10038-008-0339-2

    Web of Science

    researchmap

  • Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population

    Shusuke Numata, Shu ichi Ueno, Jun ichi Iga, Hongwei Song, Masahito Nakataki, Shin'Ya Tayoshi, Satsuki Sumitani, Masahito Tomotake, Mitsuo Itakura, Akira Sano, Tetsuro Ohmori

    Journal of Psychiatric Research   43 ( 1 )   7 - 12   2008年11月

     詳細を見る

    The phosphodiesterase 4B (PDE4B) gene is located at 1p31, a susceptibility region for schizophrenia (SZ). Moreover, PDE4B interacts with DISC1, which is a known genetic risk factor for SZ. Recently, it was reported that the PDE4B gene is associated with SZ in Caucasian and African American populations. In this study, case-controlled association analyses were performed in the Japanese population to determine if the PDE4B gene is implicated in SZ. Thirteen single nucleotide polymorphisms (SNPs) were analyzed in 444 schizophrenic patients and 452 control subjects. Three SNPs (rs2180335, rs910694 and rs472952) were significantly associated with SZ after applying multiple test correction (p = 0.039, 0.004 and 0.028). In addition, a significant association was found between specific haplotypes (rs2180335 and rs910694) and SZ (permutation p = 0.001). Our result suggests that variations at the PDE4B locus may play a significant role in the etiology of SZ in the Japanese population. © 2008 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jpsychires.2008.01.013

    Scopus

    PubMed

    researchmap

  • Predictors of subjective and objective quality of life in outpatients with schizophrenia

    Ken Yamauchi, Hirofumi Aki, Masahito Tomotake, Jun-Ichi Iga, Syusuke Numata, Ikuyo Motoki, Yumiko Izaki, Shinya Tayoshi, Sawako Kinouchi, Satsuki Sumitani, Sumiko Tayoshi, Yumiko Takikawa, Yasuhiro Kaneda, Takahide Taniguchi, Yasuhito Ishimoto, Syu-Ichi Ueno, Tetsuro Ohmori

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   62 ( 4 )   404 - 411   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Aim: In recent years, greater attention has been given to quality of life (QOL) in schizophrenia and several studies reported that negative and depressive symptoms and cognitive dysfunction are related to patient QOL. But because a variety of QOL measures have been used in the previous studies, there seems to be no unanimous predictors for subjective and objective QOL. The purpose of the present study was to elucidate the relationship between clinical variables and subjective and objective QOL in outpatients with schizophrenia, using schizophrenia disease-specific QOL measures. Particular attention was paid to cognitive function as a predictor of QOL.
    Methods: Schizophrenia symptoms of the Positive and Negative Syndrome Scale (PANSS) were divided into five factors: positive factor, negative factor, cognitive factor, emotional discomfort, and hostility. The study sample consisted of 84 schizophrenia outpatients. Subjective and objective QOL were assessed with Schizophrenia Quality of Life Scale (SQLS) and the Quality of Life Scale (QLS), respectively.
    Results: Subjective QOL correlated significantly with emotional discomfort, positive factor, negative factor, extrapyramidal symptoms and cognitive factor, while objective QOL correlated with negative factor, cognitive factor, emotional discomfort, extrapyramidal symptoms, and dose of antipsychotics. Total score and three of four subscales in the QLS correlated significantly with cognitive factor, while cognitive factor had a significant correlation with only one of three scales of SQLS. Stepwise regression showed that subjective QOL was significantly predicted by emotional discomfort and extrapyramidal symptoms, while negative factor was the most important predictor of objective QOL.
    Conclusion: Cognitive dysfunction had a greater influence on objective QOL than subjective QOL. Treating depressive and negative symptoms and extrapyramidal symptoms might contribute to enhanced subjective and objective QOL.

    DOI: 10.1111/j.1440-1819.2008.01818.x

    Web of Science

    PubMed

    researchmap

  • 日本人における統合失調症と疾患感受性遺伝子G72多型の関連研究(Associations of candidate gene G72 polymorphisms with schizophrenia in a Japanese population)

    大井 一高, 橋本 亮太, 安田 由華, 吉田 哲彦, 高橋 秀俊, 井池 直美, 岩瀬 真生, 紙野 晃人, 石井 良平, 数井 裕光, 喜多村 祐里, 疇地 道代, 池澤 浩二, 鎌形 英一郎, 谷向 仁, 田上 真次, 森原 剛史, 大河内 正康, 大沼 徹, 沼田 周助, 池田 匡志, 上野 修一, 福永 知子, 田中 稔久, 工藤 喬, 新井 平伊, 大森 哲郎, 岩田 仲生, 尾崎 紀夫, 武田 雅俊

    神経化学   47 ( 2-3 )   228 - 228   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • 日本人におけるPNPO遺伝子と統合失調症の関連(Association between PNPO and schizophrenia in the Japanese population)

    宋 鴻偉, 上野 修一, 沼田 周助, 伊賀 淳一, 渋谷 純子, 吉, 中瀧 理仁, 田吉 信哉, 山内 健, 住谷 さつき, 友竹 正人, 多田 友人, 棚橋 としひと, 板倉 光夫, 大森 哲郎

    神経化学   47 ( 2-3 )   228 - 228   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • TGFBR2 gene expression and genetic association with schizophrenia

    Shusuke Numata, Shu-ichi Ueno, Jun-ichi Iga, Ken Yamauchi, Song Hongwei, Ryota Hashimoto, Masatoshi Takeda, Hiroshi Kunugi, Mitsuo Itakurla, Tetsuro Ohmori

    JOURNAL OF PSYCHIATRIC RESEARCH   42 ( 6 )   425 - 432   2008年5月

     詳細を見る

    記述言語:英語   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    TGFBR2 gene is a tumor suppressor gene located at chromosome 3p22, and the locus is reported to be linked with schizophrenia susceptibility. According to the previous studies, a reduced incidence of cancer is observed in schizophrenic patients compared with the general population and tumor suppressor genes may be associated with schizophrenia. We measured the mRNA expression of TGFBR2 gene in the peripheral leukocytes from 19 medication-free schizophrenics and 25 medication-free major depressive patients compared with age- and sex-matched control subjects using a quantitative real-time PCR method. We also followed up the TGFBR2 mRNA expression levels from 13 schizophrenics after several weeks - antipsychotic treatments. The TGFBR2 mRNA levels of medication free schizophrenics were significantly higher than those of control subjects and decreased to almost the same level as controls after antipsychotic treatment. On the other hand, the TGFBR2 mRNA levels of medication-free major depressive patients were not significantly different from controls. In genetic studies, we failed to find any association between the TGFBR2 gene and schizophrenia with 10 SNPs of TGFBR2 gene in Japanese subjects (279 subjects each) and there was no significant difference with haplotype analysis, either. Our results suggest that the TGFBR2 gene itself does not link to schizophrenia but that the TGFBR2 mRNA levels in the peripheral leukocytes may be a potential state marker for schizophrenia. (c) 2007 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jpsychires.2007.04.002

    Web of Science

    researchmap

  • 日本人における統合失調症と疾患感受性遺伝子G72の関連研究

    大井 一高, 橋本 亮太, 安田 由華, 吉田 哲彦, 高橋 秀俊, 井池 直美, 岩瀬 真生, 紙野 晃人, 石井 良平, 数井 裕光, 沼田 周助, 池田 匡志, 上野 修一, 福永 知子, 田中 稔久, 工藤 喬, 大森 哲郎, 岩田 仲生, 尾崎 紀夫, 武田 雅俊

    精神神経学雑誌   ( 2008特別 )   S - 218   2008年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • FKBP5, SERT and COMT mRNA expressions in the peripheral leukocytes during menstruation cycle in healthy reproductive females

    Sawako Kinouchi, Jun-Ichi Iga, Shu-Ichi Ueno, Ken Yamauchi, Shusuke Numata, Hongwei Song, Satsuki Sumitani, Sumiko Shibuya-Tayoshi, Mari Haku, Toshiyuki Yasui, Minoru Irahara, Kyoko Morita, Kazuhito Rokutan, Tetsuro Ohmori

    NEUROSCIENCE LETTERS   434 ( 1 )   124 - 128   2008年3月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    There have been several evidences that the mRNA expressions in the peripheral leukocytes may indicate not only physical but also psychological states. The purpose of this study is whether the mRNA expressional changes in the leukocytes are related to the mental states across the menstrual cycle in reproductive healthy female subjects. Thirty-eight female subjects (22.4 +/- 11.4 year-old) were participated in this study at three menstruation cycle periods (menstrual, follicular and luteal phase). The FKBP5 (FK506-binding protein gene), SERT (serotonin transporter gene) and COMT (catechol-o-methyltransferase gene) mRNA expressions in the leukocytes were determined with hormonal data. The psychological changes were assessed with self-rating hospital anxiety and depression scale (HADS). Only one thirds of subjects (n = 12) had regular menstrual cycles during the experiment. So we analyzed the data from these 12 subjects. The anxiety score of each subject was changed across the menstrual cycle (Friedman test: P &lt; 0.05). The FKBP5 mRNA expression was significantly lower in the follicular phase than in the other phases but no changes were seen in either SERT or COMT mRNA expressions among the phases. In conclusion, there are differences of HADS anxiety score and FKBP5 mRNA expression in the leukocytes across the menstrual cycle but there is no correlation between anxiety scores and FKBP5 mRNA. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2008.01.039

    Web of Science

    researchmap

  • Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia

    Hirofumi Aki, Masahito Tornotake, Yasuhiro Kaneda, Jun-Ichi Iga, Sawako Kinouchi, Surniko Shibuya-Tayoshi, Shin-Ya Tayoshi, Ikuyo Motoki, Kazuhiko Moriguchi, Satsuki Sumitani, Ken Yamauchi, Takahide Taniguchi, Yasuhito Ishimoto, Shu-Ichi Ueno, Tetsuro Ohmori

    PSYCHIATRY RESEARCH   158 ( 1 )   19 - 25   2008年2月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    The purpose of the present Study is to investigate the relationships among subjective and objective quality of life (QOL), and levels of life skills, and their clinical determinants in outpatients with schizophrenia by using schizophrenia disease-specific QOL measures.. Data collected from 64 Outpatients were analyzed. Subjective QOL was measured with the Schizophrenia Quality of Life Scale (SQLS) and objective QOL with the Quality of Lire Scale (QLS). Patients' family members completed the Life Skills Profile (LSP). Clinical symptoms were also assessed with several scales including the Brief Psychiatric Rating Scale (BPRS) and the Calgary Depression Scale for Schizophrenia (CDSS). Only the motivation/energy scale, but lot the Other scales of the SQLS, correlated with the QLS. The LSP rated by the family showed significant correlations with both the SQLS and the QLS. The CDSS score predicted each scale of the SQLS, and the BPRS negative symptoms score predicted the QLS. The LSP was predicted by the BPRS negative symptoms score and the CDSS score independently. These results indicate that the Patient's QOL could be predicted by the life: skills measured by a family member and Suggest that active treatment for depressive and negative symptoms might be recommended to improve the patient's QOL and life skills. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.psychres.2006.05.017

    Web of Science

    researchmap

  • No association between the NDE1 gene and schizophrenia in the Japanese population

    Shusuke Numata, Shu ichi Ueno, Jun ichi Iga, Masahito Nakataki, Toshihito Tanahashi, Mitsuo Itakura, Akira Sano, Kazutaka Ohi, Ryota Hashimoto, Masatoshi Takeda, Tetsuro Ohmori

    Schizophrenia Research   99 ( 1-3 )   367 - 369   2008年2月

     詳細を見る

    掲載種別:速報,短報,研究ノート等(学術雑誌)  

    DOI: 10.1016/j.schres.2007.10.032

    Scopus

    PubMed

    researchmap

  • Hemodynamic changes in the prefrontal cortex during mental stress task as measured by multi channel near infrared spectroscopy

    S. Sumitani, M. Morimune, K. Kikuchi, S. Ueno, T. Ohmori

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   62 ( 1 )   S11 - S11   2008年2月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BLACKWELL PUBLISHING  

    Web of Science

    researchmap

  • Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy

    Sumiko Shibuya-Tayoshi, Shin'Ya Tayoshi, Satsuki Sumitani, Shu-Ichi Ueno, Masafumi Harada, Tetsuro Ohmori

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY   32 ( 1 )   249 - 256   2008年1月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Lithium is a first-line medicinal treatment for acute bipolar disorder and is also used prophylactically in manic depressive illnesses; however, its mechanism of action is still largely unknown. Animal and human studies have suggested that lithium modulates glutamatergic and GABAergic neurotransmissions. The aim of this study is to investigate the effects of lithium on brain glutamate (Glu), glutamine (Gln), and gamma-aminobutyric acid (GABA) levels in healthy individuals using proton magnetic resonance spectroscopy (H-1-MRS). In vivo 3 Tesla H-1-MRS was performed on the anterior cingulate cortex and bilateral basal ganglia initially and after two weeks of lithium administration on 8 healthy mate subjects who had a mean age of 34.9 years. After two weeks of lithium administration, Gln significantly decreased in the left basal ganglia and showed a decreasing trend in the right basal ganglia. Additionally, Glu + Gln (Glx) significantly decreased in the right basal ganglia and showed a decreasing trend in the left basal ganglia. Glu did not significantly change in any of the three tested areas, and GABA exhibited no significant change after the lithium administration when measured in the anterior cingulate cortex and left basal ganglia. This study is the first to demonstrate that subchronic lithium treatment decreases Gln and Glx levels in the bilateral basal ganglia of healthy individuals. Our finding might suggest that the decrease of Glx levels is associated with the pharmacological actions of subchronic lithium treatment. (c) 2007 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.pnpbp.2007.08.015

    Web of Science

    researchmap

  • 【気分障害研究の最前線】 うつ病の分子マーカー

    伊賀 淳一, 上野 修一, 大森 哲郎

    分子精神医学   8 ( 1 )   2 - 9   2008年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)先端医学社  

    うつ病は脳内の機能変調により生じるが、その影響は全身に及ぶ。そのため末梢組織を利用した分子マーカーを作製し、診断や治療効果の判定に利用しようとする研究が盛んに行われている。そこで本稿では、末梢血や死後脳など患者検体を用いた研究で得られてきている分子マーカーに関する最近のトピックスについて総説的に紹介する。(著者抄録)

    researchmap

  • Molecular assessment of depression from mRNAs in the peripheral leukocytes

    Jun-Ichi Iga, Shu-Ichi Ueno, Tetsuro Ohmori

    ANNALS OF MEDICINE   40 ( 5 )   336 - 342   2008年

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:INFORMA HEALTHCARE  

    Depression is a disorder not only in the central nervous system (CNS), but also in the systemic neuroendocrine, autonomic nervous, and immune systems. The changes in these systems have been widely studied in depression by using serum proteins because they are easily and repetitively studied before, during, and after treatment. Recently, gene expressions in the peripheral blood leukocytes have been used to assess the depressive changes in the CNS by DNA microarrays and/or real-time polymerase chain reaction (PCR) methods. These studies will give us clues to assess depression because circulating peripheral leukocytes are influenced by systems that underlie depression, and the quantification of mRNAs in them is methodologically precise and easier than that of protein. In this paper, we review the studies on the leukocyte gene expression, including our own, and discuss the limitations and strengths of the current gene expression-based molecular assessment of depression by the leukocyte mRNA expression.

    DOI: 10.1080/07853890802082088

    Web of Science

    researchmap

  • Positive Association of the PCNT2 gene with Major Depressive Disorder in the Japanese Population.

    S. Numata, J. Iga, M. Nakataki, S. Tayoshi, T. Tanahashi, M. Itakura, S. Ueno, T. Ohmori

    J Psychiatry Neurosci   43   7 - 12   2008年

     詳細を見る

  • The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients

    Jun Ichi Iga, Shu Ichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Tayoshi-Shibuya, Sawako Kinouchi, Masahito Nakataki, Hongwei Song, Kazuhiko Hokoishi, Hirotaka Tanabe, Akira Sano, Tetsuro Ohmori

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics   144 ( 8 )   1003 - 1006   2007年12月

     詳細を見る

    Recent researches have suggested that brain-derived neurotrophic factor (BDNF) may be implicated in the pathophysiology of mood disorder. This study examined the association between the BDNF Val66Met polymorphism and major depressive disorder (MDD) in a Japanese population. We genotyped the BDNF Val66Met polymorphism in 154 major depressive patients and 154 age- and sex-matched control subjects. The genotypic distributions and allele frequencies were similar among the patients and control subjects. When the relationships of the polymorphism with several clinical variables (i.e., age, sex, age of onset, number of episode, presence of psychotic features, suicidal behavior, and family history) were examined, the dose of Met allele had significant effects on psychotic feature and suicidal behavior and family history. These results suggest that the BDNF Val66Met polymorphism is not related to the development of MDD but related to clinical features of MDD in a Japanese population. © 2007 Wiley-Liss, Inc.

    DOI: 10.1002/ajmg.b.30520

    Scopus

    PubMed

    researchmap

  • Activation of the prefrontal cortex during the Trail-Making Test detected with multichannel near-infrared spectroscopy

    Sumiko Shibuya-Tayoshi, Satsuki Sumitani, Kumiko Kikuchi, Tsunehiko Tanaka, Shin'ya Tayoshi, Shu-ichi Ueno, Tetsuro Ohmori

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   61 ( 6 )   616 - 621   2007年12月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    The Trail-Making Test (TMT) is a neuropsychological test for evaluating executive function, and the TMT Part B reflects more complex cognitive processes including cognitive set shifting. The prefrontal cortex (PFC) is thought to be involved in these cognitive processes. The purpose of the present paper was to investigate PFC activation during performance of the TMT Part A and Part B using multichannel near-infrared spectroscopy (NIRS). Subjects were 41 healthy right-handed volunteers. The hemodynamic changes in the PFC during the TMT were measured on a 22-channel NIRS machine. The subjects had a greater increase of oxygenated hemoglobin ([oxyHb]) during the TMT Part B than during Part A in the PFC. Twenty-seven out of the 41 subjects had a bilateral increase of [oxyHb] in the PFC during Part B according to laterality index. NIRS detected activation in the PFC during the performance of the TMT Part B and this PFC activation may reflect executive functions including cognitive set shifting involved in the TMT Part B.

    DOI: 10.1111/j.1440-1819.2007.01.727.x

    Web of Science

    PubMed

    researchmap

  • Association between PNPO and schizophrenia in the Japanese population

    Hongwei Song, Shu-ichi Ueno, Shusuke Numata, Jun-ichi Iga, Sumiko Shibuya-Tayoshi, Masahito Nakataki, Shin'Ya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Tomohito Tomotake, Tomohito Tada, Toshihito Tanahashi, Mitsuo Itakura, Tetsuro Ohmori

    SCHIZOPHRENIA RESEARCH   97 ( 1-3 )   264 - 270   2007年12月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    Accumulating evidence suggests that both homocysteine metabolism and monoaminergic neurotransmitter systems are important in schizophrenia pathology. We hypothesized that the gene PNPO (pyridoxine 5'-phospliatase oxidase gene) might be a candidate for susceptibility to schizophrenia because PNPO encodes pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5), a rate-limiting enzyme in pyridoxal 5'-phosphate (PLP, vitamin B-6) Synthesis. PLP is a metabolically-active form of vitamin B-6 and thus, is required as a co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. We examined 8 single nucleotide polymorphisms (SNPs) in PNPO and its 5'-flanking regions in 359 schizophrenia patients and 582 control subjects. Four marker regions of PNPO showed significant levels of allelic associations with schizophrenia (the highest was rs2325751, P=0.004). In addition, the haplotype case-control study revealed a significant association (permutation P&lt;0.00001) between PNPO and schizophrenia. These findings suggest that variations in PNPO may contribute to overall genetic risk for schizophrenia in the Japanese population. (C) 2007 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.schres.2007.08.004

    Web of Science

    researchmap

  • BDNFと統合失調症 (特集 統合失調症の分子精神医学)

    沼田 周助, 上野 修一

    分子精神医学   7 ( 4 )   335 - 340   2007年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:先端医学社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2008042151

  • うつ病を遺伝子から考える

    上野修一, 伊賀純一, 沼田周助, 宋鴻偉, 田吉伸哉, 中滝理仁, 山内健, 大森哲郎

    精神神經學雜誌 = Psychiatria et neurologia Japonica   109 ( 9 )   859 - 863   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本精神神経学会  

    CiNii Books

    researchmap

  • Association of serum cytokine concentrations with psychological symptoms in midlife women

    Toshiyuki Yasui, Masahiko Maegawa, Junko Tomita, Yuka Miyatani, Masayo Yamada, Hirokazu Uemura, Shu-ichi Ueno, Shusuke Numata, Tetsuro Ohmori, Naoko Tsuchiyac, Mitsutoshi Yuzurihara, Shuichi Takeda, Minoru Irahara

    JOURNAL OF REPRODUCTIVE IMMUNOLOGY   75 ( 1 )   56 - 62   2007年8月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    Objective: The purpose of the present study was to clarify the association of serum cytokine concentrations, determined using a multiplexed cytokine assay, with psychological symptoms in midlife women.
    Methods: Fifty-three peri- and post-menopausal women with and without psychological symptoms in Greene's climacteric scale were enrolled in this study. Level, of 17 cytokines in serum samples were measured simultaneously using a multiplexed human cytokine assay.
    Results: Serum interleukin (IL)-6 concentration in women with psychological symptoms (2.71 +/- 047 pg/ml) was significantly (p = 0.009) higher than that in women without psychological symptoms (0.98 +/- 0.18 pg/ml). Serum IL-8 concentration in women with psychological symptoms(33.4 +/- 8.17 pg/ml) was also significantly (p = 0.048) higher than that in women without psychological symptoms (7.87 +/- 1.64 pg/ml), In addition, serum IL-10 concentration in women with psychological symptoms (0.74 +/- 0.26 pg/ml) was significantly (p = 0.048) higher than that in women without psychological symptoms (0.07 +/- 0.04 pg/ml). Tumor necrosis factor (TNF)-alpha in serum was detected only in women with psychological symptoms. Serum IL-2 concentration in women with psychological symptoms tended (p = 0.066) to be higher than that in women without psychological symptoms. No significant differences were found between levels of other cytokines in women with and without psychological symptoms.
    Conclusion: Psychological stress manifested as climacteric symptoms in midlife women may be associated with increases in serum concentrations of IL-6, IL-8, IL-10, and TNF-alpha. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.jri.2007.02.004

    Web of Science

    PubMed

    researchmap

  • 女子学生における性周期と精神状態の変化についての検討

    木内 佐和子, 上野 修一, 伊賀 淳一, 山内 健, 沼田 周助, 宋 鴻偉, 住谷 さつき, 田吉 純子, 葉久 真理, 竹内 美恵子, 安井 敏之, 苛原 稔, 大森 哲郎

    心療内科   11 ( 3 )   205 - 209   2007年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    健康な女子学生50名(22.3±2.2歳)を対象に性周期を調査し、性周期における精神状態の変動があるかについて検討した。その結果、約3分の1が月経不順を自覚またはその既往があった。また、基礎体温値や血中黄体ホルモンによる評価により月経が規則的な被験者でも約3分の1に黄体機能不全や排卵障害が認められた。月経障害のない被験者を対象に性周期でのHADS(病院不安抑うつ尺度)スコアを解析したところ、不安スコアが変動するという結果が得られ、HADSが性周期中での精神状態の変化を予測する手段となりうる可能性が示唆された。

    researchmap

  • Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder

    Jun ichi Iga, Shu ichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Tayoshi-Shibuya, Sawako Kinouchi, Masahito Nakataki, Hongwei Song, Kazuhiko Hokoishi, Hirotaka Tanabe, Akira Sano, Tetsuro Ohmori

    Progress in Neuro-Psychopharmacology and Biological Psychiatry   31 ( 3 )   658 - 663   2007年4月

     詳細を見る

    Vascular endothelial growth factor (VEGF) has been implicated in neuronal survival, neuroprotection, regeneration, growth, differentiation, and axonal outgrowth, which are known to be involved in the pathophysiology of major depressive disorder (MDD). Recently, the VEGF mRNA expression in the peripheral leukocytes from Alzheimer's disease or cardiovascular disease was reported to be changed. We hypothesized that the expression of the VEGF mRNA in the peripheral leukocytes may be a good candidate for the biological marker for MDD. Thirty two patients with MDD and age- and sex-matched control subjects were included in this expression study. The VEGF mRNA levels in the peripheral leukocytes from drug-naive MDD patients were significantly higher than those from the control subjects and the magnitude of the decrease of VEGF mRNA after 8-week treatment significantly correlated with clinical improvement. Then, we genotyped two single nucleotide polymorphic markers of VEGF gene, which were reported to be associated with amyotrophic lateral sclerosis and Alzheimer's disease, in patients with MDD and control subjects (n = 154, each). We did not find any significant association between these markers and MDD or its clinical subtypes. Our investigation indicates that the higher expression levels of VEGF mRNA in the peripheral leukocytes are associated with the depressive state and their recovery after treatment may be associated with the clinical improvement. © 2006 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.pnpbp.2006.12.011

    Scopus

    PubMed

    researchmap

  • 3T proton magnetic resonance spectroscopy investigation in obsessive-compulsive disorder

    S. Sumitani, M. Harada, H. Kubo, S. Tayoshi, S. Shibuya-Tayoshi, S. Kinouchi, S. Ueno, T. Ohmori

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   61 ( 2 )   S15 - S16   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BLACKWELL PUBLISHING  

    Web of Science

    researchmap

  • Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression

    Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sawako Kinouchi, Sumiko Tayoshi-Shibuya, Hongwei Song, Tetsuro Ohmori

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY   31 ( 3 )   628 - 632   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Background: Gene expressions of the peripheral leukocytes in depressive patients might reflect the systemic dysfunction of major depression. We determined mRNA expression levels of Historic deacetylase 5 (HDAC5) gene and cyclic AMP response element-binding protein 1 (CREB) gene in the leukocyte of depressive patients. HDAC5 and CREB are reported to be important targets of antidepressants, the latter being located in the downstream of the former in lymphocyte calcium signaling.
    Methods: 25 patients with major depression and 25 age- and sex-matched healthy controls were included in this study. Twenty patients were able to be followed up until the 8 week-treatment. The mRNA levels were determined by a quantitative RT-PCR method.
    Result: Levels of HDAC5 and CREB mW4A were significantly higher in drug-free depressive patients than those of controls and the higher mRNA levels decreased to control levels after 8-week paroxetine treatment. There were positive correlation between levels of HDAC5 and CREB. Conclusion: Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.
    (c) 2007 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.pnpbp.2006.12.014

    Web of Science

    researchmap

  • Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia

    Shusuke Numata, Shu-ichi Ueno, Jun-ichi Iga, Ken Yamauchi, Song Hongwei, Ryota Hashimoto, Masatoshi Takeda, Hiroshi Kunugi, Mitsuo Itakura, Tetsuro Ohmori

    NEUROSCIENCE LETTERS   415 ( 1 )   28 - 33   2007年3月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    PDLIM5 modulates neuronal calcium signaling, co-localizes with synaptic vesicles of neurotransmitters and positive association between its gene and schizophrenia was reported but its relation is still ambiguous. The differential expression of the PDLIM5 gene both in the brain and in the lymphoblasts has been found in schizophrenia compared to control subjects. In this study, we measured the expression level of the PDLIM5 gene transcripts in the peripheral leukocytes from 19 medication-free and 21 chronically medicated schizophrenic patients as well as age- and sex-matched control subjects using a quantitative real-time PCR method. The mRNA levels of the PDLIM5 gene in the leukocytes of medication-free schizophrenic patients were significantly higher than those of control subjects. On the other hand, our group has previously shown that its mRNA expression in the leukocytes of medication-free major depressive patients was significantly lower compared with controls. There was no difference in the PDLIM5 mRNA levels between chronic schizophrenic patients with antipsychotic medication and their controls. Further, we failed to find any genetic association between the PDLIM5 gene and schizophrenia with six single nucleotide polymorphics (SNPs) of the PDLIM5 gene in Japanese subjects (279 subjects each) and there was no significant relation between PDLIM5 gene and schizophrenia with the haplotype analysis (P=0.48), either. We suggest that the higher expression levels of the PDLIM5 mRNA in the peripheral leukocytes may be a candidate marker for medication-free schizophrenic patients. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2007.01.018

    Web of Science

    researchmap

  • うつ病患者の末梢白血球LIM(PDLIM5)遺伝子発現と遺伝子関連解析

    伊賀 淳一, 沼田 周助, 宋 鴻偉, 山内 健, 上野 修一, 大森 哲郎

    精神薬療研究年報   ( 39 )   139 - 145   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    PDLIM5(LIM) mRNA量を大うつ病患者と健常村照で比較し、次にLIM遺伝多型と大うつ病の遺伝子関連解析を行った。大うつ病患者20例と健常対照者20例を対象とした。患者群では、治療前及び治療4週後に臨床症状の評価を行い、薬物血中濃度と遺伝子発現を測定した。遺伝子関連解析は、大うつ病患者130例と性年齢の一致した健常対照者130例を解析した。患者群の治療前のLIM mRNA量は健常対照群と比較して有意に減少し、4週間のparoxetine投与により有意に増加し、健常対照群と同程度となった。遺伝子関連解析の結果、LIM遺伝子と大うつ病に関連は認めなかった。末梢白血球LIM mRNA量の測定が、大うつ病の生物学的指標となることが示唆された。

    researchmap

  • Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia

    S. Numata, S. Ueno, J. Iga, K. Yamauchi, S. Hongwei, S. Kinouchi, S. Shibuya-Tayoshi, S. Tayoshi, H. Aki, S. Sumitani, M. Itakura, T. Ohmori

    JOURNAL OF NEURAL TRANSMISSION   114 ( 2 )   255 - 259   2007年2月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER WIEN  

    Catechol-O-methyltransferase (COMT) gene is one of the candidate genes for schizophrenia because it codes an enzyme that participates in the metabolic inactivation of dopamine and noradrenaline and a limiting factor of dopamine metabolism in the prefrontal cortex. COMT gene lies on chromosome 22q11.2, which has been associated with schizophrenia susceptibility. A single-nucleotide polymorphism of COMT gene at position 108/158 results in an amino acid substitution from valine (val) to methionine (met), which modifies its enzymatic activity and may change the brain morphology and expressional behaviors. On the other hand, brain-derived neurotrophic factor (BDNF) plays a critical role in the development of mesolimbic dopaminergic- related systems. BDNF also contains a functional single-nucleotide polymorphism at codon 66 (Val66Met) of its prodomain and this polymorphism is responsible for schizophrenia susceptibility. In this study, we first investigated the relationship between COMT Val108/158Met polymorphism and age at onset as well as levels of clinical symptoms in 158 of chronic schizophrenia inpatients and then we investigated the gene-by-gene interaction between COMT Val108/158Met polymorphism and BDNF Val66Met polymorphism with age- and sex-matched control subjects (n = 318). We concluded that the COMT Val108/158Met polymorphism was not related to either the onset at age or the levels of clinical symptoms after long-term antipsychotic treatment in schizophrenia.

    DOI: 10.1007/s00702-006-0543-1

    Web of Science

    researchmap

  • Subjective and objective measures of quality of life have different predictors for people with schizophrenia

    Masahito Tomotake, Yasuhiro Kaneda, Jun-Ichi Iga, Sawako Kinouchi, Sumiko Tayoshi, Ikuyo Motoki, Satsuki Sumitani, Ken Yamauchi, Takahide Taniguchi, Yasuhito Ishimoto, Shu-Ichi Ueno, Tetsuro Ohmori

    PSYCHOLOGICAL REPORTS   99 ( 2 )   477 - 487   2006年10月

     詳細を見る

    記述言語:英語   出版者・発行元:PSYCHOLOGICAL REPORTS  

    This study investigated the relationship between subjective and objective quality of life and assessed predictors in people with schizophrenia. The study population consisted of 99 stabilized outpatients with schizophrenia (DSM-IV) who had been regularly receiving outpatient treatment at the Department of Psychiatry, The Tokushima University Hospital. Subjective and objective quality of life were estimated using the Schizophrenia Quality of Life Scale and the Quality of Life Scale, respectively. Psychiatric symptoms were also measured with the Brief Psychiatric Rating Scale and the Calgary Depression Scale for Schizophrenia. Scores on the Schizophrenia Quality of Life Scale Motivation and Energy scales significantly correlated with the Quality of Life Scale total scores -.40 (p &lt;.001), and with the scores on Interpersonal Relations subscale -.42 (p &lt;.001), Instrumental Role subscale -.28 (p=.005), Intrapsychic Foundations subscale -39 (p &lt;.001), and Common Objects and Activities subscale -.25 (P=.014). The Schizophrenia Quality of Life Scale Psychosocial scale significantly correlated with only the Quality of Life Scale total score -.20 (p=.05), and there was no significant correlation between the scores on the Schizophrenia Quality of Life Scale Symptoms and Side-effects scales and the Quality of Life Scale. Stepwise regression analyses showed that the Calgary Depression Scale for Schizophrenia score was the most important predictor of each scale of the Schizophrenia Quality of Life Scale, and the Brief Psychiatric Rating Scale Negative Symptoms score was the most important predictor of the Quality of Life Scale total score and each subscale. These results suggest that subjective and objective quality of life have different predictors and should be considered as separate and complementary outcome variables.

    DOI: 10.2466/PR0.99.2.477-487

    Web of Science

    researchmap

  • うつ病患者の末梢白血球LIM(PDLIM5)遺伝子発現と遺伝子関連解析

    伊賀 淳一, 上野 修一, 山内 健, 沼田 周助, 木内 佐和子, 田吉 純子, 宋 鴻偉, 田邉 敬貴, 佐野 輝, 大森 哲郎

    神経化学   45 ( 2-3 )   382 - 382   2006年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • Activation of the prefrontal cortex during the trail making test detected with multi-channel near-infrared spectroscopy authors

    S. Shibuya-Tayoshi, S. Sumitani, S. Ueno, T. Ohmori

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   9   S198 - S198   2006年7月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:CAMBRIDGE UNIV PRESS  

    Web of Science

    researchmap

  • DNAマイクロアレイによるうつ病の新しい診断マーカー

    大森哲郎, 森田恭子, 上野修一, 伊賀淳一, 斉藤俊郎, 太田雅之, 六反一仁

    精神神經學雜誌 = Psychiatria et neurologia Japonica   108 ( 6 )   642 - 645   2006年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本精神神経学会  

    CiNii Books

    researchmap

  • Brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

    S. Numata, S. Ueno, J. Iga, K. Yamauchi, S. Hongwei, K. Ohta, S. Kinouchi, S. Shibuya-Tayoshi, S. Tayoshi, M. Aono, N. Kameoka, S. Sumitani, M. Tomotake, Y. Kaneda, T. Taniguchi, Y. Ishimoto, T. Ohmori

    Neurosci Lett   401 ( 1-2 )   1 - 5   2006年6月

     詳細を見る

  • 統合失調症患者の主観的及び客観的QOLに与える要因についての検討

    山内 健, 安藝 浩史, 兼田 康宏, 沼田 周助, 伊賀 淳一, 木内 佐和子, 田吉 純子, 元木 郁代, 住谷 さつき, 田吉 伸哉, 井崎 ゆみ子, 谷口 隆英, 石元 康仁, 上野 修一, 大森 哲郎

    精神神経学雑誌   ( 2006特別 )   S200 - S200   2006年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 精神症状と全身性ジストニアを呈したホモシスチン尿症の一例 VitB6反応性と分子遺伝学的考察

    伊賀 淳一, 山内 健, 谷口 隆英, 上野 修一, 大森 哲郎

    精神神経学雑誌   108 ( 3 )   298 - 298   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 神経栄養因子と抗精神病薬 (特集 抗精神病薬の神経保護作用--ニューロプロテクションの新たな知見)

    沼田 周助, 上野 修一

    分子精神医学   6 ( 1 )   16 - 21   2006年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:先端医学社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2006127845

  • Activation of the prefrontal cortex during the Wisconsin Card Sorting Test as measured by multichannel near-infrared spectroscopy

    S Sumitani, T Tanaka, SY Tayoshi, K Ota, N Kameoka, S Ueno, T Ohmori

    NEUROPSYCHOBIOLOGY   53 ( 2 )   70 - 76   2006年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    Background: The Wisconsin Card Sorting Test (WCST) is a neuropsychological test to evaluate the function of the prefrontal cortex (PFC). However, inconsistent results have been reported concerning whether this task activates the PFC symmetrically or asymmetrically. Objectives: To investigate the brain activation in the PFC during the WCST, we examined blood oxygenation changes of healthy subjects by using multichannel near-infrared spectroscopy (NIRS). Methods: Subjects were 32 healthy volunteers, 18 males and 14 females. The WCST was administered using a computerized version, and the hemodynamic changes of the PFC during the WCST were measured by a 24-channei NIRS system. Results: A bilateral increase in oxygenated hemoglobin (oxyHb) was observed in the PFC in 20 subjects during the WCST. However, 5 subjects showed predominant activation on the left side and 3 subjects one on the right side. No oxyHb change was observed in 4 subjects, although they had good performances in the WCST. Conclusions: These results directly confirmed that the PFC was activated during the WCST in vivo by using the optical technique and suggested that the distribution of the activation in the PFC is different among healthy individuals. Copyright (C) 2006 S. Karger AG, Basel.

    DOI: 10.1159/000091722

    Web of Science

    researchmap

  • Trait and state marker, serotonin transporter gene expression

    S. Ueno, T. Ohmori

    JOURNAL OF PHARMACOLOGICAL SCIENCES   101   31 - 31   2006年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  • ChAc mouse model using gene-targeting technique to introduce ehime-deletion mutation

    Y Tomemori, M Ichiba, A Kusumoto, E Mizuno, D Sato, S Muroya, M Nakamura, H Kawaguchi, H Yoshida, S Ueno, K Nakao, K Nakamura, A Aiba, M Katsuki, A Sano

    MOVEMENT DISORDERS   20 ( 12 )   1683 - 1684   2005年12月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-LISS  

    Web of Science

    researchmap

  • Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine

    J Iga, S Ueno, K Yamauchi, Motoki, I, S Tayoshi, K Ohta, HW Song, K Morita, K Rokutan, T Ohmori

    NEUROSCIENCE LETTERS   389 ( 1 )   12 - 16   2005年11月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    Serotonin transporter (5HTT) is thought to be involved in the pathophysiology of major depression and the target of antidepressants. We hypothesized that 5HTT mRNA levels in peripheral leukocytes may be associated with depressive states and the therapeutic response to antidepressant treatments. Fifteen patients with major depression and age-, sex-matched control subjects were studied. 5HTT mRNA levels were determined with quantitative real-time PCR method. 5HTT mRNA levels in leukocytes were significantly higher in depressive patients at baseline (before medication) than in control subjects. 5HTT mRNA levels were decreased significantly after 8 weeks of paroxetine medication compared with those at baseline. Our investigation suggested that the increased expression of 5HTT mRNA in peripheral leukocytes may be related with the pathophysiology of depression and its reduction after treatment may reflect the adaptive change induced by the antidepressant. (C) 2005 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2005.06.048

    Web of Science

    researchmap

  • 正常女性の白血球におけるFKBP5と5HTTのmRNA発現に対する月経周期の影響(Effects of menstrual cycle on mRNA expression of FKBP5 and 5HTT in leukocytes of normal female)

    木内 佐和子, 伊賀 淳一, 上野 修一, 山内 健, 沼田 周助, 宋 鴻偉, 田吉 純子, 葉久 真理, 竹内 美惠子, 安井 敏之, 苛原 稔, 森田 恭子, 六反 一仁, 大森 哲郎

    神経化学   44 ( 2-3 )   200 - 200   2005年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • 血液透析患者におけるfluvoxamineの血中動態

    伊賀 淳一, 上野 修一, 山内 健, 宗 鴻偉, 川島 周, 水口 潤, 大森 哲郎

    ムードディスオーダー・カンファランス   ( 6回 )   15 - 20   2005年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)星和書店  

    慢性腎不全に対して血液透析を行っている4症例を対象に、fluvoxamineの血液透析による血中濃度の変化について検討した。透析直前と透析終了時の血中濃度を各3回測定した。その結果、バラツキが認められるものの、透析により血中濃度は平均で86%に減少することが明らかとなった。しかし、薬物濃度そのものは透析を行っていない成人の場合とほぼ同等であり、血中濃度の変化も非透析患者の場合とほぼ同等であった。したがって、本剤は血液透析が必要な腎機能不全患者であっても、用法、用量を調節する必要がなく、安全性に優れた薬剤であると考えられた。

    researchmap

  • 統合失調症患者の主観的及び客観的QOLと家族による生活技能評価との関連の検討

    安藝 浩史, 友竹 正人, 兼田 康宏, 伊賀 淳一, 木内 佐和子, 田吉 純子, 田吉 信哉, 元木 郁代, 森口 和彦, 住谷 さつき, 山内 健, 谷口 隆英, 石元 康仁, 上野 修一, 大森 哲郎

    精神神経学雑誌   ( 2005特別 )   S220 - S220   2005年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 統合失調症外来患者の主観的ウェルビーイングと関連する臨床的諸要因についての検討

    友竹 正人, 安藝 浩史, 兼田 康宏, 伊賀 淳一, 木内 佐和子, 田吉 純子, 田吉 伸哉, 元木 郁代, 森口 和彦, 住谷 さつき, 山内 健, 谷口 隆英, 石元 康仁, 上野 修一, 大森 哲郎

    精神神経学雑誌   ( 2005特別 )   S219 - S219   2005年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 統合失調症患者の主観的及び客観的QOLと家族による生活技能評価との関連の検討

    安藝 浩史, 友竹 正人, 兼田 康宏, 伊賀 淳一, 木内 佐和子, 田吉 純子, 田吉 伸哉, 元木 郁代, 森口 和彦, 住谷 さつき, 山内 健, 谷口 隆英, 石元 康仁, 上野 修一, 大森 哲郎

    精神薬療研究年報   ( 37 )   169 - 176   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    統合失調症患者105例を対象に,主観的QOLと客観的QOLとの関係,家族による生活技能評価と各QOLとの関係,さらに主観的および客観的QOLや,家族による生活技能評価に影響を及ぼす諸要因について検討した.自己評価による主観的QOLには抑うつ症状が,医師の評価する客観的QOLには陰性症状が影響を与え,家族による生活技能評価LSPは抑うつ症状と陰性症状の2つが影響した.主観的QOLと客観的QOLの間にはある程度の相関を認めたが,両者はQOLの異なった側面を反映していると思われた.QOLや生活技能の向上という観点から見ると,抑うつ症状と陰性症状に対する治療が重要であることが示唆された

    researchmap

  • A gene-targeted mouse model for chorea-acanthocytosis

    Yuko Tomemori, Mio Ichiba, Akira Kusumoto, Emiko Mizuno, Daisuke Sato, Shinji Muroya, Masayuki Nakamura, Hiroaki Kawaguchi, Hiroki Yoshida, Shu Ichi Ueno, Kazuki Nakao, Kenji Nakamura, Atsu Aiba, Motoya Katsuki, Akira Sano

    Journal of Neurochemistry   92 ( 4 )   759 - 766   2005年2月

     詳細を見る

    Chorea-acanthocytosis (CHAC) is a hereditary neurodegenerative disorder with autosomal recessive transmission, in which selective degeneration of striatum has been reported in brain pathology. Clinically, CHAC shows Huntington's disease-like neuropsychiatric symptoms and red blood cell acanthocytosis. Recently, we identified the gene, CHAC, encoding a novel protein, chorein, in which a deletion mutation was found in Japanese families with CHAC. In the present study, we have identified the mouse CHAC cDNA sequence and the exon-intron structures of the gene and produced a CHAC model mouse introducing no. 60-61 exon deletion corresponding to a human disease mutation by a gene-targeting technique. The mice began to show acanthocytosis and motor disturbance in old age. In behavioral observations, locomotor activity was significantly decreased and the contact time at social interaction test was decreased significantly in the model mice. In the brain pathology, many apoptotic cells were observed in the striatum of the mutant mice. In neurochemical determinations, the dopamine metabolite, homovanillic acid, concentration decreased significantly in the portion including the midbrain of the mutant mice. These findings are consistent with the human results reported elsewhere and indicate that the CHAC model mice showed a mild phenotype with late adult onset. The CHAC model mouse therefore provides a good model system to study the human disease.

    DOI: 10.1111/j.1471-4159.2004.02924.x

    Scopus

    PubMed

    researchmap

  • 更年期障害に対するparoxetineの使用経験

    友竹 正人, 上野 修一, 伊賀 淳一, 山内 健, 滝川 稚也, 上村 浩一, 安井 敏之, 苛原 稔, 大森 哲郎

    心身医学   45 ( 1 )   69 - 69   2005年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本心身医学会  

    researchmap

  • 近赤外線スペクトロスコピーを用いたWisconsin Card Sorting Testによる脳賦活の検討

    住谷さつき, 田中恒彦, 田吉伸哉, 太田耕士, 亀岡尚美, 上野修一, 大森哲郎

    日本生物学的精神医学会プログラム・講演抄録   27th   137   2005年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 精神症状と全身性ジストニアを呈したホモシスチン尿症の一例 VitB6反応性と分子遺伝学的考察

    伊賀 淳一, 亀山 真和, 花房 徹郎, 吉田 和生, 渡辺 優江, 山内 健, 谷口 隆英, 上野 修一, 大森 哲郎

    四国医学雑誌   60 ( 5〜6 )   202 - 202   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:徳島医学会  

    researchmap

  • 新規抗うつ薬の血中濃度及び治療反応性の検討

    宋 鴻偉, 伊賀 淳一, 山内 健, 上野 修一, 大森 哲郎

    四国医学雑誌   60 ( 5〜6 )   201 - 202   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:徳島医学会  

    researchmap

  • Parkinson病定位脳手術前後での精神症状の変化についての検討

    青野 成孝, 山内 健, 伊賀 淳一, 上野 修一, 大森 哲郎

    精神神経学雑誌   106 ( 11 )   1492 - 1493   2004年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • 統合失調症外来患者の主観的QOLと客観的QOL

    友竹 正人, 伊賀 淳一, 木内 佐和子, 澁谷 純子, 元木 郁代, 住谷 さつき, 山内 健, 小谷 泰教, 兼田 康宏, 谷口 隆英, 石元 康仁, 上野 修一, 大森 哲郎

    精神神経学雑誌   106 ( 11 )   1443 - 1443   2004年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本精神神経学会  

    researchmap

  • DNAチップを用いたうつ病の診断と病態解析

    大森哲郎, 森田恭子, 上野修一, 谷口隆英, 木内佐和子, 田吉純子, 斉藤俊郎, 太田雅之, 六反一仁

    精神神經學雜誌 = Psychiatria et neurologia Japonica   106 ( 8 )   1045 - 1049   2004年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本精神神経学会  

    CiNii Books

    researchmap

  • Subjective and objective measures of quality of life have different symptomatic determinants in people with schizophrenia

    M Tomotake, Y Kaneda, J Iga, S Kinouchi, S Shibuya, Motoki, I, S Sumitani, K Yamauchi, Y Kotani, T Taniguchi, Y Ishimoto, S Ueno, T Ohmori

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   7   S419 - S420   2004年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:CAMBRIDGE UNIV PRESS  

    Web of Science

    researchmap

  • Comparison of the temperament between obsessive-compulsive disorder and idiopathic dystonia

    S Sumitani, M Matsushita, K Wada, M Tomotake, S Ueno, T Yamashita, S Matsumoto, R Kaji, T Ohmori

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   7   S197 - S197   2004年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:CAMBRIDGE UNIV PRESS  

    Web of Science

    researchmap

  • 統合失調症外来患者のQOLに影響を及ぼす諸要因に関する検討

    友竹 正人, 伊賀 淳一, 木内 佐和子, 渋谷 純子, 元木 郁代, 住谷 さつき, 山内 健, 小谷 泰教, 兼田 康宏, 谷口 隆英, 石元 康仁, 上野 修一, 大森 哲郎

    精神薬療研究年報   36 ( 36 )   145 - 152   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    通院中のDSM-IVの診断基準を満たす統合失調症患者99例を対象に,主観的QOLと客観的QOLとの関係を調べ,さらにQOLに影響を及ぼすと考えられる諸要因について検討した.統合失調症患者の主観的QOLと客観的QOLとの間には乖離があり,異なった要因の影響を受けて変化することが示された

    researchmap

  • Identification and functional analysis of the gene CHAC, liable for chorea-acanthocytosis

    S Ueno, Y Tomemori, M Ichiba, E Morita, A Kusumoto, D Satoh, M Nakamura, A Sano

    JOURNAL OF NEUROCHEMISTRY   88   14 - 14   2004年2月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BLACKWELL PUBLISHING LTD  

    Web of Science

    researchmap

  • 徳島大学医学部精神科研修プログラム (特集 新・必修精神科研修プログラム(1)主要病院における研修プラン)

    上野 修一, 大森 哲郎

    精神科   3 ( 1 )   47 - 49   2003年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:科学評論社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2003291791

  • 精神神経疾患と有棘赤血球舞踏病遺伝子CHACの解析研究 査読

    留守 ゆう子, 中村 雅之, 池田 学, 上野 修一, 佐野 輝, 田邉 敬貴

    精神薬療研究年報   ( 35 )   286 - 289   2003年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    神経精神症状に加え有棘赤血球症を示す稀な常染色体劣性遺伝性疾患である有棘赤血球舞踏病(CHAC)患者4症例3家系の連鎖解析・ポジショナルクローニングから病因遺伝子CHACを発見し,病因となるEhime-欠失変異を同定した.この変異をヘテロ接合性にもつ保因者の中に,精神症状を呈する場合があることから,CHAC遺伝子と精神障害との関連を検討した.CHAC遺伝子Exon 69には,GATのトリプレット繰り返し配列が存在するが,これがGAT繰り返し数に多型を示すことを明らかにした上で,Ehime-欠失変異と合わせて精神疾患のケースコントロール研究を行った.その結果,Ehime-欠失変異では気分障害患者では2名ヘテロ接合性に確認されたが,統計学的には有意ではなかった.GAT繰り返し多型では,痴呆で関連する傾向はみられたものの統計学的には有意ではなかった

    researchmap

  • Genetic polymorphisms of serotonin and dopamine transporters in mental disorders

    Shu-ichi Ueno

    Journal of Medical Investigation   50 ( 1-2 )   25 - 31   2003年2月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等  

    Transporter-assisted uptake of serotonin (5-HT) and dopamine (DA) has been accounted for activities in human behavior or mental status, because they are the sites of action of widely used antidepressant and psychoactive drugs. Both the human serotonin transporter (5-HTT) and human dopamine transporter (DAT1) genes are good candidates for etiological involvement in various psychiatric conditions. The serotonin transporter gene has two types of functional polymorphisms. One is serotonin transporter linked polymorphic region (5-HTTLPR) consisting of length variation of the repetitive sequence containing 20-23-bp-long repeat elements in the 5′-upstream region of the gene. Another polymorphism is that serotonin transporter variable number of tandem repeats (5-HTTVNTR) in its second intron. Both polymorphisms affect the transcription ratio of 5-HTT gene and may modify neuronal transmission by changing its protein expression. On the other hand, DAT1 gene has a variable number of tandem repeats type polymorphism (DAT1VNTR) in the 3′-untranslated region of the mRNA, which was also reported to change its gene expression. So polymorphic variations of transporters would change the behavioral and neuropathological tendency. Here, the feature of those two transporters and their relations to psychiatric disorders are described.

    Scopus

    PubMed

    researchmap

  • S. Ueno: Genetic polymorphisms of serotonin and dopamine transporters in mental disorders

    J. Med. Invest   50, 25-31   2003年

     詳細を見る

  • The silencer activity of the novel human serotonin transporter linked polymorphic regions

    Kazuo Sakai, Masayuki Nakamura, Shu Ichi Ueno, Akira Sano, Norio Sakai, Yasuhito Shirai, Naoaki Saito

    Neuroscience Letters   327 ( 1 )   13 - 16   2002年7月

     詳細を見る

    Enhancer/silencer activity of each allelic variant of the human serotonin transporter linked polymorphic region (5-HTTLPR) including newly found ones was measured in several cell lines including raphe-nucleus-derived RN46A. 5-HTTLR variants ligated in pGL-3 promoter vector increased luciferase activity in COS-7 cells and PC12 cells, where no significant differences among the variants were observed. In RN46 cell lines, however, 5-HTTLPRs decreased luciferase activity to 80-30%, acting as silencers not as enhancers. Some allelic variants (15, 19, 20 and 22) showed even significantly stronger silencer activities than others in RN46A. We also examined relationship between allelic frequencies, the enhancer/silencer activities and incidents of mood disorder. The categorized genotypic or allelic frequencies was not significantly different between the mood disorder and the control. No significant difference was detected either when analyzed by silencer activities of each allelic variant. © 2002 Elsevier Science Ireland Ltd. All rights reserved.

    DOI: 10.1016/S0304-3940(02)00348-8

    Scopus

    PubMed

    researchmap

  • 新たな痴呆関連遺伝子 CHACの分子遺伝学の研究 査読

    上野 修一, 留守 ゆう子, 繁信 和恵, 中村 雅之, 田邉 啓貴, 佐野 輝

    精神薬療研究年報   ( 34 )   206 - 212   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    神経精神症状に加え有棘赤血球症を示す遺伝性神経変性疾患である有棘赤血球舞踏病(chorea-acanthocytosis)を3家系4患者を経験した.遺伝子連鎖解析で遺伝子候補領域を狭め,病因遺伝子をポジショナルクローニング法で同定した.発見した病因遺伝子CHACは新規遺伝子で,コードされる遺伝子産物をchoreinと命名した.患者では,欠失変異対立遺伝子をホモ接合性に持ち,choreinを部分的断片にしか合成できないことを予想した.Choreinは,酵母,粘菌,線虫,ショウジョウバエといった下等生物で報告されている構造蛋白質と相同性が高く,高等動物ではいまだ確認されていない新規のカテゴリーに属すると考えられた

    researchmap

  • Positional candidate approach for the gene responsible for benign adult familial myoclonic epilepsy

    Akira Sano, Masaaki Mikami, Masayuki Nakamura, Shu ichi Ueno, Hirotaka Tanabe, Sunao Kaneko

    Epilepsia   43 ( SUPPL. 9 )   26 - 31   2002年

     詳細を見る

    Benign adult familial myoclonic epilepsy (BAFME) is an autosomal dominant idiopathic epileptic syndrome characterized by adult-onset tremulous finger movement, myoclonus, epileptic seizures, and nonprogressive course, recognized in Japanese families. We recently assigned the gene locus to chromosome 8q23.3-q24.11 by linkage analysis. In this study, we identified the sequence of human cDNA encoding Kv8.1, a neuronal modulatory α-subunit of the voltage-gated potassium channel, mapped to human chromosome 8q22.3-8q24.1. Human Kv8.1. cDNA had a 1,500-nucleotide open reading frame encoding a polypeptide of 500 amino acids, in which six hydrophobic transmembrane segments were well conserved, and its overall amino acids homology as compared with those of rat and golden hamster was 95.0% and 95.0%. Tissue-distribution analysis by reverse transcription-polymerase chain reaction (RT-PCR) showed the presence of the Kv 8.1 transcript exclusively in the brain. The analysis of the genomic organization of the human gene revealed consistency of three exons interrupted by two introns each of 1.2 and 3.5 kb. We analyzed the genomic sequence of the patients with BAFME and found no change in the pathogenesis of the disease.

    DOI: 10.1046/j.1528-1157.43.s.9.7.x

    Scopus

    PubMed

    researchmap

  • S.Ueno, Y.maruki, M.Nakamura, Y.Tomemori, K.Kamae, H.Tanabe, Y.Yamashita, S.Matsuda, S.Kaneko,and A.Sano: The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis.

    Nature Genet   28,121-122   2002年

     詳細を見る

  • K.Sakai, M.Nakamura, S.Ueno, A.Sano, N.Sakai, Y.Shirai, and N.Saito: The silencer activity of the novel human serotonin transporter polymorphic regions.

    Neurosci. lett.   327,13-16   2002年

     詳細を見る

  • トランスポーター遺伝子多型と精神疾患との関連研究(第2報) 査読

    中村 雅之, 三神 正昭, 上野 修一, 佐野 輝, 田邊 敬貴

    精神薬療研究年報   ( 33 )   257 - 262   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    シナプス間隙から前シナプス細胞にモノアミンを再取り込みする機能性蛋白質であるモノアミントランスポーターに注目し,セロトニントランスポーターおよびドーパミントランスポーター遺伝子について解析した.ヒトセロトニントランスポーター遺伝子のプロモーター領域上流に転写活性の変化を伴う機能性多型(5-HTTLPR)が報告されているが,前回,これまで報告のあった4種の多型に加えて,10種の新規多型が存在することを確認し,その多型分布に人種差を認めた.ヒトドーパミントランスポーター遺伝子については,5'近傍領域を解析し,新規多型を同定して,その多型分布に人種差を認めたが精神分裂病との間には有意な関連はなかった.今回はそれぞれのトランスポーター遺伝子多型について,気分障害およびパニック障害との関連を検討した

    researchmap

  • The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis

    Shu Ichi Ueno, Yoshiko Maruki, Masayuki Nakamura, Yuko Tomemori, Kazue Kamae, Hirotaka Tanabe, Yoriaki Yamashita, Seiji Matsuda, Sunao Kaneko, Akira Sano

    Nature Genetics   28 ( 2 )   121 - 122   2001年

     詳細を見る

    Chorea-acanthocytosis is a neurodegenerative disorder with peripheral red cell acanthocytosis. Linkage of chorea-acanthocytosis to chromosome 9q21 has been found. We refined the locus region and identified a previously unknown, full-length cDNA encoding a presumably structural protein, which we called chorein. We found a deletion in the coding region of the cDNA leading to a frame shift resulting in the production of a truncated protein in both alleles of patients and in single alleles of obligate carriers.

    DOI: 10.1038/88825

    Scopus

    PubMed

    researchmap

  • 【ゲノム時代の脳神経医学】分子遺伝学 てんかんの分子遺伝学 査読

    上野 修一, 佐野 輝

    Molecular Medicine   37 ( 臨増 ゲノム時代の脳神経医学 )   8 - 15   2000年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中山書店  

    researchmap

  • トランスポーター遺伝子多型と精神疾患との関連研究 査読

    中村 雅之, 三神 正昭, 上野 修一, 佐野 輝, 田邉 敬貴

    精神薬療研究年報   ( 32 )   127 - 134   2000年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    シナプス間隙から前シナプス細胞にモノアミンを再取り込みする機能性蛋白質であるモノアミントランスポーターに注目し,セロトニントランスポーター及びドーパミントランスポーター遺伝子について解析した.ヒトセロトニントランスポーター遺伝子のプロモーター領域上流に転写活性の変化を伴う機能性多型(5-HTTLPR)が報告されているが,これまで報告のあった4種の多型に加えて,10種の新規多型が存在することを確認した.新規多型を加えた14種の5-HTTLPR多型分布において人種差を認めた

    researchmap

  • M.Nakamura, S.Ueno, A.Sano, and H.Tanabe: The Human serotonin transporter genelinked polymorphism(5-HTTLPR) shows ten novel allelic variants.

    Mol. Psychiat   5,32-38   2000年

     詳細を見る

  • The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

    M. Nakamura, S. Ueno, A. Sano, H. Tanabe

    Molecular Psychiatry   5 ( 1 )   32 - 38   2000年

     詳細を見る

    The serotonin transporter (5-HTT) gene is a promising candidate for introducing the heritability of interindividual variation in personality and the genetic susceptibility for various psychiatric diseases. Transcription of the gene is modulated by a common polymorphism in its upstream regulatory region (5-HTT gene-linked polymorphic region: 5-HTTLPR). The 5-HTTLPR consists of variation of the repetitive sequence containing GC-rich, 20-23-bp-long repeat elements. A deletion/insertion in the 5-HTTLPR was first reported to create a short (S) allele and a long (L) allele (14- and 16-repeats, respectively). Three other kinds of alleles (18-, 19- and 20-repeats) in addition to the S and L alleles in 5-HTTLPR have been reported. In the present study, we examined the 5-HTTLPR polymorphism in detail and identified ten novel sequence variants, concluding that the alleles reported as S and L are divided into four and six kinds of allelic variant, respectively. Subsequently, we developed a method for genotyping. The total number of alleles (14-A, 14-B, 14-C, 14-D, 15, 16-A, 16-B, 16-C, 16-D, 16-E, 16-F, 19, 20 and 22) in the 5-HTTLPR was 14 in our populations (Japanese: n = 131; Caucasian: n = 74) in the present study. In addition, a significant ethnic difference between Japanese and Caucasian populations was observed for distributions of alleles and genotypes (P < 0.0001 and P < 0.0001, respectively). Our results suggest that the analyses of the 5-HTTLPR should be revised by genotyping with a more complete subdivision of alleles.

    DOI: 10.1038/sj.mp.4000698

    Scopus

    PubMed

    researchmap

  • ドーパミントランスポーター遺伝子の5'領域多型についての検討

    上野 修一, 中村 雅之, 三神 正昭, 田邉 敬貴, 石黒 浩毅, 有波 忠雄, 小宮山 徳太郎, 三ツ汐 洋, 佐野 輝

    神経化学   38 ( 3 )   314 - 314   1999年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • TRH(thyrotropin-releasing hormone)受容体遺伝子の5'-flanking領域における新規多型の発見とその疾患関連

    三神 正昭, 中村 雅之, 上野 修一, 佐野 輝, 田辺 敬貴

    神経化学   38 ( 3 )   268 - 268   1999年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1

    M Mikami, T Yasuda, A Terao, M Nakamura, S Ueno, H Tanabe, T Tanaka, T Onuma, Y Goto, S Kaneko, A Sano

    AMERICAN JOURNAL OF HUMAN GENETICS   65 ( 3 )   745 - 751   1999年9月

     詳細を見る

    記述言語:英語   出版者・発行元:UNIV CHICAGO PRESS  

    Benign adult familial myoclonic epilepsy is an autosomal dominant idiopathic epileptic syndrome characterized by adult-onset tremulous finger movement, myoclonus, epileptic seizures, and nonprogressive course. It was recently recognized in Japanese families. In this study, we report that the gene locus is assigned to the distal long arm of chromosome 8, by linkage analysis in a large Japanese kindred with a maximum two-point LOD score of 4.31 for D8S555 at recombination fraction of 0 (maximum multipoint LOD score of 5.42 for the interval between D8S555 and D8S1779). Analyses of recombinations place the locus within an 8-cM interval, between D8S1784 and D8S1694, in which three markers, D8S1830, D8S555, and D8S1779, show no recombination with the phenotypes. Although three other epilepsy-related loci on chromosome 8q have been recognized-one on chromosome 8q13-21 (familial febrile convulsion) and two others on chromosome 8q24 (KCNQ3 and childhood absence epilepsy)-the locus assigned here is distinct from these three epilepsy-related loci. This study establishes the presence of a new epilepsy-related locus on 8q23.3-q24.11.

    Web of Science

    researchmap

  • GABAA受容体α4サブユニット遺伝子新規多型とアルコール依存症との関連研究

    中村 雅之, 上野 修一, 三神 正昭, 田邉 敬貴, 有波 忠雄, 石黒 浩毅, 小宮山 徳太郎, 三ツ汐 洋, 佐野 輝

    神経化学   38 ( 3 )   313 - 313   1999年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • セロトニントランスポーター遺伝子多型と精神疾患 査読

    中村 雅之, 上野 修一, 小谷 泰教, 三神 正昭, 佐野 輝, 田邉 敬貴

    精神薬療基金研究年報   ( 31 )   83 - 90   1999年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    これ迄報告されているセロトニントランスポーター(5-HTT)のプロモーター領域の多型が,実は更に数種類以上に細分された

    researchmap

  • Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1

    Masaaki Mikami, Takeshi Yasuda, Akira Terao, Masayuki Nakamura, Shu Ichi Ueno, Hirotaka Tanabe, Toshihiro Tanaka, Teiichi Onuma, Yu Ichi Goto, Sunao Kaneko, Akira Sano

    American Journal of Human Genetics   65 ( 3 )   745 - 751   1999年

     詳細を見る

    Benign adult familial myoclonic epilepsy is an autosomal dominant idiopathic epileptic syndrome characterized by adult-onset tremulous finger movement, myoclonus, epileptic seizures, and nonprogressive course. It was recently recognized in Japanese families. In this study, we report that the gene locus is assigned to the distal long arm of chromosome 8, by linkage analysis in a large Japanese kindred with a maximum two-point LOD score of 4.31 for D8S555 at recombination fraction of 0 (maximum multipoint LOD score of 5.42 for the interval between D8S555 and D8S1779). Analyses of recombinations place the locus within an 8-cM interval, between D8S1784 and D8S1694, in which three markers, D8S1830, D8S555, and D8S1779, show no recombination with the phenotypes. Although three other epilepsy-related loci on chromosome 8q have been recognized one on chromosome 8q13-21 (familial febrile convulsion) and two others on chromosome 8q24 (KCNQ3 and childhood absence epilepsy) - the locus assigned here is distinct from these three epilepsy-related loci. This study establishes the presence of a new epilepsy- related locus on 8q23.3-q24.11.

    DOI: 10.1086/302535

    Scopus

    PubMed

    researchmap

  • Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism

    S. Ueno, M. Nakamura, M. Mikami, K. Kondoh, H. Ishiguro, T. Arinami, T. Komiyama, H. Mitsushio, A. Sano, H. Tanabe

    Molecular Psychiatry   4 ( 6 )   552 - 557   1999年

     詳細を見る

    Human dopamine transporter gene (DAT1) has a variable number of tandem repeats (VNTR) in its 3'-untranslated region (UTR). The association between the VNTR polymorphism and neuropsychiatric disorders has been studied, but their relationship is still unclear. Here we identified a novel polymorphism in the 3'-UTR of the DAT1 gene, G2319A, and a significant association between the polymorphism and alcoholism was observed in both genotypic and allelic frequencies (P = 0.040 and 0.019, extended Fisher's exact test, respectively). There was a significant gene dose effect on the risk for alcoholism associated with the 2319-A allele (χ2 = 6.16, df = 2, P = 0.046, linearity tendency test: Cochranq-Armitage analysis). Moreover, in the haplotype analysis with G2319A- and VNTR-polymorphisms, a positive gene dose efffect on the risk with the A10 allele (P = 0.044, linearity tendency test) and a negative gene dose effect with the G10 allele (P = 0.010, linearity tendency test) for alcoholism were significantly detected. Odds ratio for alcoholism with the A10 and G10 alleles were 1.76 (1.12-2.76) and 0.53 (0.32-0.79), respectively. These results indicate that the DAT1 gene may confer vulnerability to alcoholism.

    DOI: 10.1038/sj.mp.4000562

    Scopus

    PubMed

    researchmap

  • M.Nakamura, S.Ueno, H.Tanabe, and A.Sano: The human homorogue of white gene polymorphisms are associated with mood and panic disorders.

    Mo1.Psychiat.   4,155-162   1999年

     詳細を見る

  • S.Ueno, M.Nakamura, M.Mikami, K.Kondoh, H.Ishiguro, T.Arinami, T.Komiyama, H.Mitsushio, A.Sano, and H.Tanabe: Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcholism.

    Mol.Psychiat   4,552-557   1999年

     詳細を見る

  • Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders

    M. Nakamura, S. Ueno, A. Sano, H. Tanabe

    Molecular Psychiatry   4 ( 2 )   155 - 162   1999年

     詳細を見る

    The Drosophila white gene is a member of the ATP-binding cassette (ABC) transporter superfamily and is involved in the cellular uptake of tryptophan. Its human homologue gene (hW) has been mapped to chromosome 21q22.3. Tryptophan is the precursor for the neurotransmitter serotonin, which has been implicated in the regulation of mood and anxiety. The locus 21q22.3 has also been reported to be associated with mood disorders. The 3'-untranslated region (3'-UTR) in the hW gene has been shown to contain a polymorphic poly(T) region. We have identified a new polymorphism G2457A in the 3'-UTR in the present study. We examined the relationship between these polymorphisms and mood and panic disorders, and a significant association between the poly(T) polymorphisms and mood disorders was detected (P = 0.039 (allele frequency)). Associations were found between the polymorphisms and mood (poly(T) polymorphism: P = 0.047 (allele frequency), G2457A: P = 0.040 (allele frequency), P = 0.044 (genotype frequency)) and panic disorders (G2457A: P = 0.026 (allele frequency), P = 0.011 (genotype frequency)) in males, but not in females. These findings suggest that the hW gene may be an important gene in the control of mood and anxiety as well as one of the genetic factors related to mood disorders and panic disorder in males. The statistical significance of the association remains relatively low and larger materials facilitating further dissection of the clinical phenotype will be needed to confirm and independently validate this finding and to evaluate its significance.

    DOI: 10.1038/sj.mp.4000515

    Scopus

    PubMed

    researchmap

  • ドーパミントランスポーターの多型と精神分裂病との関連研究

    上野 修一, 中村 雅之, 三神 正昭, 近藤 啓次, 佐野 輝

    神経化学   37 ( 3 )   378 - 378   1998年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • 気分障害と21番染色体長腕遺伝子との相関について

    中村 雅之, 三神 正昭, 小谷 泰教, 上野 修一, 佐野 輝, 田邉 敬貴

    日本体質学雑誌   60 ( 2 )   119 - 120   1998年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本体質医学会  

    researchmap

  • 6番染色体短腕マーカーと精神分裂病の相関研究及び毛様体神経栄養因子,セロトニントランスポーター遺伝子多型と精神疾患

    小谷 泰教, 中村 雅之, 三神 正昭, 上野 修一, 佐野 輝, 田邉 敬貴

    日本体質学雑誌   60 ( 2 )   120 - 120   1998年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本体質医学会  

    researchmap

  • 気分及びパニック障害とヒトWhite遺伝子多型との関連研究

    中村 雅之, 上野 修一, 佐野 輝

    神経化学   37 ( 3 )   378 - 378   1998年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • 気分及びパニック障害とセロトニントランスポーター遺伝子多型との関連研究

    中村 雅之, 上野 修一, 佐野 輝

    神経化学   37 ( 3 )   378 - 378   1998年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    researchmap

  • 脳科学シリ-ズ-22-精神と遺伝子

    上野修一, 佐野輝

    臨床科学   34 ( 5 )   673 - 680   1998年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:エ-スア-ト  

    CiNii Books

    researchmap

  • 【精神神経疾患の分子遺伝学】三塩基繰り返し配列の伸長と精神神経疾患

    上野 修一, 小牟禮 修, 佐野 輝

    脳と精神の医学   8 ( 3 )   245 - 254   1997年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生物学的精神医学会  

    researchmap

  • トリプレットリピ-ト病--臨床的側面からみた分子病態

    小牟礼修, 上野修一, 佐野輝

    蛋白質核酸酵素   42 ( 11 )   1840 - 1857   1997年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:共立出版  

    CiNii Books

    researchmap

  • Triplet repeat disorders: from the clinical view

    O. Komure, S. Ueno, A. Sano

    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme   42 ( 11 )   1840 - 1857   1997年8月

     詳細を見る

    掲載種別:書評論文,書評,文献紹介等  

    Scopus

    PubMed

    researchmap

  • 悪性症候群発症の遺伝的背景に関する研究 査読

    上野 修一, 佐野 輝, 田邉 敬貴

    精神薬療基金研究年報   ( 28 )   238 - 241   1997年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    一組の母娘を含む9名の悪性症候群患者について検討した.抗精神病薬の代謝に関与するチトクロームP450群の酵素CYP2D6では遺伝的多型が認められるが,悪性症候群患者群では酵素活性低下を起こすA変異及びB変異は認めなかった.A'変異については家系症例で変異を示した以外は全て野生型であった.ドーパミンの再取り込みに関与するドーパミントランスポーター遺伝子の多型については,3'-非翻訳領域繰り返し配列に日本人コントロールと差を認めなかった

    researchmap

  • てんかん関連遺伝子 査読

    佐野 輝, 上野 修一

    Medical Practice   14 ( 1 )   158 - 159   1997年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)文光堂  

    researchmap

  • 精神医学における分子生物学的研究 歯状核赤核淡蒼球ルイ体萎縮症の分子生物学的研究 査読

    上野 修一, 山内 紀子, 佐野 輝

    精神医学   38 ( 11 )   1197 - 1201   1996年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    DOI: 10.11477/mf.1405905024

    researchmap

  • EHOC-1遺伝子のalternative splicingおよび組織発現

    上野修一, 中村雅之, 佐野輝, 田邉敬貴, YAMAKAWAK, KORENBERGR

    神経化学   35 ( 3 )   254 - 255   1996年9月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Cytochrome P-450 2D6 gene polymorphism is not associated with neuroleptic malignant syndrome 査読

    Shu Ichi Ueno, Koichi Otani, Sunao Kaneko, Kazuko Koshiro, Keiji Kondoh, Yasunori Kotani, Akira Sano

    Biological Psychiatry   40 ( 1 )   72 - 74   1996年7月

  • A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo

    Yasunori Kotani, Seiji Matsuda, Tong Chun Wen, Masahiro Sakanaka, Junya Tanaka, Nobuji Maeda, Keiji Kondoh, Shu Ichi Ueno, Akira Sano

    Journal of Neurochemistry   66 ( 5 )   2197 - 2200   1996年5月

     詳細を見る

    Prosaposin, a 517-amino-acid glycoprotein, not only acts as the precursor of saposin A, B, C, and D but also possesses neurotrophic activity to rescue hippocampal CA1 neurons from ischemic damage in vivo and to promote neurite extension of neuroblastoma cells in vitro. Recently, the trophic activity of prosaposin on human neuroblastoma cells has been shown to reside in the NH2- terminal hydrophilic sequence (LIDNNRTEEILY) of the human saposin C. Here we show that prosaposin, saposin C, and a peptide comprising the 18-amino-acid sequence (18-mer peptide; LSELIINNATEELLIKGL) located in the NH2-terminal hydrophilic sequence of the rat saposin C-domain promoted survival and neurite outgrowth of cultured rat hippocampal neurons in a dose-dependent manner. Moreover, infusion for 7 days of the 18-mer peptide into the lateral ventricle of gerbils, starting either 2 h before or immediately after 3 min of forebrain ischemia, protected ischemia-induced learning disability and hippocampal CA1 neuronal loss. Thus, we ascribe the in vitro and in vivo trophic actions of prosaposin on hippocampal neurons to the linear 18-mer sequence and raise the possibility that this peptide can be used as an agent for the treatment of forebrain ischemic damage.

    DOI: 10.1046/j.1471-4159.1996.66052197.x

    Scopus

    PubMed

    researchmap

  • Prosaposin facilitates sciatic nerve regeneration in vivo(共著) 査読

    Journal of Neurochemistry   66 ( 5 )   2019 - 2025   1996年5月

  • プロサポシンの末梢神経再生促進作用のターゲット神経細胞

    小谷泰教, 松田正司, 阪中雅広, 近藤啓次, 上野修一, 佐野輝

    神経化学   34 ( 2 )   274 - 275   1995年6月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Somatic mosaicism of CAG repeat in dentatorubral-pallidoluysian atrophy (DRPLA) (共著) 査読

    Human Molecular Genetics   4 ( 4 )   663 - 666   1995年4月

  • DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation(共著) 査読

    Neurology   45 ( 1 )   143 - 149   1995年1月

  • NEUROTROPHIC EFFECTS OF PROSAPOSIN

    Y KOTANI, K KONDOH, S MATSUDA, M SAKANAKA, S UENO, A SANO

    JOURNAL OF NEUROCHEMISTRY   65   S178 - S178   1995年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT-RAVEN PUBL  

    Web of Science

    researchmap

  • SOMATIC MOSAICISM OF DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY GENE

    S UENO, K KONDOH, Y KOTANI, O KOMURE, H KUNO, J KAWAI, F HAZAMA, A SANO

    JOURNAL OF NEUROCHEMISTRY   65   S147 - S147   1995年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT-RAVEN PUBL  

    Web of Science

    researchmap

  • Protection by prosaposin against ischemia-induced learning disability and neuronal loss 査読

    Akira Sano, Seiji Matsuda, Tong Chun Wen, Yasunori Kotani, Keiji Kondoh, Shu Ichi Ueno, Yasuo Kakimoto, Hiroyuki Yoshimura, Masahiro Sakanaka

    Biochemical and Biophysical Research Communications   204 ( 2 )   994 - 1000   1994年10月

     詳細を見る

    Prosaposin, the protein precursor of saposins A, B, C, and D which activate sphingolipid hydrolases, is abundant in several brain regions including the hippocampus. We infused prosaposin continuously for 7 days into the lateral ventricle of gerbils starting 3 hours before 3-min of forebrain ischemia. Using the step-down passive avoidance task, we demonstrated that ischemia-induced learning disability is prevented almost completely by prosaposin infusion. Subsequent light and electron microscopic examinations showed that pyramidal neurons in the CA1 field of the hippocampus as well as synapses within the strata moleculare, lacunosum/radiatum and oriens of the field were significantly more numerous in gerbils infused with prosaposin infusion than in those receiving saline infusion. These findings suggest that prosaposin possesses neurotrotrophic activity to protect hippocampal CA1 neurons from lethal ischemic damage. © 1994 Academic Press, Inc.

    DOI: 10.1006/bbrc.1994.2558

    Scopus

    researchmap

  • The 3'-untranslated region of mouse myelin basic protein gene increases the amount of mRNA in immortalized mouse oligodendrocytes 査読

    Shu Ichi Ueno, Yasunori Kotani, Keiji Kondoh, Akira Sano, Yasuo Kakimoto, Anthony T. Campagnoni

    Biochemical and Biophysical Research Communications   204 ( 3 )   1352 - 1357   1994年

     詳細を見る

    The 3'-untranslated region (UTR) of the myelin basic protein (MBP) mRNA has been found previously to enhance the translational efficiency of the coding region by two-fold in cell-free translational systems. In this study, we transfected eukaryotic expression vectors containing the reporter cDNA for chloramphenicol acetyltransferase (CAT) with or without the mouse MBP cDNA 3'-UTR into cultured cells. CAT activity in the mouse oligodendrocyte cell line, N20.1, transfected with a CAT cDNA containing the MBP 3'-UTR [CAT-MBP 3'-UTR], was twice as high as that of the CAT cDNA without the 3'-UFR; CAT activities for the two constructs were the same in the mouse fibroblast cell line, NIH 3T3. Using reverse transcriptase PCR quantitative analysis, the expression of mRNA was determined. The level of the [CAT-MBP 3'-UTR] mRNA was about ten times higher than CAT mRNA in N20.1 cells but they were the same in NIH 3T3 cells. We conclude that the 3'-UTR of MBP gene increases gene expression at both the mRNA and protein levels in oligodrocyte cell lines, probably through a post-transcriptional mechanism such as message stabilization. © 1994 Academic Press, Inc.

    DOI: 10.1006/bbrc.1994.2612

    Scopus

    researchmap

  • Saposin-C from bovine spleen; complete amino acid sequence and relation between the structure and its biological activity 査読

    Akira Sano, Tatsuo Mizuno, Keiji Kondoh, Takashi Hineno, Shu ichi Ueno, Yasuo Kakimoto, Naoki Morita

    Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular   1120 ( 1 )   75 - 80   1992年3月

     詳細を見る

    Saposin-C, a small acidic glycoprotein that can activate glucosylceramide-ß-glucosidase, has been isolated from bovine spleen. The complete amino acid sequence of bovine saposin-C was determined by Edman degradation of the purified protein and its fragmented peptides. It contains 80 amino acids, one carbohydrate chain attached to a single aspargine residue and six cysteine residues in oxidized form. The sequence of bovine saposin-C is 76 and 65% identical with the sequences of saposin-C from human spleen and guinea pig liver, respectively. Hydropathy profiles of the sequence of saposin-C from three species were similar despite the significant residue substitutions. Bovine saposin-C had a stronger effect in stimulating bovine ß-glucosidase compared to human saposin-C. However, the effect of human saposin-C in stimulating human enzyme was stronger than that of bovine saposin-C. The region around residue 35, which is next to the extremely hydrophilic region, seems to be important to produce an interaction with the enzyme. © 1992.

    DOI: 10.1016/0167-4838(92)90426-E

    Scopus

    PubMed

    researchmap

  • 恐慌性障害を呈したTurner症候群の1例 査読

    上野 修一, 佐野 輝, 岡田 謙

    精神医学   33 ( 12 )   1357 - 1359   1991年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    DOI: 10.11477/mf.1405903168

    researchmap

  • Secretion of sphingolipid hydrolase activator precursor, prosaposin 査読

    Takashi Hineno, Akira Sano, Keiji Kondoh, Shu ichi Ueno, Yasuo Kakimoto, Ken ichi Yoshida

    Biochemical and Biophysical Research Communications   176 ( 2 )   668 - 674   1991年4月

     詳細を見る

    Sphingolipid hydrolases are activated by activator proteins or saposins. The precursor protein has been expected from the studies on the cDNA for saposins. Here we demonstrate that prosaposin occurs in various kinds of human secretory fluids such as cerebrospinal fluid, semen, milk, pancreatic juice, and bile. However, mature type saposins were not detected in these fluids. In human milk the amount of prosaposin changed during the lactating period; it became high in concentration within a few days after delivery, decreased during the transitional milk lactating stage, and then increased again toward the mature milk lactating stage. Prosaposin was released from human platelets in response to stimulation by thrombin, but mature saposins were not. From the time course of the release of prosaposin induced by thrombin and from the fact that weak platelet agonists, ADP, epinephrine, and collagen, did not cause the release of prosaposin, prosaposin secretion from platelets seemed to be from lysosome like granules. We postulate that some prosaposin works as a precursor for saposins in the lysosomes and the other serves as an extracellular protein with other specific roles. © 1991 Academic Press, Inc.

    DOI: 10.1016/S0006-291X(05)80236-0

    Scopus

    PubMed

    researchmap

  • Isolation and Identification of alpha-(beta- Alanyl)-Hypusine from Bovine Brain(共著) 査読

    Biochimica et Biophysica Acta   1073 ( 1 )   233 - 235   1991年1月

  • Further Studies on D-3-Aminoisobutyrate-pyruvate Aminotransferase(共著) 査読

    Biochimica et Biophysica Acta   1035 ( 2 )   128 - 131   1990年8月

  • Purification and characterization of D-3-aminobutyrate-pyruvate aminotransferase from rat liver(共著) 査読

    Biochimica et Biophysica Acta   1033 ( 2 )   169 - 175   1990年2月

  • Sphingolipd Hydrolase Activator Proteins and Their Precursors(共著) 査読

    Biochemical and Biophysical Research Communications   165 ( 3 )   1191 - 1197   1989年12月

  • Distribution of α‐(γ‐Aminobutyryl)‐Hypusine 査読

    Akira Sano, Kazuhiko Kotani, Shuichi Ueno, Yasuo Kakimoto

    Journal of Neurochemistry   48 ( 3 )   681 - 683   1987年3月

     詳細を見る

    Abstract: The distribution of α‐(γ‐aminobutyryl)‐hypusine was examined in several organs of the rabbit and in the brain of the rat, rabbit, dog, ox, and monkey. The peptide occurred only in the brains, but appeared to be absent from dog brain. Concentrations were higher in the cerebral hemispheres than in other portions of the brain. No significant difference between white and gray matter was observed. Copyright © 1987, Wiley Blackwell. All rights reserved

    DOI: 10.1111/j.1471-4159.1987.tb05569.x

    Scopus

    PubMed

    researchmap

  • α-(γ-アミノブチリル)-ハイプシンの分布 査読

    佐野 輝, 胡谷 和彦, 上野 修一

    神経化学   25 ( 1 )   202 - 204   1986年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経化学会  

    α-(γ-アミノブチリル)-ハイプシンの定量法を開発し,ほ乳類における臓器分布,脳内分布および種差について検索を行った.定量法は,組織をトリクロル酢酸でホモジナイズし,その遠心上清からイオン交換樹脂を用いてα-(γ-アミノブチリル)-ハイプシンを含む分画を得た後,陽イオン交換樹脂を用いた高速液体クロマトグラフィーにより定量した.本ペプチドはウサギ臓器において脳に特異的に検出された.またウシ,ウサギ,ラット,サル脳内には1〜10 nmole/g wet weight検出された.一方イヌ,ネコの脳内からは検出されなかった.さらにサル脳内における詳細な分布を検索した結果,大脳半球に最も高濃度存在した.白質と灰白質の間では有意の濃度差は検出されなかった

    researchmap

▼全件表示

Works(作品等)

  • 有棘赤血球症病因遺伝子の発現に関する研究

    2002年

     詳細を見る

  • the sutdy for the expression of chorein

    2002年

     詳細を見る

共同研究・競争的資金等の研究課題

  • 一酸化窒素系を介した精神障害の発症機序を遺伝学的に解析する集団ベース研究

    2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    上野 修一, 田原 康玄, 三宅 吉博, 伊賀 淳一, 大澤 春彦

      詳細を見る

    配分額:17550000円 ( 直接経費:13500000円 、 間接経費:4050000円 )

    一酸化窒素(NO)は、統合失調症や認知症との関連も報告されている重要な物質である。NO合成を調節する2つの酵素アラニン:グリオキシル酸アミノ基転移酵素2(AGXT2)とジメチルアルギニンジメチルアミノ水酸化酵素(DDAH)が、高齢者の生活習慣病や認知症の発症に関連するかどうかを検討した。AGXT2遺伝子の4つの多型およびDAAH1遺伝子の5多型を用いて、65歳以上の全住民を対象とした集団ベース研究の解析(750名、平均年齢77.0 ± 7.6 歳)から、血圧および血糖値とAGXT2遺伝子が有意に相関することを確認した。一方、DDAH1とは関連しなかった。

    researchmap

  • エクソーム解析と遺伝子発現解析を利用した精神障害の解析研究

    2016年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業  挑戦的萌芽研究

    上野 修一

      詳細を見る

    配分額:3380000円 ( 直接経費:2600000円 、 間接経費:780000円 )

    2つの家系解析を行った。1つめの家系は、7名の発症者がおり、知的障害、筋力低下、幻覚妄想を認めた。2つめの家系は、4人同胞のうち2名が二次性徴がなく知的障害を認めた。双方の病因遺伝子の決定のため、倫理委員会で承認されたインフォームドコンセントの後、血液を採取し解析した。その結果、最初の家系では7遺伝子まで絞り込めたものの決め手がなく病因遺伝子は決定できていない。次の家系では、1遺伝子変異を確認したが、劣性遺伝と考えられるものの発症者はヘテロ接合性であり、末梢血白血球mRNA発現解析でも変化していなかった。以上から、新たな症例や家系の追加やモデル動物を用いた研究を追加する必要があると思われた。

    researchmap

  • ラットによる間歇型一酸化炭素中毒の病態解明及び治療の究明

    2016年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業  若手研究(B)

    越智 紳一郎, 上野 修一, 伊賀 淳一, 西原 佑

      詳細を見る

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    ラットを意識障害を起こすまで一酸化炭素(CO)に暴露した後、3週間認知機能低下を受動回避試験により確認し、間歇型CO中毒モデルラットを作成した。
    免疫染色では、CO群で、ミクログリアとSOX2陽性神経細胞の細胞数が減少傾向にあること、ミクログリアの形態異常を確認した。またアストロサイトの細胞数が増加傾向にあることを認めた。更に海馬組織を単細胞懸濁液に分散し、セルソーターで分離し・定量的に解析したところ、CO群で有意にミクログリアの減少を認めた。これらのことから、間歇型CO中毒の認知機能障害はグリア細胞の異常を介して海馬の成体細胞神経新生に影響を及ぼすことが関与している可能性が示唆された。

    researchmap

  • アミノ酸転移酵素AGXT2に注目した精神障害の解析研究

    2013年 - 2015年

    文部科学省  科学研究費補助金(基盤研究(B))  基盤研究(B)

    上野 修一, 安部 賢郎

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:10400000円 ( 直接経費:8000000円 、 間接経費:2400000円 )

    まず、alanine:glyoxylate aminotransferase 2(AGXT2)の脳内分布を調べるために、ラットを用い、AGXT2遺伝子mRNAの脳内分布を調べた。ラットの脳組織(大脳皮質、大脳白質、線条体、視床、中脳、橋、小脳)よりRNA分画を精製しcDNAを作成する。そのあと、AGXT2遺伝子mRNAに特異的Taqman probeを用い定量的real-time PCR法を行い、各組織でのAGXT2mRNA定量を行った。内部標準としてGAPDH遺伝子を用いた。その結果、ラットのすべての脳組織でAGXT2遺伝子が発現していることが確認され、有意ではないが、大脳皮質や海馬に発現が多かった。AGXT2遺伝子には、機能性多型があり、日本人の約3割がこの酵素活性を欠損していることがわかっている。AGXT2活性の欠損するものでは、尿中のアミノイソ酪酸量が増加することから、AGXT2遺伝子の機能性多型を調べるため、5名の日本人のすべてのエクソンを含む領域の遺伝子配列を決定し、尿中アミノイソ酪酸との関連を調べた。3つのAGXT2遺伝子の一塩基多型と尿中アミノイソ酪酸量と関連することを確認した後、健常日本人85名の尿中アミノイソ酪酸量を定量し、確認した。その結果、既に報告のある3番エクソンにあるrs37370および4番エクソンにあるrs37369の他に、6番エクソンにあるrs180749の一塩基多型も関係していることがわかった。これらの多型はすべて連鎖平衡の位置にあるため、異なった創始者効果を持っていると考えられた。また、これら3つの一塩基多型以外にAGXT2活性に影響を与える多型は存在しないことを確認した。

    researchmap

  • DNAチップを用いた間歇型一酸化中毒への進展を予測する指標作成のための研究

    2011年 - 2012年

    文部科学省  科学研究費補助金(挑戦的萌芽研究)  挑戦的萌芽研究

    上野 修一, 吉田 謙一

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3640000円 ( 直接経費:2800000円 、 間接経費:840000円 )

    急性一酸化炭素中毒から一旦回復した後の間歇型一酸化炭素中毒の原因は不明である。今回、ラットを用い間歇型一酸化炭素中毒モデルを作成し、その行動変化および脳内の遺伝子発現変化を網羅的に DNA チップを用い調べた。受動的回避行動試験では、2 週後から有意な障害が認められモデル動物となることを確認した。このラットを 3 週後断頭し、海馬での遺伝子発現をDNA チップを用いてコントロールラットと比較して調べたが、遺伝子発現に有意な変化は確認できなかった。今後、例数を増やし検討する予定である。

    researchmap

  • クリニカルパスを用いた精神科看護管理支援システムの開発・評価・改良

    2008年 - 2011年

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    谷岡 哲也, 川西 千恵美, 上野 修一, 友竹 正人, 片岡 三佳, 千葉 進一, 安原 由子, 任 福継, 大坂 京子, 松本 和幸, 三品 賢一, 高坂 要一郎, 三船 和史

      詳細を見る

    配分額:18200000円 ( 直接経費:14000000円 、 間接経費:4200000円 )

    コンピュータを用いて各種クリニカルパス(以下,パス)を作成し,患者アウトカムを看護管理支援システムで管理し,看護管理者役割の一部を支援することが研究目的である.
    完成させたプログラムは,コンピュータによるパスの管理,多職種による患者アウトカムの管理,バリアンスの蓄積と解析,看護日誌システム,看護計画システムと看護管理支援システムである.今後の研究開発の課題はシステムの標準化と商品化である。

    researchmap

  • 末梢血白血球遺伝子発現からの機能性精神障害の解明

    2007年 - 2008年

    文部科学省  科学研究費補助金(基盤研究(C))  基盤研究(C)

    上野 修一, 大森 哲郎, 沼田 周助

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    機能性精神障害(統合失調症、気分障害など)を対象に、末梢血白血球遺伝子発現を指標にして病因候補遺伝子を抽出し、候補遺伝子との相関研究を行った。その結果、末梢血白血球のmRNA量は、統合失調症では、PDLIM5およびTGFBR2遺伝子発現量が、うつ病では、HDAC5およびCREB、VEGF遺伝子発現量が変化しており、状態像を示す候補遺伝子マーカーとして挙げられた。一方、疾患対照相関解析から、統合失調症ではPDE4B遺伝子、うつ病ではPCNT2遺伝子が、その発症の脆弱性に関与する疾患特異的マーカーと思われた。

    researchmap

  • 高磁場MRSを用いた脳内アミノ酸神経伝達物質動態による気分、不安障害の解明

    2006年 - 2007年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    住谷 さつき, 原田 雅史, 上野 修一

      詳細を見る

    配分額:3890000円 ( 直接経費:3500000円 、 間接経費:390000円 )

    機能性精神疾患における神経細胞の機能や代謝の異常を解明するために、3Teslaの高磁場MR装置を用いて気分、不安障害患者の帯状回、左右基底核におけるプロトンMRS (proton magnetic resonance spectroscopy:^1H-MRS)の撮像を行った。中でもこれまで検出困難であったグルタミン酸やGABAなどの脳内アミノ酸神経伝達物質の変化に注目した。
    強迫性障害患者は帯状回でN-acetyl aspertate: NAAの有意な低下がみられグルタミン酸も健常者と比較して有意に低値であった。GABAは低値となる傾向があるものの、有意な差は見られなかった。基底核における強迫性障害患者のNAAは健常者と比較して高い傾向があり、右が左に比べて有意に高かったが、脳内アミノ酸神経伝達物質は健常者との間に有意な差はなく左右差も見られなかった。パニック障害患者では右基底核におけるグルタミン酸+グルタミンが健常者よりも有意に高かった。大うつ病障害患者では帯状回でグルタミン酸が健常者よりも有意に低かった。
    今回の研究では高磁場装置による強迫性障害、パニック障害、大うつ病における脳内アミノ酸神経伝遠物質の定量が行われ、それぞれの疾患に特有な脳部位における脳内代謝物変化が生じているという知見を得た。今後は症例数を増やし臨床症状の特徴との関連、薬物の影響を検討し、治療前後での比較を行うことを計画している。

    researchmap

  • 機能的神経・精神疾患における高磁場MRIを用いた脳内分子機構の可視化と病態評価

    2005年 - 2006年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    原田 雅史, 梶 龍兒, 上野 修一, 久保 均

      詳細を見る

    配分額:3900000円 ( 直接経費:3900000円 )

    (目的)臨床用3Tesla装置によるニューロトランスミッターに関連する代謝物として興奮性シナプスのグルタミン酸に加えて抑制性シナプスのγ-amino酪酸を中心に検出法を検討した。昨年開発したMEGA-PRESSによるJ-difference subtraction法を用いて、測定部位内の組織の特異性や容積効果を補正した指標を考案して検討に加えた。差分前のスペクトルからNAA及びCrの値を基準としてニューロン内や脳組織内のGABA濃度を反映するGABAnergic indexを作成して評価を試みた。(対象と方法)対象は正常ボランティア5名と脳回異常を有する小児5名である。使用した装置は臨床用3テスラMRI装置(Signa 3T Excite)であり、信号の送受信には頭部用標準コイルを用いた。MEGA-PRESS法を用いて1.9ppmの周波数選択パルスを印加したスペクトルと印加しないスペクトルとを差分することにより3.01ppmのGABAの信号を評価した。測定条件はTR=1500ms, TE=67ms,積算=256回,FOV=27mlである。周波数選択パルスを印加しないスペクトルのNAA信号をneuronal densityとして、Cr信号をbrain tissue densityとしてGABAの信号を較正した。(結果及び考察)正常者の脳内部位の相違によるGABA濃度の違いは、基底核部で最も高く、前頭葉白質、帯状回の順で低かった。Crを指標として脳脊髄液等の脳組織以外の構成を較正した指標でも、同様の傾向であったが、NAAを指標とした場合、前頭葉と帯状回とでは有意差が認められなかった。これは前頭葉と帯状回とでニューロンと非ニューロン内のGABA濃度の分布に相違があることを示唆すると考えられた。GABAの外部摂取では、血圧低下等の生理的変化が認められ、脳内では前頭葉のGABA濃度及びGABAnergic indexの増加が認められた。脳回異常ではneuronal GABAnergic indexの上昇が著明であった。(結語)GABA濃度測定に加えて、他の代謝物の指標を用いることにより部分容積効果の回避と組織成分におけるGABA分布の相違を評価可能と考えられた。

    researchmap

  • 統合失調症のQOLを含めた薬物治療反応の継時的評価と薬物応答性の解析

    2004年 - 2005年

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    大森 哲郎, 六反 一仁, 板倉 光夫, 上野 修一

      詳細を見る

    配分額:10800000円 ( 直接経費:10800000円 )

    統合失調症を出来る限り抗精神病薬単剤で治療し、臨床症状とQOLの継時的な観察を行った。同時に、治療反応を規定する状態依存的な要因として、白血球内に発現するmRNA発現の変化を探索した。さらに遺伝子規定的な要因として、遺伝子多型(SNP)解析を行い薬物応答性の個体差の分子遺伝学的解析を行った。まず調査研究を行い、自己評価QOLには抑うつ症状が、観察者評価QOLには陰性症状が、家族による生活技能評価には抑うつ症状と陰性症状が規定因子として重要であることを示した。これらの所見はQOLと生活技能の向上には、抑うつ症状と陰性症状に着目する必要性を示唆している。白血球内mRNA発現においては統合失調症特有の変化があることを示唆する所見を得た。これらが診断および治療に有用な生物学的指標となるかを、リアルタイムRT-PCRを用いて引き続き検討している。遺伝子多型解析では慢性例の解析を先行させ、臨床症状を取りながら数百の検体を収集し、遺伝子を抽出した。これまでに、BDNFのVal66Met多型において、Met保有例においては発症年齢が低いことを見出した。またBDNFVal66Met多型は長期抗精神病薬治療後に残存する症状とも関連があることを示した。これらの所見を初発例の経時的な臨床経過を追いながら前方視的にも検討している。また、高磁場3テスラMRI装置が使用可能となったので研究企画の中に画像解析を組み込み複合的な検討も開始している。

    researchmap

  • 治療的コミュニケーション技術を教育するための「客観的感情表示システム」の作成

    2003年 - 2006年

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    谷岡 哲也, 上野 修一, 多田 敏子, 橋本 文子, 松下 恭子, 任 福継, 永峰 勲

      詳細を見る

    配分額:11400000円 ( 直接経費:11400000円 )

    平成15年度には,音声に含まれる感情に起因する成分と音声認識により得られた言語情報を用いた実験を行った.同年11月に「15年度科学研究費補助金交付決定」が通知されたため,通知を受けて即座に,「脳波・言語・音声情報を融合した感情推定モデル」作成するための実験装置を作成する準備を行った.具体的には,(1)本研究を行う上で,脳波データから人間の基本的な感情要素(喜怒哀楽など)の時間変化を解析することが重要であるため,株式会社エヌエフ回路設計ブロック製「感性スペクトル解析装置ESA-16」を購入した.次に,(2)言語および音声から得られるデータ解析を行うためのマイク装置一式を購入し,前述した(1)と(2)を同期させたデータを収集するための実験環境の整備を行った.
    平成16年度には,平成15年度に作成した実験装置群を基にして,「脳波・言語・音声情報を融合した感情推定モデル」を検討し,作成した感情推定モデルを検討するための予備実験を行った.具体的には,脳波と言語・音声・表情情報を融合した,データ収集方法を実験により確認した.感情データ特性の解析手法が未だ構築されていないため,感性の中でも感動時における脳波活動からその特性波形を抽出する実験プロトコルと解析手法の概念枠組みを同定し,それを実証するための実験を重ねた.
    平成17年度は,治療的コミュニケーション技術の中でも特に重要な「ケアリング」の特性を実験プロトコルに組み込み実験を行った.その成果は,9月にスペインのBenidormで行われたThe 9th IASTED International Conference on ARTIFICIAL INTELLIGENCE & SOFT COMPUTING 2005,また10月に中国の武漢で行われたIEEE International Conference on Natural Language Processing and Knowledge Engineeringで発表した.
    平成18年度は,感情推定モデルを用いて「客観的感情表示システム」のシステム化のフローを作成し,その方向性を示した.さらに脳波を用いた感情分析とケアリングとの関係などについて,オーストラリアで行われたInternational Association for Human Caring Conference,またフィリピンで行われたThe 10th East Asian Forum on Nursing Science Conferenceなどで発表した.

    researchmap

  • DNAマイクロアレイを用いた精神疾患の素因と発病準備性の探索的研究

    2003年 - 2004年

    日本学術振興会  科学研究費助成事業  萌芽研究

    大森 哲郎, 六反 一仁, 上野 修一

      詳細を見る

    配分額:3200000円 ( 直接経費:3200000円 )

    我々は、神経伝達・免疫・内分泌あるいはストレス応答に関連する千数百種のmRNA発現量をマイクロアレイによって一括定量する画期的な方法を確立した。必要なサンプルはわずか2.5mlの血液であり、定量精度は従来のマイクロアレイ法をはるかに上回る。本研究は、このマイクロアレイを用いて罹患時に対照群に比較して発現の増減が認められ、その変化が回復後にも持続しているmRNA群を探索するものである。このようなmRNA群は素因あるいは発症準備状態に関連している可能性がある。従来の素因研究とは異なった観点から、精神疾患の素因あるいは発症準備性にアプローチすることを可能とする新たな研究戦略である。これまでに気分障害約30例、統合失調症約10例、不安障害約20例について、治療前と回復後のサンプルを得て、順次マイクロアレイ解析を終了している。研究期間内には、うつ病の解析が最も進み、治療前に全例にほぼ共通して有意に発現量が変化している遺伝子約20種が見つかった。また、クラスター解析から、うつ病の半数では変化するが残る半数では変化しない遺伝子群も約50種存在した。これらの変化は、健常者のストレス負荷時の所見や統合失調症の所見とは異なっていた。以上の所見は、mRNAの発現パターンが、うつ病の診断や治療の評価方法としてきわめて有用なことを示唆している。これらのうつ病における所見のうち、うつ病の半数で発現量の変化する遺伝子群は治療後に正常化するのに対し、全例に共通して発現量の変化する遺伝子の多くは治療後にも変化が見られなかった。したがって、後者の変化は素因と関連する可能性が示唆された。現在論文を準備している。またうつ病以外の精神疾患に関しても予備的なデータを得ている。マイクロアレイ法で発現量の変動している遺伝子群に注目して、素因解明につなげてゆく手法は、先駆的な報告が始まったばかりである。本研究によって神経伝達・免疫・内分泌あるいはストレス応答に関連する遺伝子に着目する我々の方法の有効性が実証された。

    researchmap

  • ストレス関連遺伝子発現を指標とした精神疾患の縦断的研究

    2002年 - 2003年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    永峰 勲, 上野 修一, 六反 一仁, 大森 哲郎, 友竹 正人, 山内 健

      詳細を見る

    配分額:3500000円 ( 直接経費:3500000円 )

    統合失調症、気分障害、不安障害などの精神疾患は、青年期以降に発症する精神疾患であり、その頻度は極めて高いうえに、社会的にも損失となることが多い。早期に診断し、治療する事がこれらの疾病においては重要である。しかしながら、精神疾患の診断においては、生物学的な指標がなく、病歴の聴取と現症把握に基づいて熟練した精神科医が専門的な知識に基づき判断しなくてはならない。今回の研究では、精神疾患の病態の把握や診断、治療および予後を測定できる方法として、簡便に行える血液を用いた解析を検討する事とした。まず、精神疾患のために徳島大学病院を初診した薬物治療を受けていない患者において、ICD-10に準拠して診断し、重症度を質問紙法で評価し、末梢血白血球から発現mRNAを取り出した。この発現遺伝子の差を精神疾患患者群と健常対照群で比較すると同時に、治療により改善した後にも採血し治療前後をも比較した。具体的にはそれぞれのmRNAを逆転写しDNAとした後に、RNAポリメラーゼにて蛍光ラベルしたRNAを合成し、cDNAを固定したDNAチップ(マイクロアレイ)を用いてその蛍光強度を比較する。このDNAチップはわれわれのグループが開発したものであり、ストレス時に変動しうる遺伝子群の一括定量を実現している。本研究において、統合失調症約20例、気分障害約40例、不安障害約30例からサンプルを得て、その半数以上からは治療後のサンプルも得ることができた。気分障害においては遺伝子発現実験およびクラスター解析を終了し、特徴的な発現パターンの反転が見られた。統合失調症と不安障害については、遺伝子発現実験を終了し、現在クラスター解析に着手している。末梢血白血球におけるmRNA発現解析が新たな生物学的指標として縦断的経過観察や治療反応予測にも有望であるという所見を得ている。

    researchmap

  • 新たな痴呆関連遺伝子CHACの分子生物学的研究

    2001年 - 2002年

    文部科学省  科学研究費補助金(基盤研究(B))  基盤研究(B)

    上野 修一, 中村 雅之

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:5200000円 ( 直接経費:5200000円 )

    有棘赤血球舞踏病(chorea-acanthocytosis、CHAC)は、日本人に多い遺伝性神経変性疾患で、成人期になり、ハンチントン病類似の不随意運動やてんかん、痴呆、統合失調症様の精神症状などの中枢神経症状に加え、末梢神経症状、末梢血液像での有棘赤血球症を示す。私のグループでは、3家系、4症例の日本人家系解析から9番染色体長腕9q21領域に遺伝子座位を絞り込み、CHAC遺伝子を発見した。CHAC遺伝子は、初めて高等動物で示されたタイプの細胞構成たんぱく質であり、240kbpの大きさを持つ70個以上のエクソンから構成される遺伝子で、ほとんどすべての組織で発現されていた。経験したCHAC患者ではホモ接合性に遺伝子DNAの60番と61番エクソンを含む5,937bpが欠失するため発症すると考えられた。CHACは常染色体劣性遺伝と思われているが、欠失変異対立遺伝子を1つ持つヘテロ接合体(保因者)である患者の親で感情の不安定性や認知の障害があること、また、前頭側頭型痴呆を伴う筋萎縮性側索硬化症家系がCHAC遺伝子座位の近傍に連鎖していることが報告されていることから、CHAC遺伝子変異が痴呆など精神障害を起こす可能性を考え、解析を行った。統合失調症、気分障害、アルツハイマー病、前頭側頭型痴呆、特発性てんかんなどの患者群および健康対照群を対象とし、エクソン60、61の欠失変異および新規確認したGAT三塩基繰り返し型多型を用いて検討した。その結果、統合失調症、アルツハイマー病、前頭側頭葉痴呆、特発性てんかん患者では全く見られなかった欠失変異が、気分障害患者では2名ヘテロ接合性に確認された。しかしながら、遺伝子解析の結果、上記精神障害とCHAC遺伝子の間に統計学的に有意な所見は得られなかった。

    researchmap

  • ドーパミントランスポーター遺伝子機能の分子薬理遺伝的総合的検討

    2001年 - 2002年

    文部科学省  科学研究費補助金(基盤研究(C))  基盤研究(C)

    上野 修一

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3600000円 ( 直接経費:3600000円 )

    ドーパミントランスポーター(dopamine transporter, DAT)は、ドーパミン神経細胞で特異的に発現し、ドーパミン再取り込み機能を持つ蛋白質である。シナプス間隙のドーパミンは、シナプスに放出された後にDATによってシナプス前細胞に再取り込みされ、伝達を終える。DATはドーパミン神経終末でのドーパミン量を調節していると考えられており、ドーパミン系の神経伝達に大きな影響を持つ。これまで、機能画像研究からアルコール常用によって線条体のDATが有意に減少すること、また、DATを欠損したマウスではアルコール症などの薬物依存を起こしやすいことが報告されていることから、私は、DAT遺伝子の新規SNP多型(2319G/A)とVNTR(variable number of tandem repeats)多型を用い、DAT遺伝子の2319番目の塩基がアデニンでありVNTR多型10回繰返しのハプロタイプ遺伝子型がアルコール症患者において有意に多いことを確認した(Mol. Psychiatry 4:552-557,1999)。今回、DAT遺伝子の5'上流領域の遺伝子発現調節に関わると思われる領域の多型を、直接配列決定法、SSCP(single strand conformation polymorphism)法を用いて解析し、新規のSNP多型(-1173C/G多型、-843C/T多型)があることを確認した。-1173C/G多型は、zinc finger typeの転写因子結合部位の可能性がある部位の多型であり、また一方、-843C/T多型はalcohol dehydrogenase遺伝子の調節領域と相同性が高い部位である。そのため、これらの多型を用いて、アルコール症182名の患者群と健常対照者群106名の相関研究を行った。その結果、これらDAT遺伝子の新規SNP多型とアルコール症との間には有意な相関は導き出せなかった。今後、レポーター遺伝子活性の変化に基づいた機能性多型に絞って解析する必要性を考えている。

    researchmap

  • 新たな神経細胞死カスケードの解明-有棘赤血球舞踏病遺伝子の分子生物学的研究-

    2001年

    日本学術振興会  科学研究費助成事業  特定領域研究(C)

    佐野 輝, 中村 雅之, 上野 修一

      詳細を見る

    配分額:3200000円 ( 直接経費:3200000円 )

    有棘赤血球舞踏病(chorea-acanthocytosis)は、神経精神症状に加え有棘赤血球症を示す遺伝性神経変性疾患である。遺伝形式は常染色体劣性で、その遺伝子座位は染色体9q21への連鎖が確認されていた。今回我々は、3家系4患者を経験し、遺伝子連鎖解析で遺伝子候補領域を狭め、病因遺伝子をポジショナルクローニング法で同定した。発見した病因遺伝子CHACは新規遺伝子で、コードされる遺伝子産物をchoreinと命名した。Choreinは、3,095個のアミノ酸からなり、24%の親水基を持つアミノ酸から成るpI5.58の蛋白質と予想された。CHAC遺伝子のノーザンブロツトでは、約10kbpの主要なバンドは、神経系のみならず、筋肉、心筋、腎臓など多臓器で発現していた。ヒトゲノム計画で報告された配列NT_008343と合わせて解析すると、CHAC遺伝子は、69個のエクソンから構成されていた。患者は、cDNAでは260bp・遺伝子DNAでは60番と61番のエクソンを含む5,937bpが欠失している変異対立遺伝子をホモ接合性に持ち、この欠失によりフレームシフトを引き起こし、C末端の271残基が形成されず、truncated form(切断型)となることが予想された。100名の日本人、74名のヨーロツパ系の健常対照者では同様の欠失のある対立遺伝子を認めなかったため、この欠失は疾患特異的と思われた。Choreinは、これまで報告されているDrosophila melanogasterのCG2093やCaenorhabditis elegansのT08G11.1、Saccharomyces cerevisiaeのVPS13、Schizosaccharomyces pombe等の構造蛋白質と相同性が高かったが、高等動物ではいまだ確認されていない新規のカテゴリーに属すると考えられた。

    researchmap

  • The study for genetics of mental disorder

    2000年 - 2002年

    SCF Interministerial Basic Research 

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 精神障害の病因に関する研究

    2000年 - 2002年

    科学技術振興調整費による省際基礎研究 

      詳細を見る

    資金種別:競争的資金

    researchmap

  • プロサポシンの神経栄養因子作用

    1999年

    日本学術振興会  科学研究費助成事業  特定領域研究(A)

    佐野 輝, 上野 修一

      詳細を見る

    配分額:1300000円 ( 直接経費:1300000円 )

    サポシンA,B,C,Dは、リソゾーム水解酵素を活性化する分子量約1万の糖蛋白質で、プロサポシンはこれら4種のサポシンをドメインとして持つ前駆体蛋白質である。脳神経系では、そのほとんどがプロセスされないプロサポシンの形で存在し、ある種の神経核その神経路の神経細胞に限局して分布している。最近我々は、プロサポシンがin vivoにおいて虚血性神経細胞死を抑制すること、坐骨神経切断後の神経再生を促進すること、培養海馬神経細胞の突起進展を促進し、その細胞死を抑制することを明らかにし、さらにこの神経栄養因子活性がプロサポシンのサポシンCドメインのアミノ末端側に限局することを実証してきた。
    今回我々は、神経栄養因子プロサポシンが含有される神経細胞の詳細を明らかにするため、免疫組織化学的手法を用いてラット内側中隔核・対角帯核-海馬系を中心に検討を行った。光顕レベルでは、内側中隔核・対角帯核にはプロサポシン陽性神経細胞体、海馬CA1領域にはプロサポシン陽性の神経終末と思われる像を得た。海馬にフルオロゴールド注入後、内側中隔核・対角帯核を含む切片にプロサポシン免疫組織化学染色を施した結果、二重染色細胞を認めた。これらの結果から、内側中隔核・対角帯核のプロサボシン陽性神経細胞が、海馬に投射していることが考えられた。内側中隔核・対角帯核を含む切片に、抗コリンアセチルトランスフェラーゼ(CAT)で免疫染色を行った後、プロサポシン免疫組織化学染色を施した結果、両染色はほぼ一致したパターンで二重染色細胞を認めた。すなわち、内側中隔核・対角帯核から海馬に投射しているプロサポシン陽性神経細胞はコリン作動性神経細胞であることが考えられた。内側中隔核・対角帯核領域の免疫電顕的観察では、神経細胞体内のリソゾーム様構造物及びそれ以外にゴルジ関連構造物に陽性反応を認めた。

    researchmap

  • プロサポシンの神経栄養因子作用

    1998年

    日本学術振興会  科学研究費助成事業  特定領域研究(A)

    佐野 輝, 上野 修一

      詳細を見る

    配分額:1600000円 ( 直接経費:1600000円 )

    ニューロンの生存と分化には種々の因子が関与することが明らかにされているが、ニューロンに豊富に存在する糖脂質も重要な因子の一つと考えられている。糖脂質の代謝に関わる種々の水解酵素の活性制御には活性化蛋白質が関与しているが、β-グルコシダーゼ活性化蛋白質(Saposin C)は我々が世界に先駆けて単離しその構造を明らかにした。以後我々は、Saposin Cおよびその前駆体蛋白質であるprosaposinに関する研究を継続的に行ってきた。Prosaposinは、4種の活性化蛋白質saposinsをドメインとして持つ高分子蛋白質であり、精巣における精子形成の分化過程に働く、セルトリ細胞から分泌される分化因子候補の硫酸化糖蛋白質1と同一蛋白質であったところから、prosaposinの神経栄養因子としての可能性を考え、prosaposinが海馬神経細胞保護作用や末梢神経再生作用を有することを実証してきた。最近、パーキンソン病モデルラットの脳に精巣由来のセルトリ細胞を移植することで、著明な改善を生じることが報告された(Sanberg et al.(1997)Nature Med 3,1129)。この事実は、セルトリ細胞から分泌される何らかの栄養因子がドーパミン細胞に非常に強い効果を有していることを示しているが、prosaposinはセルトリ細胞から細胞外に分泌される主要な蛋白質の一つであり、prosaposinあるいはその部分ペプチドがパーキンソン病への治療応用をも考慮されるべき可能性を示している。今回我々は、胎生15日齢胎児ラット腹側中脳細胞培養系を用いて、ドーパミン神経細胞に対するprosaposin神経活性ペプチド(prosaposinアミノ末端神経栄養因子活性部位親水性領域18-merペプチド;LSELIINNATEELLIKGL)の神経栄養因子活性効果を検討した。Tyrosine hydroxylase(TH)-陽性生存細胞数およびTyrosinehydroxylase(TH)-陽性細胞における神経突起伸展は、ペプチド濃度依存性に増加した。これらの効果は、先に我々が報告した胎生17日齢胎児ラット海馬神経細胞の対する効果と同濃度で同程度であった。これらの結果は、prosaposin神経活性ペプチドがドーパミン作動性ニューロンに対して、優れた神経栄養因子活性を持つことを意味し、パーキンソン病をはじめとしたドーパミンニューロン変性疾患に対してprosaposin神経活性ペプチドが治療的応用されうる可能性を示唆している。

    researchmap

  • 神経栄養因子プロサポシンの分子的作用機序

    1997年 - 1998年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    佐野 輝, 上野 修一

      詳細を見る

    配分額:2400000円 ( 直接経費:2400000円 )

    ニューロンの生存と分化には種々の因子が関与することが明らかにされているが、ニューロンに豊富に存在する糖脂質も重要な因子の一つと考えられている。糖脂質の代謝に関わる種々の水解酵素の活性制御には活性化蛋白質が関与しているが、β-グルコシダーゼ活性化蛋白質(Saposin C)は我々が世界に先駆けて単離しその構造を明らかにした。以後我々は、Saposin Cおよびその前駆体蛋白質であるprosaposinに関する研究を継続的に行ってきた。Prosaposinは、4種の活性化蛋白質saposinsをドメインとして持つ高分子蛋白質であり、精巣における精子形成の分化過程に働く、セルトリ細胞から分泌される分化因子候補の硫酸化糖蛋白質1と同一蛋白質であった。その後、prosaposinの神経栄養因子としての可能性を考え、prosaposinが海馬神経細胞保護作用や末梢神経再生作用を有することを実証してきた。最近、パーキンソン病モデルラットの脳に精巣由来のセルトリ細胞を移植することで、著明な改善を生じることが報告された(Sanberg et al.(1997) Nature Med3,1129)。この事実は、セルトリ細胞から分泌される何らかの栄養因子がドーパミン細胞に非常に強い効果を有することを示しているが、prosaposinはセルトリ細胞から細胞外に分泌される主要な蛋白質の一つであり、prosaposinあるいはその部分ペプチドがパーキンソン病への治療応用をも考慮されるべき可能性を示している。今回我々は、胎生15日齢胎児ラット腹側中脳細胞培養系を用いて、ドーパミン神経細胞に対するprosaposin神経活性ペプチド(アミノ末端神経栄養因子活性部位親水性領域18-merペプチド;LSELINNATEELLIKGL)の神経栄養因子活性効果を検討した。Tyrosine hydroxylase(TH)-陽性生存細胞数およびTH-陽性細胞における神経突起伸展は、ペプチド濃度依存性に増加した。この効果は、胎生17日齢胎児ラット海馬神経細胞の対する効果と同濃度で同程度であった。これらの結果は、prosaposin がドーパミン作動性ニューロンに対して、優れた神経栄養因子活性を持つことを意味し、パーキンソン病をはじめとするドーパミンニューロン変性疾患に対してprosaposin神経活性ペプチドが治療的応用の可能性を示唆している。

    researchmap

  • 感情障害発症機序の分子生物学的解明-21番染色体長腕との関連

    1997年 - 1998年

    文部科学省  科学研究費補助金(奨励研究(A))  奨励研究(A)

    上野 修一

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1700000円 ( 直接経費:1700000円 )

    精神障害のなかで、感情障害(気分障害)は精神分裂病と並んで頻度の高い疾患群であるが、遺伝的要因が大きいとされる。感情障害に関連する遺伝子変異の解明により、病因に基づいた新たな治療法の開発が可能となる。最近、感情障害と21番染色体長腕(21q22.3)に存在するPFKLやD21S171などのマーカーとの連鎖が報告され、この領域に疾患関連遺伝子があると予想される。今回私は、感情障害と21q22.3座位の関連を明らかにすべく、PFKL座位からわずか数100kb以内に存在する4つの遺伝子、hDW(hurman drosophila white、トリプトファン輸送にかかわると予想される蛋白質)、TMEM1(transmembrane protein 1、Na^+チャンネル類似の膜貫通型たんぱく質)、PWP2(Periodic Tryptophan(W)Proteln 2、Gたんぱく質βサブユニット類似たんぱく質)、GT335(神経系で発現している未知の遺伝子)を候補遺伝子と考え、これらの遺伝子中の多型を確認し、感情障害(うつ病性障害、双極性障害)を中心に分裂感情障害、パニック障害、強迫性障害患者群を精神的健常対照群と比較してその関連を検討した。それぞれ文書によるインフォームドコンセントを得た後に採血し、白血球から遺伝子DNAを抽出し、遺伝子特異的PCRを行って、多型について制限酵素で切断(PCR-RFLP)、もしくは、SSCP(single sequence conformation polymorphism)を行い解析した。精神障害の病型分類は、DSM-IVに基づき行った。その結果、感情障害とhDWとの間には症例が少ないながらも関連が予想されたが、その他の3つの遺伝子では関連は確認することはできなかった。今後、症例数を増やしてさらに検討する予定である。

    researchmap

  • プロサポシンの神経栄養因子作用

    1997年

    日本学術振興会  科学研究費助成事業  重点領域研究

    佐野 輝, 上野 修一

      詳細を見る

    配分額:1500000円 ( 直接経費:1500000円 )

    我々は世界に先駆けてβ-グルコシダーゼ活性化蛋白質(Saposin C)を単離し、その機能の追及中に前駆体prosaposinの存在を発見した。Prosaposinは脳脊髄液等の細胞外分泌液に豊富に存在し、血小板で機能的に分泌される。免疫組織学的には、prosaposinは脳神経系の中でも神経細胞に特異的でコリン作動性神経細胞とその投射部位の神経腺維に豊富に存在する。最近我々は、スナネズミ前脳虚血モデルで海馬遅発性神経細胞死に対しprosaposinが著明な保護効果を持つことを見い出し(Sano et al.(1994)Biochem.Biophys.Res.Comm.204,994-1000)、続いてモルモット坐骨神経切除モデルでprosaposinの抹消神経再生促進効果を明らかにした(Kotani et al.(1996)J.Neurochem.66,2019-2025)。更にprosaposin分子中のsaposinCドメインの親水領域に神経栄養因子活性中心が存在することを実証した(Kotani et al.(1996)J.Neurochem.66,2197-2200)。今回我々はprosaposinが種々の哺乳動物のミルク中に含まれ、その存在洋式としては乳清(Whey)中に顆粒画分に結合することなく可溶化された状態でモノマーとして存在し、熱変性沈殿化に耐性であることを見い出した(Patton et al.(1997)J.Dairy Sci.80,264-272)。これらの事実は、他の神経栄養因子群が母乳中に高濃度含有される事実と合わせ考えると、母乳中のprosaposinが乳児期の神経系に寄与している可能性を示唆するものである。

    researchmap

  • 神経変性疾患における精神症状発症機序の分子生物学的解明(歯状核赤核淡蒼球ルイ体萎縮症の遺伝子異常と遺伝子発現について)

    1996年

    文部科学省  科学研究費補助金(奨励研究(A))  奨励研究(A)

    上野 修一

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1100000円 ( 直接経費:1100000円 )

    歯状核赤核淡蒼球ルイ体萎縮症(DRPLA)は、日本人に多い常染色体優性遺伝性神経変性疾患であり、12番染色体短腕にあるDRPLA遺伝子のCAG繰り返し配列が異常伸張することによって生じる。この遺伝子変異と臨床症状との関連性については確認されたが、選択的神経細胞死が起こる分子的機構については未だ不明である。今回の私の研究では、本疾患の選択的細胞死に遺伝子転写系が関与していないかどうかを調べる目的で、DRPLA患者7名及び対照患者10名の剖検組織を用いてDRPLA遺伝子mRNAの発現を解析した。インフォームドコンセントを得た死亡患者の剖検組織からRNAを精製し逆転写酵素でDNAを作成したのちに、DRPLA遺伝子mRNA量をβ-アクチンの発現量を指標として調べた。その結果、1)ゲノムDNAのCAG繰り返し回数は細胞間、組織間で異なっており、脳では特にその繰り返し回数が多いことがわかっているが、その繰り返し回数は、ゲノムDNAとmRNAではほとんど同じでありよく保存されていた。2)DRPLAmRNAは諸組織で広く発現しており、CAG異常伸張対立遺伝子と正常対立遺伝子の発現量に差はなかった。3)DRPLAおよび対照患者脳では、共にDRPLAmRNAの発現量は他の組織に比べて高かった。4)DRPLA及び正常対照患者患者間のDRPLAmRNAの発現量の差を調べるために、4つの脳部位を用いてその発現量を比較したが、有意差を認めなかった。以上のことから、DRPLA遺伝子のCAG繰り返し配列の異常伸張はDNAからRNAにいたる転写段階では病的意義を与えず、DRPLAにおける選択的細胞死は、遺伝子転写以後の過程で起こるものと推定された。

    researchmap

  • プロサポシンの神経栄養因子作用

    1996年

    日本学術振興会  科学研究費助成事業  重点領域研究

    佐野 輝, 上野 修一

      詳細を見る

    配分額:1800000円 ( 直接経費:1800000円 )

    最近我々は、スナネズミの前脳虚血モデルを用いて海馬CA1錐体細胞の神経細胞死に対しプロサポシンが著名な神経細胞保護効果を持つことを見い出した。今回我々は、プロサポシンの神経栄養因子作用の効果対象となる神経細胞の同定を進め、次にプロサポシンの神経栄養因子活性の分子作用機構の解明するためプロサポシンの部分配列を持つペプチドを作成し、培養系やin vivoにおける神経栄養因子活性を検討した。モルモット坐骨神経切除後の再生に対するプロサポシンの効果を検討したところ、プロサポシンの強力な末梢神経再生促進作用をを見い出した。すなわち、プロサポシンは濃度依存性に再生神経の線維数、断面積を増大させ、至適有効濃度(20ng/ml)はこれまで報告された成長因子群より低濃度であった。さらに、プロサポシンの末梢神経再生促進作用のターゲットとなる神経細胞を明らかにするため、坐骨神経切除モルモットの脊髄及び後根神経節のニューロンに対する効果を検討した。プロサポシンは、脊髄前角の大型運動ニューロン及び後根神経節の小型知覚ニューロンにおける軸策離断後のニッスル小体の変性(クロマトリシス)および神経細胞萎縮を防止した。続いて、プロサポシン分子中のいづれの部位に生理活性が含まれるかを検討するため、プロサポシン分子中のサポシンA-Dの4種のドメインフラグメントおよびサポシンCドメイン中の親水性領域を構成する18merペプチドについて、ラット胎児海馬神経細胞の初代培養を用いて生存延長効果と神経突起伸展促進作用を検討した。その結果、プロサポシン分子の生理活性はサポシンCドメイン中の親水性領域に含まれることが明らかとなった。スナネズミ虚血モデルを用いてこの18merペプチドの海馬錐体細胞保護作用を検討した結果、ペプチドはin vivoにおいても活性を保持していた。

    researchmap

  • プロサポシンの神経栄養因子作用

    1995年

    日本学術振興会  科学研究費助成事業  重点領域研究

    佐野 輝, 上野 修一

      詳細を見る

    配分額:1800000円 ( 直接経費:1800000円 )

    プロサポシンは神経系に豊富に存在し、神経栄養因子としての機能が徐々に明らかとなりつつある。今回我々は、モルモット坐骨神経切除後の再生に対するプロサポシンの効果を検討したところ、プロサポシンが強力な末梢神経再生促進作用を持つことを見い出した。すなわち、プロサポシンは濃度依存性に再生神経の線維数、断面積を増大させた。至適有効濃度(20ng/ml)はこれまで報告された成長因子群より低濃度であった。さらに、プロサポシンの末梢神経再生促進作用のターゲットとなる神経細胞を明らかにするため、坐骨神経切除モルモットの脊髄及び後根神経節のニューロン群に対するプロサポシンの効果を検討した。プロサポシンは、脊髄前角の大型運動ニューロン及び後根神経節の小型知覚ニューロンにおける軸索離断後のニッスル小体の変性(クロマトリシス)および神経細胞萎縮を防止していた。(Kotani et al.J.Neurochem.^ain press)続いて、プロサポシン分子中のいづれの部位に生理活性が含まれるかを検討するため、プロサポシン分子中のサポシンA-Dの4種のドメインフラグメントおよびサポシンCドメイン中の親水性領域を構成する18merペプチドについて、ラット胎児海馬神経細胞の初代培養を用いて生存延長効果と神経突起伸展促進作用を検討した。その結果、プロサポシン分子の生理活性はサポシンCドメイン中の親水性領域に含まれることが明らかとなった。スナネズミ虚血モデルを用いてこの18merペプチドの海馬錐体細胞保護作用を検討した結果、ペプチドはin vivoにおいても活性を保持していた(Kotani et al.J.Neurochem.^bin press)。

    researchmap

  • 精神障害の病因に関する研究

      詳細を見る

    資金種別:競争的資金

    researchmap

  • the study for genetics of mental disorder

      詳細を見る

    資金種別:競争的資金

    researchmap

▼全件表示